"study_id","study_class","treatment_focus_study_level","treatment_focus_arm_level","treatment_focus_subclass_arm_level","total_n_randomized","intervention_group","arm_n_randomized","arm_n_randomized_qual","treatment_name","ncptsd_treatment_name","treatment_desc","psychotherapy","psychotherapy_subclass","pharmacotherapy","pharmacotherapy_subclass","cih","cih_subclass","nonpharm_biologic","nonpharm_cognitive_therapy","control","other","collaborative_care","format","delivery_method","dose","session_length","frequency","treatment_duration_weeks","treatment_duration_qual","def_treatment_completion","percent_completed","completed_psychotherapy_percent_detail","def_treatment_adherence","percent_adhered","adhered_pharmacotherapy_percent_detail","psychotherapy_sessions_mean","psychotherapy_sessions_sd","psychotherapy_sessions_qual","dose_at_study_end_point_mean","dose_at_study_end_point_sd","dose_at_study_end_point_qual","military_status","percent_active_duty_military","percent_veteran","percent_community","female_percent","female_percent_qual","male_percent","trauma_type","trauma_detail","risk_of_bias_rating_study_level","citation","ptsdpubs_id","year_added_to_ptsd_repository"
"acarturk2016_A","Psychotherapy","PTSD","PTSD",,"98","A","49",,"EMDR Recent Traumatic Episode Protocol","Eye Movement Desensitization and Reprocessing (EMDR)","Patient asked to make eye movements or exposed to bilateral tones or tapping while recalling traumatic events, with focus on most recent traumatic events with an extended time perspective.","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,,,,"8 phases","completed full EMDR therapy","0.7551",,,,,"4.2","1.3",,,,,"Community",,,"1","0.7449",,"0.2551","Terrorism/political violence/forced displacement",,"Medium","Acarturk C, Konuk E, Cetinkaya M, et al. The efficacy of eye movement desensitization and reprocessing for post-traumatic stress disorder and depression among Syrian refugees: results of a randomized controlled trial. Psychol Med. 2016 Sep;46(12):2583-93. doi: 10.1017/S0033291716001070. PMID: 27353367.","45262","2019"
"acarturk2016_B","Psychotherapy","PTSD","Control",,"98","B","49",,"Waitlist","Waitlist","Patients not allowed to receive any treatment through 5-week followup period","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,,,,"5",,,,,,,,,,,,,,"Community",,,"1","0.7449",,"0.2551","Terrorism/political violence/forced displacement",,"Medium","Acarturk C, Konuk E, Cetinkaya M, et al. The efficacy of eye movement desensitization and reprocessing for post-traumatic stress disorder and depression among Syrian refugees: results of a randomized controlled trial. Psychol Med. 2016 Sep;46(12):2583-93. doi: 10.1017/S0033291716001070. PMID: 27353367.","45262","2019"
"acierno2017_A","Psychotherapy","PTSD","PTSD",,"150","A","76",,"PE delivered in-person","Prolonged Exposure (PE)","Trauma-focused CBT according to the manual by Foa, Hembree, & Rothbaum, 2007","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"1.5 hours",,,"10 to 12 sessions total","completed ≥6 treatment sessions","0.7237",,,,,"8.6","3.2",,,,,"Veteran",,"1",,"0.0379",,"0.9621","Combat-related",,"Medium","Acierno RE, Knapp RG, Tuerk PW, et al. A non-inferiority trial of prolonged exposure for posttraumatic stress disorder: in person versus home-based telehealth. Behav Res Ther. 2017;89:57-65. doi: 10.1016/j.brat.2016.11.009. PMID: 27894058.","45948","2019"
"acierno2017_B","Psychotherapy","PTSD","PTSD",,"150","B","74",,"PE delivered via home-based telehealth","Prolonged Exposure (PE)","Trauma-focused CBT according to the manual by Foa, Hembree, & Rothbaum, 2007","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","Video",,"1.5 hours",,,"10 to12 sessions total","completed ≥6 treatment sessions","0.5811",,,,,"7.6","3.6",,,,,"Veteran",,"1",,"0.0379",,"0.9621","Combat-related",,"Medium","Acierno RE, Knapp RG, Tuerk PW, et al. A non-inferiority trial of prolonged exposure for posttraumatic stress disorder: in person versus home-based telehealth. Behav Res Ther. 2017;89:57-65. doi: 10.1016/j.brat.2016.11.009. PMID: 27894058.","45948","2019"
"adenauer2011_A","Psychotherapy","PTSD","PTSD",,"34","A","16",,"NET","Narrative Exposure Therapy (NET)","Trauma-focused CBT with patients constructing a detailed chronological account of his/her biography, with particular attention on traumatic experiences. Therapy aims to reorganize fragmented report of traumatic experiences into a coherent narrative with details about current and past emotional, physiological, cognitive, and behavioral reactions.","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"NR (session continues until trauma-related fear reaction shows a significant diminution; mean session length was 108 [SD 17.0] minutes)","Weekly or biweekly",,"2 sessions total","did not drop out of treatment","0.9375",,,,,,,,,,,"Community",,,"1","0.4412",,"0.5588","Terrorism/political violence/forced displacement",,"High","Adenauer H, Catani C, Gola H, et al. Narrative exposure therapy for PTSD increases top-down processing of aversive stimuli -- evidence from a randomized controlled treatment trial. BMC Neurosci. 2011 Dec 19;12:127. doi: 10.1186/1471-2202-12-127. PMID: 22182346.","37889","2019"
"adenauer2011_B","Psychotherapy","PTSD","Control",,"34","B","18",,"Waitlist","Waitlist",,"No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.4412",,"0.5588","Terrorism/political violence/forced displacement",,"High","Adenauer H, Catani C, Gola H, et al. Narrative exposure therapy for PTSD increases top-down processing of aversive stimuli -- evidence from a randomized controlled treatment trial. BMC Neurosci. 2011 Dec 19;12:127. doi: 10.1186/1471-2202-12-127. PMID: 22182346.","37889","2019"
"ahmadi2015_A","Mixed: Psychotherapy & CIH","PTSD","PTSD",,"48","A","16",,"EMDR","Eye Movement Desensitization and Reprocessing (EMDR)","Sequences of large-magnitude, rhythmic saccadic eye movements while holding in mind the most salient aspect of a traumatic memory. (As described in: Shapiro F. Eye movement desensitization: a new treatment for post-traumatic stress disorder. J Behav Ther Exp Psychiatry. 1989 Sep;20(3):211-7. PubMed PMID: 2576656.)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,,,,,,,,,,,,,,,,,"Active Duty Military","1","0","0","0",,"1","Combat-related",,"High","Ahmadi K, Hazrati M, Ahmadizadeh MJ, et al. REM desensitization as a new therapeutic method for post-traumatic stress disorder: a randomized controlled trial. Acta Med Indones. 2015 Apr;47(2):111-9.  PMID: 26260553.","46896","2019"
"ahmadi2015_B","Mixed: Psychotherapy & CIH","PTSD","PTSD",,"48","B","16",,"REM Desensitization","Rapid Eye Movement (REM) Desentization","Patients wore glasses during sleep that possess sensors with the ability to detect infrared waves that during the rapid eye movements (REM) period and which activates a musical instrument which delivers a light music","No","Not Applicable","No","Not Applicable","No","Not Applicable","Yes","No","No","No","No","Individual","In Person",,,,,,,,,,,,,,,,,,"Active Duty Military","1","0","0","0",,"1","Combat-related",,"High","Ahmadi K, Hazrati M, Ahmadizadeh MJ, et al. REM desensitization as a new therapeutic method for post-traumatic stress disorder: a randomized controlled trial. Acta Med Indones. 2015 Apr;47(2):111-9.  PMID: 26260553.","46896","2019"
"ahmadi2015_C","Mixed: Psychotherapy & CIH","PTSD","Control",,"48","C","16",,"Control","Waitlist",,"No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,,,,,,,,,,,,,,,,,,"Active Duty Military","1","0","0","0",,"1","Combat-related",,"High","Ahmadi K, Hazrati M, Ahmadizadeh MJ, et al. REM desensitization as a new therapeutic method for post-traumatic stress disorder: a randomized controlled trial. Acta Med Indones. 2015 Apr;47(2):111-9.  PMID: 26260553.","46896","2019"
"ahmadizadeh2019_A","Nonpharmacologic biological","PTSD","PTSD",,"40","A","20",,"Transcranial direct current stimulation (tDCS)","Transcranial direct current stimulation (tDCS)","Ten tDCS sessions delivered to the right (cathode) and left (anode) dorsolateral prefrontal cortex, with brain areas localized using EEG, over 10 consecutive weekdays","No","Not Applicable","No","Not Applicable","No","Not Applicable","Yes","No","No","No","No","Individual","In Person",,"20 minute treatment with 2mA delivered to scalp electrodes","5 days per week","2",,,,,,,,,,,,,,"Community",,,"1","0.65",,"0.35",,,"Medium","Ahmadizadeh MJ, Rezaei M, Fitzgerald PB. Transcranial direct current stimulation (tDCS) for post-traumatic stress disorder (PTSD): a randomized, double-blinded, controlled trial. Brain research bulletin. 2019;153:273-8. PMID: 31560945.","1545324","2020"
"ahmadizadeh2019_B","Nonpharmacologic biological","PTSD","Control",,"40","B","20",,"Sham transcranial direct current stimulation","Sham","Ten sham treatment sessions, with scalp electrodes applied to the dorsolateral prefrontal cortex, over 10 consecutive weekdays.  Current ramped up for 30s and then ramped down.","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person",,"20 minute sham treatment","5 days per week","2",,,,,,,,,,,,,,"Community",,,"1","0.65",,"0.35",,,"Medium","Ahmadizadeh MJ, Rezaei M, Fitzgerald PB. Transcranial direct current stimulation (tDCS) for post-traumatic stress disorder (PTSD): a randomized, double-blinded, controlled trial. Brain research bulletin. 2019;153:273-8. PMID: 31560945.","1545324","2020"
"ahmadizadeh2018_A","Nonpharmacologic biological","PTSD","PTSD",,"65","A","22",,"Bilateral rTMS","Transcranial magnetic stimualtion (TMS)","Stimulation applied to bilateral dorsolateral prefrontal cortex","No","Not Applicable","No","Not Applicable","No","Not Applicable","Yes","No","No","No","No","Individual","In Person",,"20 Hz for 2 seconds with inter-train interval of 28 seconds. Total train of 30, 1200 pulse per 15-minute session","Three times a week for first 2 weeks, then 2 times a week for 2 weeks","4",,"10 sessions of treatment","0.7273",,,,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"Medium","Ahmadizadeh MJ, Rezaei M. Unilateral right and bilateral dorsolateral prefrontal cortex transcranial magnetic stimulation in treatment post-traumatic stress disorder: a randomized controlled study. Brain Res Bull. 2018;140:334-40. doi: 10.1016/j.brainresbull.2018.06.001. PMID: 29883597.","50480","2019"
"ahmadizadeh2018_B","Nonpharmacologic biological","PTSD","PTSD",,"65","B","21",,"Unilateral rTMS","Transcranial magnetic stimualtion (TMS)","Stimulation applied to right dorsolateral prefrontal cortex","No","Not Applicable","No","Not Applicable","No","Not Applicable","Yes","No","No","No","No","Individual","In Person",,"20 Hz for 2 seconds with inter-train interval of 28 seconds. Total train of 60, 2400 pulse per 30-minute session","Three times a week for first 2 weeks, then 2 times a week for 2 weeks","4",,"10 sessions of treatmnt","0.8095",,,,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"Medium","Ahmadizadeh MJ, Rezaei M. Unilateral right and bilateral dorsolateral prefrontal cortex transcranial magnetic stimulation in treatment post-traumatic stress disorder: a randomized controlled study. Brain Res Bull. 2018;140:334-40. doi: 10.1016/j.brainresbull.2018.06.001. PMID: 29883597.","50480","2019"
"ahmadizadeh2018_C","Nonpharmacologic biological","PTSD","Control",,"65","C","22",,"Sham rTMS","Sham","Participants received stimulation that induced a contraction of the abductor pollicis brevis muscle, then magnetic coil switched to a sham coil with identical looks and sounds but prevents magnetic energy from plastic shell","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person",,,"Three times a week for first 2 weeks, then 2 times a week for 2 weeks","4",,"10 sessions of sham treatment","0.7273",,,,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"Medium","Ahmadizadeh MJ, Rezaei M. Unilateral right and bilateral dorsolateral prefrontal cortex transcranial magnetic stimulation in treatment post-traumatic stress disorder: a randomized controlled study. Brain Res Bull. 2018;140:334-40. doi: 10.1016/j.brainresbull.2018.06.001. PMID: 29883597.","50480","2019"
"ahmadpanah2014_A","Pharmacotherapy","PTSD","PTSD",,"100","A","33",,"Prazosin","Prazosin","Alpha-1 receptor blocker; titrated over 10 days, then maintained at 15 mg for duration of study","No","Not Applicable","Yes","Antiadrenergic","No","Not Applicable","No","No","No","No","No","Individual","In Person","15 mg; titration: increased from 1 mg to 15 mg over first 10 days",,"Once Daily","8",,,,,,,,,,,,,,"Community",,,"1","0.28",,"0.72","Mixed","combat-related, accidents, natural or manmade disasters, other (not specified)","Medium","Ahmadpanah M, Sabzeiee P, Hosseini SM, et al. Comparing the effect of prazosin and hydroxyzine on sleep quality in patients suffering from posttraumatic stress disorder. Neuropsychobiology. 2014 2016-09-15;69(4):235-42. doi: http://dx.doi.org/10.1159/000362243. PMID: 24993832.","43996","2019"
"ahmadpanah2014_B","Pharmacotherapy","PTSD","PTSD",,"100","B","34",,"Hydroxyzine","Hydroxyzine","Histamine H-1 blocker; increased from 10 mg over first 10 days to 100 mg, maintained at 100 mg for duration of study","No","Not Applicable","Yes","Antianxiety: nonbenzodiazepine","No","Not Applicable","No","No","No","No","No","Individual","In Person","Initiated at 10 mg, increased to 100 mg",,"Daily","8",,,,,,,,,,,,,,"Community",,,"1","0.28",,"0.72","Mixed","combat-related, accidents, natural or manmade disasters, other (not specified)","Medium","Ahmadpanah M, Sabzeiee P, Hosseini SM, et al. Comparing the effect of prazosin and hydroxyzine on sleep quality in patients suffering from posttraumatic stress disorder. Neuropsychobiology. 2014 2016-09-15;69(4):235-42. doi: http://dx.doi.org/10.1159/000362243. PMID: 24993832.","43996","2019"
"ahmadpanah2014_C","Pharmacotherapy","PTSD","Control",,"100","C","33",,"Placebo","Placebo","Identical shape and color to prazosin and hydroxyzine","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person",,,"Daily","8",,,,,,,,,,,,,,"Community",,,"1","0.28",,"0.72","Mixed","combat-related, accidents, natural or manmade disasters, other (not specified)","Medium","Ahmadpanah M, Sabzeiee P, Hosseini SM, et al. Comparing the effect of prazosin and hydroxyzine on sleep quality in patients suffering from posttraumatic stress disorder. Neuropsychobiology. 2014 2016-09-15;69(4):235-42. doi: http://dx.doi.org/10.1159/000362243. PMID: 24993832.","43996","2019"
"akbarian2015_A","Mixed: Psychotherapy & pharmacotherapy","PTSD","PTSD",,"40","A","20",,"CBT","Trauma-focused cognitive behavioral therapy (TF-CBT)","Group sessions of CBT for PTSD based on Clark and Beck's method; all patients also received ""SSRIs, neuroleptics, or benzodiazepines""","Yes","TF","Yes","Other pharmacotherapy","No","Not Applicable","No","No","No","No","No","Group","In Person",,"60 to 90 minutes","Weekly","10",,,,,,,,,,,,,,"Community",,,"1","0.7857",,"0.2143","Mixed","intimate partner violence, accidents, illness/medical procedure","Medium","Akbarian F, Bajoghli H, Haghighi M, et al. The effectiveness of cognitive behavioral therapy with respect to psychological symptoms and recovering autobiographical memory in patients suffering from post-traumatic stress disorder. Neuropsychiatr Dis Treat. 2015;11:395-404. doi: 10.2147/NDT.S79581. PMID: 25737635.","43629","2019"
"akbarian2015_B","Mixed: Psychotherapy & pharmacotherapy","PTSD","Control",,"40","B","20",,"Control condition (psychopharmacologic treatment only)","Medication as usual","All patients received ""SSRIs, neuroleptics, or benzodiazepines;"" control patients visited treatment center for medical and medication check","No","Not Applicable","Yes","Other pharmacotherapy","No","Not Applicable","No","No","No","No","No","Individual","In Person",,,"Weekly","10",,,,,,,,,,,,,,"Community",,,"1","0.7857",,"0.2143","Mixed","intimate partner violence, accidents, illness/medical procedure","Medium","Akbarian F, Bajoghli H, Haghighi M, et al. The effectiveness of cognitive behavioral therapy with respect to psychological symptoms and recovering autobiographical memory in patients suffering from post-traumatic stress disorder. Neuropsychiatr Dis Treat. 2015;11:395-404. doi: 10.2147/NDT.S79581. PMID: 25737635.","43629","2019"
"akuchekian2004_A","Pharmacotherapy","PTSD","PTSD",,"67","A","34",,"Topiramate augmentation","Topiramate augmentation","Anticonvulsant drug; augmentation of participant's existing pharmacotherapy (such as neuroleptics, TCAs, benzodiazepines, SSRIs, sodium valproate, or carbamazepine)","No","Not Applicable","Yes","Mood Stabilizer","No","Not Applicable","No","No","No","No","No","Individual","In Person","12.5 to 500 mg; titration: 12.5 or 25 mg initial dose, increased in increments of 25 to 50 mg every 3 to 4 days until clinical response up to maximum dose of 500 mg",,"Daily","12",,,,,,,,,,,,,,"Veteran",,"1","0","0",,"1","Combat-related",,"Medium","Akuchekian S, Amanat S. The Comparison of Topiramate and Placebo in the Treatment of Posttraumatic Stress Disorder: A Randomized, Double- Blind Study. J Res Med Sci. 2004;9(5):240-4.","50403","2019"
"akuchekian2004_B","Pharmacotherapy","PTSD","Control",,"67","B","33",,"Placebo augmentation","Placebo","Identical in appearance to topiramate 50 mg form; augmentation of participant's existing pharmacotherapy (such as neuroleptics, tricyclic antidepressants, benzodiazepines, SSRIs, sodium valproate, or carbamazepine).","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","Titration details NR (Topiramate group started at 12.5 or 25 mg with maximum dose of 500 mg)",,"Daily","12",,,,,,,,,,,,,,"Veteran",,"1","0","0",,"1","Combat-related",,"Medium","Akuchekian S, Amanat S. The Comparison of Topiramate and Placebo in the Treatment of Posttraumatic Stress Disorder: A Randomized, Double- Blind Study. J Res Med Sci. 2004;9(5):240-4.","50403","2019"
"aldahadha2012_A","Psychotherapy","PTSD","PTSD",,"51","A","25",,"EMDR","Eye Movement Desensitization and Reprocessing (EMDR)","Patient asked to focus on traumatic memory, then therapist queries for salient negative and positive cognitions related to the targeted memory while patients move his/her eyes to the therapist's index finger","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,,"Once every 3 weeks",,"2 to 3 sessions total",,,,,,,,,,,,,"Community",,,"1","0.5294",,"0.4706","Accidents",,"High","Aldahadha B, Al-Harthy H, Sulaiman S. The Efficacy of Eye Movement Desensitization Reprocessing in Resolving the Trauma Caused by the Road Accidents in the Sultanate of Oman. Journal of Instructional Psychology. 2012;39(3/4):146-58.","1548482","2019"
"aldahadha2012_B","Psychotherapy","PTSD","Control",,"51","B","26",,"Waitlist","Waitlist",,"No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.5294",,"0.4706","Accidents",,"High","Aldahadha B, Al-Harthy H, Sulaiman S. The Efficacy of Eye Movement Desensitization Reprocessing in Resolving the Trauma Caused by the Road Accidents in the Sultanate of Oman. Journal of Instructional Psychology. 2012;39(3/4):146-58.","1548482","2019"
"alghamdi2015_A","Psychotherapy","PTSD","PTSD",,"34","A","17",,"NET","Narrative Exposure Therapy (NET)","Patients narrate their biography and encouraged to relive their trauma-related emotions until habituation was achieved","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"60 to 90 minutes","Every 2-4 days","3",,,,,,,,,,,,,,"Community","0","0","1","0",,"1",,,"Medium","Alghamdi M, Hunt NC, Thomas SA. The effectiveness of narrative exposure therapy with traumatised firefighters in Saudi Arabia: a randomized controlled study. Behav Res Ther. 2015 Mar;66:64-71. doi: 10.1016/j.brat.2015.01.008. PMID: 25701801.","46524","2020"
"alghamdi2015_B","Psychotherapy","PTSD","Control",,"34","B","17",,"Waitlist","Waitlist",,"No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,,,,"3",,,,,,,,,,,,,,"Community","0","0","1","0",,"1",,,"Medium","Alghamdi M, Hunt NC, Thomas SA. The effectiveness of narrative exposure therapy with traumatised firefighters in Saudi Arabia: a randomized controlled study. Behav Res Ther. 2015 Mar;66:64-71. doi: 10.1016/j.brat.2015.01.008. PMID: 25701801.","46524","2020"
"ardani2017_A","Pharmacotherapy","PTSD","PTSD",,"36","A","12",,"Rivastigmine augmentation","Rivastigmine augmentation","Acetylcholinesterase inhibitor; augmentation of treatment with citalopram and valproate; randomized following 4-week run-in with citalopram and valproate; rivastigmine 3 mg (total daily dose) for 4 weeks then 6 mg (total daily dose) for 8 weeks.","No","Not Applicable","Yes","Other pharmacotherapy","No","Not Applicable","No","No","No","No","No","Individual","In Person","3 mg (total daily dose 6 mg); titration: 1.5 mg for 4 weeks (total daily dose 3 mg) then 3 mg for 8 weeks (total daily dose 6 mg)",,"Twice Daily","12",,,,,"used ""Standard compliance checklist""",,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"Medium","Ardani AR, Hosseini G, Bordbar MRF, et al. Effect of rivastigmine augmentation in treatment of male patients with combat-related chronic posttraumatic stress disorder: a randomized controlled trial. J Clin Psychopharmacol. 2017 Feb;37(1):54-60. doi: 10.1097/jcp.0000000000000624. PMID: 27930500.","47465","2019"
"ardani2017_B","Pharmacotherapy","PTSD","Control",,"36","B","12",,"Placebo augmentation","Placebo","Placebo identical to rivastigmine; after 4-week run-in with citalopram and valproate, randomized to placebo for 8 weeks in addition to treatment with citalopram and valproate.","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person",,,,"12",,,,,"used ""Standard compliance checklist""",,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"Medium","Ardani AR, Hosseini G, Bordbar MRF, et al. Effect of rivastigmine augmentation in treatment of male patients with combat-related chronic posttraumatic stress disorder: a randomized controlled trial. J Clin Psychopharmacol. 2017 Feb;37(1):54-60. doi: 10.1097/jcp.0000000000000624. PMID: 27930500.","47465","2019"
"ardani2017_C","Pharmacotherapy","PTSD","Control",,"36","C","12",,"TAU","Treatment as usual (TAU)","After 4-week run-in with citalopram and valproate, randomized to no additional medications for 8 weeks, and continued routine medications (citalopram and valproate as established in run-in).","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person",,,,"12",,,,,"used ""Standard compliance checklist""",,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"Medium","Ardani AR, Hosseini G, Bordbar MRF, et al. Effect of rivastigmine augmentation in treatment of male patients with combat-related chronic posttraumatic stress disorder: a randomized controlled trial. J Clin Psychopharmacol. 2017 Feb;37(1):54-60. doi: 10.1097/jcp.0000000000000624. PMID: 27930500.","47465","2019"
"arntz2007_A","Psychotherapy","PTSD","PTSD",,"67","A","28",,"Imaginal Exposure + Imagery Rescripting","Imaginal exposure plus imagery rescripting","Imaginal exposure portion based on program by Foa & Rothbaum (1989) with 60 minutes of imagery work each session; 3 sessions of imaginal exposure only, then 6 sessions focused on identifying and imagining reacting as they wished they had done, until a satisfying response could be used repetitively in imagery.","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"90 minutes","Weekly","10",,"completed ≥8 sessions","0.75",,,,,,,,,,,"Community",,,"1","0.6567",,"0.3433","Mixed","rape/sexual assault, accidents, community/school violence, other (witnessing trauma of others, unspecified childhood trauma)","High","Arntz A, Tiesema M, Kindt M. Treatment of PTSD: a comparison of imaginal exposure with and without imagery rescripting. Journal of Behavior Therapy and Experimental Psychiatry. 2007 2016-09-15;38(4):345-70. doi: http://dx.doi.org/10.1016/j.jbtep.2007.10.006. PMID: 18005935.","30284","2019"
"arntz2007_B","Psychotherapy","PTSD","PTSD",,"67","B","39",,"IE","Imaginal exposure","Based on the program by Foa & Rothbaum (1989) with 60 minutes of imagery exposure, but no in vivo exposure. Homework to listen to audiotaped exposure session 5 days per week and complete Standard Homework Diary Forms, which were reviewed at each therapy session.","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"90 minutes","Weekly","10",,"completed ≥8 sessions","0.4872",,,,,,,,,,,"Community",,,"1","0.6567",,"0.3433","Mixed","rape/sexual assault, accidents, community/school violence, other (witnessing trauma of others, unspecified childhood trauma)","High","Arntz A, Tiesema M, Kindt M. Treatment of PTSD: a comparison of imaginal exposure with and without imagery rescripting. Journal of Behavior Therapy and Experimental Psychiatry. 2007 2016-09-15;38(4):345-70. doi: http://dx.doi.org/10.1016/j.jbtep.2007.10.006. PMID: 18005935.","30284","2019"
"arntz2007_C","Psychotherapy","PTSD","Control",,"67","C","21",,"Waitlist","Waitlist","Waitlist group created when waiting time to treatment increased ""to about 3 months"" at which time participants were informed they would start treatment after waiting period.","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,,,,"10 to 15",,"completed treatment course","0.7619",,,,,,,,,,,"Community",,,"1","0.6567",,"0.3433","Mixed","rape/sexual assault, accidents, community/school violence, other (witnessing trauma of others, unspecified childhood trauma)","High","Arntz A, Tiesema M, Kindt M. Treatment of PTSD: a comparison of imaginal exposure with and without imagery rescripting. Journal of Behavior Therapy and Experimental Psychiatry. 2007 2016-09-15;38(4):345-70. doi: http://dx.doi.org/10.1016/j.jbtep.2007.10.006. PMID: 18005935.","30284","2019"
"asukai2010_A","Psychotherapy","PTSD","PTSD",,"24","A","12",,"PE + TAU","Prolonged Exposure (PE)","PE: manualized therapy consisting of psychoeducation, breathing retraining, in vivo exposure, imagery exposure, and processing; 2 introductory sessions and imagery exposure and processing during remaining sessions (6 to maximum of 13 sessions).

TAU: participants continued any treatment received before the study, including supportive counseling and medication; patients were asked to not change medication or dosages for duration of treatment.","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"90 minutes","Weekly","8 to 15",,,"0.75",,,,,,,,,,,"Community",,,"1","0.875",,"0.125","Mixed","rape/sexual assault, accidents, community/school violence","Medium","Asukai N, Saito A, Tsuruta N, et al. Efficacy of exposure therapy for Japanese patients with posttraumatic stress disorder due to mixed traumatic events: A randomized controlled study. J Trauma Stress. 2010 Dec;23(6):744-50. doi: 10.1002/jts.20589. PMID: 21171135.","84311","2019"
"asukai2010_B","Psychotherapy","PTSD","Control",,"24","B","12",,"TAU","Treatment as usual (TAU)","TAU while on waitlist; continuation of any treatment received before the study, including supportive counseling and medication; patients were asked to not change medication or dosages for duration of treatment","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,,,,"10",,"completed treatment course","0.9167",,,,,,,,,,,"Community",,,"1","0.875",,"0.125","Mixed","rape/sexual assault, accidents, community/school violence","Medium","Asukai N, Saito A, Tsuruta N, et al. Efficacy of exposure therapy for Japanese patients with posttraumatic stress disorder due to mixed traumatic events: A randomized controlled study. J Trauma Stress. 2010 Dec;23(6):744-50. doi: 10.1002/jts.20589. PMID: 21171135.","84311","2019"
"back2019_A","Psychotherapy","PTSD+SUD","PTSD+SUD","Integrated","81","A","54",,"COPE","Concurrent Treatment for PTSD and Substance Use Disorder Using Prolonged Exposure (COPE)","Integrates Prolonged Exposure and CBT for SUD; sessions include psychoeducation, in vivo exposure and imaginal exposure; abstinence is not required to participate but is strongly encouraged.","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"90 minutes",,,"total 12 sessions","attended 12 sessions","0.537",,,,,"8.8","4.1",,,,,"Veteran","0","1","0","0.091",,"0.909","Mixed","Combat-related, Rape/sexual assault, Accidents, Community/school violence, Natural or manmade disasters, Terrorism/policital violence/forced displacement; Other (physical assault, assault with a weapon, unwanted or uncomfortable sexual experience, captivity, severe human suffering, sudden violent death of someone close, sudden unexpected death of someone close, other very stressful event or experience)","Medium","Back SE, Killeen T, Badour CL, et al. Concurrent treatment of substance use disorders and PTSD using prolonged exposure: a randomized clinical trial in military veterans. Addict Behav. 2019 Mar;90:369-77. doi: 10.1016/j.addbeh.2018.11.032. PMID: 30529244.","51384","2020"
"back2019_B","Psychotherapy","PTSD+SUD","SUD","Not integrated","81","B","27",,"Relapse Prevention","Relapse Prevention","Manualized evidence-based treatment; ""teaches skills to help manage cravings and high-risk situations that commonly precipitate substance use.""","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"90 minutes",,,"total 12 sessions","attended 12 sessions","0.481",,,,,"7.4","5.0",,,,,"Veteran","0","1","0","0.091",,"0.909","Mixed","Combat-related, Rape/sexual assault, Accidents, Community/school violence, Natural or manmade disasters, Terrorism/policital violence/forced displacement; Other (physical assault, assault with a weapon, unwanted or uncomfortable sexual experience, captivity, severe human suffering, sudden violent death of someone close, sudden unexpected death of someone close, other very stressful event or experience)","Medium","Back SE, Killeen T, Badour CL, et al. Concurrent treatment of substance use disorders and PTSD using prolonged exposure: a randomized clinical trial in military veterans. Addict Behav. 2019 Mar;90:369-77. doi: 10.1016/j.addbeh.2018.11.032. PMID: 30529244.","51384","2020"
"badurabrack2015astudy1_A","Nonpharmacologic cognitive","PTSD","PTSD",,"52","A","27",,"Attention Bias Modification","Attention bias modification (ABM)","Computerized cognitive training strategies to alter biases in attention. Intervention utilized the dot-probe task to train attention bias away from threat","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","Yes","No","No","No","Individual","In Person",,"Each session consisted of 160 trials with 500 millisecond centrally-presented fixation cross, then replaced by a pair of words presented for 500 millisecond","Weekly","4",,,,,,,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"Medium","Badura-Brack AS, Naim R, Ryan TJ, et al. Effect of attention training on attention bias variability and PTSD symptoms: randomized controlled trials in Israeli and U.S. combat veterans. Am J Psychiatry. 2015 Dec;172(12):1233-41. doi: 10.1176/appi.ajp.2015.14121578. PMID: 26206075.","44617","2019"
"badurabrack2015astudy1_B","Nonpharmacologic cognitive","PTSD","PTSD",,"52","B","25",,"Attention Control Training","Attention bias modification (ABM)","Repeated trials train patients to normalize fluctuations in threat-related attention bias","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","Yes","No","No","No","Individual","In Person",,"Each session consisted of 160 trials with 500 millisecond centrally-presented fixation cross, then replaced by a pair of words presented for 500 millisecond","Weekly","4",,,,,,,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"Medium","Badura-Brack AS, Naim R, Ryan TJ, et al. Effect of attention training on attention bias variability and PTSD symptoms: randomized controlled trials in Israeli and U.S. combat veterans. Am J Psychiatry. 2015 Dec;172(12):1233-41. doi: 10.1176/appi.ajp.2015.14121578. PMID: 26206075.","44617","2019"
"badurabrack2015bstudy2_A","Nonpharmacologic cognitive","PTSD","PTSD",,"46","A","22",,"Attention Bias Modification","Attention bias modification (ABM)","Computerized cognitive training strategies to alter biases in attention. Intervention utilized the dot-probe task with pairs of angry and neutral faces to train attention bias away from threat","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","Yes","No","No","No","Individual","In Person",,"Each session consisted of 120 trials with 500 millisecond centrally-presented fixation cross, followed by a face pair display for 500 millisecond","Twice weekly","4",,,,,,,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"Medium","Badura-Brack AS, Naim R, Ryan TJ, et al. Effect of attention training on attention bias variability and PTSD symptoms: randomized controlled trials in Israeli and U.S. combat veterans. Am J Psychiatry. 2015 Dec;172(12):1233-41. doi: 10.1176/appi.ajp.2015.14121578. PMID: 26206075.","44617","2019"
"badurabrack2015bstudy2_B","Nonpharmacologic cognitive","PTSD","PTSD",,"46","B","24",,"Attention Control Training","Attention bias modification (ABM)","Repeated trials train patients to normalize fluctuations in threat-related attention bias","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","Yes","No","No","No","Individual","In Person",,"Each session consisted of 120 trials with 500 millisecond centrally-presented fixation cross, followed by a face pair display for 500 millisecond","Twice weekly","4",,,,,,,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"Medium","Badura-Brack AS, Naim R, Ryan TJ, et al. Effect of attention training on attention bias variability and PTSD symptoms: randomized controlled trials in Israeli and U.S. combat veterans. Am J Psychiatry. 2015 Dec;172(12):1233-41. doi: 10.1176/appi.ajp.2015.14121578. PMID: 26206075.","44617","2019"
"baker1995_A","Pharmacotherapy","PTSD","PTSD",,"118","A","56",,"Brofaromine","Brofaromine","Reversible MAOI with SSRI activity; flexible dose with titration","No","Not Applicable","Yes","Antidepressant: MAOI","No","Not Applicable","No","No","No","No","No","Individual","In Person","150 mg; flexible dosing, titration: starting dose NR, titrated up to 150 mg",,,"12",,,,,,,,,,,,,,"Mixed","0","0.602","0.398","0.193",,"0.807","Mixed","combat-related, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (not specified)","Medium","Baker DG, Diamond BI, Gillette GM, et al. A double-blind, randomized, placebo-controlled, multi-center study of brofaromine in the treatment of post-traumatic stress disorder. Psychopharmacology (Berl). 1995 Dec;122(4):386-9. doi: 10.1007/BF02246271. PMID: 8657838.","06773","2019"
"baker1995_B","Pharmacotherapy","PTSD","Control",,"118","B","58",,"Placebo","Placebo","Placebo","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person",,,,"12",,,,,,,,,,,,,,"Mixed","0","0.602","0.398","0.193",,"0.807","Mixed","combat-related, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (not specified)","Medium","Baker DG, Diamond BI, Gillette GM, et al. A double-blind, randomized, placebo-controlled, multi-center study of brofaromine in the treatment of post-traumatic stress disorder. Psychopharmacology (Berl). 1995 Dec;122(4):386-9. doi: 10.1007/BF02246271. PMID: 8657838.","06773","2019"
"baniasadi2014_A","Pharmacotherapy","PTSD","PTSD",,"37","A","18",,"Pregabalin augmentation","Pregabalin","Anticonvulsant; augmentation of standard medications of SSRIs (citalopram 20 to 40 mg per day or sertraline 50 to 200 mg per day) and sodium valproate (1000 to 1800 mg per day)","No","Not Applicable","Yes","Other pharmacotherapy","No","Not Applicable","No","No","No","No","No","Individual","In Person","150 mg (total daily dose 300 mg); titration: 75 mg per day for one week, then 75 mg twice daily for one week, then 150 mg twice daily",,"Twice Daily","6",,,,,"monitored using a compliance checkllist",,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"Medium","Baniasadi M, Hosseini G, Fayyazi Bordbar MR, et al. Effect of pregabalin augmentation in treatment of patients with combat-related chronic posttraumatic stress disorder: a randomized controlled trial. J Psychiatr Pract. 2014 Nov;20(6):419-27. doi: 10.1097/01.pra.0000456590.12998.41. PMID: 25406046.","44618","2019"
"baniasadi2014_B","Pharmacotherapy","PTSD","Control",,"37","B","19",,"Placebo augmentation","Placebo","Placebo augmentation of standard medications of SSRIs (citalopram 20 to 40 mg per day or sertraline 50 to 200 mg per day) and sodium valproate (1000 to 1800 mg per day)","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,,,"6",,,,,,,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"Medium","Baniasadi M, Hosseini G, Fayyazi Bordbar MR, et al. Effect of pregabalin augmentation in treatment of patients with combat-related chronic posttraumatic stress disorder: a randomized controlled trial. J Psychiatr Pract. 2014 Nov;20(6):419-27. doi: 10.1097/01.pra.0000456590.12998.41. PMID: 25406046.","44618","2019"
"basoglu2007_A","Psychotherapy","PTSD","PTSD",,"31","A","16",,"Behavioral treatment","Exposure therapy","Treatment rationale, treatment target setting, and self-exposure instructions provided in first session. Then patients were exposed to simulated earthquake tremors with ability to control intensity, and instructed to confront their fear until they felt in control","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"60 for first session, variable for simulation (mean 33 minutes, SD 18)","Once","1",,,,,,,,,,,,,,"Community","0","0","1","0.871",,"0.129","Natural or manmade disasters",,"Medium","Basoglu M, Salcioglu E, Livanou M. A randomized controlled study of single-session behavioural treatment of earthquake-related post-traumatic stress disorder using an earthquake simulator. Psychological Medicine. 2007;37(2):203-13. doi: 10.1017/S0033291706009123. PMID: 17254365.","29446","2020"
"basoglu2007_B","Psychotherapy","PTSD","Control",,"31","B","15",,"Repeated assessment","Waitlist","Participants assessed at week 4 and 8 after randomization, then received treatment","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person",,,,"8",,,,,,,,,,,,,,"Community","0","0","1","0.871",,"0.129","Natural or manmade disasters",,"Medium","Basoglu M, Salcioglu E, Livanou M. A randomized controlled study of single-session behavioural treatment of earthquake-related post-traumatic stress disorder using an earthquake simulator. Psychological Medicine. 2007;37(2):203-13. doi: 10.1017/S0033291706009123. PMID: 17254365.","29446","2020"
"basoglu2005_A","Psychotherapy","PTSD","PTSD",,"59","A","31",,"Modified behavioral treatment","Trauma-focused cognitive behavioral therapy (TF-CBT)","Shorter version of CBT with cognitive intervention limited to explanation of treatment rationale, focusing on reduction of fear and avoidance, and shifting focus from habituation to anxiogenic stimuli to enhancement of sense of control over traumatic stressor","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"60 minutes","Once","1",,,,,,,,,,,,,,"Community",,,"1","0.8475",,"0.1525","Natural or manmade disasters",,"Medium","Basoglu M, Salcioglu E, Livanou M, et al. Single-session behavioral treatment of earthquake-related posttraumatic stress disorder: a randomized waiting list controlled trial. J Trauma Stress. 2005;18(1):1-11. doi: 10.1002/jts.20011. PMID: 16281190.","18886","2019"
"basoglu2005_B","Psychotherapy","PTSD","Control",,"59","B","28",,"Waitlist","Waitlist","Participants completed a 6-week waiting period then were re-assessed","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,,,,"6",,,,,,,,,,,,,,"Community",,,"1","0.8475",,"0.1525","Natural or manmade disasters",,"Medium","Basoglu M, Salcioglu E, Livanou M, et al. Single-session behavioral treatment of earthquake-related posttraumatic stress disorder: a randomized waiting list controlled trial. J Trauma Stress. 2005;18(1):1-11. doi: 10.1002/jts.20011. PMID: 16281190.","18886","2019"
"batki2014_B","Pharmacotherapy","PTSD+SUD","Control","Not integrated","30","B","16",,"Placebo","Placebo","Placebo identical to topiramate","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","dose as topiramate-equivalent; 25 to 300 mg per day flexible dosing determined by tolerability; titration schedule: 25 mg/day for 1 week, increased to 50 mg/day in week 2, then increased in 50 mg/day increments each week to maximum of 300 mg/day in week 6, final dose maintained weeks 6 through 11, then tapered and discontinued in week 12.",,"Daily in divided doses","12",,,,,"Self-report and pill count, medication adherence rate calculated as total dose reported taken/total dose prescribed x 100",,"mean medication adherence rate 60.2% (SD 21.5%)",,,,"281 mg","45 mg",,"Veteran","0","1","0","0.0667",,"0.9333","Mixed","combat-related, other (""civilian related trauma"")","Medium","Batki SL, Pennington DL, Lasher B, et al. Topiramate treatment of alcohol use disorder in veterans with posttraumatic stress disorder: a randomized controlled pilot trial. Alcohol Clin Exp Res. 2014 Aug;38(8):2169-77. doi: 10.1111/acer.12496. PMID: 25092377.","42646","2020"
"batki2014_A","Pharmacotherapy","PTSD+SUD","PTSD+SUD","Not integrated","30","A","14",,"Topiramate","Topiramate","Anticonvulsant medication + weekly medication management manualized counseling to promote adherence and reduce alcohol use","No","Not Applicable","Yes","Mood stabilizer","No","Not Applicable","No","No","No","No","No","Individual","In Person","25 to 300 mg per day flexible dosing determined by tolerability; titration schedule: 25 mg/day for 1 week, increased to 50 mg/day in week 2, then increased in 50 mg/day increments each week to maximum of 300 mg/day in week 6, final dose maintained weeks 6 through 11, then tapered and discontinued in week 12.",,"Daily in divided doses","12",,,,,"Self-report and pill count, medication adherence rate calculated as total dose reported taken/total dose prescribed x 100",,"mean medication adherence rate 63.1% (SD 20.3%)",,,,"286 mg","20 mg",,"Veteran","0","1","0","0.0667",,"0.9333","Mixed","combat-related, other (""civilian related trauma"")","Medium","Batki SL, Pennington DL, Lasher B, et al. Topiramate treatment of alcohol use disorder in veterans with posttraumatic stress disorder: a randomized controlled pilot trial. Alcohol Clin Exp Res. 2014 Aug;38(8):2169-77. doi: 10.1111/acer.12496. PMID: 25092377.","42646","2020"
"battaglia2016_A","Other mixed","PTSD+SUD","PTSD+SUD","Not integrated","175","A","89",,"MI for smoking cessation + PTSD home telehealth care management program","Motivational Interviewing (MI) for smoking cessation + PTSD home telehealth care management program","MI-based written smoking cessation curricula on home telehealth Health Buddy computer program and weekly telephone smoking cessation MI counseling by a nurse in addition to PTSD home telehealth care management program and nurse care manager. Mi-based smoking cessation curricula used MI material. A participant's response to a question dictated a different reply based on his or her stage of change. Nurse care managers used responses to promote identified health behavior change, and participants acquire a positive behavior (tobacco cessation)","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","Yes","Individual","Mixed",,"PTSD Health Buddy: 2 minutes;
MI counseling sessions: NR (average duration of call: 16.7 minutes)","PTSD Health Buddy: daily; MI counseling sessions: weekly","12",,,,,,,,,,"MI counseling sessions: 12.3 (5.5)",,,,"Veteran","0","1","0","0.1371",,"0.8629",,,"Medium","Battaglia C, Peterson J, Whitfield E, et al. Integrating motivational interviewing into a home telehealth program for veterans with posttraumatic stress disorder who smoke: a randomized controlled trial. J Clin Psychol. 2016 Mar;72(3):194-206. doi: 10.1002/jclp.22252. PMID: 26783736.","49060","2020"
"battaglia2016_B","Other mixed","PTSD+SUD","PTSD","Not integrated","175","B","86",,"PTSD home telehealth care management program","PTSD home telehealth care management program","PTSD home telehealth care management services with a device called the Health Buddy, designed to help those with PTSD self-monitor and self-manage. This computer-like device is 12x8x4 inches with a LCD screen. Patient read information and four large buttons for responding to questions. Patient responses transmitted overnight to a secure data center and the next day's curriculum was downloaded to device. Control nurse care managers read patients responses daily, monitored changes in health status, placed outreach phone calls to patients with urgent needs, and coordinated care with primary medical and/or mental health providers.","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","Technology Alone",,"PTSD Health Buddy sessions: 2 minutes","Daily","12","90 sessions",,,,,,,,,,,,,"Veteran","0","1","0","0.1371",,"0.8629",,,"Medium","Battaglia C, Peterson J, Whitfield E, et al. Integrating motivational interviewing into a home telehealth program for veterans with posttraumatic stress disorder who smoke: a randomized controlled trial. J Clin Psychol. 2016 Mar;72(3):194-206. doi: 10.1002/jclp.22252. PMID: 26783736.","49060","2020"
"battersby2013_A","Collaborative care","PTSD","PTSD",,"82","A","46",,"Flinders Program + Usual Care","Flinders Program","Multicomponent intervention consisting of Flinders Program, usual care, self-help materials, and optional participation in the Stanford Chronic Disease Self-Management group program.","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","No","No","Yes","Individual","Mixed",,,"Varied (RN visits at 1, 3, 6, 9 months with phone calls at 4.5 and 7.5 months; standard group weekly over 2.5 hours for 6 weeks)","36",,"completed intervention","0.9565",,,,,,,,,,,"Veteran","0","1","0",,,,,,"Medium","Battersby MW, Beattie J, Pols RG, et al. A randomised controlled trial of the Flinders Program™ of chronic condition management in Vietnam veterans with co-morbid alcohol misuse, and psychiatric and medical conditions. Aust N Z J Psychiatry. 2013 May;47(5):451-62. doi: 10.1177/0004867412471977. PMID: 23307806.",,"2020"
"battersby2013_B","Collaborative care","PTSD","Control",,"82","B","31",,"Usual care","Treatment as usual (TAU)","Services available included ""crisis intervention, alcohol-related education and counselling, pharmacological interventions, and cognitive behavioural and group pro- grams.""","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person",,,,"36",,"completed per protocol","0.9032",,,,,,,,,,,"Veteran","0","1","0",,,,,,"Medium","Battersby MW, Beattie J, Pols RG, et al. A randomised controlled trial of the Flinders Program™ of chronic condition management in Vietnam veterans with co-morbid alcohol misuse, and psychiatric and medical conditions. Aust N Z J Psychiatry. 2013 May;47(5):451-62. doi: 10.1177/0004867412471977. PMID: 23307806.",,"2020"
"beck2009_A","Psychotherapy","PTSD","PTSD",,"44","A","26",,"Group CBT","Trauma-focused cognitive behavioral therapy (TF-CBT)","Based on Blanchard and Hickling's individual CBT with modifications: treatment extended; detailed manual developed to standardize treatment; imaginal exposure assigned as homework and exposure to target trauma (MVA) conducted in writing; emphasis placed on teaching the principles of extinction to facilitate exposure during homework; treatment delivered by two therapists. Included: psychoeducation; exposure; mindfulness meditation; progressive muscle relaxation; cognitive therapy interventions and assertion training; behavioral activation; and, relapse prevention training.","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Group","In Person",,"2 hours","Weekly","14",,"attended ≥75% of sessions","0.7308",,,,,,,,,,,"Community",,,"1","0.8182",,"0.1818","Accidents",,"High","Beck JG, Coffey SF, Foy DW, et al. Group cognitive behavior therapy for chronic posttraumatic stress disorder: an initial randomized pilot study. Behav Ther. 2009 Mar;40(1):82-92. doi: 10.1016/j.beth.2008.01.003. PMID: 19187819.","32054","2019"
"beck2009_B","Psychotherapy","PTSD","Control",,"44","B","18",,"Minimum contact","Minimal attention","Telephone contact by project coordinator using structured script to assess PTSD symptomatology and suicidality; minimal support provided; no active intervention administered.","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","Phone",,,"Every 4 weeks","14",,"completed treatment course","0.8889",,,,,,,,,,,"Community",,,"1","0.8182",,"0.1818","Accidents",,"High","Beck JG, Coffey SF, Foy DW, et al. Group cognitive behavior therapy for chronic posttraumatic stress disorder: an initial randomized pilot study. Behav Ther. 2009 Mar;40(1):82-92. doi: 10.1016/j.beth.2008.01.003. PMID: 19187819.","32054","2019"
"becker2007_A","Pharmacotherapy","PTSD","PTSD",,"30","A","18",,"Bupropion sustained release","Bupropion","Antidepressant with a monocyclic aminoketone structure and weak norepinephrine and dopamine reuptake inhibitor.","No","Not Applicable","Yes","Antidepressant: Other","No","Not Applicable","No","No","No","No","No","Individual","In Person","100 to 300 mg total daily dose; titration: 100 mg for first 2 weeks, then if indicated, dosing increased to 100 mg twice daily. At week 4, if indicated, dosing increased to 150 mg twice daily",,"Daily to twice daily","8",,,,,,,,,,,"300 mg for completers, 180 mg for noncompleters",,,"Mixed","0","0.7857","0.2143","0.2143",,"0.7857","Mixed","combat-related, child sexual abuse, child physical abuse, intimate partner violence, rape/sexual assault, accidents, illness/medical procedure, other (homicide, death/suicide of a loved one)","Medium","Becker ME, Hertzberg MA, Moore SD, et al. A placebo-controlled trial of bupropion SR in the treatment of chronic posttraumatic stress disorder. J Clin Psychopharmacol. 2007 Apr;27(2):193-7. doi: 10.1097/JCP.0b013e318032eaed. PMID: 17414245.","31131","2019"
"becker2007_B","Pharmacotherapy","PTSD","Control",,"30","B","10",,"Placebo","Placebo","Placebo","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person",,,"Daily to twice daily","8",,,,,,,,,,,,,,"Mixed","0","0.7857","0.2143","0.2143",,"0.7857","Mixed","combat-related, child sexual abuse, child physical abuse, intimate partner violence, rape/sexual assault, accidents, illness/medical procedure, other (homicide, death/suicide of a loved one)","Medium","Becker ME, Hertzberg MA, Moore SD, et al. A placebo-controlled trial of bupropion SR in the treatment of chronic posttraumatic stress disorder. J Clin Psychopharmacol. 2007 Apr;27(2):193-7. doi: 10.1097/JCP.0b013e318032eaed. PMID: 17414245.","31131","2019"
"beidel2011_A","Psychotherapy","PTSD","PTSD",,"35","A","18",,"Trauma Management Therapy with Exposure Therapy","Trauma Management Therapy with exposure therapy","Intensive exposure therapy including imaginal and in vivo exposure. Social and emotional rehabilitation involves general social skills training with anger management skills","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Mixed","In Person",,"Individual exposure sessions: NR

Group social and emotional rehabilitation sessions: 90 minutes","Individual exposure sessions: 3 times weekly for 5 weeks

Group social and emotional rehabilitation sessions: twice weekly for 2 weeks, then once weekly for 10 weeks (14 total sessions)","16",,"completing all individual exposure sessions and 75% of group sessions",,,,,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"High","Beidel DC, Frueh BC, Uhde TW, et al. Multicomponent behavioral treatment for chronic combat-related posttraumatic stress disorder: a randomized controlled trial. J Anxiety Disord. 2011 Mar;25(2):224-31. doi: 10.1016/j.janxdis.2010.09.006. PMID: 20951543.","35248","2019"
"beidel2011_B","Psychotherapy","PTSD","PTSD",,"35","B","17",,"Exposure Therapy + psychoeducation","Exposure therapy","Intensive exposure therapy including imaginal and in vivo exposure, then therapist lead group psychoeducation and traditional ""rap"" group sessions where participants share experiences and garner support from other group members","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Mixed","In Person",,"Individual exposure sessions: NR

Group psychoeducation sessions: 90 minutes","Individual exposure sessions: 3 times weekly for 5 weeks

Group social and emotional rehabilitation sessions: twice weekly for 2 weeks, then once weekly for 10 weeks (14 total sessions)","16",,"completing all individual exposure sessions and 75% of group sessions",,,,,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"High","Beidel DC, Frueh BC, Uhde TW, et al. Multicomponent behavioral treatment for chronic combat-related posttraumatic stress disorder: a randomized controlled trial. J Anxiety Disord. 2011 Mar;25(2):224-31. doi: 10.1016/j.janxdis.2010.09.006. PMID: 20951543.","35248","2019"
"bell2019_B","Complementary and integrative health (CIH)","PTSD","Control",,"24","B","12",,"Heart rate variability biofeedback","Heart rate variability biofeedback","Participants guided to breathe at resonant frequency and increase heartrate variability metrics using audiovisual feedback (participant watching a movie and the screen and volume zoom in/out based on physiological measures and set thresholds, used Zukor Media Player) and breath pacer on training screen.","No","Not Applicable","No","Not Applicable","Yes","Relaxation","No","No","No","No","No","Individual","In Person",,"20 minutes","Twice a week","7.5","total 15 sessions",,,,,,,,,,,,,"Community","0",,"1",,,,"Mixed","combat-related, rape/sexual assault, community/school violence, illness/medical procedure, natural or manmade disasters, child other abuse, other (""work-related trauma [e.g. first responders]"")","Medium","Bell AN, Moss D, Kallmeyer RJ. Healing the neurophysiological roots of trauma: a controlled study examining loreta z-score neurofeedback and HRV biofeedback for chronic PTSD. NeuroRegulation. 2019;6(2):54-70. doi: 10.15540/nr.6.2.54.",,"2020"
"bell2019_A","Complementary and integrative health (CIH)","PTSD","PTSD",,"24","A","12",,"LORETA z-score neurofeedback","LORETA z-score neurofeedback","Training protocol individualized using NeuroGuide's Symptom Checklist-Neural Network Match method, with 3 networks and 5 metrics for each participant. Audiovisual feedback by participant watching a movie and the screen and volume zoom in/out based on physiological measures and set thresholds (used Zukor Media Player). Reward provision used Z-Tunes method with 2 selection criteria: 1) 70% of targeted metrics within set z-score range; 2) average of remaining 30% were moving in direction of z=0 (negative slope); z-score threshold adjusted during each session for reward rate of 24 to 36 rewards per minute.","No","Not Applicable","No","Not Applicable","Yes","Relaxation","No","No","No","No","No","Individual","In Person",,"20 minutes","Twice a week","7.5","total 15 sessions",,,,,,,,,,,,,"Community","0",,"1",,,,"Mixed","combat-related, rape/sexual assault, community/school violence, illness/medical procedure, natural or manmade disasters, child other abuse, other (""work-related trauma [e.g. first responders]"")","Medium","Bell AN, Moss D, Kallmeyer RJ. Healing the neurophysiological roots of trauma: a controlled study examining loreta z-score neurofeedback and HRV biofeedback for chronic PTSD. NeuroRegulation. 2019;6(2):54-70. doi: 10.15540/nr.6.2.54.",,"2020"
"belleville2018_A","Psychotherapy","PTSD","PTSD",,"42","A","22",,"Imagery rehearsal therapy + CBT","Imagery rehearsal training (IRT) + trauma-focused cognitive behavioral therapy (TF-CBT)","Imagery rehearsal therapy sessions intended to alter the association between sleep and nightmares by rehearsing an alternate dream script in the daytime; followed by series of CBT sessions that included exposure to traumatic memories and to feared objects, activities and situations","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"Session length: 60 minutes for imagery rehearsal; 60 to 90 minutes for CBT","Weekly","20","5 for imagery rehearsal, 15 for CBT",,,,,,,,,,,,,"Community","0","0","1","0.881",,"0.119","Mixed","child sexual abuse, rape/sexual assault","Medium","Belleville G, Dube-Frenette M, Rousseau A. Efficacy of imagery rehearsal therapy and cognitive behavioral therapy in sexual assault victims with posttraumatic stress disorder: a randomized controlled trial. J Trauma Stress. 2018 Aug;31(4):591-601. doi: 10.1002/jts.22306. PMID: 30070398.","50883","2020"
"belleville2018_B","Psychotherapy","PTSD","PTSD",,"42","B","20",,"CBT only","Trauma-focused cognitive behavioral therapy (TF-CBT)","CBT sessions included exposure to traumatic memories and to feared objects, activities and situations. Sessions followed a 5-week waiting period including weekly check-in phone calls of about 5 minutes' duration.","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"60 to 90 minutes","Weekly","15",,,,,,,,,,,,,,"Community","0","0","1","0.881",,"0.119","Mixed","child sexual abuse, rape/sexual assault","Medium","Belleville G, Dube-Frenette M, Rousseau A. Efficacy of imagery rehearsal therapy and cognitive behavioral therapy in sexual assault victims with posttraumatic stress disorder: a randomized controlled trial. J Trauma Stress. 2018 Aug;31(4):591-601. doi: 10.1002/jts.22306. PMID: 30070398.","50883","2020"
"bichescu2007_A","Psychotherapy","PTSD","PTSD",,"18","A","9",,"NET","Narrative Exposure Therapy (NET)","Therapist provided same psychoeducation as control group, explaining PTSD-related symptoms and dysfunctions that frequently occur. Patient, assisted by the therapist, construct a chronological report of his own biography with special focus on traumatic experience.","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"120 minutes","Weekly or biweekly","10","5 sessions total",,,,,,,,,,,,,"Community",,,"1","0.0556",,"0.9444","Terrorism/political violence/forced displacement",,"High","Bichescu D, Neuner F, Schauer M, et al. Narrative exposure therapy for political imprisonment-related chronic posttraumatic stress disorder and depression. Behav Res Ther. 2007 Sep;45(9):2212-20. doi: 10.1016/j.brat.2006.12.006. PMID: 17288990.","29906","2019"
"bichescu2007_B","Psychotherapy","PTSD","Control",,"18","B","9",,"Psychoeducation","Psychoeducation","Therapist explain PTSD-related symptoms and dysfunctions that frequently occur","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","No","Yes","No","Individual","In Person",,,"Once","1",,,,,,,,,,,,,,"Community",,,"1","0.0556",,"0.9444","Terrorism/political violence/forced displacement",,"High","Bichescu D, Neuner F, Schauer M, et al. Narrative exposure therapy for political imprisonment-related chronic posttraumatic stress disorder and depression. Behav Res Ther. 2007 Sep;45(9):2212-20. doi: 10.1016/j.brat.2006.12.006. PMID: 17288990.","29906","2019"
"blanchard2003_A","Psychotherapy","PTSD","PTSD",,"98","A","37",,"CBT","Trauma-focused cognitive behavioral therapy (TF-CBT)","Manualized treatment with emphasis on helping the patient understand PTSD as a reaction to trauma and to normalize patient's view of his/her symptoms. Treatment included progressive muscle relaxation, reading aloud description of the MVA, in vivo exposure, and behavioral activation to counteract the numbing symptoms","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,,"Weekly",,"planned 8 to 12 sessions total with an expected mode of 10",,,,,,,"9.8000000000000007","1.2",,,,,"Community",,,"1","0.7347",,"0.2653","Accidents",,"Medium","Blanchard EB, Hickling EJ, Devineni T, et al. A controlled evaluation of cognitive behavioural therapy for posttraumatic stress in motor vehicle accident survivors. Behav Res Ther. 2003 Jan;41(1):79-96.  PMID: 12488121.","25272","2019"
"blanchard2003_B","Psychotherapy","PTSD","PTSD",,"98","B","36",,"Supportive psychotherapy","PTSD psychotherapy","Manualized treatment with emphasis on helping the patient understand PTSD as a reaction to trauma and to normalize patient's view of his/her symptoms. Therapist provided support on issues raised, including interpersonal or relationship issues, work issues, etc.","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,,"Weekly",,"planned 8 to 12 sessions total with an expected mode of 10",,,,,,,"10","1.2",,,,,"Community",,,"1","0.7347",,"0.2653","Accidents",,"Medium","Blanchard EB, Hickling EJ, Devineni T, et al. A controlled evaluation of cognitive behavioural therapy for posttraumatic stress in motor vehicle accident survivors. Behav Res Ther. 2003 Jan;41(1):79-96.  PMID: 12488121.","25272","2019"
"blanchard2003_C","Psychotherapy","PTSD","Control",,"98","C","25",,"Waitlist","Waitlist","Waitlist","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.7347",,"0.2653","Accidents",,"Medium","Blanchard EB, Hickling EJ, Devineni T, et al. A controlled evaluation of cognitive behavioural therapy for posttraumatic stress in motor vehicle accident survivors. Behav Res Ther. 2003 Jan;41(1):79-96.  PMID: 12488121.","25272","2019"
"boals2015_A","Psychotherapy","PTSD","PTSD",,"70","A","26",,"ACT analog","Acceptance and Commitment Therapy (ACT) + expressive writing","Participants listened to audio recording that included an acceptance-based rationale and a guided mindfulness exercise. Participants then completed 2 expressive writing exercises","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","Mixed",,"Audio: 10 minutes

Writing sessions: 20 minutes",,"1",,,,,"Score ≥2 on following writing direction","0.5926",,,,,,,,"Community",,,"1",,,,,,"High","Boals A, Murrell AR, Berntsen D, et al. Experimentally reducing event centrality using a modified expressive writing intervention. J Contextual Behav Sci. 2015 Oct;4(4):269-76. doi: 10.1016/j.jcbs.2015.10.001.","1548485","2019"
"boals2015_B","Psychotherapy","PTSD","PTSD",,"70","B","20",,"CBT analog","Cognitive behavioral therapy (CBT) + expressive writing","Participants listened to audio recording that included CBT rationale and a guided imagery exercise. Participants then completed 2 expressive writing exercises","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","Mixed",,"Audio: 10 minutes

Writing sessions: 20 minutes",,"1",,,,,"Score ≥2 on following writing direction","0.50",,,,,,,,"Community",,,"1",,,,,,"High","Boals A, Murrell AR, Berntsen D, et al. Experimentally reducing event centrality using a modified expressive writing intervention. J Contextual Behav Sci. 2015 Oct;4(4):269-76. doi: 10.1016/j.jcbs.2015.10.001.","1548485","2019"
"boals2015_C","Psychotherapy","PTSD","Control",,"70","C","23",,"Neutral script and writing","Control writing","Participants listened to audio recording on history of baseline then completed 2 expressive writing exercises","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","Mixed",,"Audio: 10 minutes

Writing sessions: 20 minutes",,"1",,,,,"Score ≥2 on following writing direction","0.9565",,,,,,,,"Community",,,"1",,,,,,"High","Boals A, Murrell AR, Berntsen D, et al. Experimentally reducing event centrality using a modified expressive writing intervention. J Contextual Behav Sci. 2015 Oct;4(4):269-76. doi: 10.1016/j.jcbs.2015.10.001.","1548485","2019"
"boggio2010_A","Nonpharmacologic biological","PTSD","PTSD",,"30","A","10",,"High-frequency left rTMS","Transcranial magnetic stimualtion (TMS)","Magnetic stimulation applied to the left Dorsolateral Pre-frontal Cortex","No","Not Applicable","No","Not Applicable","No","Not Applicable","Yes","No","No","No","No","Individual","In Person","20 Hz at 80% of patient's motor threshold; 1600 pulses per session",,"Once daily on weekdays","2","10 sessions total",,,,,,,,,,,,,"Community",,,"1","0.7",,"0.3","Mixed","rape/sexual assault, community/school violence, other (death or severe disease of relative, perceived physical harm/psychological distress)","Medium","Boggio PS, Rocha M, Oliveira MO, et al. Noninvasive brain stimulation with high-frequency and low-intensity repetitive transcranial magnetic stimulation treatment for posttraumatic stress disorder. J Clin Psychiatry. 2010 Aug;71(8):992-9. doi: 10.4088/JCP.08m04638blu. PMID: 20051219.","33726","2019"
"boggio2010_B","Nonpharmacologic biological","PTSD","PTSD",,"30","B","10",,"High-frequency Right rTMS","Transcranial magnetic stimualtion (TMS)","Magnetic stimulation applied to the right dorsolateral prefrontal cortex","No","Not Applicable","No","Not Applicable","No","Not Applicable","Yes","No","No","No","No","Individual","In Person","21 Hz at 80% of patient's motor threshold; 1600 pulses per session",,"Once daily on weekdays","2","10 sessions total",,,,,,,,,,,,,"Community",,,"1","0.7",,"0.3","Mixed","rape/sexual assault, community/school violence, other (death or severe disease of relative, perceived physical harm/psychological distress)","Medium","Boggio PS, Rocha M, Oliveira MO, et al. Noninvasive brain stimulation with high-frequency and low-intensity repetitive transcranial magnetic stimulation treatment for posttraumatic stress disorder. J Clin Psychiatry. 2010 Aug;71(8):992-9. doi: 10.4088/JCP.08m04638blu. PMID: 20051219.","33726","2019"
"boggio2010_C","Nonpharmacologic biological","PTSD","Control",,"30","C","10",,"Sham rTMS","Sham","Administered the same TMS methodology as intervention groups only without magnetic stimulation from the coil. The sham TMS had a small electrical stimulator to mimic scalp sensation.","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person",,,"Once daily on weekdays","2","10 sessions total",,,,,,,,,,,,,"Community",,,"1","0.7",,"0.3","Mixed","rape/sexual assault, community/school violence, other (death or severe disease of relative, perceived physical harm/psychological distress)","Medium","Boggio PS, Rocha M, Oliveira MO, et al. Noninvasive brain stimulation with high-frequency and low-intensity repetitive transcranial magnetic stimulation treatment for posttraumatic stress disorder. J Clin Psychiatry. 2010 Aug;71(8):992-9. doi: 10.4088/JCP.08m04638blu. PMID: 20051219.","33726","2019"
"bohus2013_A","Psychotherapy","PTSD","PTSD",,"82","A","43",,"DBT-PTSD","Dialectical Behavior Therapy (DBT) +  trauma-focused cognitive behavioral therapy (TF-CBT)","Integrated trauma-focused cognitive and exposure-based interventions described by Foa et al (2007) and Ehlers & Clark (2000). Intervention included individual exposure-based treatment plus the following weekly group treatments: skills training, self-esteem intervention, mindfulness sessions, PTSD-specific psychoeducation, and non-specific group interventions (music therapy, art therapy)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Mixed","In Person",,"Individual sessions: 45 minutes

Group sessions: 90 minutes skills training, 60 minutes self-esteem intervention, 25 minutes mindfulness, 60 minutes PTSD-specific psychoeducation, and 90 minutes non-specific interventions","Individual sessions: twice weekly

Group sessions: weekly","12",,,,,,,,"25",,,,,,"Community",,,"1","1",,"0","Child sexual abuse",,"Medium","Bohus MJ, Dyer AS, Priebe K, et al. Dialectical behaviour therapy for post-traumatic stress disorder after childhood sexual abuse in patients with and without borderline personality disorder: a randomised controlled trial. Psychother Psychosom. 2013 Jun;82(4):221-33. doi: 10.1159/000348451. PMID: 23712109.","41533","2019"
"bohus2013_B","Psychotherapy","PTSD","Control",,"82","B","39",,"TAU waitlist","Treatment as usual (TAU)","Participants received 6 months of any treatment of their choice except DBT-PTSD","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,"In Person",,,,"12",,,,,,,,,,,,,,"Community",,,"1","1",,"0","Child sexual abuse",,"Medium","Bohus MJ, Dyer AS, Priebe K, et al. Dialectical behaviour therapy for post-traumatic stress disorder after childhood sexual abuse in patients with and without borderline personality disorder: a randomised controlled trial. Psychother Psychosom. 2013 Jun;82(4):221-33. doi: 10.1159/000348451. PMID: 23712109.","41533","2019"
"bomyea2015_A","Nonpharmacologic cognitive","PTSD","PTSD",,"42","A","22",,"High Interference Control Training","Interference control training","Computerized cognitive training designed to prevent interfering thoughts from entering consciousness and removing them once they come to mind by improving cognitive performance on a working memory capacity test involving testing of sentence accuracy and memory under a condition of high proactive interference with item memoranda that were words for all trials; 3 blocks of training (45 trials) completed per session.","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","Yes","No","No","No","Individual","In Person",,"30 minutes","Twice weekly","4",,,,,,,,,,,,,,"Community",,,"1","1",,"0","Rape/sexual assault",,"Medium","Bomyea J, Stein MB, Lang AJ. Interference control training for PTSD: A randomized controlled trial of a novel computer-based intervention. J Anxiety Disord. 2015 Aug;34:33-42. doi: 10.1016/j.janxdis.2015.05.010. PMID: 26114901.","44517","2019"
"bomyea2015_B","Nonpharmacologic cognitive","PTSD","Control",,"42","B","20",,"Low Interference Control Training","Interference control training","Computerized cognitive training designed to prevent interfering thoughts from entering consciousness and removing them once they come to mind by improving cognitive performance on a working memory capacity test involving testing of sentence accuracy and memory under a condition of low proactive interference with item memoranda that alternated between words and numbers every 3 trials; 3 blocks of training (45 trials) completed per session.","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person",,"30 minutes","Twice weekly","4",,,,,,,,,,,,,,"Community",,,"1","1",,"0","Rape/sexual assault",,"Medium","Bomyea J, Stein MB, Lang AJ. Interference control training for PTSD: A randomized controlled trial of a novel computer-based intervention. J Anxiety Disord. 2015 Aug;34:33-42. doi: 10.1016/j.janxdis.2015.05.010. PMID: 26114901.","44517","2019"
"bormann2008_A","Complementary and integrative health (CIH)","PTSD","PTSD",,"29","A","14",,"Mantram","Mantram Repetition","Education on PTSD symptoms and skills on how to choose and silently repeat a mantram - a word or phrase with spiritual associations chosen by the participant from a provided list. Repetition on Mantram is intended to train attention. Includes concepts of ""slowing down"" and ""one-pointed attention"". Used as a ""pause button"" for the mind to decrease reactivity to stress.","No","Not Applicable","No","Not Applicable","Yes","Meditation","No","No","No","No","No","Group","In Person",,"90 minutes","Weekly","6",,,,,,,,,,,,,,"Veteran",,"1",,"0",,"1","Combat-related",,"Medium","Bormann JE, Thorp S, Wetherell JL, et al. A spiritually based group intervention for combat veterans with posttraumatic stress disorder: feasibility study. J Holist Nurs. 2008 Jun;26(2):109-16. doi: 10.1177/0898010107311276. PMID: 18356284.","30929","2019"
"bormann2008_B","Complementary and integrative health (CIH)","PTSD","Control",,"29","B","15",,"Usual care delayed-treatment","Treatment as usual (TAU)","Usual medical care with weekly or monthly case manager and/or primary care provider visits and medication management.","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,"In Person",,,"Weekly or monthly","6",,,,,,,,,,,,,,"Veteran",,"1",,"0",,"1","Combat-related",,"Medium","Bormann JE, Thorp S, Wetherell JL, et al. A spiritually based group intervention for combat veterans with posttraumatic stress disorder: feasibility study. J Holist Nurs. 2008 Jun;26(2):109-16. doi: 10.1177/0898010107311276. PMID: 18356284.","30929","2019"
"bormann2013_A","Complementary and integrative health (CIH)","PTSD","PTSD",,"146","A","71",,"Mantram Repetition Program + TAU","Mantram Repetition","Mantram Repetition Program is a portable, meditation-based intervention that teaches concentrative meditation, slowing down, and one-pointed attention for training attention and regulating emotion; group sessions contained lectures, discussion, sharing, questions and answers, and homework.

TAU consisted of case management as needed to evaluate mental health status and to monitor treatments","No","Not Applicable","No","Not Applicable","Yes","Meditation","No","No","No","No","No","Group","In Person",,"90 minutes","Weekly","6",,,,,,,,,,,,,,"Veteran",,"1",,"0.0274",,"0.9726","Combat-related",,"Low","Bormann JE, Thorp SR, Wetherell JL, et al. Meditation-based mantram intervention for veterans with posttraumatic stress disorder: A randomized trial. Psychol Trauma. 2013 May;5(3):259-67. doi: 10.1037/a0027522.","38465","2019"
"bormann2013_B","Complementary and integrative health (CIH)","PTSD","Control",,"146","B","75",,"TAU","Treatment as usual (TAU)","Case management as needed to evaluate mental health status and to monitor treatments","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,"In Person",,"As needed","As needed","6",,,,,,,,,,,,,,"Veteran",,"1",,"0.0274",,"0.9726","Combat-related",,"Low","Bormann JE, Thorp SR, Wetherell JL, et al. Meditation-based mantram intervention for veterans with posttraumatic stress disorder: A randomized trial. Psychol Trauma. 2013 May;5(3):259-67. doi: 10.1037/a0027522.","38465","2019"
"bradshaw2014_A","Psychotherapy","PTSD","PTSD",,"10","A","5",,"Observed and  Experiential Integration - Switching component","Observed and  Experiential Integration - Switching component","Participant instructed to close his/her eyes and envision the traumatic incident. When patient experiences physical or emotional signs of distress, instruction is given to uncover the nondominant eye and cover the dominant eye. Dominant/nondominant eye is alternatingly covered or both uncovered.","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"60 minutes",,"2","3 sessions total",,,,,,,,,,,,,"Community",,,"1","0.8",,"0.2","Mixed","rape/sexual assault, intimate partner violence, accidents, community/school violence","High","Bradshaw RA, McDonald MJ, Grace R, et al. A randomized clinical trial of Observed and Experiential Integration (OEI): a simple, innovative intervention for affect regulation in clients with PTSD. Traumatology (Tallahass Fla). 2014 Sep;20(3):161-71. doi: 10.1037/h0099401.","45231","2019"
"bradshaw2014_B","Psychotherapy","PTSD","Control",,"10","B","5",,"Waitlist","Waitlist",,"No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,,,,"2",,,,,,,,,,,,,,"Community",,,"1","0.8",,"0.2","Mixed","rape/sexual assault, intimate partner violence, accidents, community/school violence","High","Bradshaw RA, McDonald MJ, Grace R, et al. A randomized clinical trial of Observed and Experiential Integration (OEI): a simple, innovative intervention for affect regulation in clients with PTSD. Traumatology (Tallahass Fla). 2014 Sep;20(3):161-71. doi: 10.1037/h0099401.","45231","2019"
"brady2005_B","Pharmacotherapy","PTSD+SUD","Control","Not integrated","94","B","45",,"Placebo + CBT for alcohol dependence","Cognitive behavioral therapy (CBT) for alcohol use","Placebo tablets matched sertraline tablets.","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person",,,"Daily","12",,,,,"100 mg riboflavin tablets given with study drugs; also monitored by pill count",,,,,,,,,"Community",,,"1","0.457",,"0.543","Mixed","rape/sexual assault, accidents, community/school violence, other (childhood trauma not specified)","Medium","Brady KT, Sonne SC, Anton RF, et al. Sertraline in the treatment of co-occurring alcohol dependence and posttraumatic stress disorder. Alcohol Clin Exp Res. 2005 Mar;29(3):395-401. doi: 10.1097/01.ALC.0000156129.98265.57. PMID: 15770115.","27416","2020"
"brady2005_A","Pharmacotherapy","PTSD+SUD","PTSD+SUD","Not integrated","94","A","49",,"Sertraline + CBT for alcohol dependence","Cognitive behavioral therapy (CBT) for alcohol use + sertraline","SSRI; 50 mg tablets","Yes","Non-TF","Yes","Antidepressant: SSRI","No","Not Applicable","No","No","No","No","No","Individual","In Person","150 mg; titration: 50 mg for 2 days, 100 mg for 2 days, then 150 mg for the rest of the study",,"Daily","12",,,,,"100 mg riboflavin tablets given with study drugs; also monitored by pill count",,,,,,"150 mg",,,"Community",,,"1","0.457",,"0.543","Mixed","rape/sexual assault, accidents, community/school violence, other (childhood trauma not specified)","Medium","Brady KT, Sonne SC, Anton RF, et al. Sertraline in the treatment of co-occurring alcohol dependence and posttraumatic stress disorder. Alcohol Clin Exp Res. 2005 Mar;29(3):395-401. doi: 10.1097/01.ALC.0000156129.98265.57. PMID: 15770115.","27416","2020"
"brady2000_A","Pharmacotherapy","PTSD","PTSD",,"187","A","94",,"Sertraline","Sertraline","SSRI; flexible dosing titrated in 50-mg increments based on clinical response and tolerability at no less than weekly intervals. Followed a 2-week single-blind placebo run-in period.","No","Not Applicable","Yes","Antidepressant: SSRI","No","Not Applicable","No","No","No","No","No","Individual","In Person","50 to 200 mg; titration: 25 mg for 1 week then increased to 50 mg, further increases in 50-mg increments with maximum 200 mg dose",,"Daily","12",,,,,"compliance monitored by counts of returned medication",,,,,,"133.3 mg","59.2",,"Community",,,"1","0.733",,"0.267","Mixed","combat-related, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (seeing someone hurt or die, kidnapping)","Medium","Brady K, Pearlstein T, Asnis GM, et al. Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial. JAMA. 2000 Apr;283(14):1837-44. doi: 10.1001/jama.283.14.1837. PMID: 10770145.","22232","2019"
"brady2000_B","Pharmacotherapy","PTSD","Control",,"187","B","93",,"Placebo","Placebo","Matched placebo. Followed a 2-week single-blind placebo run-in period.","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person",,,"Daily","12",,,,,"compliance monitored by counts of returned medication",,,,,,,,,"Community",,,"1","0.733",,"0.267","Mixed","combat-related, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (seeing someone hurt or die, kidnapping)","Medium","Brady K, Pearlstein T, Asnis GM, et al. Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial. JAMA. 2000 Apr;283(14):1837-44. doi: 10.1001/jama.283.14.1837. PMID: 10770145.","22232","2019"
"braun1990_A","Pharmacotherapy","PTSD","PTSD",,"16","A","16","7 assigned to alprazolam in first treatment period","Alprazolam","Alprazolam","Benzodiazepine; titration over 2 weeks then steady dose for 3 weeks, followed by 2-week taper for patients taking alprazolam in first period (not included in treatment period)","No","Not Applicable","Yes","Antianxiety: benzodiazepine","No","Not Applicable","No","No","No","No","No","Individual","In Person","1.5 to 6 mg; titration: initiated at 1.5 mg, titrated over 2 weeks to maximum 6 mg",,"Daily (divided doses)","5",,,,,,,,,,,"4 mg/day",,,"Community",,,"1",,,,"Mixed","combat-related, accidents, terrorism/political violence/forced displacement","High","Braun P, Greenberg D, Dasberg H, et al. Core symptoms of posttraumatic stress disorder unimproved by alprazolam treatment. J. Clin. Psychiatry. 1990 Jun;51(6):236-8.  PMID: 2189869.","02466","2019"
"braun1990_B","Pharmacotherapy","PTSD","Control",,"16","B","16","9 assigned to placebo in first treatment period","Placebo","Placebo","Placebo","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person",,,"Daily (divided doses)","5",,,,,,,,,,,,,,"Community",,,"1",,,,"Mixed","combat-related, accidents, terrorism/political violence/forced displacement","High","Braun P, Greenberg D, Dasberg H, et al. Core symptoms of posttraumatic stress disorder unimproved by alprazolam treatment. J. Clin. Psychiatry. 1990 Jun;51(6):236-8.  PMID: 2189869.","02466","2019"
"bremner2017_A","Mixed: Psychotherapy & CIH","PTSD","PTSD",,"26","A","17",,"MBSR","Mindfulness-based stress reduction (MBSR)","Mindfulness-based Stress Reduction based on Kabat-Zinn approach tailored to PTSD and veterans. Elements include body scan meditation, sitting meditation, hatha yoga via group sessions and home practice","No","Not Applicable","No","Not Applicable","Yes","Meditation","No","No","No","No","No","Group","In Person",,"2.5 hour sessions plus one 6-hour session during week 6","Weekly","8",,"completed the group and study procedures","0.5294",,,,,,,,,,,"Veteran",,"1",,"0",,"1","Combat-related",,"Medium","Bremner JD, Mishra S, Campanella C, et al. A pilot study of the effects of mindfulness-based stress reduction on post-traumatic stress disorder symptoms and brain response to traumatic reminders of combat in Operation Enduring Freedom/Operation Iraqi Freedom combat veterans with post-traumatic stress disorder. Front Psychiatry. 2017 Aug 25;8:157. doi: 10.3389/fpsyt.2017.00157. PMID: 28890702.","49077","2019"
"bremner2017_B","Mixed: Psychotherapy & CIH","PTSD","PTSD",,"26","B","9",,"Group PCT","Present Centered Therapy (PCT)","Psychoeducation and group support","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Group","In Person",,"NR (same total number of hours as Mindfulness-based Stress Reduction group)","Weekly","8",,"completed the group and study procedures","0.8889",,,,,,,,,,,"Veteran",,"1",,"0",,"1","Combat-related",,"Medium","Bremner JD, Mishra S, Campanella C, et al. A pilot study of the effects of mindfulness-based stress reduction on post-traumatic stress disorder symptoms and brain response to traumatic reminders of combat in Operation Enduring Freedom/Operation Iraqi Freedom combat veterans with post-traumatic stress disorder. Front Psychiatry. 2017 Aug 25;8:157. doi: 10.3389/fpsyt.2017.00157. PMID: 28890702.","49077","2019"
"brom1989_A","Mixed: Psychotherapy & CIH","PTSD","PTSD",,"112","A","31",,"Trauma Desensitization","Exposure therapy","After the patient has learned relaxation techniques, they are encouraged to re-experience the traumatic event. The patient is then confronted with the previously avoided stimuli, which beforehand are categorized in hierarchies, and learns skills to strengthen the feeling of control.","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,,,,,,,,,,,"15.0","2.9",,,,,"Community",,,"1","0.79",,"0.21","Mixed","accidents, community/school violence, illness/medical procedure, other (loss of loved one, undefined)","High","Brom D, Kleber RJ, Defares PB. Brief psychotherapy for posttraumatic stress disorders. J Consult Clin Psychol. 1989;57(5):607-12.  PMID: 2571625.","03090","2019"
"brom1989_B","Mixed: Psychotherapy & CIH","PTSD","PTSD",,"112","B","29",,"Hypnotherapy","Hypnotherapy","Treatment goal was to bring the patient in contact with the reality of the traumatic event and to bring about a decrease in the conditioned responses triggered by the event","No","Not Applicable","No","Not Applicable","Yes","Clinical hypnosis","No","No","No","No","No","Individual","In Person",,,,,,,,,,,,"14.4","1.4",,,,,"Community",,,"1","0.79",,"0.21","Mixed","accidents, community/school violence, illness/medical procedure, other (loss of loved one, undefined)","High","Brom D, Kleber RJ, Defares PB. Brief psychotherapy for posttraumatic stress disorders. J Consult Clin Psychol. 1989;57(5):607-12.  PMID: 2571625.","03090","2019"
"brom1989_C","Mixed: Psychotherapy & CIH","PTSD","PTSD",,"112","C","29",,"Psychodynamic therapy","Psychodynamic psychotherapy","Aim of this therapy is limited to the solving of the intrapsychic conflicts resulting from the traumatic experience, with the therapist playing an active role.","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,,,,,,,,,,,"18.8","2.6",,,,,"Community",,,"1","0.79",,"0.21","Mixed","accidents, community/school violence, illness/medical procedure, other (loss of loved one, undefined)","High","Brom D, Kleber RJ, Defares PB. Brief psychotherapy for posttraumatic stress disorders. J Consult Clin Psychol. 1989;57(5):607-12.  PMID: 2571625.","03090","2019"
"brom1989_D","Mixed: Psychotherapy & CIH","PTSD","Control",,"112","D","23",,"Waitlist","Waitlist",,"No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,,,,"16",,,,,,,,,,,,,,"Community",,,"1","0.79",,"0.21","Mixed","accidents, community/school violence, illness/medical procedure, other (loss of loved one, undefined)","High","Brom D, Kleber RJ, Defares PB. Brief psychotherapy for posttraumatic stress disorders. J Consult Clin Psychol. 1989;57(5):607-12.  PMID: 2571625.","03090","2019"
"brom2017_A","Complementary and integrative health (CIH)","PTSD","PTSD",,"63","A","33",,"Somatic Experiencing","Somatic Experiencing","Body awareness with psychotherapy","No","Not Applicable","No","Not Applicable","Yes","Meditation","No","No","No","No","No","Individual","In Person",,"1 hour","Weekly","15",,,"0.8485",,,,,,,,,,,"Community",,,"1","0.507",,"0.493","Mixed","combat-related, accidents, illness/medical procedure, community/school violence terrorism/political violence/forced displacement, other (death or injury of family member, threat)","Medium","Brom D, Stokar Y, Lawi C, et al. Somatic experiencing for posttraumatic stress disorder: a randomized controlled outcome study. J Trauma Stress. 2017 Jun;30(3):304-12. doi: 10.1002/jts.22189. PMID: 28585761.","48274","2019"
"brom2017_B","Complementary and integrative health (CIH)","PTSD","Control",,"63","B","30",,"Waitlist","Waitlist",,"No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,,,,"15",,"completed treatment course","1.00",,,,,,,,,,,"Community",,,"1","0.507",,"0.493","Mixed","combat-related, accidents, illness/medical procedure, community/school violence terrorism/political violence/forced displacement, other (death or injury of family member, threat)","Medium","Brom D, Stokar Y, Lawi C, et al. Somatic experiencing for posttraumatic stress disorder: a randomized controlled outcome study. J Trauma Stress. 2017 Jun;30(3):304-12. doi: 10.1002/jts.22189. PMID: 28585761.","48274","2019"
"brunet2018_A","Mixed: Psychotherapy & pharmacotherapy","PTSD","PTSD",,"61","A","30",,"Propranolol + traumatic memory reactivation","Propranolol + imaginal exposure (experimental paradigm)","Beta blocker taken 90 minutes prior to trauma reactivation; all patients in study underwent trauma reactivation, writing a trauma narrative at the first visit which they read aloud at each visit.","Yes","TF","Yes","Antiadrenergic","No","Not Applicable","No","No","No","No","No","Individual","In Person","1.67 mg/kg: 0.67 mg/kg short-acting plus 1.0 mg/kg long-acting",,"Weekly","6",,"completed ≥ 5 sessions","0.50",,,,,,,,,,,"Community",,,"1","0.5833",,"0.4167","Mixed","combat-related. rape/sexual assault, accidents, illness/medical procedure, community/school violence, other (war zone, captivity, life threat, sudden unexpected death, other trauma not specified)","Medium","Brunet A, Saumier D, Liu A, et al. Reduction of PTSD Symptoms with pre-reactivation propranolol therapy: a randomized controlled trial. Am J Psychiatry. 2018 May 1doi: 10.1176/appi.ajp.2017.17050481. PMID: 29325446.","49661","2019"
"brunet2018_B","Mixed: Psychotherapy & pharmacotherapy","PTSD","Control",,"61","B","31",,"Placebo + traumatic memory reactivation","Imaginal exposure (experimental paradigm) + placebo","All patients in study underwent trauma reactivation, writing a trauma narrative at the first visit which they read aloud at each visit 90 minutes after receiving medication.","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person",,,"Weekly","6",,"completed ≥ 5 sessions","0.4839",,,,,,,,,,,"Community",,,"1","0.5833",,"0.4167","Mixed","combat-related. rape/sexual assault, accidents, illness/medical procedure, community/school violence, other (war zone, captivity, life threat, sudden unexpected death, other trauma not specified)","Medium","Brunet A, Saumier D, Liu A, et al. Reduction of PTSD Symptoms with pre-reactivation propranolol therapy: a randomized controlled trial. Am J Psychiatry. 2018 May 1doi: 10.1176/appi.ajp.2017.17050481. PMID: 29325446.","49661","2019"
"bryant2019_B","Psychotherapy","PTSD","PTSD",,"100","B","33",,"CBT with brief exposure","Trauma-focused cognitive behavioral therapy (TF-CBT)","CBT included psychoeducation, CBT skills building, brief imaginal exposure, in vivo exposure, cognitive restructuring and relapse prevention.","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"60 minutes with 10 minutes of imaginal exposure","Weekly","12",,,,,,,,,,,,,,"Community","0","0","1","0.23",,"0.77","Other (emergency service personnel including police, firefighters, and paramedics; exposure to fatality)",,"Medium","Bryant RA, Kenny L, Rawson N, et al. Efficacy of exposure-based cognitive behaviour therapy for post-traumatic stress disorder in emergency service personnel: a randomised clinical trial. Psychol Med. 2019 Jul;49(9):1565-73. doi: 10.1017/S0033291718002234. PMID: 30149825.","51039","2020"
"bryant2019_A","Psychotherapy","PTSD","PTSD",,"100","A","33",,"CBT with prolonged exposure","Trauma-focused cognitive behavioral therapy (TF-CBT)","CBT included psychoeducation, CBT skills building, prolonged imaginal exposure, in vivo exposure, cognitive restructuring and relapse prevention.","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"90 minutes with 40 minutes of imaginal exposure","Weekly","12",,,,,,,,,,,,,,"Community","0","0","1","0.23",,"0.77","Other (emergency service personnel including police, firefighters, and paramedics; exposure to fatality)",,"Medium","Bryant RA, Kenny L, Rawson N, et al. Efficacy of exposure-based cognitive behaviour therapy for post-traumatic stress disorder in emergency service personnel: a randomised clinical trial. Psychol Med. 2019 Jul;49(9):1565-73. doi: 10.1017/S0033291718002234. PMID: 30149825.","51039","2020"
"bryant2019_C","Psychotherapy","PTSD","Control",,"100","C","34",,"Waitlist","Waitlist","WL participants underwent a 3-month waiting period while CBT patients received treatment; WL patients then randomized to active treatment.","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,,,,"12",,,,,,,,,,,,,,"Community","0","0","1","0.23",,"0.77","Other (emergency service personnel including police, firefighters, and paramedics; exposure to fatality)",,"Medium","Bryant RA, Kenny L, Rawson N, et al. Efficacy of exposure-based cognitive behaviour therapy for post-traumatic stress disorder in emergency service personnel: a randomised clinical trial. Psychol Med. 2019 Jul;49(9):1565-73. doi: 10.1017/S0033291718002234. PMID: 30149825.","51039","2020"
"bryant2003_A","Psychotherapy","PTSD","PTSD",,"58","A","20",,"Prolonged Imaginal Exposure with Cognitive Restructuring","Trauma-focused cognitive behavioral therapy (TF-CBT)","Psychoeducation and education about cognitive restructuring (first session); 6 sessions consisted of 25 minutes of cognitive restructuring including monitoring of thoughts and affective states, modifying thoughts, and identification and modification of underlying beliefs, followed by 45 minutes of imaginal exposure with patient-provided narrative of trauma experience, and homework included daily exercise of imaginal exposure; the final session focused om relapse prevention using both IE and CR strategies.","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"90 minutes","Weekly","8",,"completed treatment course","0.75",,,,,,,,,,,"Community",,,"1","0.52",,"0.48","Mixed","accidents, community/school violence","Medium","Bryant RA, Moulds ML, Guthrie RM, et al. Imaginal exposure alone and imaginal exposure with cognitive restructuring in treatment of posttraumatic stress disorder. J Consult Clin Psychol. 2003 Aug;71(4):706.  PMID: 12924676.","25807","2019"
"bryant2003_B","Psychotherapy","PTSD","PTSD",,"58","B","20",,"Imaginal Exposure","Imaginal exposure","Psychoeducation and trauma narrative (first session); 6 sessions consisted of 45 minutes of imaginal exposure with patient-provided narrative of trauma experience,25 minutes of supportive counseling, and monitored homework included daily exercise of imaginal exposure; the final session focused om relapse prevention using exposure-based strategies. Cognitive restructuring was not provided in any sessions.","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"90 minutes","Weekly","8",,"completed treatment course","0.75",,,,,,,,,,,"Community",,,"1","0.52",,"0.48","Mixed","accidents, community/school violence","Medium","Bryant RA, Moulds ML, Guthrie RM, et al. Imaginal exposure alone and imaginal exposure with cognitive restructuring in treatment of posttraumatic stress disorder. J Consult Clin Psychol. 2003 Aug;71(4):706.  PMID: 12924676.","25807","2019"
"bryant2003_C","Psychotherapy","PTSD","PTSD",,"58","C","18",,"Supportive Counseling","Supportive counseling","Therapy in unconditionally supportive role with trauma education and general problem-solving skills; homework to keep diary of current problems and mood states. Cognitive restructuring and imaginal exposure techniques were specifically avoided.","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"90 minutes","Weekly","8",,,"0.83",,,,,,,,,,,"Community",,,"1","0.52",,"0.48","Mixed","accidents, community/school violence","Medium","Bryant RA, Moulds ML, Guthrie RM, et al. Imaginal exposure alone and imaginal exposure with cognitive restructuring in treatment of posttraumatic stress disorder. J Consult Clin Psychol. 2003 Aug;71(4):706.  PMID: 12924676.","25807","2019"
"bryant2008_A","Psychotherapy","PTSD","PTSD",,"118","A","31",,"Imaginal Exposure","Imaginal exposure","Exposure to traumatic memories using personal narrative of trauma, discussion of exposure experience, and homework for daily repetition of exposure exercise with monitoring; relapse prevention using imaginal exposure-based strategies. Each session was comprised of: 40 minutes of imaginal exposure, 50 minutes of supportive counseling, and 10 minutes of homework assignments.","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"100 minutes","Weekly","8",,"completed treatment course","0.7419",,,,,,,,,,,"Community",,,"1",,,,"Mixed","accidents, community/school violence","Medium","Bryant RA, Moulds ML, Guthrie RM, et al. A randomized controlled trial of exposure therapy and cognitive restructuring for posttraumatic stress disorder. J Consult Clin Psychol. 2008 Aug;76(4):695-703. doi: 10.1037/a0012616. PMID: 18665697.","31196","2019"
"bryant2008_B","Psychotherapy","PTSD","PTSD",,"118","B","28",,"In vivo exposure","In vivo exposure","Hierarchy of feared situations, in vivo exercises during sessions when appropriate, and daily homework assignments for approaching and remaining in feared situations until anxiety decreased by 50%; relapse prevention using in vivo exposure-based strategies. Each session comprised of: 25 minutes in vivo exposure instructions, 65 minutes of supportive counseling, and 10 minutes of homework assignments.","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"100 minutes","Weekly","8",,"completed treatment course","0.7857",,,,,,,,,,,"Community",,,"1",,,,"Mixed","accidents, community/school violence","Medium","Bryant RA, Moulds ML, Guthrie RM, et al. A randomized controlled trial of exposure therapy and cognitive restructuring for posttraumatic stress disorder. J Consult Clin Psychol. 2008 Aug;76(4):695-703. doi: 10.1037/a0012616. PMID: 18665697.","31196","2019"
"bryant2008_C","Psychotherapy","PTSD","PTSD",,"118","C","31",,"Imaginal exposure + In vivo exposure","Trauma-focused cognitive behavioral therapy (TF-CBT)","Development of hierarchy of feared situations, imaginal exposure to traumatic memories, in vivo exposure exercises (in vivo exercises during sessions when appropriate, homework assignments for approaching and remaining in feared situations until anxiety decreased by 50%), and relapse prevention using both imaginal exposure and in vivo exposure strategies. Each session comprised of: 40 minutes of imaginal exposure, 25 minutes of in vivo exposure, 25 minutes of supportive counseling, and 10 minutes of homework assignments.","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"100 minutes","Weekly","8",,"completed treatment course","0.6774",,,,,,,,,,,"Community",,,"1",,,,"Mixed","accidents, community/school violence","Medium","Bryant RA, Moulds ML, Guthrie RM, et al. A randomized controlled trial of exposure therapy and cognitive restructuring for posttraumatic stress disorder. J Consult Clin Psychol. 2008 Aug;76(4):695-703. doi: 10.1037/a0012616. PMID: 18665697.","31196","2019"
"bryant2008_D","Psychotherapy","PTSD","PTSD",,"118","D","28",,"Imaginal exposure + In vivo exposure + Cognitive restructuring","Trauma-focused cognitive behavioral therapy (TF-CBT)","Sessions comprised of 25 minutes cognitive restructuring, 40 minutes of imaginal exposure, 25 minutes of in vivo exposure, and 10 minutes of homework assignments. Final session for relapse prevention using strategies from all 3 approaches.

Imaginal exposure: exposure to traumatic memories using personal narrative of trauma, discussion of exposure experience.

In vivo exposure: hierarchy of feared situations, in vivo exercises during sessions when appropriate, assignments to approaching and remaining in feared situations until anxiety decreased by 50%.

Cognitive restructuring: identification and monitoring of dysfunctional, unrealistic, and catastrophic thoughts, and affect states and use of Socratic questioning, probabilistic reasoning and evidence-based thinking to modify thoughts.","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"100 minutes","Weekly","8",,"completed treatment course","0.8571",,,,,,,,,,,"Community",,,"1",,,,"Mixed","accidents, community/school violence","Medium","Bryant RA, Moulds ML, Guthrie RM, et al. A randomized controlled trial of exposure therapy and cognitive restructuring for posttraumatic stress disorder. J Consult Clin Psychol. 2008 Aug;76(4):695-703. doi: 10.1037/a0012616. PMID: 18665697.","31196","2019"
"bryant2011_A","Psychotherapy","PTSD","PTSD",,"28","A","16",,"CBT","Trauma-focused cognitive behavioral therapy (TF-CBT)","Individual sessions including education about trauma reactions, anxiety management techniques (including Thai meditation), prolonged imaginal exposure, in vivo exposure to avoided situations, cognitive restructuring (modified to recognize ongoing and realistic threat of terrorist attacks), and relapse prevention.","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"60 minutes","Weekly","8",,,,,,,,"6.6","1",,,,,"Community",,,"1","0.9643",,"0.0357","Terrorism/political violence/forced displacement",,"Medium","Bryant RA, Ekassawin S, Chakkraband MLS, et al. A randomized controlled effectiveness trial of cognitive behavior therapy for post-traumatic stress disorder in terrorist-affected people in Thailand. World Psychiatry. 2011 Oct;10(3):205-9.  PMID: 21991280.","37395","2019"
"bryant2011_B","Psychotherapy","PTSD","Control",,"28","B","12",,"TAU","Supportive counseling","Supportive counseling without anxiety management, exposure, or cognitive restructuring.","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"60 minutes","Weekly","8",,,,,,,,"5.5","2.5",,,,,"Community",,,"1","0.9643",,"0.0357","Terrorism/political violence/forced displacement",,"Medium","Bryant RA, Ekassawin S, Chakkraband MLS, et al. A randomized controlled effectiveness trial of cognitive behavior therapy for post-traumatic stress disorder in terrorist-affected people in Thailand. World Psychiatry. 2011 Oct;10(3):205-9.  PMID: 21991280.","37395","2019"
"bryant2013_A","Psychotherapy","PTSD","PTSD",,"70","A","36",,"Emotion Regulation Training + CBT","Emotion Regulation Training followed by trauma-focused cognitive behavioral therapy (TF-CBT)","Emotion regulation training (4 sessions) followed by CBT (7 sessions), with one introductory session for psychoeducation.

Emotion regulation training: individualized strategies with emotion tolerance skills, breathing retraining, or progressive muscle relaxation.

CBT: cognitive restructuring, imaginal exposure, in vivo exposure, hierarchy of feared events, and relapse prevention.","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"90 minutes","Weekly","12",,"completed treatment","0.8333",,,,,,,"Emotion regulation training: 3.12 (1.26); CBT: 5.97 (3.00)",,,,"Community",,,"1","0.5429",,"0.4571","Mixed","accidents, community/school violence","Medium","Bryant RA, Mastrodomenico JA, Hopwood S, et al. Augmenting cognitive behaviour therapy for post-traumatic stress disorder with emotion tolerance training: a randomized controlled trial. Psychol Med. 2013 Oct;43(10):2153-60. doi: 10.1017/S0033291713000068. PMID: 23406821.","40045","2019"
"bryant2013_B","Psychotherapy","PTSD","PTSD",,"70","B","34",,"Supportive counseling + CBT","Supportive counseling followed by trauma-focused cognitive behavioral therapy (TF-CBT)","Supportive counseling (4 sessions) followed by CBT (7 sessions), with one introductory session for psychoeducation.

Supportive counseling: non-directive with patient-led approach; avoided specific strategies and components of emotional regulation.

CBT: cognitive restructuring, imaginal exposure, in vivo exposure, hierarchy of feared events, and relapse prevention.","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"90 minutes","Weekly","12",,"completed treatment","0.6176",,,,,,,"Supportive counseling sessions: 2.98 (1.22)
CBT sessions: 4.24 (2.96)",,,,"Community",,,"1","0.5429",,"0.4571","Mixed","accidents, community/school violence","Medium","Bryant RA, Mastrodomenico JA, Hopwood S, et al. Augmenting cognitive behaviour therapy for post-traumatic stress disorder with emotion tolerance training: a randomized controlled trial. Psychol Med. 2013 Oct;43(10):2153-60. doi: 10.1017/S0033291713000068. PMID: 23406821.","40045","2019"
"buhmann2016_A","Mixed: Psychotherapy & pharmacotherapy","PTSD","PTSD",,"280","A","71",,"CBT + sertraline and/or mianserin","Trauma-focused cognitive behavioral therapy (TF-CBT) + sertraline and/or mianserin","Manualized CBT including methods from acceptance and commitment therapy, mindfulness exercises, and in vivo and visualized exposure. Doctor adjusts SSRI and provides psychoeducation at each consultation, which was manualized and cover the illness, treatment, sleep, lifestyle, physical activity and social relations, pain, cognitive function, and influence of illness on the family. Patients have weekly consultation with doctor for first 2 months, then monthly consultation for 4 months. Participants reporting sleeping problems were supplemented with mianserin (atypical antipsychotic). Participants with too many side effects from sertraline were switched to mianserin.","Yes","TF","Yes","Mixed","No","Not Applicable","No","No","No","No","No","Individual","In Person","Sertraline: 25 to 200mg; titration: initial dose 2 mg, increased in 25 to 50 mg increments every 1 to 2 weeks with maximum dose of 200 mg
Mianserin: 10 to 30 mg",,"Psychotherapy: weekly

Sertraline/mianserin: daily","Psychotherapy: 16, Sertraline/mianserin: 24",,,,,,,,"11","3",,"Sertraline: 93.3 mg/day
Mianserin: 14.4 mg/day","Sertraline: 48
Mianserin: 7",,"Community",,,"1","0.4101",,"0.5899","Terrorism/political violence/forced displacement",,"Medium","Buhmann CB, Nordentoft M, Ekstrom M, et al. The effect of flexible cognitive-behavioural therapy and medical treatment, including antidepressants on post-traumatic stress disorder and depression in traumatised refugees: pragmatic randomised controlled clinical trial. Br J Psychiatry. 2016 Mar;208(3):252-9. doi: 10.1192/bjp.bp.114.150961. PMID: 26541687.","46863","2019"
"buhmann2016_B","Mixed: Psychotherapy & pharmacotherapy","PTSD","PTSD",,"280","B","70",,"CBT","Trauma-focused cognitive behavioral therapy (TF-CBT)","Manualized CBT including methods from acceptance and commitment therapy, mindfulness exercises, and in vivo and visualized exposure.","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,,,"24","16 total sessions",,,,,,,"13","3",,,,,"Community",,,"1","0.4101",,"0.5899","Terrorism/political violence/forced displacement",,"Medium","Buhmann CB, Nordentoft M, Ekstrom M, et al. The effect of flexible cognitive-behavioural therapy and medical treatment, including antidepressants on post-traumatic stress disorder and depression in traumatised refugees: pragmatic randomised controlled clinical trial. Br J Psychiatry. 2016 Mar;208(3):252-9. doi: 10.1192/bjp.bp.114.150961. PMID: 26541687.","46863","2019"
"buhmann2016_C","Mixed: Psychotherapy & pharmacotherapy","PTSD","PTSD",,"280","C","71",,"Sertraline and/or mianserin","Sertraline and/or mianserin","Doctor adjusts SSRI and provides psychoeducation at each consultation, which was manualized and cover the illness, treatment, sleep, lifestyle, physical activity and social relations, pain, cognitive function, and influence of illness on the family. Patients have weekly consultation with doctor for first 2 months, then monthly consultation for 4 months. Participants reporting sleeping problems were supplemented with mianserin (atypical antipsychotic). Participants with too many side effects from sertraline were switched to mianserin","No","Not Applicable","Yes","Mixed","No","Not Applicable","No","No","No","No","No","Individual","In Person","Sertraline: 25 to 200mg; titration: initial dose 2 mg, increased in 25 to 50 mg increments every 1 to 2 weeks with maximum dose of 200 mg
Mianserin: 10 to 30 mg",,"Daily","24",,,,,,,,,,,"Sertraline: 95.2 mg
Mianserin: 14.4 mg","Sertraline: 58
Mianserin: 8",,"Community",,,"1","0.4101",,"0.5899","Terrorism/political violence/forced displacement",,"Medium","Buhmann CB, Nordentoft M, Ekstrom M, et al. The effect of flexible cognitive-behavioural therapy and medical treatment, including antidepressants on post-traumatic stress disorder and depression in traumatised refugees: pragmatic randomised controlled clinical trial. Br J Psychiatry. 2016 Mar;208(3):252-9. doi: 10.1192/bjp.bp.114.150961. PMID: 26541687.","46863","2019"
"buhmann2016_D","Mixed: Psychotherapy & pharmacotherapy","PTSD","Control",,"280","D","68",,"Waitlist","Waitlist",,"No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person",,,,"24",,,,,,,,,,,,,,"Community",,,"1","0.4101",,"0.5899","Terrorism/political violence/forced displacement",,"Medium","Buhmann CB, Nordentoft M, Ekstrom M, et al. The effect of flexible cognitive-behavioural therapy and medical treatment, including antidepressants on post-traumatic stress disorder and depression in traumatised refugees: pragmatic randomised controlled clinical trial. Br J Psychiatry. 2016 Mar;208(3):252-9. doi: 10.1192/bjp.bp.114.150961. PMID: 26541687.","46863","2019"
"butler2018_A","Psychotherapy","PTSD","PTSD",,"20","A","11",,"EMDR + PMR + group psychoeducation","Eye Movement Desensitization and Reprocessing (EMDR) + progressive muscle relaxation (PMR) + group psychoeducation","Individual trauma-specific therapy sessions using EMDR, plus relaxation therapy using PMR, and group psychoeducation sessions. Participants also had occupational therapy (100 minutes per day), sports therapy (50 minutes per day), and physiotherapy (100 minutes per week).","Yes","TF","No","Not Applicable","Yes","Relaxation","No","No","No","Yes","No","Individual","In Person",,"EMDR: 120 minutes;
PMR: 50 minutes;
Group psychoeducation: NR (total 250 minutes per week)","EMDR: twice per week; PMR: daily; Group psychoeducation: NR (total 250 minutes per week)","6",,"completed therapy","1",,,,,,,,,,,"Active Duty Military","1","0","0","0",,"1","Combat-related",,"High","Butler O, Willmund G, Gleich T, et al. Hippocampal gray matter increases following multimodal psychological treatment for combat-related post-traumatic stress disorder. Brain Behav. 2018 May;8(5):e00956. doi: 10.1002/brb3.956. PMID: 29761009.",,"2020"
"butler2018_B","Psychotherapy","PTSD","Control",,"20","B","9",,"Waitlist","Waitlist","Waiting list control group","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,,,,"6",,,,,,,,,,,,,,"Active Duty Military","1","0","0","0",,"1","Combat-related",,"High","Butler O, Willmund G, Gleich T, et al. Hippocampal gray matter increases following multimodal psychological treatment for combat-related post-traumatic stress disorder. Brain Behav. 2018 May;8(5):e00956. doi: 10.1002/brb3.956. PMID: 29761009.",,"2020"
"butollo2016_B","Psychotherapy","PTSD","PTSD",,"141","B","67","74 randomized to CPT, excluded 7 patients treated as pilot case","CPT","Cognitive Processing Therapy (CPT)","CBT targeting dysfunctional cognitions about the traumatic event, includes written exposure component.","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,,"Flexible treatment frequency",,"mean 6.37 [SD 2.36] months, maximum 24 sessions",,,,,,,"20.39","6.80",,,,,"Community",,,"1","0.6596",,"0.4404","Mixed","accidents, illness/medical procedure, other (""interpersonal"", ""loss"", not specified)","High","Butollo WH, Karl R, König J, et al. A randomized controlled clinical trial of dialogical exposure therapy versus cognitive processing therapy for adult outpatients suffering from PTSD after type I trauma in adulthood. Psychother Psychosom. 2016 Jan;85(1):16-26. doi: 10.1159/000440726. PMID: 26610167.","45076","2020"
"butollo2016_A","Psychotherapy","PTSD","PTSD",,"141","A","74",,"Dialogical Exposure Therapy","Dialogical Exposure Therapy","Based on gestalt therapy and consisted of 4 phases (safety, stability, confrontation, and integration). Therapist help patients identify and resolve the disruptions of contact so patient will be able to experience continuity of self and regain ability to shape interactions with the environment. Therapy includes exposure to traumatic event (confrontation phase)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,,"Flexible treatment frequency",,"mean 6.42 [SD 3.10] months, maximum 24 sessions",,,,,,,"20.15","6.99","up to 24",,,,"Community",,,"1","0.6596",,"0.4404","Mixed","accidents, illness/medical procedure, other (""interpersonal"", ""loss"", not specified)","High","Butollo WH, Karl R, König J, et al. A randomized controlled clinical trial of dialogical exposure therapy versus cognitive processing therapy for adult outpatients suffering from PTSD after type I trauma in adulthood. Psychother Psychosom. 2016 Jan;85(1):16-26. doi: 10.1159/000440726. PMID: 26610167.","45076","2020"
"butterfield2001_A","Pharmacotherapy","PTSD","PTSD",,"15","A","10",,"Olanzapine","Olanzapine","Atypical antipsychotic; binds to serotonin receptor subtypes with substantial affinities greater than its dopamine affinities. Effective serotonin receptor antagonist.","No","Not Applicable","Yes","Antipsychotic","No","Not Applicable","No","No","No","No","No","Individual","In Person","5 to 20 mg; titration: initial dose of 5 mg for 1 week, then 10 mg for 3 weeks, 15 mg for 2 weeks, up to potential maximum dose of 20 mg",,"Daily","10",,,,,,,,,,,"14.1 mg/day (mean peak daily dosage during study)",,,"Veteran","0","1","0","0.9333",,"0.0667","Mixed","MST, child physical abuse, rape/sexual assault, intimate partner violence, community/school violence, other (military harassment, ""nurse in Vietnam"", ""Persian Gulf"" [non-combat trauma])","Medium","Butterfield M, Becker M, Connor K, et al. Olanzapine in the treatment of post-traumatic stress disorder: a pilot study. Int Clin Psychopharmacol. 2001;16(4):197-203.  PMID: 11459333.","23547","2019"
"butterfield2001_B","Pharmacotherapy","PTSD","Control",,"15","B","5",,"Placebo","Placebo","Placebo","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person",,,"Once daily","10",,,,,,,,,,,"13.9 mg (mean peak daily dosage during study)",,,"Veteran","0","1","0","0.9333",,"0.0667","Mixed","MST, child physical abuse, rape/sexual assault, intimate partner violence, community/school violence, other (military harassment, ""nurse in Vietnam"", ""Persian Gulf"" [non-combat trauma])","Medium","Butterfield M, Becker M, Connor K, et al. Olanzapine in the treatment of post-traumatic stress disorder: a pilot study. Int Clin Psychopharmacol. 2001;16(4):197-203.  PMID: 11459333.","23547","2019"
"capone2018_A","Psychotherapy","PTSD+SUD","PTSD+SUD","Integrated","44","A","21",,"Integrated CBT","Integrated Cognitive Behavioral Therapy (ICBT)","Manual-guided intervention designed to improve both PTSD and substance use, adapted for veterans and delivered in both individual and group format (sessions 1-4 delivered individually and sessions 5-12 in group format).","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,,,,"total 12 sessions","attended ≥8 sessions","0.381",,,,,"5.48",,,,,,"Veteran","0","1","0","0.0455",,"0.9545","Mixed","MST, combat-related, child sexual abuse, rape/sexual assault","Medium","Capone C, Presseau C, Saunders E, et al. Is integrated CBT effective in reducing PTSD symptoms and substance use in Iraq and Afghanistan veterans? Results from a randomized clinical trial. Cognit Ther Res. 2018;42(6):735-46. doi: 10.1007/s10608-018-9931-8.","50582","2020"
"capone2018_B","Psychotherapy","PTSD+SUD","Control","Not integrated","44","B","23",,"TAU","Treatment as usual (TAU)","Continuation of ""usual VA care, such as medication management and individual or group psychotherapy in the substance use treatment program or PTSD clinics…""; trauma-focused treatments were not prohibited but more often treatments included skills training or supportive therapy.","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person",,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0.0455",,"0.9545","Mixed","MST, combat-related, child sexual abuse, rape/sexual assault","Medium","Capone C, Presseau C, Saunders E, et al. Is integrated CBT effective in reducing PTSD symptoms and substance use in Iraq and Afghanistan veterans? Results from a randomized clinical trial. Cognit Ther Res. 2018;42(6):735-46. doi: 10.1007/s10608-018-9931-8.","50582","2020"
"carey2012_A","Pharmacotherapy","PTSD","PTSD",,"34","A",,,"Olanzapine","Olanzapine","Second-generation antipsychotic","No","Not Applicable","Yes","Antipsychotic","No","Not Applicable","No","No","No","No","No","Individual","In Person","10 to 15 mg; titration: 5 mg for first week, 7.5 mg for second week, then 10 mg for 2 weeks, dose maintained for next 4 weeks or titrated up to 15 mg",,"Daily","8",,,,,,,,,,,,,,"Community",,,"1","0.6071",,"0.3929","Mixed","intimate partner violence, community/school violence","Medium","Carey P, Suliman S, Ganesan K, et al. Olanzapine monotherapy in posttraumatic stress disorder: efficacy in a randomized, double-blind, placebo-controlled study. Hum Psychopharmacol. 2012 Jul;27(4):386-91. doi: 10.1002/hup.2238. PMID: 22730105.","38996","2019"
"carey2012_B","Pharmacotherapy","PTSD","Control",,"34","B",,,"Placebo","Placebo","Matching placebo","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person",,,"Daily","8",,,,,,,,,,,,,,"Community",,,"1","0.6071",,"0.3929","Mixed","intimate partner violence, community/school violence","Medium","Carey P, Suliman S, Ganesan K, et al. Olanzapine monotherapy in posttraumatic stress disorder: efficacy in a randomized, double-blind, placebo-controlled study. Hum Psychopharmacol. 2012 Jul;27(4):386-91. doi: 10.1002/hup.2238. PMID: 22730105.","38996","2019"
"carlson1998_A","Mixed: Psychotherapy & CIH","PTSD","PTSD",,"35","A","10",,"EMDR","Eye Movement Desensitization and Reprocessing (EMDR)","Manual-based intervention according to Shapiro 1995. Each session included 20 to 28 back-and-forth motions while participants listened to traumatic scripts and focused on related images, negative cognitions and bodily sensations, and finally on the positive cognition","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"60 to 75 minutes","Twice weekly","6",,,,,,,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"Medium","Carlson JG, Chemtob CM, Rusnak K, et al. Eye Movement Desensitization and Reprocessing (EMDR) treatment for combat-related posttraumatic stress disorder. J Trauma Stress. 1998 Jan;11(1):3-24. doi: 10.1023/A:1024448814268. PMID: 9479673.","13921","2019"
"carlson1998_B","Mixed: Psychotherapy & CIH","PTSD","PTSD",,"35","B","13",,"Biofeedback-assisted relaxation","Biofeedback-assisted relaxation","Electromyographic electrode placement and feedback administration followed manualized protocol by Carlson, Basilio, & Heaukulani 1983. Biofeedback included a pure tone on the  headphones. Participants were also given a recorded cassette containing modified progressive relaxation instructions and written instructions for daily home use","No","Not Applicable","No","Not Applicable","Yes","Relaxation","No","No","No","No","No","Individual","In Person",,"40 minutes","Twice weekly","6",,,,,,,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"Medium","Carlson JG, Chemtob CM, Rusnak K, et al. Eye Movement Desensitization and Reprocessing (EMDR) treatment for combat-related posttraumatic stress disorder. J Trauma Stress. 1998 Jan;11(1):3-24. doi: 10.1023/A:1024448814268. PMID: 9479673.","13921","2019"
"carlson1998_C","Mixed: Psychotherapy & CIH","PTSD","Control",,"35","C","12",,"TAU waitlist","Treatment as usual (TAU)",,"No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,,,,"6",,,,,,,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"Medium","Carlson JG, Chemtob CM, Rusnak K, et al. Eye Movement Desensitization and Reprocessing (EMDR) treatment for combat-related posttraumatic stress disorder. J Trauma Stress. 1998 Jan;11(1):3-24. doi: 10.1023/A:1024448814268. PMID: 9479673.","13921","2019"
"carlsson2018_A","Psychotherapy","PTSD","PTSD",,"140","A","70",,"SIT","Stress Inoculation Training (SIT)","Manualized program including relaxation, attention diversion, and behavioral activation","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"45 to 60 minutes",,"24","16 sessions total","completed ≥8 sessions","0.7571",,,,,"11.3","4.1399999999999997",,,,,"Community",,,"1","0.4365",,"0.5635","Terrorism/political violence/forced displacement",,"Medium","Carlsson J, Sonne C, Vindbjerg E, et al. Stress management versus cognitive restructuring in trauma-affected refugees‚Äö√Ñ√Æa pragmatic randomised study. Psychiatry Res. 2018 Aug;266:116-23. doi: 10.1016/j.psychres.2018.05.015. PMID: 29859498","1519484","2019"
"carlsson2018_B","Psychotherapy","PTSD","PTSD",,"140","B","70",,"CR","Trauma-focused cognitive behavioral therapy (TF-CBT)","Manualized intervention consisting of psychoeducation and cognitive restructuring of negative thoughts resulting form traumatic experiences and exposure","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"45 to 60 minutes",,"24","16 sessions total",,,,,,,,,,,,,"Community",,,"1","0.4365",,"0.5635","Terrorism/political violence/forced displacement",,"Medium","Carlsson J, Sonne C, Vindbjerg E, et al. Stress management versus cognitive restructuring in trauma-affected refugees‚Äö√Ñ√Æa pragmatic randomised study. Psychiatry Res. 2018 Aug;266:116-23. doi: 10.1016/j.psychres.2018.05.015. PMID: 29859498","1519484","2019"
"carr2012_A","Complementary and integrative health (CIH)","PTSD","PTSD",,"17","A","9",,"Music Therapy","Music therapy","Manualized group music therapy employing methods used in psychodynamic music therapy, combination of active and receptive activities and emphasis on free improvisation. Patients were introduced to instruments and encouraged to improvise and therapists gave improvised instrumental support; verbal reflection on thoughts and feelings was encouraged; therapists used supportive psychotherapeutic interventions; personal statements about symptoms were highlighted and made relevant to the whole group.","No","Not Applicable","No","Not Applicable","Yes","Creative therapies","No","No","No","No","No","Group","In Person",,"1 hour","Weekly","10",,"attended ≥7 sessions","0.7778",,,,,"7",,"range 2 to 9",,,,"Community",,,"1","0.5625",,"0.4375","Mixed","child sexual abuse, rape/sexual assault, community/school violence, terrorism/political violence/forced displacement, other (torture)","Medium","Carr C, D'Ardenne P, Sloboda A, et al. Group music therapy for patients with persistent post-traumatic stress disorder -- an exploratory randomized controlled trial with mixed methods evaluation. Psychol Psychother. 2012 Jun;85(2):179-202. doi: 10.1111/j.2044-8341.2011.02026.x. PMID: 22903909.","39454","2019"
"carr2012_B","Complementary and integrative health (CIH)","PTSD","Control",,"17","B","8",,"Waitlist","Waitlist","Maintained on clinic caseload with access to mental health care; assessments conducted by telephone. Received music therapy intervention after waiting period and completion of end of evaluation assessment.","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,,,,"10",,,,,,,,,,,,,,"Community",,,"1","0.5625",,"0.4375","Mixed","child sexual abuse, rape/sexual assault, community/school violence, terrorism/political violence/forced displacement, other (torture)","Medium","Carr C, D'Ardenne P, Sloboda A, et al. Group music therapy for patients with persistent post-traumatic stress disorder -- an exploratory randomized controlled trial with mixed methods evaluation. Psychol Psychother. 2012 Jun;85(2):179-202. doi: 10.1111/j.2044-8341.2011.02026.x. PMID: 22903909.","39454","2019"
"carter2013_A","Complementary and integrative health (CIH)","PTSD","PTSD",,"31","A","16",,"Sudarshan Kriya Yoga","Yoga","Comprised of 3 rounds of cyclical breathing. Treatment also includes psychoeducation about stress reduction and group processes. Intervention consisted of a week-long workshop, followed by weekly group sessions for the first month and monthly group session for the next 5 months","No","Not Applicable","No","Not Applicable","Yes","Yoga","No","No","No","No","No","Group","In Person",,"22 hours total during weeklong workshop, 2 hours subsequent group session","Daily during weeklong workshop, weekly for subsequent 1 month, then monthly for next 5 months","24",,,,,,,,,,,,,,"Veteran","0","1","0","0",,"1",,,"Medium","Carter JJ, Gerbarg PL, Brown RP, et al. Multi-component yoga breath program for Vietnam veteran post traumatic stress disorder: randomized controlled trial. J Trauma Stress Disord Treat. 2013 Jul 31;2(3)doi: 10.4172/2324-8947.1000108.","46976","2019"
"carter2013_B","Complementary and integrative health (CIH)","PTSD","Control",,"31","B","15",,"Waitlist","Waitlist",,"No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,,,,"24",,,,,,,,,,,,,,"Veteran","0","1","0","0",,"1",,,"Medium","Carter JJ, Gerbarg PL, Brown RP, et al. Multi-component yoga breath program for Vietnam veteran post traumatic stress disorder: randomized controlled trial. J Trauma Stress Disord Treat. 2013 Jul 31;2(3)doi: 10.4172/2324-8947.1000108.","46976","2019"
"castillo2016_A","Psychotherapy","PTSD","PTSD",,"86","A","44",,"Group-delivered Cognitive/Exposure Therapy","Trauma-focused cognitive behavioral therapy (TF-CBT)","Three-module treatment including imaginal exposure (trauma narrative writing and identification of coping strategies), cognitive restructuring (from CPT), and behavioral skills development","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Group","In Person",,"90 minutes",,"16",,,,,,,,,,,,,,"Veteran",,"1",,"1",,"0","Mixed","MST, combat-related, other (not specified)","Medium","Castillo DT, Chee CL, Nason E, et al. Group-delivered cognitive/exposure therapy for PTSD in women veterans: a randomized controlled trial. Psychol Trauma. 2016 May;8(3):404-12. doi: 10.1037/tra0000111. PMID: 26854355.","44771","2019"
"castillo2016_B","Psychotherapy","PTSD","Control",,"86","B","42",,"Waitlist with minimal intervention","Supportive counseling","Unstructured, nondirective individual support, which excluded treatment such as trauma review, cognitive restructuring, or behavioral treatment techniques","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","Mixed",,"60 minutes","Bimonthly","16",,,,,,,,,,,,,,"Veteran",,"1",,"1",,"0","Mixed","MST, combat-related, other (not specified)","Medium","Castillo DT, Chee CL, Nason E, et al. Group-delivered cognitive/exposure therapy for PTSD in women veterans: a randomized controlled trial. Psychol Trauma. 2016 May;8(3):404-12. doi: 10.1037/tra0000111. PMID: 26854355.","44771","2019"
"celik2011_A","Pharmacotherapy","PTSD","PTSD",,"50","A","25",,"Paroxetine","Paroxetine","SSRI","No","Not Applicable","Yes","Antidepressant: SSRI","No","Not Applicable","No","No","No","No","No","Individual","In Person","60 mg; titration: initiated at 10 mg/day, increased by 10 mg every 2 weeks until 60 mg, then maintained for weeks 8 through 12 if tolerated and clinically indicated",,"Daily","12",,,,,,,,,,,,,,"Community",,,"1",,,,"Combat-related",,"High","Celik C, Ozdemir B, Ozmenler KN, et al. Efficacy of paroxetine and amitriptyline in posttraumatic stress disorder: an open-label comparative study. Klinik Psikofarmakol B√ºlteni. 2011 Sep;21(3):179-85. doi: 10.5455/bcp.20110627111141.","1519639","2019"
"celik2011_B","Pharmacotherapy","PTSD","PTSD",,"50","B","25",,"Amitriptyline","Amitriptyline","TCA","No","Not Applicable","Yes","Antidepressant: TCA","No","Not Applicable","No","No","No","No","No","Individual","In Person","Initiated at 25 mg/day for first 3 days, followed by 50 mg/day on days 4 to 7, then 75 mg/day for following 2 weeks. Dose could be increased to 100 mg/day as necessary for weeks 3 and 4, then to 200 mg/day at end of week 5",,"Daily","12",,,,,,,,,,,,,,"Community",,,"1",,,,"Combat-related",,"High","Celik C, Ozdemir B, Ozmenler KN, et al. Efficacy of paroxetine and amitriptyline in posttraumatic stress disorder: an open-label comparative study. Klinik Psikofarmakol B√ºlteni. 2011 Sep;21(3):179-85. doi: 10.5455/bcp.20110627111141.","1519639","2019"
"chard2005_A","Psychotherapy","PTSD","PTSD",,"71","A","36",,"CPT for sexual abuse survivor","Cognitive Processing Therapy (CPT)","Adapted from Resick & Schnicke's (1993) CPT manual to include schema-discrepant and schema-congruent beliefs, and a session on assertiveness/communications, sexual intimacy, and social support. Intervention included weekly group sessions and individual therapy session in the first 9 and last week of intervention","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Mixed","In Person",,"Group session: 90 minutes

Individual session: 60 minutes","Weekly","17",,,,,,,,,,,,,,"Community",,,"1","1",,"0","Child sexual abuse",,"Medium","Chard KM. An evaluation of cognitive processing therapy for the treatment of posttraumatic stress disorder related to childhood sexual abuse. J Consult Clin Psychol. 2005 Oct;73(5):965-71. doi: 10.1037/0022-006X.73.5.965. PMID: 16287396.","27944","2019"
"chard2005_B","Psychotherapy","PTSD","Control",,"71","B","35",,"Minimal attention waitlist","Minimal attention","Telephone call to assess current emotional state and give supportive, nondirective, brief counseling if experiencing a crisis","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","Telephone",,"5 to 10 minutes","Weekly","17",,,,,,,,,,,,,,"Community",,,"1","1",,"0","Child sexual abuse",,"Medium","Chard KM. An evaluation of cognitive processing therapy for the treatment of posttraumatic stress disorder related to childhood sexual abuse. J Consult Clin Psychol. 2005 Oct;73(5):965-71. doi: 10.1037/0022-006X.73.5.965. PMID: 16287396.","27944","2019"
"chung2004_A","Pharmacotherapy","PTSD","PTSD",,"113","A",,,"Mirtazapine","Mirtazapine","Atypical antidepressant (alpha-2 agonist); dose could be adjusted after 1, 2, and 6 weeks of treatment","No","Not Applicable","Yes","Antidepressant: Other","No","Not Applicable","No","No","No","No","No","Individual","In Person","Initiated at 15 mg; maximum dose NR",,"Daily","6",,,,,,,,,,,"38.5 mg/day","12.1",,"Veteran","0","1","0","0",,"1","Combat-related",,"High","Chung MY, Min KH, Jun YJ, et al. Efficacy and tolerability of mirtazapine and sertraline in Korean veterans with posttraumatic stress disorder: a randomized open label trial. Hum Psychopharmacol. 2004 Oct;19(7):489-94. doi: 10.1002/hup.615. PMID: 15378676.","26712","2019"
"chung2004_B","Pharmacotherapy","PTSD","PTSD",,"113","B",,,"Sertraline","Sertraline","SSRI; dose could be adjusted after 1, 2, and 6 weeks' therapy, maximum dose NR","No","Not Applicable","Yes","Antidepressant: SSRI","No","Not Applicable","No","No","No","No","No","Individual","In Person","Initiated at 50 mg; maximum dose NR",,"Daily","6",,,,,,,,,,,"115.3 mg/day","36.02",,"Veteran","0","1","0","0",,"1","Combat-related",,"High","Chung MY, Min KH, Jun YJ, et al. Efficacy and tolerability of mirtazapine and sertraline in Korean veterans with posttraumatic stress disorder: a randomized open label trial. Hum Psychopharmacol. 2004 Oct;19(7):489-94. doi: 10.1002/hup.615. PMID: 15378676.","26712","2019"
"church2013_A","Psychotherapy","PTSD","PTSD",,"59","A","30",,"Emotional Freedom Technique","Emotional Freedom Technique (EFT)","Brief exposure therapy with a somatic and cognitive component. The subject pairs the traumatic memory with a self-acceptance statement, then taps a sequence of points on his/her body repeatedly until subjective units of distress decreases to 0. All subjects also received the standard of care at VA.","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"1 hour",,"4","6 sessions total",,,,,,,,,,,,,"Veteran","0","1","0","0.1017",,"0.8983",,,"Medium","Church D, Hawk C, Brooks AJ, et al. Psychological trauma symptom improvement in veterans using Emotional Freedom Techniques. J Nerv Ment Dis. 2013 Feb;201(2):153-60. doi: 10.1097/NMD.0b013e31827f6351. PMID: 23364126.","40000","2019"
"church2013_B","Psychotherapy","PTSD","Control",,"59","B","29",,"Standard of care","Treatment as usual (TAU)",,"No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,,,,"4",,,,,,,,,,,,,,"Veteran","0","1","0","0.1017",,"0.8983",,,"Medium","Church D, Hawk C, Brooks AJ, et al. Psychological trauma symptom improvement in veterans using Emotional Freedom Techniques. J Nerv Ment Dis. 2013 Feb;201(2):153-60. doi: 10.1097/NMD.0b013e31827f6351. PMID: 23364126.","40000","2019"
"classen2001_A","Psychotherapy","PTSD","PTSD",,"58","A",,,"Trauma-focused or Present-focused group therapy","Trauma-focused cognitive behavioral therapy (TF-CBT)","Both treatment groups combined for analysis.

Trauma-focused group therapy: goal of treatment is to help survivors work through and integrate their traumatic abuse experiences; involves: reconstructing traumatic experiences; integrating the affect associated with the trauma; modifying negative views of self which arose due to the abuse; integration of traumatic history into conscious awareness of self and others.

Present-focused group therapy: goal to help survivors identify and modify maladaptive patterns of behavior which had arisen as a result of their traumatic past; treatment assumption that by focusing on the present, survivors can alter their current functioning and thereby address the impact of their abuse history.","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Group","In Person",,"90 minutes","Weekly","24",,,,,,,,,,,,,,"Community",,,"1","1","Sexual orientation
Heterosexual: 82.69%
Lesbian: 9.62%
Bisexual: 7.69%","0","Child sexual abuse",,"High","Classen CC, Koopman C, Nevill-Manning K, et al. A preliminary report comparing trauma-focused and present-focused group therapy against a wait-listed condition among childhood sexual abuse survivors with PTSD. J Aggress Maltreat Trauma. 2001 Jun;4(2):265-88. doi: 10.1300/J146v04n02_12.","16145","2019"
"classen2001_B","Psychotherapy","PTSD","Control",,"58","B",,,"Waitlist","Present Centered Therapy (PCT)",,"Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Group","In Person",,,,"24",,,,,,,,,,,,,,"Community",,,"1","1","Sexual orientation
Heterosexual: 82.69%
Lesbian: 9.62%
Bisexual: 7.69%","0","Child sexual abuse",,"High","Classen CC, Koopman C, Nevill-Manning K, et al. A preliminary report comparing trauma-focused and present-focused group therapy against a wait-listed condition among childhood sexual abuse survivors with PTSD. J Aggress Maltreat Trauma. 2001 Jun;4(2):265-88. doi: 10.1300/J146v04n02_12.","16145","2019"
"cloitre2010_A","Psychotherapy","PTSD","PTSD",,"104","A","33",,"STAIR + Exposure Treatment","Skills Training in Affect and Interpersonal Regulation (STAIR) + exposure therapy","STAIR (8 sessions) followed by exposure treatment (8 sessions). Exposure treatment was modified from prolonged exposure protocol with interpersonal skills practice instead of in vivo exposure to trauma stimuli, and meaning analysis introduced after the exposure.","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,,"Weekly","16",,"completed treatment course","0.85",,,,,,,,,,,"Community",,,"1","1",,"0","Mixed","child physical abuse, child sexual abuse, child other abuse, intimate partner violence, rape/sexual assault, community/school violence, other (""other interpersonal victimization"")","Medium","Cloitre M, Stovall-McClough KC, Nooner K, et al. Treatment for PTSD related to childhood abuse: a randomized controlled trial. Am J Psychiatry. 2010 Aug;167(8):915-24. doi: 10.1176/appi.ajp.2010.09081247. PMID: 20595411.","34562","2020"
"cloitre2010_B","Psychotherapy","PTSD","PTSD",,"104","B","38",,"STAIR + Supportive Counseling","Skills Training in Affect and Interpersonal Regulation (STAIR) + supportive therapy","STAIR (8 sessions) followed by supportive counseling (8 sessions). Supportive counseling with client-directed discussion of abuse history-related life problems.","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,,"Weekly","16",,"completed treatment course","0.74",,,,,,,,,,,"Community",,,"1","1",,"0","Mixed","child physical abuse, child sexual abuse, child other abuse, intimate partner violence, rape/sexual assault, community/school violence, other (""other interpersonal victimization"")","Medium","Cloitre M, Stovall-McClough KC, Nooner K, et al. Treatment for PTSD related to childhood abuse: a randomized controlled trial. Am J Psychiatry. 2010 Aug;167(8):915-24. doi: 10.1176/appi.ajp.2010.09081247. PMID: 20595411.","34562","2020"
"cloitre2010_C","Psychotherapy","PTSD","PTSD",,"104","C","33",,"Supportive Counseling + Exposure Treatment","Supportive counseling + exposure","Supportive counseling (8 sessions) and exposure treatment (8 sessions). Supportive counseling with client-directed discussion of abuse history-related life problems. Exposure treatment was modified from prolonged exposure protocol with interpersonal skills practice instead of in vivo exposure to trauma stimuli, and meaning analysis introduced after the exposure.","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,,"Weekly","16",,"completed treatment course","0.61",,,,,,,,,,,"Community",,,"1","1",,"0","Mixed","child physical abuse, child sexual abuse, child other abuse, intimate partner violence, rape/sexual assault, community/school violence, other (""other interpersonal victimization"")","Medium","Cloitre M, Stovall-McClough KC, Nooner K, et al. Treatment for PTSD related to childhood abuse: a randomized controlled trial. Am J Psychiatry. 2010 Aug;167(8):915-24. doi: 10.1176/appi.ajp.2010.09081247. PMID: 20595411.","34562","2020"
"cloitre2002_A","Psychotherapy","PTSD","PTSD",,"58","A","31",,"STAIR + modified PE","Skills Training in Affect and Interpersonal Regulation (STAIR) plus modified Prolonged Exposure (PE)","STAIR is CBT targeting development of emotion management and interpersonal skills. Topics include labeling and identifying feelings, emotion management, distress tolerance, acceptance of feelings, identification of trauma-based interpersonal schemas and conflict between trauma-generated feelings and current interpersonal goals, and role play related to issue of power and control. PE followed technique described by Foa & Rothbaum (1998), except in vivo exposure to rape-related cues was eliminated, while postexposure stabilization check, postexposure emotion-focused processing, and identification of negative interpersonal schemas and addressed with skills from STAIR.","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"STAIR: 1 hour; Modified PE: 1.5 hour","STAIR: weekly; Modified PE: twice weekly","12",,,,,,,,,,,,,,"Community",,,"1","1",,"0","Mixed","child physical abuse, child sexual abuse","Medium","Cloitre M, Koenen KC, Cohen LR, et al. Skills training in affective and interpersonal regulation followed by exposure: a phase-based treatment for PTSD related to childhood abuse. J Consult Clin Psychol. 2002 Oct;70(5):1067-74. doi: 10.1037//0022-006X.70.5.1067. PMID: 12362957.","24762","2019"
"cloitre2002_B","Psychotherapy","PTSD","Control",,"58","B","27",,"Minimal attention","Minimal attention","Study coordinator monitored participants through phone session","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","Phone",,"15 minutes","Weekly","12",,,,,,,,,,,,,,"Community",,,"1","1",,"0","Mixed","child physical abuse, child sexual abuse","Medium","Cloitre M, Koenen KC, Cohen LR, et al. Skills training in affective and interpersonal regulation followed by exposure: a phase-based treatment for PTSD related to childhood abuse. J Consult Clin Psychol. 2002 Oct;70(5):1067-74. doi: 10.1037//0022-006X.70.5.1067. PMID: 12362957.","24762","2019"
"coffey2006_A","Psychotherapy","PTSD","PTSD",,"43","A",,,"Imaginal Exposure","Imaginal exposure","Manualized intervention according to Foa & Rothbaum 1998. Intervention includes participants repeatedly describe their trauma. All participants received outpatient substance use treatment, which included three times per week group coping-skills-based therapy for addiction and once every 1 or 2 weeks individual treatment for addition.","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"60 minutes",,,"6 sessions total","attending all laboratory and clinical sessions","0.50",,,,,,,,,,,"Community",,,"1","0.6744",,"0.3256","Mixed","child physical abuse, child sexual abuse","High","Coffey SF, Stasiewicz PR, Hughes PM, et al. Trauma-focused imaginal exposure for individuals with comorbid posttraumatic stress disorder and alcohol dependence: revealing mechanisms of alcohol craving in a cue reactivity paradigm. Psychol Addict Behav. 2006 Dec;20(4):425-35. doi: 10.1037/0893-164X.20.4.425. PMID: 17176177.","34482","2019"
"coffey2006_B","Psychotherapy","PTSD","Control",,"43","B",,,"Relaxation","Relaxation","Participants listened to an imagery-based relaxation audiotape during treatment session","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person",,"60 minutes",,,"6 sessions total","attending all laboratory and clinical sessions","0.60",,,,,,,,,,,"Community",,,"1","0.6744",,"0.3256","Mixed","child physical abuse, child sexual abuse","High","Coffey SF, Stasiewicz PR, Hughes PM, et al. Trauma-focused imaginal exposure for individuals with comorbid posttraumatic stress disorder and alcohol dependence: revealing mechanisms of alcohol craving in a cue reactivity paradigm. Psychol Addict Behav. 2006 Dec;20(4):425-35. doi: 10.1037/0893-164X.20.4.425. PMID: 17176177.","34482","2019"
"coffey2016_A","Psychotherapy","PTSD","PTSD+SUD","Not integrated","126","A","40",,"Modified PE with trauma-focused motivational enhancement session, plus standard SUD TAU","Motivational enhancement session followed by modified Prolonged Exposure (PE) + standard substance use treatment as usual","Prior to first PE session, participants received a 90-minute motivational enhancement therapy consisting of eliciting/developing discrepancy, presenting feedback, and future directions. Traditional PE according to Foa et al. (2007) consisting of imaginal and in vivo exposure techniques, psychoeducation about PTSD and its relationship with SUD, and breathing retraining. If participant's PTSD symptoms did not decrease by 70% by the end of 9 sessions, additional 3 sessions were offered. Standard SUD treatment consisted of daily group therapy for 3 hours, daily recreation therapy, Alcohol Anonymous and Narcotics Anonymous meetings, individual drug counseling sessions, and completion of drug counseling homework.","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"60 minutes","Twice weekly","5 to 8",,"completed ≥8 sessions","0.60",,,,,,,,,,,"Community",,,"1","0.4603",,"0.5397","Mixed","child sexual abuse, child physical abuse, rape/sexual assault, accidents, natural or manmade disasters","Medium","Coffey SF, Schumacher JA, Nosen E, et al. Trauma-focused exposure therapy for chronic posttraumatic stress disorder in alcohol and drug dependent patients: a randomized controlled trial. Psychol. Addict Behav. 2016 Nov;30(7):778-90. doi: 10.1037/adb0000201. PMID: 27786516.","48230","2019"
"coffey2016_B","Psychotherapy","PTSD","PTSD+SUD","Not integrated","126","B","45",,"Modified PE plus standard SUD TAU","Prolonged Exposure (PE)","Prior to first PE session, participants received a 60-minute relaxation session. Traditional PE according to Foa et al. (2007) consisting of imaginal and in vivo exposure techniques, psychoeducation about PTSD and its relationship with SUD, and breathing retraining. If participant's PTSD symptoms did not decrease by 70% by the end of 9 sessions, additional 3 sessions were offered. Standard SUD treatment consisted of daily group therapy for 3 hours, daily recreation therapy, Alcohol Anonymous and Narcotics Anonymous meetings, individual drug counseling sessions, and completion of drug counseling homework.","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"60 minutes","Twice weekly","5 to 8",,"completed ≥8 sessions","0.6222",,,,,,,,,,,"Community",,,"1","0.4603",,"0.5397","Mixed","child sexual abuse, child physical abuse, rape/sexual assault, accidents, natural or manmade disasters","Medium","Coffey SF, Schumacher JA, Nosen E, et al. Trauma-focused exposure therapy for chronic posttraumatic stress disorder in alcohol and drug dependent patients: a randomized controlled trial. Psychol. Addict Behav. 2016 Nov;30(7):778-90. doi: 10.1037/adb0000201. PMID: 27786516.","48230","2019"
"coffey2016_C","Psychotherapy","PTSD","SUD",,"126","C","41",,"Healthy lifestyle sessions plus standard SUD TAU","Healthy lifetsyle session +  substance use treatment as usual","Prior to first education session, participants received a 60-minute relaxation session. Education on health-related topics included sleep hygiene, progressive muscle relaxation, starting/maintaining an exercise program, personal role identification, healthy eating and nutrition, diabetes, monitoring goals and values, cancer, and HIV. If participant's PTSD symptoms did not decrease by 70% by the end of Session 9, additional 3 sessions were offered. Standard SUD treatment consisted of daily group therapy for 3 hours, daily recreation therapy, Alcohol Anonymous and Narcotics Anonymous meetings, individual drug counseling sessions, and completion of drug counseling homework.","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person",,"60 minutes","Twice weekly","5 to 8",,"completed ≥8 sessions","0.8537",,,,,,,,,,,"Community",,,"1","0.4603",,"0.5397","Mixed","child sexual abuse, child physical abuse, rape/sexual assault, accidents, natural or manmade disasters","Medium","Coffey SF, Schumacher JA, Nosen E, et al. Trauma-focused exposure therapy for chronic posttraumatic stress disorder in alcohol and drug dependent patients: a randomized controlled trial. Psychol. Addict Behav. 2016 Nov;30(7):778-90. doi: 10.1037/adb0000201. PMID: 27786516.","48230","2019"
"cohen2004_A","Nonpharmacologic biological","PTSD","PTSD",,"29","A","10",,"Low frequency rTMS","Transcranial magnetic stimualtion (TMS)","rTMS performed with Magstim stimulator with 9-cm diameter. Motor threshold was determined in each subject once which was defined as lowest stimulation intensity capable of inducing a visible movement at least five times out of 10. 

Treatment was administered over the right dorsolateral prefrontal cortex (defined as 5 cm anterior to the motor cortex - following a parasagittal line)

Stimulus intensity was 80% of subject's motor threshold intensity","No","Not Applicable","No","Not Applicable","No","Not Applicable","Yes","No","No","No","No","Individual","In Person","1 Hz for 5 seconds with intertrain interval of 55 seconds","20 minutes","Once daily on weekdays","2",,,,,,,,,,,,,,"Community",,,"1","0.29",,"0.71","Mixed","combat-related, accidents, rape/sexual assault, community/school violence, other (occupational, unexpected death of relative)","High","Cohen H, Kaplan Z, Kotler M, et al. Repetitive transcranial magnetic stimulation of the right dorsolateral prefrontal cortex in posttraumatic stress disorder: a double-blind, placebo-controlled study. Am J Psychiatry. 2004 Mar;161(3):515-24. doi: 10.1176/appi.ajp.161.3.515. PMID: 14992978.","26291","2019"
"cohen2004_B","Nonpharmacologic biological","PTSD","PTSD",,"29","B","11",,"High frequency rTMS","Transcranial magnetic stimualtion (TMS)","rTMS performed with Magstim stimulator with 9-cm diameter. Motor threshold was determined in each subject once which was defined as lowest stimulation intensity capable of inducing a visible movement at least five times out of 10. 

Treatment was administered over the right dorsolateral prefrontal cortex (defined as 5 cm anterior to the motor cortex - following a parasagittal line)

Stimulus intensity was 80% of subject's motor threshold intensity.","No","Not Applicable","No","Not Applicable","No","Not Applicable","Yes","No","No","No","No","Individual","In Person","1 Hz for 2 seconds per train with intertrain interval of 55 seconds","Session length: 20 minutes","Once daily on weekdays","2",,,,,,,,,,,,,,"Community",,,"1","0.29",,"0.71","Mixed","combat-related, accidents, rape/sexual assault, community/school violence, other (occupational, unexpected death of relative)","High","Cohen H, Kaplan Z, Kotler M, et al. Repetitive transcranial magnetic stimulation of the right dorsolateral prefrontal cortex in posttraumatic stress disorder: a double-blind, placebo-controlled study. Am J Psychiatry. 2004 Mar;161(3):515-24. doi: 10.1176/appi.ajp.161.3.515. PMID: 14992978.","26291","2019"
"cohen2004_C","Nonpharmacologic biological","PTSD","Control",,"29","C","8",,"Sham rTMS","Sham","Sham rTMS","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person",,"20 minutes","Once daily on weekdays","2",,"completed 10 sessions with properly calibrated machine","0.75",,,,,,,,,,,"Community",,,"1","0.29",,"0.71","Mixed","combat-related, accidents, rape/sexual assault, community/school violence, other (occupational, unexpected death of relative)","High","Cohen H, Kaplan Z, Kotler M, et al. Repetitive transcranial magnetic stimulation of the right dorsolateral prefrontal cortex in posttraumatic stress disorder: a double-blind, placebo-controlled study. Am J Psychiatry. 2004 Mar;161(3):515-24. doi: 10.1176/appi.ajp.161.3.515. PMID: 14992978.","26291","2019"
"connor1999_A","Pharmacotherapy","PTSD","PTSD",,"54","A","27",,"Fluoxetine","Fluoxetine","SSRI; increased by 10 mg per week to maximum 60 mg/day based on response and tolerability","No","Not Applicable","Yes","Antidepressant: SSRI","No","Not Applicable","No","No","No","No","No","Individual","In Person","10 to 60 mg; titration: initiated at 10 mg, increased by 10 mg per week to maximum 60 mg",,"Daily","12",,,,,"Pill counts",,"95-99% for both groups",,,,,,"Median 30 mg (IQR 20 to 40 mg)","Community","0","0","1","0.91",,"0.09","Mixed","rape/sexual assault, accidents, illness/medical procedure, community/school violence, natural or manmade disasters. other (traumatic bereavement, father in intensive care unit, witnessed emotional abuse)","Medium","Connor KM, Sutherland SM, Tupler LA, et al. Fluoxetine in post-traumatic stress disorder: randomised, double-blind study. Br J Psychiatry. 1999 Jul;175:17-22.  PMID: 10621763.","21108","2019"
"connor1999_B","Pharmacotherapy","PTSD","Control",,"54","B","27",,"Placebo","Placebo","Capsules matched fluoxetine and titration schedule the same","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","Initiated at 10 mg, titrated to maximum 60 mg",,"Daily","12",,,,,"Pill counts",,"95-99% for both groups",,,,,,"Median 40 mg equivalent (IQR 20 to 50 mg)","Community","0","0","1","0.91",,"0.09","Mixed","rape/sexual assault, accidents, illness/medical procedure, community/school violence, natural or manmade disasters. other (traumatic bereavement, father in intensive care unit, witnessed emotional abuse)","Medium","Connor KM, Sutherland SM, Tupler LA, et al. Fluoxetine in post-traumatic stress disorder: randomised, double-blind study. Br J Psychiatry. 1999 Jul;175:17-22.  PMID: 10621763.","21108","2019"
"connor2006_A","Pharmacotherapy","PTSD","PTSD",,"18","A","10",,"Tiagabine","Tiagabine","Selective GABA reuptake inhibitor; initial 12-week open-label tiagabine treatment for all patients, those with at least minimal response or better on CGI-I scale randomized for continuation at same dose","No","Not Applicable","Yes","Mood Stabilizer","No","Not Applicable","No","No","No","No","No","Individual","In Person","2 to 16 mg; continued dose established in open-label phase (open-label phase titration: 2 mg for 1 week then increased by 4 mg increments per week with maximum 16 mg)",,"Daily","12",,,,,,,,,,,"10.8 mg/day",,,"Community",,,"1","0.7308",,"0.2692","Mixed","combat-related, rape/sexual assault, accidents, community/school violence, other (unexpected death of or threat of harm to a loved one; unwanted therapeutic abortion)","High","Connor KM, Davidson JRT, Weisler RH, et al. Tiagabine for posttraumatic stress disorder: effects of open-label and double-blind discontinuation treatment. Psychopharmacology (Berl). 2006 Jan;184(1):21-5. doi: 10.1007/s00213-005-0265-3. PMID: 16341846.","29324","2019"
"connor2006_B","Pharmacotherapy","PTSD","Control",,"18","B","8",,"Placebo","Placebo","Matched placebo. Followed 12-week open-label tiagabine period, with those randomized to placebo tapered off tiagabine by 2 mg every 3 days.","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person",,,"Daily","12",,,,,,,,,,,"10.5 mg tiagabine equivalent",,,"Community",,,"1","0.7308",,"0.2692","Mixed","combat-related, rape/sexual assault, accidents, community/school violence, other (unexpected death of or threat of harm to a loved one; unwanted therapeutic abortion)","High","Connor KM, Davidson JRT, Weisler RH, et al. Tiagabine for posttraumatic stress disorder: effects of open-label and double-blind discontinuation treatment. Psychopharmacology (Berl). 2006 Jan;184(1):21-5. doi: 10.1007/s00213-005-0265-3. PMID: 16341846.","29324","2019"
"cook2010_A","Psychotherapy","PTSD","PTSD",,"124","A","61",,"Imagery Rehearsal","Imagery Rehearsal Training (IRT)","Veterans chose a repetitive nightmare related to their war-zone experiences, alter the nightmare script during waking hours using imagery techniques, and mentally research the revised script daily","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"90 minutes","Weekly","6",,"completed 5 out of 6 sessions","0.6393",,,,,"4.10","2.29",,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"Medium","Cook JM, Harb GC, Gehrman PR, et al. Imagery rehearsal for posttraumatic nightmares: a randomized controlled trial. J Trauma Stress. 2010 Oct;23(5):553-63. doi: 10.1002/jts.20569. PMID: 20839311.","84153","2019"
"cook2010_B","Psychotherapy","PTSD","PTSD",,"124","B","63",,"Sleep and nightmare management","Sleep and nightmare management","Contains psychoeducation about PTSD nightmares and sleep disturbances and elements of CBT for insomnia","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"90 minutes","Weekly","6",,"completed 5 out of 6 sessions","0.8095",,,,,"5.05","1.66",,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"Medium","Cook JM, Harb GC, Gehrman PR, et al. Imagery rehearsal for posttraumatic nightmares: a randomized controlled trial. J Trauma Stress. 2010 Oct;23(5):553-63. doi: 10.1002/jts.20569. PMID: 20839311.","84153","2019"
"cottraux2008_A","Psychotherapy","PTSD","PTSD",,"60","A","31",,"CBT","Trauma-focused cognitive behavioral therapy (TF-CBT)","Standard therapy including imaginal or in vivo exposure, relaxation techniques, and cognitive therapy targeting anxious cognitions, automatic thoughts, dysfunctional beliefs, vulnerability schemas and emotions related to the trauma","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"1 to 2 hours",,"16","10 to 16 sessions total",,,,,,,,,,,,,"Community",,,"1","0.7619",,"0.2381","Mixed","rape/sexual assault, accidents, illness/medical procedure, community/school violence, other (not specified)","Medium","Cottraux J, Note I, Yao S-N, et al. Randomized controlled comparison of cognitive behavior therapy with Rogerian supportive therapy in chronic post-traumatic stress disorder: a 2-year follow-up. Psychother Psychosom. 2008 Jan;77(2):101-10. doi: 10.1159/000112887. PMID: 18230943.","30573","2019"
"cottraux2008_B","Psychotherapy","PTSD","Control",,"60","B","29",,"Rogerian supportive therapy","Supportive counseling","Therapy does not include any active component of CBT (e.g., relaxation, exposure advice, structured cognitive therapy). Therapist used active listening with an empathic attitude, and had unconditionally positive regard for the patients. Therapist reassured patients when they expressed anxiety and emphasize the importance to ventilate problems verbally","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"1 hour","Weekly","16",,,,,,,,,,,,,,"Community",,,"1","0.7619",,"0.2381","Mixed","rape/sexual assault, accidents, illness/medical procedure, community/school violence, other (not specified)","Medium","Cottraux J, Note I, Yao S-N, et al. Randomized controlled comparison of cognitive behavior therapy with Rogerian supportive therapy in chronic post-traumatic stress disorder: a 2-year follow-up. Psychother Psychosom. 2008 Jan;77(2):101-10. doi: 10.1159/000112887. PMID: 18230943.","30573","2019"
"davidson1990_A","Pharmacotherapy","PTSD","PTSD",,"46","A","25",,"Amitriptyline","Amitriptyline","TCA; variable dose with initial titration over 2 weeks followed by increase if necessary and tolerated; both groups received supportive therapy and medication management","No","Not Applicable","Yes","Antidepressant: TCA","No","Not Applicable","No","No","No","No","No","Individual","In Person","50 to 300 mg variable dose; titration: 50 mg increased in 25 mg increments to 100 mg over 1 week, by 50 mg increments to 200 mg over the following week, then increased if necessary as tolerated",,"Daily","8",,,,,,,,,,,"169 mg/day",,,"Veteran","0","1","0",,,,"Combat-related",,"High","Davidson J, Kudler H, Smith R, et al. Treatment of posttraumatic stress disorder with amitriptyline and placebo. Arch Gen Psychiatry. 1990 Mar;47(3):259-66. PMID: 2407208.","00912","2019"
"davidson1990_B","Pharmacotherapy","PTSD","Control",,"46","B","21",,"Placebo","Placebo","Placebo; both groups received supportive therapy and medication management","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person",,,"Daily","8",,,,,,,,,,,"237 mg amitriptyline equivalent",,,"Veteran","0","1","0",,,,"Combat-related",,"High","Davidson J, Kudler H, Smith R, et al. Treatment of posttraumatic stress disorder with amitriptyline and placebo. Arch Gen Psychiatry. 1990 Mar;47(3):259-66. PMID: 2407208.","00912","2019"
"davidson2001_A","Pharmacotherapy","PTSD","PTSD",,"208","A","100",,"Sertraline","Sertraline","Flexible dose sertraline based on clinical response and tolerability with 1 week run-in period at 25 mg dose.","No","Not Applicable","Yes","Antidepressant: SSRI","No","Not Applicable","No","No","No","No","No","Individual","In Person","50 to 200 mg; titration: 1 week run-in at 25 mg",,"Daily","12",,,,,"pill counts of returned medication",,,,,,"146 mg/day","49.3",,"Community",,,"1","0.7788",,"0.2212","Mixed","accidents, rape/sexual assault, combat-related, natural or manmade disasters, community/school violence, other (""seeing someone hurt or die"", ""other event"")","Medium","Davidson JR, Rothbaum BO, van der Kolk BA, et al. Multicenter, double-blind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder. Arch Gen Psychiatry. 2001 May;58(5):485-92. PMID: 11343529.","23358","2019"
"davidson2001_B","Pharmacotherapy","PTSD","Control",,"208","B","108",,"Placebo","Placebo","Matched placebo","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person",,,"Daily","12",,,,,"pill counts of returned medication",,,,,,,,,"Community",,,"1","0.7788",,"0.2212","Mixed","accidents, rape/sexual assault, combat-related, natural or manmade disasters, community/school violence, other (""seeing someone hurt or die"", ""other event"")","Medium","Davidson JR, Rothbaum BO, van der Kolk BA, et al. Multicenter, double-blind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder. Arch Gen Psychiatry. 2001 May;58(5):485-92. PMID: 11343529.","23358","2019"
"davidson2003_A","Pharmacotherapy","PTSD","PTSD",,"29","A","17",,"Mirtazapine","Mirtazapine","Atypical antidepressant","No","Not Applicable","Yes","Antidepressant: Other","No","Not Applicable","No","No","No","No","No","Individual","In Person","45 mg; titration: 15 mg starting dose titrated weekly up to 45 mg",,"Once daily","8",,,,,,,,,,,"38.82 mg/day",,,"Community",,,"1",,"65.00% of 8-week completers",,"Mixed","child sexual abuse, community/school violence, combat-related, accidents, other (non-specified)","Medium","Davidson JR, Weisler RH, Butterfield MI, et al. Mirtazapine vs. placebo in posttraumatic stress disorder: a pilot trial. Biol Psychiatry. 2003 Jan 15;53(2):188-91. PMID: 12547477.","25290","2019"
"davidson2003_B","Pharmacotherapy","PTSD","Control",,"29","B","9",,"Placebo","Placebo","Placebo","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person",,,"Once daily","8",,,,,,,,,,,,,,"Community",,,"1",,"65.00% of 8-week completers",,"Mixed","child sexual abuse, community/school violence, combat-related, accidents, other (non-specified)","Medium","Davidson JR, Weisler RH, Butterfield MI, et al. Mirtazapine vs. placebo in posttraumatic stress disorder: a pilot trial. Biol Psychiatry. 2003 Jan 15;53(2):188-91. PMID: 12547477.","25290","2019"
"davidson2006a_A","Pharmacotherapy","PTSD","PTSD",,"329","A","161",,"Venlafaxine extended release","Venlafaxine","Extended release SNRI; flexible dosing based on tolerability titrated to achieve remission (CAPS-SX17 ≤ 20)","No","Not Applicable","Yes","Antidepressant: SNRI","No","Not Applicable","No","No","No","No","No","Individual","In Person","75 to 300 mg flexible dosing; titration: lead-in dose 37.5 mg increased to maximum doses of 75 mg at day 5, 150 mg at day 14, 225 mg at day 28, and 300 mg at day 42",,"Daily","24",,,,,,,,,,,"Mean average daily: 181.7 mg/day
Mean maximum: 221.5 mg/day",,,"Community",,,"1","0.541",,"0.459","Mixed","combat-related, child sexual abuse, rape/sexual assault, accidents, natural or manmade disasters, other (nonsexual abuse, witnessing unexpected death)","Medium","Davidson JRT, Baldwin DV, Stein DJ, et al. Treatment of posttraumatic stress disorder with venlafaxine extended release: a 6-month randomized controlled trial. Arch Gen Psychiatry. 2006 Oct;63(10):1158-65. doi: 10.1001/archpsyc.63.10.1158. PMID: 17015818.","28838","2019"
"davidson2006a_B","Pharmacotherapy","PTSD","Control",,"329","B","168",,"Placebo","Placebo","Placebo","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person",,,"Daily","24",,,,,,,,,,,,,,"Community",,,"1","0.541",,"0.459","Mixed","combat-related, child sexual abuse, rape/sexual assault, accidents, natural or manmade disasters, other (nonsexual abuse, witnessing unexpected death)","Medium","Davidson JRT, Baldwin DV, Stein DJ, et al. Treatment of posttraumatic stress disorder with venlafaxine extended release: a 6-month randomized controlled trial. Arch Gen Psychiatry. 2006 Oct;63(10):1158-65. doi: 10.1001/archpsyc.63.10.1158. PMID: 17015818.","28838","2019"
"davidson2006b_A","Pharmacotherapy","PTSD","PTSD",,"538","A","179",,"Venlafaxine extended release","Venlafaxine","Extended release SNRI; flexible dosing 75 to 300 mg based on efficacy and tolerability to achieve remission (CAPS-SX17 score ≤20)","No","Not Applicable","Yes","Antidepressant: SNRI","No","Not Applicable","No","No","No","No","No","Individual","In Person","75 to 300 mg; titration: 37.5 mg lead-in dose, increased to maximum daily dose of 75 mg at day 5, 150 mg at day 14, 225 mg at day 28, and 300 mg at day 42.",,"Daily","12",,,,,,,,,,,"Mean average daily: 164.4 mg/day
Mean maximum: 224.6 mg/day",,,"Community",,,"1",,,,"Mixed","combat-related, child sexual abuse, rape/sexual assault, accidents, community/school violence, other (""unexpected death"")","Medium","Davidson JRT, Rothbaum BO, Tucker PM, et al. Venlafaxine extended release in posttraumatic stress disorder: a sertraline- and placebo-controlled study. J Clin Psychopharmacol. 2006 Jun 1;26(3):259-67. doi: 10.1097/01.jcp.0000222514.71390.c1. PMID: 16702890.","28788","2019"
"davidson2006b_B","Pharmacotherapy","PTSD","PTSD",,"538","B","173",,"Sertraline","Sertraline","SSRI; flexible dose following within-label dosing guidelines for sertraline for PTSD; lead-in dose of 25 mg/day, increased based on efficacy and tolerability to achieve remission (CAPS-SX17 score ≤20) with maximum doses of 50 mg/day at day 5, 100 mg/day at day 14, 150 mg/day at day 28, and 200 mg/d at day 42.","No","Not Applicable","Yes","Antidepressant: SSRI","No","Not Applicable","No","No","No","No","No","Individual","In Person","50 to 200 mg; titration: 25 mg lead-in dose, increased to maximum daily dose of 50mg at day 5, 100 mg at day 14, 150 mg at day 28, and 200 mg at day 42.",,"Daily","12",,,,,,,,,,,"Mean average daily: 110.2 mg/day
Mean maximum: 151.4 mg/day",,,"Community",,,"1",,,,"Mixed","combat-related, child sexual abuse, rape/sexual assault, accidents, community/school violence, other (""unexpected death"")","Medium","Davidson JRT, Rothbaum BO, Tucker PM, et al. Venlafaxine extended release in posttraumatic stress disorder: a sertraline- and placebo-controlled study. J Clin Psychopharmacol. 2006 Jun 1;26(3):259-67. doi: 10.1097/01.jcp.0000222514.71390.c1. PMID: 16702890.","28788","2019"
"davidson2006b_C","Pharmacotherapy","PTSD","Control",,"538","C","179",,"Placebo","Placebo","Placebo","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person",,,"Daily","12",,,,,,,,,,,,,,"Community",,,"1",,,,"Mixed","combat-related, child sexual abuse, rape/sexual assault, accidents, community/school violence, other (""unexpected death"")","Medium","Davidson JRT, Rothbaum BO, Tucker PM, et al. Venlafaxine extended release in posttraumatic stress disorder: a sertraline- and placebo-controlled study. J Clin Psychopharmacol. 2006 Jun 1;26(3):259-67. doi: 10.1097/01.jcp.0000222514.71390.c1. PMID: 16702890.","28788","2019"
"davidson2007_A","Pharmacotherapy","PTSD","PTSD",,"232","A","116",,"Tiagabine","Tiagabine","Anticonvulsant; during titration, doses were increased unless medication adverse events, not expected to increase efficacy, or not desired by the patient.","No","Not Applicable","Yes","Mood Stabilizer","No","Not Applicable","No","No","No","No","No","Individual","In Person","16 mg; titration: 4 mg/day for 1 week, individually titrated in up to 4 mg increments weekly to maximum of 16 mg, no dose increases after week 6",,"Twice daily","12",,,,,,,,,,,"11.2 mg/day",,,"Community",,,"1","0.66",,"0.34","Mixed","rape/sexual assault, community/school violence, accidents, combat-related, natural or manmade disasters, other (non-specified)","Medium","Davidson JR, Brady K, Mellman TA, et al. The efficacy and tolerability of tiagabine in adult patients with post-traumatic stress disorder. J Clin Psychopharmacol. 2007 Feb;27(1):85-8. doi: 10.1097/JCP.0b013e31802e5115. PMID: 17224720.","29658","2019"
"davidson2007_B","Pharmacotherapy","PTSD","Control",,"232","B","116",,"Placebo","Placebo","Placebo","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person",,,"Twice daily","12",,,,,,,,,,,"11.8 mg/day equivalent",,,"Community",,,"1","0.66",,"0.34","Mixed","rape/sexual assault, community/school violence, accidents, combat-related, natural or manmade disasters, other (non-specified)","Medium","Davidson JR, Brady K, Mellman TA, et al. The efficacy and tolerability of tiagabine in adult patients with post-traumatic stress disorder. J Clin Psychopharmacol. 2007 Feb;27(1):85-8. doi: 10.1097/JCP.0b013e31802e5115. PMID: 17224720.","29658","2019"
"davis2018b_A","Pharmacotherapy","PTSD","PTSD",,"214","A","107",,"MBSR","Mindfulness-based stress reduction (MBSR)","MBSR sessions included body scan meditation, sitting meditation, and mindful stretching. Six-hour retreat prior to week 6 included extended practices and mindful walking and eating. Participants given two guided meditation CDs to practice at home.","No","Not Applicable","No","Not Applicable","Yes","Meditation","No","No","No","No","No","Group","In Person",,"Sessions: 90 minutes; Retreat: 6 hours","Sessions: weekly; Retreat: once","8",,"completed all 8 sessions","0.2195",,,,,,,,,,,"Veteran","0","1","0","0.162",,"0.838","Mixed","Combat-related; Rape/sexual assault; Other (noncombat military, civilian)","Low","Davis LL, Whetsell C, Hamner MB, et al. A multisite randomized controlled trial of mindfulness-based stress reduction in the treatment of posttraumatic stress disorder. Psychiatric Research and Clinical Practice. 2018b Nov 5;1(2):39-48. doi: 10.1176/appi.prcp.20180002..","51046","2020"
"davis2018b_B","Pharmacotherapy","PTSD","Control",,"214","B","107",,"Present-centered group therapy","Present Centered Therapy (PCT)","Therapy was psycho-educational and addressed symptoms of PTSD and the effects of PTSD on daily life. Allowed shared support and positive experiences with other veterans. The groups had a present focus that avoided discussion of traumas. Participants were assigned to keep a journal and had a lunch gathering to partially control for the MBSR retreat.","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Group","In Person",,"Sessions: 90 minutes; Lunch: 2 hours","Sessions: weekly; Lunch: once","8",,"completed all 8 sessions","0.2523",,,,,,,,,,,"Veteran","0","1","0","0.162",,"0.838","Mixed","Combat-related; Rape/sexual assault; Other (noncombat military, civilian)","Low","Davis LL, Whetsell C, Hamner MB, et al. A multisite randomized controlled trial of mindfulness-based stress reduction in the treatment of posttraumatic stress disorder. Psychiatric Research and Clinical Practice. 2018b Nov 5;1(2):39-48. doi: 10.1176/appi.prcp.20180002..","51046","2020"
"davis2020_B","Pharmacotherapy","PTSD","Control",,"212","B","101",,"Wellness lifestyle program","Wellness lifestyle program","Designed primarily as an attention control, but in order for the program to be perceived as a credible treatment, it matched the physical activity of the yoga program with low intensity walking in addition to didactics and discussion of wellness topics","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Mixed","In Person",,"Session (class) length: 90 minutes","Weekly","16",,,,,,,,,,,,,,"Mixed",,,"0.086","0.34",,"0.66","Mixed","MST; Combat-related; Rape/sexual assault; Other (childhood, not specified; other adult, not specified)","Medium","Davis LW, Schmid AA, Daggy JK, et al. Symptoms improve after a yoga program designed for PTSD in a randomized controlled trial with veterans and civilians. Psychol Trauma. 2020 Apr 20 doi: https://dx.doi.org/10.1037/tra0000564. PMID: 32309986.",,"2020"
"davis2020_A","Pharmacotherapy","PTSD","PTSD",,"212","A","108",,"Holistic yoga program","Yoga","Yoga instruction including components of Hatha Yoga: postures (asanas), breathing practices (pranayama), and relaxation. Home practice support included instructional DVD and audio device, handout with figures depicting sequence of poses, and a yoga mat and eye pillow.","No","Not Applicable","No","Not Applicable","Yes","Yoga","No","No","No","No","No","Mixed","In Person",,"Session (class) length: 90 minutes","Weekly","16",,,,,,,,,,,,,,"Mixed",,,"0.086","0.34",,"0.66","Mixed","MST; Combat-related; Rape/sexual assault; Other (childhood, not specified; other adult, not specified)","Medium","Davis LW, Schmid AA, Daggy JK, et al. Symptoms improve after a yoga program designed for PTSD in a randomized controlled trial with veterans and civilians. Psychol Trauma. 2020 Apr 20 doi: https://dx.doi.org/10.1037/tra0000564. PMID: 32309986.",,"2020"
"davis2004_A","Pharmacotherapy","PTSD","PTSD",,"42","A","27",,"Nefazodone","Nefazodone","Phenylpiperazine derivative; presynaptic serotonin reuptake inhibitor, postsynaptic 5-hydroxytryptamine 2A receptor antagonist, with modest norepinephrine uptake inhibition","No","Not Applicable","Yes","Antidepressant: Other","No","Not Applicable","No","No","No","No","No","Individual","In Person","200 to 600 mg total daily dose; initial dose 200 mg titrated in increments of 100 mg every 4 days as tolerated to maximum therapeutic benefit, with a maximum dose of 600 mg",,"Twice daily","12",,,,,,,,,,,"435 mg/day",,,"Mixed","0","0.9762","0.0238","0.0238",,"0.9762","Mixed","combat-related, rape/sexual assault","High","Davis LL, Jewell ME, Ambrose S, et al. A placebo-controlled study of nefazodone for the treatment of chronic posttraumatic stress disorder: a preliminary study. J Clin Psychopharmacol. 2004;24(3):291-7.  PMID: 15118483.","26401","2019"
"davis2004_B","Pharmacotherapy","PTSD","Control",,"42","B","15",,"Placebo","Placebo","Look-a-like placebo capsules","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person",,,"Twice daily","12",,,,,,,,,,,,,,"Mixed","0","0.9762","0.0238","0.0238",,"0.9762","Mixed","combat-related, rape/sexual assault","High","Davis LL, Jewell ME, Ambrose S, et al. A placebo-controlled study of nefazodone for the treatment of chronic posttraumatic stress disorder: a preliminary study. J Clin Psychopharmacol. 2004;24(3):291-7.  PMID: 15118483.","26401","2019"
"davis2008a_A","Pharmacotherapy","PTSD","PTSD",,"36","A","18",,"Guanfacine","Guanfacine","Centrally-acting alpha-2 agonist; increased from 1 to 2 mg based on symptoms and side effects, as tolerated","No","Not Applicable","Yes","Antiadrenergic","No","Not Applicable","No","No","No","No","No","Individual","In Person","1 to 2 mg",,"Daily","8",,,,,,,,,,,"2 mg",,,"Veteran","0","1","0","0.0571",,"0.9429","Combat-related",,"Medium","Davis LL, Ward C, Rasmusson A, et al. A placebo-controlled trial of guanfacine for the treatment of posttraumatic stress disorder in veterans. Psychopharmacol Bull. 2008;41(1):8-18.  PMID: 18362867.","34102","2019"
"davis2008a_B","Pharmacotherapy","PTSD","Control",,"36","B","18",,"Placebo","Placebo","Placebo intervention not described;  trial reported as double-blind","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person",,,"Daily","8",,,,,,,,,,,,,,"Veteran","0","1","0","0.0571",,"0.9429","Combat-related",,"Medium","Davis LL, Ward C, Rasmusson A, et al. A placebo-controlled trial of guanfacine for the treatment of posttraumatic stress disorder in veterans. Psychopharmacol Bull. 2008;41(1):8-18.  PMID: 18362867.","34102","2019"
"davis2008b_A","Pharmacotherapy","PTSD","PTSD",,"85","A","44",,"Divalproex","Divalproex","Increases GABA levels in brain; enteric-coated, delayed release; dose increased as tolerated to maximum benefit","No","Not Applicable","Yes","Mood Stabilizer","No","Not Applicable","No","No","No","No","No","Individual","In Person","1000 to 3000 mg total daily dose; titration: initial dose 500 mg twice a day, increased in 500-mg increments with maximum dose 3000 mg/day",,"Daily (2 divided doses)","8",,,,,"Blinded serum valproic acid morning trough levels",,"serum level 82.9 (30.1) mg/L at week 8 (authors conclude that ""compliance may have been variable"")",,,,"2309 mg daily","508",,"Veteran","0","1","0","0.0244",,"0.9756","Mixed","combat-related, other (non-specified)","Low","Davis LL, Davidson JR, Ward LC, et al. Divalproex in the treatment of posttraumatic stress disorder: a randomized, double-blind, placebo-controlled trial in a veteran population. J Clin Psychopharmacol. 2008 Feb;28(1):84-8. doi: 10.1097/JCP.0b013e318160f83b. PMID: 18204347","30463","2019"
"davis2008b_B","Pharmacotherapy","PTSD","Control",,"85","B","44",,"Placebo","Placebo","Visually identical to divalproex tablets","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person",,,"Twice daily","8",,,,,"Technician provided sham reports for morning trough levels for placebo group",,,,,,,,,"Veteran","0","1","0","0.0244",,"0.9756","Mixed","combat-related, other (non-specified)","Low","Davis LL, Davidson JR, Ward LC, et al. Divalproex in the treatment of posttraumatic stress disorder: a randomized, double-blind, placebo-controlled trial in a veteran population. J Clin Psychopharmacol. 2008 Feb;28(1):84-8. doi: 10.1097/JCP.0b013e318160f83b. PMID: 18204347","30463","2019"
"decker2018_A","Mixed: Psychotherapy & CIH","PTSD","PTSD",,"38","A","19",,"Art therapy + CPT","Art therapy + Cognitive Processing Therapy (CPT)","Concurrent individual CPT and art therapy.
CPT: sessions 1 through 8 of manualized treatment (Resick, Monson, & Chard, 2007) ""designed to challenge negative cognitions associated with trauma"" .
Art therapy: followed protocol by Campbell (2014) and involving ""psychoeducation, goal setting, creating a sense of safety, creating and processing one’s visual trauma narrative, identifying and addressing symptoms and triggers, integrating the trauma with the rest of their experiences, identifying grief and loss caused by combat trauma, reconstructing worldviews and self-concept, and reviewing artworks and recovery-oriented goals... participants were given six directives to construct the visual trauma narrative: 1) Create an image of a time before the trauma that you felt peaceful and safe—a positive memory; 2) Create an image of the last moment you remember directly before the trauma; 3) Create an image of what happened during the trauma; 4) Create an image of a moment you can remember right after the trauma; 5) Create an image of a time when you were safe from the physical threats of war; 6) Create an image of a time when you tried to self-soothe.""","Yes","TF","No","Not Applicable","Yes","Creative therapies","No","No","No","No","No","Individual","In Person",,"60 minutes",,,"total 16 hours; 8 hours CPT plus 8 hours art therapy",,,,,,,,,,,,,"Veteran","0","1","0","0.0323",,"0.9677","Combat-related",,"High","Decker KP, Deaver SP, Abbey V, et al. Quantitatively improved treatment outcomes for combat-associated PTSD with adjunctive art therapy: randomized controlled trial. Art Therapy. 2018;35(4):184-94. doi: 10.1080/07421656.2018.1540822.",,"2020"
"decker2018_B","Mixed: Psychotherapy & CIH","PTSD","PTSD",,"38","B","19",,"Supportive psychotherapy + CPT","Supportive psychotherapy + Cognitive Processing Therapy (CPT)","Concurrent individual CPT and supportive psychotherapy.
CPT: sessions 1 through 8 of manualized treatment (Resick, Monson, & Chard, 2007) ""designed to challenge negative cognitions associated with trauma"".
Supportive psychotherapy: ""focused on present-centered concerns, with the goal of reinforcing healthy and adaptive patterns of thoughts and behaviors to reduce symptoms of PTSD and depression""","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"60 minutes",,,"total 16 hours; 8 hours CPT plus 8 hours supportive psychotherapy",,,,,,,,,,,,,"Veteran","0","1","0","0.0323",,"0.9677","Combat-related",,"High","Decker KP, Deaver SP, Abbey V, et al. Quantitatively improved treatment outcomes for combat-associated PTSD with adjunctive art therapy: randomized controlled trial. Art Therapy. 2018;35(4):184-94. doi: 10.1080/07421656.2018.1540822.",,"2020"
"dedert2019_A","Psychotherapy","PTSD+SUD","PTSD+SUD","Integrated","40","A","15",,"CPT + smoking cessation","Cognitive Processing Therapy (CPT) + smoking cessation","Combined CPT and smoking cessation; ""smoking was conceptualized and integrated into treatment as an avoidance behavior that interferes with processing PTSD symptoms"". Participants taught to apply cognitive restructuring skills from CPT to smoking cessation. Smoking cessation content followed Integrated Care for Smoking Cessation treatment manual, and was identical to that of the Present-focused smoking cessation arm except for use of cognitive restructuring skills in the CPT arm.","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"CPT: 60 minutes
Smoking cessation: 25 minutes","Twice a week","6",,"attended all 12 sessions","0.7333",,,,,,,,,,,"Veteran","0","1","0","0.825",,"0.175",,,"High","Dedert EA, Resick PA, Dennis PA, et al. Pilot trial of a combined cognitive processing therapy and smoking cessation treatment. J Addict Med. 2019 Jul/Aug;13(4):322-30. doi: 10.1097/ADM.0000000000000502. PMID: 30664539.",,"2020"
"dedert2019_B","Psychotherapy","PTSD+SUD","SUD","Not integrated","40","B","25",,"Present-focused smoking cessation","Smoking cessation","Cognitive behavioral smoking cessation treatment following the Integrated Care for Smoking Cessation manual; treatment is present-focused. ""The smoking cessation treatment in this arm was identical to the smoking cessation component of the [combined CPT + smoking cessation] group, except that the [present-focused smoking cessation] arm did not utilize formal cognitive restructuring to address smoking triggers.""","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"25 minutes","Twice weekly","6",,"attended all 12 sessions","0.68",,,,,,,,,,,"Veteran","0","1","0","0.825",,"0.175",,,"High","Dedert EA, Resick PA, Dennis PA, et al. Pilot trial of a combined cognitive processing therapy and smoking cessation treatment. J Addict Med. 2019 Jul/Aug;13(4):322-30. doi: 10.1097/ADM.0000000000000502. PMID: 30664539.",,"2020"
"dekleine2012_A","Mixed: Psychotherapy & pharmacotherapy","PTSD","PTSD",,"75","A","33",,"PE + D-cycloserine","Prolonged Exposure (PE) + D-cycloserine","D-cycloserine prior to PE sessions

PE: standardized program including prolonged imaginal exposure (30 minutes each session), in vivo exposure assignments and homework of exposure using recorded session audiotape.

D-cycloserine: glutamatergic N-methyl-D-aspartate receptor partial agonist, taken 1 hour prior to start of each PE session","Yes","TF","Yes","Other pharmacotherapy","No","Not Applicable","No","No","No","No","No","Individual","In Person","50 mg","30 minutes","Weekly","up to 10",,">8 sessions","0.7273",,,,,,,,,,,"Community",,,"1","0.806",,"0.194","Mixed","combat-related, rape/sexual assault, accidents, other (violent nonsexual assault; ""miscellaneous"")","Medium","de Kleine RA, Hendriks GJ, Kusters WJ, et al. A randomized placebo-controlled trial of D-cycloserine to enhance exposure therapy for posttraumatic stress disorder. Biol Psychiatry. 2012 Jun 1;71(11):962-8. doi: 10.1016/j.biopsych.2012.02.033. PMID: 22480663.","38434","2019"
"dekleine2012_B","Mixed: Psychotherapy & pharmacotherapy","PTSD","PTSD",,"75","B","34",,"PE + placebo","Prolonged Exposure (PE) + placebo","Placebo prior to PE sessions

PE: standardized program including prolonged imaginal exposure (30 minutes each session), in vivo exposure assignments and homework of exposure using recorded session audiotape.

Placebo: identical in appearance to D-cycloserine, taken 1 hour prior to start of each PE session","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person",,"30 minutes","Weekly","up to 10",,">8 sessions","0.6176",,,,,,,,,,,"Community",,,"1","0.806",,"0.194","Mixed","combat-related, rape/sexual assault, accidents, other (violent nonsexual assault; ""miscellaneous"")","Medium","de Kleine RA, Hendriks GJ, Kusters WJ, et al. A randomized placebo-controlled trial of D-cycloserine to enhance exposure therapy for posttraumatic stress disorder. Biol Psychiatry. 2012 Jun 1;71(11):962-8. doi: 10.1016/j.biopsych.2012.02.033. PMID: 22480663.","38434","2019"
"devilly1998_A","Psychotherapy","PTSD","PTSD",,"51","A","19",,"EMDR","Eye Movement Desensitization and Reprocessing (EMDR)","Participants track extreme hand movements while holding in mind a representative picture of the traumatic event. On average, 24 back-and-forth sweeps were given for each set until subjective units of distress decrease to 0. Eye movement desensitization repeated until no more imaginal picture arises","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"90 minutes","Weekly","2",,,,,,,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"High","Devilly GJ, Spence SH, Rapee RM. Statistical and reliable change with eye movement desensitization and reprocessing: treating trauma within a veteran population. Behav. Ther. 1998 Summer;29(3):435-55. doi: 10.1016/S0005-7894(98)80042-7.","20740","2019"
"devilly1998_B","Psychotherapy","PTSD","PTSD",,"51","B","16",,"Reactive Eye Dilation Desensitization and Reprocessing","Eye Movement Desensitization and Reprocessing (EMDR)","Participant concentrates on the imaginal picture and accompanying body sensation while concentrating on a black box emitting flashing light at rate of 4 flashes per second.","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"90 minutes","Weekly","2",,,,,,,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"High","Devilly GJ, Spence SH, Rapee RM. Statistical and reliable change with eye movement desensitization and reprocessing: treating trauma within a veteran population. Behav. Ther. 1998 Summer;29(3):435-55. doi: 10.1016/S0005-7894(98)80042-7.","20740","2019"
"devilly1998_C","Psychotherapy","PTSD","Control",,"51","C","16",,"Standard Psychiatric Support","Treatment as usual (TAU)","Participants continued their usual treatment without additional support from research therapist","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,,,,"5",,,,,,,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"High","Devilly GJ, Spence SH, Rapee RM. Statistical and reliable change with eye movement desensitization and reprocessing: treating trauma within a veteran population. Behav. Ther. 1998 Summer;29(3):435-55. doi: 10.1016/S0005-7894(98)80042-7.","20740","2019"
"difede2014_A","Mixed: Psychotherapy & pharmacotherapy","PTSD","PTSD",,"25","A","13",,"Exposure therapy with virtual reality plus D-cycloserine","Virtual reality exposure therapy (VRET) + D-cycloserine","Participants recounted their trauma while wearing a virtual reality helmet with a computer simulation of the September 11th attacks. Graded scenarios increased in intensity and detail, target of 45 minutes ""in the virtual world"". D-cycloserine: antibiotic, also used as a cognitive enhancer, given 90 minutes before sessions beginning with session 2.","Yes","TF","Yes","Other pharmacotherapy","No","Not Applicable","No","No","No","No","No","Individual","In Person","100 mg","90 minutes","Weekly","12",,,,,"verbal inquiry about medication ingestion before session",,,"11.00","1.00",,,,,"Community",,,"1","0.24",,"0.76","Terrorism/political violence/forced displacement",,"Medium","Difede J, Cukor J, Wyka KE, et al. D-cycloserine augmentation of exposure therapy for post-traumatic stress disorder: a pilot randomized clinical trial. Neuropsychopharmacology. 2014 Apr;39(5):1052-108. doi: 10.1038/npp.2013.317. PMID: 24217129.","41641","2019"
"difede2014_B","Mixed: Psychotherapy & pharmacotherapy","PTSD","PTSD",,"25","B","12",,"Exposure therapy with virtual reality plus placebo","Virtual reality exposure therapy (VRET) + placebo","Participants recounted their trauma while wearing a virtual reality helmet with a computer simulation of the September 11th attacks. Graded scenarios increased in intensity and detail, goal 45 minutes ""in the virtual world"". Matched placebo given 90 minutes prior to start of therapy beginning at session 2.","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person",,"90 minutes","Weekly","12",,,,,"verbal inquiry about medication ingestion before session",,,"9.33","3.34",,,,,"Community",,,"1","0.24",,"0.76","Terrorism/political violence/forced displacement",,"Medium","Difede J, Cukor J, Wyka KE, et al. D-cycloserine augmentation of exposure therapy for post-traumatic stress disorder: a pilot randomized clinical trial. Neuropsychopharmacology. 2014 Apr;39(5):1052-108. doi: 10.1038/npp.2013.317. PMID: 24217129.","41641","2019"
"dorrepaal2012_A","Psychotherapy","PTSD","PTSD",,"71","A","38",,"Group CBT","Cognitive behavioral therapy (CBT) without a trauma focus","Participants received individual treatment as usual by a psychotherapist, psychiatric nurse, or psychiatrist. In addition, participants received a stabilizing group CBT program based on manual by Zlotnick et al. (1997). Group session included psychoeducation aimed at attaining a sense of cognitive mastery, cognitive behavioral skills focused on identifying and modifying dysfunctional behavior, thoughts, and beliefs about the trauma. Treatment focused on the present, positive reinforcement, and empowerment, and avoided sharing individual trauma histories","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Group","In Person",,"2 hours","Weekly","20",,,,,,,,,,,,,,"Community",,,"1","1",,"0","Mixed","child sexual abuse, child physical abuse","High","Dorrepaal E, Thomaes K, Smit JH, et al. Stabilizing group treatment for complex posttraumatic stress disorder related to child abuse based on psychoeducation and cognitive behavioural therapy: a multisite randomized controlled trial. Psychother Psychosom. 2012;81(4):217-25. doi: 10.1159/000335044. PMID: 22585094.","39141","2019"
"dorrepaal2012_B","Psychotherapy","PTSD","Control",,"71","B","33",,"TAU","Treatment as usual (TAU)","Participants received individual treatment by a psychotherapist, psychiatric nurse, or psychiatrist","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,,,,"20",,,,,,,,,,,,,,"Community",,,"1","1",,"0","Mixed","child sexual abuse, child physical abuse","High","Dorrepaal E, Thomaes K, Smit JH, et al. Stabilizing group treatment for complex posttraumatic stress disorder related to child abuse based on psychoeducation and cognitive behavioural therapy: a multisite randomized controlled trial. Psychother Psychosom. 2012;81(4):217-25. doi: 10.1159/000335044. PMID: 22585094.","39141","2019"
"dowd2020_A","Pharmacotherapy","PTSD","PTSD",,"25","A","13",,"Eszopiclone","Eszopiclone","Gamma-aminobutyric acid (GABA) alpha receptor agonist indicated for the treatment of sleep, given at bedtime","No","Not Applicable","Yes","Antianxiety: nonbenzodiazepine","No","Not Applicable","No","No","No","No","No","Individual","In Person","3 mg",,"Daily","12",,,,,,,,,,,,,,"Mixed",,"0.04","0.96","0.40",,"0.60","Mixed","Rape/sexual assault; Accidents; Illness/medical procedure; Community/school violence; Natural or manmade disasters; Other (observed violence to or death of a loved one)","High","Dowd SM, Zalta AK, Burgess HJ, et al. Double-blind randomized controlled study of the efficacy, safety and tolerability of eszopiclone vs placebo for the treatment of patients with post-traumatic stress disorder and insomnia. World j. 2020 Mar 19;10(3):21-8. doi: https://dx.doi.org/10.5498/wjp.v10.i3.21. PMID: 32257848.",,"2020"
"dowd2020_B","Pharmacotherapy","PTSD","Control",,"25","B","12",,"Placebo","Placebo",,"No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person",,,"Daily","12",,,,,,,,,,,,,,"Mixed",,"0.04","0.96","0.40",,"0.60","Mixed","Rape/sexual assault; Accidents; Illness/medical procedure; Community/school violence; Natural or manmade disasters; Other (observed violence to or death of a loved one)","High","Dowd SM, Zalta AK, Burgess HJ, et al. Double-blind randomized controlled study of the efficacy, safety and tolerability of eszopiclone vs placebo for the treatment of patients with post-traumatic stress disorder and insomnia. World j. 2020 Mar 19;10(3):21-8. doi: https://dx.doi.org/10.5498/wjp.v10.i3.21. PMID: 32257848.",,"2020"
"duberstein2018_A","Psychotherapy","PTSD","PTSD",,"161","A","83",,"IPT-T","Interpersonal Psychotherapy (IPT)","Individual psychotherapy adapted from IPT to address needs of depressed women with childhood sexual abuse histories in the community health setting. The 4 adaptations to the IPT protocol are: 1) expanded treatment period to 16 sessions over 32 weeks; 2) used engagement analysis to ""help patients identify and problem-solve social, practical, and psychological barriers to treatment participation""; 3) used a sociocultural formulation ""to help patients identify ways in which cultural and economic influences (e.g., family beliefs, ethnic identities, religious practices, racism, and poverty) may affect their interpersonal problems and depression""; 4) an ""interpersonal-patterns"" problem area replaced the ""interpersonal deficits"" problem  area, ""the interpersonal-patterns problem area is used to help patients recognize longstanding patterns of behavior and emotion commonly seen among individuals with trauma histories that could undermine social health""","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,,,"32","total 16 sessions",,,,,,,"10.6","5.8",,,,,"Community","0","0","1","1",,"0","Child sexual abuse",,"Medium","Duberstein PR, Ward EA, Chaudron LH, et al. Effectiveness of interpersonal psychotherapy-trauma for depressed women with childhood abuse histories. J Consult Clin Psychol. 2018 Oct;86(10):868-78. doi: 10.1037/ccp0000335. PMID: 30265045.","51365","2020"
"duberstein2018_B","Psychotherapy","PTSD","PTSD",,"161","B","78",,"Clinic Psychotherapy","Psychotherapy as usual","Clinician choice of psychotherapy among treatments typically used in a community mental health clinic; therapists were not restricted from ""reasonable therapeutic activities or interventions""","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,,,"32","total 16 sessions",,,,,,,"5.7","4.2",,,,,"Community","0","0","1","1",,"0","Child sexual abuse",,"Medium","Duberstein PR, Ward EA, Chaudron LH, et al. Effectiveness of interpersonal psychotherapy-trauma for depressed women with childhood abuse histories. J Consult Clin Psychol. 2018 Oct;86(10):868-78. doi: 10.1037/ccp0000335. PMID: 30265045.","51365","2020"
"duffy2007_A","Psychotherapy","PTSD","PTSD",,"58","A","29",,"Cognitive Therapy","Cognitive Therapy for PTSD (CT-PTSD)","Based on Ehlers and Clark's model that addresses excessively negative appraisals of the traumatic event or its sequelae, disturbance in autobiographical memory, and dysfunctional cognitive and behavioral strategies. Includes behavioral activation early in therapy.","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,,"Up to weekly","12",,"completed ≥6 sessions or ended therapy earlier as agreed by the therapist because of noticeable improvement","0.6897",,,,,"5.9","2.5","patients received additional average 2.0 [SD 3.2] sessions after 12-week period for a total of 7.8 [SD 5.1] sessions",,,,"Community",,,"1","0.3966",,"0.6034","Mixed","terrorism/political violence/forced displacement, community/school violence, accidents","Medium","Duffy M, Gillespie K, Clark DM. Post-traumatic stress disorder in the context of terrorism and other civil conflict in Northern Ireland: randomised controlled trial. BMJ. 2007 Jun 2;334(7604):1147-50. doi: 10.1136/bmj.39021.846852.BE. PMID: 17495988.","29736","2019"
"duffy2007_B","Psychotherapy","PTSD","Control",,"58","B","29",,"Waitlist","Waitlist",,"No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,,,,"12",,,,,,,,,,,,,,"Community",,,"1","0.3966",,"0.6034","Mixed","terrorism/political violence/forced displacement, community/school violence, accidents","Medium","Duffy M, Gillespie K, Clark DM. Post-traumatic stress disorder in the context of terrorism and other civil conflict in Northern Ireland: randomised controlled trial. BMJ. 2007 Jun 2;334(7604):1147-50. doi: 10.1136/bmj.39021.846852.BE. PMID: 17495988.","29736","2019"
"dunlop2017_A","Pharmacotherapy","PTSD","PTSD",,"128","A","63",,"GSK561679 investigational drug","GSK561679 investigational drug","Orally active selective CRF1 receptor antagonist that suppressed ACTH response to stress, reduced anxiety","No","Not Applicable","Yes","Other pharmacotherapy","No","Not Applicable","No","No","No","No","No","Individual","In Person","350 mg",,"Daily at bedtime","6",,,,,"completed treatment and complied with medication regimen (daily dosing diary and verification by serum levels)","0.6667",,,,,"923 ng/mL (mean concentration at 6 weeks among compliant patients)","603",,,,,,"1",,"0","Mixed","combat-related, other (unspecified child abuse, unspecified)","Medium","Dunlop BW, Binder EB, Iosifescu D, et al. Corticotropin-releasing factor receptor 1 antagonism is ineffective for women with posttraumatic stress disorder. Biol Psychiatry. 2017 Dec;82(12):866-74. doi: 10.1016/j.biopsych.2017.06.024. PMID: 28793974","49315","2019"
"dunlop2017_B","Pharmacotherapy","PTSD","Control",,"128","B","65",,"Placebo","Placebo","Matching placebo tablet","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person",,,"Daily","6",,,,,"completed treatment and complied with medication regimen (daily dosing diary)","0.7538",,,,,,,,,,,,"1",,"0","Mixed","combat-related, other (unspecified child abuse, unspecified)","Medium","Dunlop BW, Binder EB, Iosifescu D, et al. Corticotropin-releasing factor receptor 1 antagonism is ineffective for women with posttraumatic stress disorder. Biol Psychiatry. 2017 Dec;82(12):866-74. doi: 10.1016/j.biopsych.2017.06.024. PMID: 28793974","49315","2019"
"dunne2012_A","Psychotherapy","PTSD","PTSD",,"26","A","13",,"Trauma-focused CBT","Trauma-focused cognitive behavioral therapy (TF-CBT)","Treatment according to the Australian Guidelines for the treatment of Adult with Acute Stress Disorder for PTSD (Australian Centre for Posttraumatic Mental Health. Australian Guidelines for the Treatment of Adults with Acute Stress Disorder and Post-traumatic Stress Disorder. Melbourne, VIC: ACPMH; 2007). Treatment included psychoeducation, anxiety management by deep breathing and progressive muscle relaxation, cognitive restructuring, imaginal exposure, graded in vivo exposure, and relapse prevention.","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"1 hour","Weekly","10",,,,,,,,"9.38","1.71",,,,,"Community",,,"1","0.5",,"0.5","Accidents",,"High","Dunne RL, Kenardy JA, Sterling M. A randomized controlled trial of cognitive-behavioral therapy for the treatment of PTSD in the context of chronic whiplash. Clin J Pain. 2012 Nov-Dec;28(9):755-65. doi: 10.1097/AJP.0b013e318243e16b. PMID: 22209798.","39572","2019"
"dunne2012_B","Psychotherapy","PTSD","Control",,"26","B","13",,"Waitlist","Waitlist",,"No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,,,,"10",,,,,,,,,,,,,,"Community",,,"1","0.5",,"0.5","Accidents",,"High","Dunne RL, Kenardy JA, Sterling M. A randomized controlled trial of cognitive-behavioral therapy for the treatment of PTSD in the context of chronic whiplash. Clin J Pain. 2012 Nov-Dec;28(9):755-65. doi: 10.1097/AJP.0b013e318243e16b. PMID: 22209798.","39572","2019"
"echeburua1996_A","Mixed: Psychotherapy & CIH","PTSD","PTSD",,"20","A","10",,"Cognitive Restructuring and coping-skills training","Cognitive restructuring and coping-skills training","Treatment seeks to modify negative thoughts associated with rape. Coping skills training includes progressive muscular relaxation, thought-stopping, cognitive distractions, and instruction in gradual exposure","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"1 hour","Weekly","5",,,,,,,,,,,,,,"Community",,,"1","1",,"0","Rape/sexual assault",,"High","Echeburua E, de Corral P, Sarasua B, et al. Treatment of acute posttraumatic stress disorder in rape victims: an experimental study. J Anxiety Disord. 1996 May-Jun;10(3):185-99. doi: 10.1016/0887-6185(96)89842-2.","07521","2019"
"echeburua1996_B","Mixed: Psychotherapy & CIH","PTSD","PTSD",,"20","B","10",,"Progressive muscular relaxation","Progressive muscle relaxation (PMR)","Progressive muscular relaxation training according to Bernstein & Borkovec (1973)","No","Not Applicable","No","Not Applicable","Yes","Relaxation","No","No","No","No","No","Individual","In Person",,"1 hour","Weekly","5",,,,,,,,,,,,,,"Community",,,"1","1",,"0","Rape/sexual assault",,"High","Echeburua E, de Corral P, Sarasua B, et al. Treatment of acute posttraumatic stress disorder in rape victims: an experimental study. J Anxiety Disord. 1996 May-Jun;10(3):185-99. doi: 10.1016/0887-6185(96)89842-2.","07521","2019"
"ehlers2003_A","Psychotherapy","PTSD","PTSD",,"85","A","28",,"Cognitive Therapy","Cognitive Therapy for PTSD (CT-PTSD)","Manualized treatment; goal is to modify excessively negative appraisals, correct the autobiographical memory disturbance, and remove the problematic behavior and cognitive responses.","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"60 to 90 minutes","Weekly for 3 months, followed by up to 3 monthly booster sessions","12 (weekly sessions), 12 (booster sessions)",,,,,,,,,,"Weekly: 9.0/12; Boosters: 2.4/3",,,,"Community",,,"1",,,,"Accidents",,"Medium","Ehlers A, Clark DM, Hackmann A, et al. A randomized controlled trial of cognitive therapy, a self-help booklet, and repeated assessments as early interventions for posttraumatic stress disorder. Arch Gen Psychiatry. 2003;60(10):1024-32. doi: 10.1001/archpsyc.60.10.1024. PMID: 14557148.","25861","2019"
"ehlers2003_B","Psychotherapy","PTSD","Control",,"85","B","28",,"Self-help booklet","Self-help booklet","Participants were given a 64-page booklet providing cognitive behavioral principles for the treatment of PTSD (Understanding Your Reactions to Trauma) and an additional 4-page sheet which focused on common avoidance behaviors and safety-seeking behaviors after motor vehicle accidents; one meeting with a clinician to explain use of the booklet and provide motivation to follow advice in the booklet.","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,,"Clinician session: 40 minutes","Clinician session: once","1",,,,,,,,,,,,,,"Community",,,"1",,,,"Accidents",,"Medium","Ehlers A, Clark DM, Hackmann A, et al. A randomized controlled trial of cognitive therapy, a self-help booklet, and repeated assessments as early interventions for posttraumatic stress disorder. Arch Gen Psychiatry. 2003;60(10):1024-32. doi: 10.1001/archpsyc.60.10.1024. PMID: 14557148.","25861","2019"
"ehlers2003_C","Psychotherapy","PTSD","Control",,"85","C","29",,"Repeated assessments","Assessment","Single meeting with clinician covering rationale and protocol for assessments and monitoring; regular monitoring with the same assessments and timing as other arms.","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person",,"Clinician session: 20 minutes","Clinician: once","1",,,,,,,,,,,,,,"Community",,,"1",,,,"Accidents",,"Medium","Ehlers A, Clark DM, Hackmann A, et al. A randomized controlled trial of cognitive therapy, a self-help booklet, and repeated assessments as early interventions for posttraumatic stress disorder. Arch Gen Psychiatry. 2003;60(10):1024-32. doi: 10.1001/archpsyc.60.10.1024. PMID: 14557148.","25861","2019"
"ehlers2014_A","Psychotherapy","PTSD","PTSD",,"121","A","30",,"Intensive Cognitive Therapy","Trauma-focused cognitive behavioral therapy (TF-CBT)","Intensive delivery (5 to 7 days) of Ehlers and Clark’s model of cognitive therapy aimed at reducing the patient’s sense of current threat by identifying and modifying excessively negative appraisals of the trauma, elaborating the trauma memory and discriminating triggers of intrusive re-experiencing, and reducing the use of cognitive strategies and behaviors that maintain the problem. Up to 2 sessions one week and one month after intensive period and up to 3 optional monthly booster sessions.","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"90 minutes to 2 hours","2 sessions per day","1",,,,,,,,,,"10.13 (2.18) regular sessions and 1.90 (0.80) booster sessions",,,,"Community",,,"1","0.5868",,"0.4132","Mixed","child other abuse, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (traumatic death of others, not specified)","Low","Ehlers A, Hackmann A, Grey N, et al. A randomized controlled trial of 7-day intensive and standard weekly cognitive therapy for PTSD and emotion-focused supportive therapy. Am J Psychiatry. 2014 Mar;171(3):294-304. doi: 10.1176/appi.ajp.2013.13040552. PMID: 24480899.","41886","2019"
"ehlers2014_B","Psychotherapy","PTSD","PTSD",,"121","B","31",,"Standard Cognitive Therapy","Cognitive Therapy for PTSD (CT-PTSD)","Standard delivery of Ehlers and Clark’s model of cognitive therapy aimed at reducing the patient’s sense of current threat by identifying and modifying excessively negative appraisals of the trauma, elaborating the trauma memory and discriminating triggers of intrusive re-experiencing, and reducing the use of cognitive strategies and behaviors that maintain the problem.","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"90 minutes, 60 minutes for booster sessions","Weekly","12","plus optional monthly booster session for 3 months",,,,,,,,,"10.10 (3.26) regular sessions; 2.07 (1.46) booster sessions",,,,"Community",,,"1","0.5868",,"0.4132","Mixed","child other abuse, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (traumatic death of others, not specified)","Low","Ehlers A, Hackmann A, Grey N, et al. A randomized controlled trial of 7-day intensive and standard weekly cognitive therapy for PTSD and emotion-focused supportive therapy. Am J Psychiatry. 2014 Mar;171(3):294-304. doi: 10.1176/appi.ajp.2013.13040552. PMID: 24480899.","41886","2019"
"ehlers2014_C","Psychotherapy","PTSD","PTSD",,"121","C","30",,"Emotion-focused supportive therapy","Supportive counseling","Therapy focused on patients’ emotional reactions rather than their cognitions; designed to provide a credible therapeutic alternative to control for nonspecific therapeutic factors","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"90 minutes, 60 minutes for booster sessions","Weekly","12","plus optional monthly booster session for 3 months",,,,,,,,,"10.27 (3.21) regular sessions and 2.20 (1.32) booster sessions",,,,"Community",,,"1","0.5868",,"0.4132","Mixed","child other abuse, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (traumatic death of others, not specified)","Low","Ehlers A, Hackmann A, Grey N, et al. A randomized controlled trial of 7-day intensive and standard weekly cognitive therapy for PTSD and emotion-focused supportive therapy. Am J Psychiatry. 2014 Mar;171(3):294-304. doi: 10.1176/appi.ajp.2013.13040552. PMID: 24480899.","41886","2019"
"ehlers2014_D","Psychotherapy","PTSD","Control",,"121","D","30",,"Waitlist","Waitlist",,"No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,,,,"14",,,,,,,,,,,,,,"Community",,,"1","0.5868",,"0.4132","Mixed","child other abuse, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (traumatic death of others, not specified)","Low","Ehlers A, Hackmann A, Grey N, et al. A randomized controlled trial of 7-day intensive and standard weekly cognitive therapy for PTSD and emotion-focused supportive therapy. Am J Psychiatry. 2014 Mar;171(3):294-304. doi: 10.1176/appi.ajp.2013.13040552. PMID: 24480899.","41886","2019"
"elbogen2019_A","Nonpharmacologic cognitive","PTSD","PTSD",,"112","A","57",,"Cognitive Applications for Life Management","Cognitive Applications for Life Management","Cognitive rehabilitation combining ""[goal management training], content-free cueing, and the n-back task, delivers these via a mobile device, and involves support o a family member or friend."" Three home visits by a clinical facilitator; mobile applications (""Mind Jogger"" for cueing, and ""IQ Boost"" for n-back task). Family member/friend attended home visits, were given goal management training educational materials, and instructed to provide support and encouragement to veteran participant.","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","Yes","No","No","No","Individual","In Person",,"Session length:
Home visits: 60 to 90 minutes
Cognitive and goal management training: NR","Home visits: every 2 months; Cognitive and goal management training: daily","24",,,,,,,,,,"Home visits: 2.73 (0.54)/3 (both arms combined);
Cognitive and goal management training, executive reviews: 188.60 (202.20);
Cognitive and goal management training, n-back application: 73.05 (84.15);",,,,"Veteran","0","1","0","0.098",,"0.902",,,"Medium","Elbogen EB, Dennis PA, Van Voorhees E,E., et al. Cognitive rehabilitation with mobile technology and social support for veterans with TBI and PTSD: a randomized clinical trial. J Head Trauma Rehabil. 2018. doi:http://dx.doi.org/10.1097/htr.0000000000000435. PMID: 30169439","51118","2020"
"elbogen2019_B","Nonpharmacologic cognitive","PTSD","Control",,"112","B","55",,"Control","Control","Psychoeducation on TBI and visual memory training using mobile device. Three home visits by a clinical facilitator; mobile application ""Unotan Memory"" for visual memory exercises. Family member/friend attended home visits, were given psychoeducational materials on TBI and brain functioning, and instructed to provide support and encouragement to veteran participant.","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person",,"Session length:
Home visits: 60 to 90 minutes
Visual memory training: NR","Home visits: every 2 months; Visual memory training: daily","24",,,,,,,,,,"Home visits: 2.73 (0.54) (both arms combined);
Visual memory training: 90.77 (57.27);",,,,"Veteran","0","1","0","0.098",,"0.902",,,"Medium","Elbogen EB, Dennis PA, Van Voorhees E,E., et al. Cognitive rehabilitation with mobile technology and social support for veterans with TBI and PTSD: a randomized clinical trial. J Head Trauma Rehabil. 2018. doi:http://dx.doi.org/10.1097/htr.0000000000000435. PMID: 30169439","51118","2020"
"engel2014_A","Complementary and integrative health (CIH)","PTSD","PTSD",,"55","A","28",,"Acupuncture + Usual PTSD care","Acupuncture","Acupuncture: Hair-thin, solid needles manually inserted into subcutaneous tissue or muscle at specified points. Acupoints include: Urinary Bladder, Liver, Large Intestine, Kidney, Heart, Pericardium, Ren, Du, Ear Shenmen, and Yingtang. 

Usual PTSD care: care as outlined in the VA/DoD Clinical Practice Guideline for Management of Post-Traumatic Stress.","No","Not Applicable","No","Not Applicable","Yes","Acupuncture","No","No","No","No","No","Individual","In Person",,"60 minutes","Twice weekly","4",,"Completion of full protocol",,,,,,,,,,,,"Active Duty Military","1","0","0","0.309",,"0.691",,,"Medium","Engel CC, Cordova EH, Benedek DM, et al. Randomized effectiveness trial of a brief course of acupuncture for posttraumatic stress disorder. Med Care. 2014 Dec;52(12 Suppl 5):S57-64. doi: 10.1097/mlr.0000000000000237. PMID: 25397825.","43160","2019"
"engel2014_B","Complementary and integrative health (CIH)","PTSD","Control",,"55","B","27",,"Usual Care","Treatment as usual (TAU)","Medications and psychotherapy as guided by existing standards, outlined in VA/DoD Clinical Practice Guideline for Management of Post-Traumatic Stress.","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,,,"Twice weekly","4",,"completed treatment course",,,,,,,,,,,,"Active Duty Military","1","0","0","0.309",,"0.691",,,"Medium","Engel CC, Cordova EH, Benedek DM, et al. Randomized effectiveness trial of a brief course of acupuncture for posttraumatic stress disorder. Med Care. 2014 Dec;52(12 Suppl 5):S57-64. doi: 10.1097/mlr.0000000000000237. PMID: 25397825.","43160","2019"
"engel2015_A","Other mixed","PTSD","PTSD",,"80","A","43",,"Delivery of Self Training and Education for Stressful Situations-Primary Care version","Delivery of Self Training and Education for Stressful Situations-Primary Care version","Online CBT-based and stress inoculation training approach in a Nurse-guided format.

Includes online educational information about PTSD, stress, and trauma. Homework activities on strategies to manage stress and anger, and to promote better sleep hygiene. Training in cognitive reframing techniques.","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","No","Yes","No","Individual","Technology Assisted",,"15 to 30 minutes","Three times weekly","6",,,,,,,,,,,,,,"Mixed","0.6","0.4",,"0.1875",,"0.8125","Mixed","combat-related, MST","Medium","Engel CC, Litz B, Magruder KM, et al. Delivery of self training and education for stressful situations (DESTRESS-PC): a randomized trial of nurse assisted online self-management for PTSD in primary care. Gen Hosp Psychiatry. 2015 Jul-Aug;37(4):323-8. doi: 10.1016/j.genhosppsych.2015.04.007. PMID: 25929985.","44647","2019"
"engel2015_B","Other mixed","PTSD","Control",,"80","B","37",,"Optimized usual PTSD care","Treatment as usual (TAU)","Consists of usual primary care PTSD treatment augmented with low intensity care management, feedback to the primary care provider, and training of the clinic providers in management of PTSD.","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,,"15 minutes","Once every two weeks","6",,,,,,,,,,,,,,"Mixed","0.6","0.4",,"0.1875",,"0.8125","Mixed","combat-related, MST","Medium","Engel CC, Litz B, Magruder KM, et al. Delivery of self training and education for stressful situations (DESTRESS-PC): a randomized trial of nurse assisted online self-management for PTSD in primary care. Gen Hosp Psychiatry. 2015 Jul-Aug;37(4):323-8. doi: 10.1016/j.genhosppsych.2015.04.007. PMID: 25929985.","44647","2019"
"engel2016_A","Collaborative care","PTSD","PTSD",,"666","A","332",,"Centrally assisted collaborative telecare","Centrally assisted collaborative telecare","Integrated, collaborative care for PTSD and depression with telecare central specialist support/services. Nurse care managers provided basic psychosocial support, monitored/encouraged medication and psychotherapy adherence, connected participants to specialty services, and helped participants make evidence-based treatment decisions; stepped pharmacologic and specialty mental health services with online cognitive-behavioral self-management, CBT by telephone with psychologist, and site therapists for face-to-face psychotherapy; central symptom registry for identification of those in need of treatment change; central specialist/services with psychiatrist for treatment monitoring and suggestions to primary care provider, psychologist delivering CBT by telephone and training/coaching care managers, and care manager to support other care managers and participants who moved, left the military, etc.","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","No","No","Yes","Individual","Phone",,,,"52",,,,,,,,,,,,,,"Active Duty Military","1","0","0","0.1907",,"0.8093",,,"Low","Engel CC, Jaycox LH, Freed MC, et al. Centrally assisted collaborative telecare for posttraumatic stress disorder and depression among military personnel attending primary care: a randomized clinical trial. JAMA Intern Med. 2016 Jul 1;176(7):948-56. doi: 10.1001/jamainternmed.2016.2402. PMID: 27294447.","45003","2019"
"engel2016_B","Collaborative care","PTSD","Control",,"666","B","334",,"Re-Engineering Systems of Primary Care Treatment in the Military","Treatment as usual (TAU)","Treatment as usual with the RESPECT-Mil program. Integrated mental health for PTSD and depression using 3-component model: 1) screening at each clinic visit and use of symptom severity tools for diagnosis and assessment; 2) monthly contact by nurse care managers, who provided symptom status to the primary care clinician; 3) increased access to non-primary care clinic-based mental health specialists.","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,,,,"52",,,,,,,,,,,,,,"Active Duty Military","1","0","0","0.1907",,"0.8093",,,"Low","Engel CC, Jaycox LH, Freed MC, et al. Centrally assisted collaborative telecare for posttraumatic stress disorder and depression among military personnel attending primary care: a randomized clinical trial. JAMA Intern Med. 2016 Jul 1;176(7):948-56. doi: 10.1001/jamainternmed.2016.2402. PMID: 27294447.","45003","2019"
"falsetti2008_A","Psychotherapy","PTSD","PTSD",,"60","A","29",,"Multiple Channel Exposure Therapy","Multiple Channel Exposure Therapy","Treatment followed the ""Patient Manual and Therapy Manual"" by Falsetti and Resnick. Treatment included components of CPT adapted from Resick & Schnicke (1993) and ""Mastery of Your Anxiety and Panic"" by Barlow & Craske (1988, 1994). Participants were presented with cognitive-behavioral models of PTSD and panic, and participated in exposures directed at physiological, cognitive, and behavioral channels of anxiety.","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"90 minutes","Weekly","12",,,,,,,,,,,,,,"Community",,,"1","1",,"0","Mixed","child sexual abuse, rape/sexual assault, community/school violence, natural or manmade disasters","High","Falsetti SA, Resnick HS, Davis JL. Multiple channel exposure therapy for women with PTSD and comorbid panic attacks. Cogn Behav Ther. 2008;37(2):117-30. doi: 10.1080/16506070801969088. PMID: 18470742.","82073","2019"
"falsetti2008_B","Psychotherapy","PTSD","Control",,"60","B","31",,"Waitlist","Minimal attention","Participants were contacted by phone every 2 weeks and offered supportive counseling","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","Phone",,,,"12",,,,,,,,,,,,,,"Community",,,"1","1",,"0","Mixed","child sexual abuse, rape/sexual assault, community/school violence, natural or manmade disasters","High","Falsetti SA, Resnick HS, Davis JL. Multiple channel exposure therapy for women with PTSD and comorbid panic attacks. Cogn Behav Ther. 2008;37(2):117-30. doi: 10.1080/16506070801969088. PMID: 18470742.","82073","2019"
"fani2009_A","Pharmacotherapy","PTSD","PTSD",,"43","A",,,"Paroxetine controlled release","Paroxetine","SSRI; titrated in 12.5 mg increments (1 capsule) to maximum of 5 capsules as tolerated over 8-week medication adjustment period","No","Not Applicable","Yes","Antidepressant: SSRI","No","Not Applicable","No","No","No","No","No","Individual","In Person","12.5 to 62.5 mg; titration: initiated at 12.5 mg, titrated to maximum 62.5 mg over 8 weeks",,"Daily","12",,,,,,,,,,,,,,"Community",,,"1","0.556",,"0.444","Mixed","combat-related, child physical abuse, child sexual abuse, rape/sexual assault, community/school violence, other (witnessing trauma)","High","Fani N, Kitayama N, Ashraf A, et al. Neuropsychological functioning in patients with posttraumatic stress disorder following short-term paroxetine treatment. Psychopharmacol Bull. 2009 Jan 1;42(1):53-68.  PMID: 19204651.","47120","2019"
"fani2009_B","Pharmacotherapy","PTSD","Control",,"43","B",,,"Placebo","Placebo","Placebo started at 1 capsule per day, increased by 1 capsule per study visit as tolerated, up to 5 capsules per day during 8 week medication adjustment period.","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","1 to 5 capsules (paroxetine equivalent 12.5 to 62.5 mg); titration: initiated at 1 capsule increased as tolerated to maximum of 5 capsules over 8 weeks",,"Daily","12",,,,,,,,,,,,,,"Community",,,"1","0.556",,"0.444","Mixed","combat-related, child physical abuse, child sexual abuse, rape/sexual assault, community/school violence, other (witnessing trauma)","High","Fani N, Kitayama N, Ashraf A, et al. Neuropsychological functioning in patients with posttraumatic stress disorder following short-term paroxetine treatment. Psychopharmacol Bull. 2009 Jan 1;42(1):53-68.  PMID: 19204651.","47120","2019"
"fecteau1999_A","Psychotherapy","PTSD","PTSD",,"21","A","11",,"CBT","Trauma-focused cognitive behavioral therapy (TF-CBT)","Treatment included education about post-trauma reactions, relaxation training, imaginal exposure therapy with cognitive restructuring, instruction for self-directed graduated in-vivo behavior practice.","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"2 hours","Weekly","4",,"completed all 4 sessions","0.9091",,,,,,,,,,,"Community",,,"1","0.7",,"0.3","Accidents",,"Medium","Fecteau GW, Nicki RM. Cognitive behavioural treatment of post traumatic stress disorder after motor vehicle accident. Behav. Cogn. Psychother. 1999 Jul;27(3):201-14.","21968","2019"
"fecteau1999_B","Psychotherapy","PTSD","Control",,"21","B","10",,"Waitlist","Waitlist",,"No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,,,,"4",,"completed treatment course","1",,,,,,,,,,,"Community",,,"1","0.7",,"0.3","Accidents",,"Medium","Fecteau GW, Nicki RM. Cognitive behavioural treatment of post traumatic stress disorder after motor vehicle accident. Behav. Cogn. Psychother. 1999 Jul;27(3):201-14.","21968","2019"
"feder2014_A","Pharmacotherapy","PTSD","PTSD",,"41","A","22",,"Ketamine hydrochloride","Ketamine","Antagonist of glutamate NMDA receptor; single intravenous infusion given over 40 minutes","No","Not Applicable","Yes","Other pharmacotherapy","No","Not Applicable","No","No","No","No","No","Individual","In Person","0.5 mg/kg",,"Once (single dose)","1",,,,,,,,,,,,,,"Community",,,"1","0.4634",,"0.5366","Mixed","combat-related. rape/sexual assault, accidents, community/school violence, other (fire, witnessed assault or death, witnessed 9/11 attacks)","High","Feder A, Parides MK, Murrough JW, et al. Efficacy of intravenous ketamine for treatment of chronic posttraumatic stress disorder: a randomized clinical trial. JAMA Psychiatry. 2014 Jun;71(6):681-8. doi: 10.1001/jamapsychiatry.2014.62. PMID: 24740528.","42218","2019"
"feder2014_B","Pharmacotherapy","PTSD","Control",,"41","B","19",,"Midazolam","Midazolam","Benzodiazepine; single intravenous infusion given over 40 minutes","No","Not Applicable","Yes","Antianxiety: benzodiazepine","No","Not Applicable","No","No","No","No","No","Individual","In Person","0.045 mg/kg",,"Single dose",,,,,,,,,,,,,,,"Community",,,"1","0.4634",,"0.5366","Mixed","combat-related. rape/sexual assault, accidents, community/school violence, other (fire, witnessed assault or death, witnessed 9/11 attacks)","High","Feder A, Parides MK, Murrough JW, et al. Efficacy of intravenous ketamine for treatment of chronic posttraumatic stress disorder: a randomized clinical trial. JAMA Psychiatry. 2014 Jun;71(6):681-8. doi: 10.1001/jamapsychiatry.2014.62. PMID: 24740528.","42218","2019"
"feng2019_A","Other mixed","PTSD","PTSD",,"240","A","60",,"Sertraline + simulated TEAS","Sertraline + simulated transcutaneous electrical acupoint stimulation","SSRI + adhesive electrode pads placed 1 cm radial to Nei-Guan (PC6) with minimum stimulation fro 30 seconds then ramped off over next 15 seconds","No","Not Applicable","Yes","Antidepressant: SSRI","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","Sertraline initiated at 25 mg/day titrated up to 100 mg/d over 7 days",,"TEAS: weekly; Sertraline: daily","12",,,,,"pill counted daily",,"reported 95% across all groups",,,,,,"median 96.4 mg/d","Community","0","0","1","0.7042",,"0.2958","Mixed","rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (death of family members)","High","Feng B, Zhang Y, Luo LY, et al. Transcutaneous electrical acupoint stimulation for post-traumatic stress disorder: assessor-blinded, randomized controlled study. Psychiatry Clin Neurosci. 2019 Apr;73(4):179-86. doi: 10.1111/pcn.12810. PMID: 30565342.",,"2020"
"feng2019_D","Other mixed","PTSD","PTSD",,"240","D","60",,"Sertraline + CBT + active TEAS","Sertraline + trauma-focused cognitive behavioral therapy (TF+CBT) + active transcutaneous electrical acupoint stimulation","SSRI + trauma-focused CBT +TEAS delivered to bilateral Nei-Guan (PC6) point on anterior forearm. Battery-drive TEAS (Shenzhen Ryan Medical Device model SNH-138) simulated at 50 Hz with pulse width of 50 microseconds and amplitude 0 to 100 mA titrated to strong but comfortable level","Yes","TF","Yes","Antidepressant: SSRI","No","Not Applicable","Yes","No","No","No","No","Individual","In Person","Sertraline initiated at 25 mg/day titrated up to 100 mg/d over 7 days","CBT session length: 45 minutes;
TEAS session length: NR","CBT and TEAS: weekly; Sertraline: daily","12",,,,,"pill counted daily",,"reported 95% across all groups",,,,,,"median 96.4 mg/day","Community","0","0","1","0.7042",,"0.2958","Mixed","rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (death of family members)","High","Feng B, Zhang Y, Luo LY, et al. Transcutaneous electrical acupoint stimulation for post-traumatic stress disorder: assessor-blinded, randomized controlled study. Psychiatry Clin Neurosci. 2019 Apr;73(4):179-86. doi: 10.1111/pcn.12810. PMID: 30565342.",,"2020"
"feng2019_C","Other mixed","PTSD","PTSD",,"240","C","60",,"CBT + active TEAS","Trauma-focused cognitive behavioral therapy (TF+CBT) + active transcutaneous electrical acupoint stimulation","Trauma-focused CBT + TEAS delivered to bilateral Nei-Guan (PC6) point on anterior forearm. Battery-drive TEAS (Shenzhen Ryan Medical Device model SNH-138) simulated at 50 Hz with pulse width of 50 microseconds and amplitude 0 to 100 mA titrated to strong but comfortable level","Yes","TF","No","Not Applicable","No","Not Applicable","Yes","No","No","No","No","Individual","In Person",,"CBT session length: 45 minutes;
TEAS session length: NR","Weekly","12",,,,,,,,,,,,,,"Community","0","0","1","0.7042",,"0.2958","Mixed","rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (death of family members)","High","Feng B, Zhang Y, Luo LY, et al. Transcutaneous electrical acupoint stimulation for post-traumatic stress disorder: assessor-blinded, randomized controlled study. Psychiatry Clin Neurosci. 2019 Apr;73(4):179-86. doi: 10.1111/pcn.12810. PMID: 30565342.",,"2020"
"feng2019_B","Other mixed","PTSD","PTSD",,"240","B","60",,"CBT + simulated TEAS","Trauma-focused cognitive behavioral therapy (TF+CBT) + simulated transcutaneous electrical acupoint stimulation","Trauma-focused CBT+ adhesive electrode pads placed 1 cm radial to Nei-Guan (PC6) with minimum stimulation fro 30 seconds then ramped off over next 15 seconds","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person",,"CBT session length: 45 minutes;
TEAS session length: NR","Weekly","12",,,,,,,,,,,,,,"Community","0","0","1","0.7042",,"0.2958","Mixed","rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (death of family members)","High","Feng B, Zhang Y, Luo LY, et al. Transcutaneous electrical acupoint stimulation for post-traumatic stress disorder: assessor-blinded, randomized controlled study. Psychiatry Clin Neurosci. 2019 Apr;73(4):179-86. doi: 10.1111/pcn.12810. PMID: 30565342.",,"2020"
"feske2008_A","Psychotherapy","PTSD","PTSD",,"27","A","13",,"PE","Prolonged Exposure (PE)","Treatment adhered to manual by Foa, Hearst-Ikeda, Dancu, Hembree & Jaycox (1997), which included breathing retraining, and imaginal and in vivo exposure. In session 8, participants with <70% improvement on PTSD outcome were encouraged to participate in additional 3 PE sessions","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"90 minutes","Weekly","9 to 12",,,,,,,,"9.3","1",,,,,"Community",,,"1","1",,"0","Mixed","child physical abuse, child sexual abuse, rape/sexual assault, intimate partner violence, community/school violence","High","Feske U. Treating low-income and minority women with posttraumatic stress disorder: a pilot study comparing prolonged exposure and treatment as usual conducted by community therapists. J Interpers Violence. 2008 Aug;23(8):1027-40. doi: 10.1177/0886260507313967. PMID: 18292398.","82117","2019"
"feske2008_B","Psychotherapy","PTSD","Control",,"27","B","14",,"TAU","Psychotherapy as usual","Individual counseling session and group treatment session (e.g., anger management)","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Mixed","In Person",,"Individual session: 60 minutes

Group session: 90 minutes","Weekly","9 to 12",,,,,,,,"9.5","1",,,,,"Community",,,"1","1",,"0","Mixed","child physical abuse, child sexual abuse, rape/sexual assault, intimate partner violence, community/school violence","High","Feske U. Treating low-income and minority women with posttraumatic stress disorder: a pilot study comparing prolonged exposure and treatment as usual conducted by community therapists. J Interpers Violence. 2008 Aug;23(8):1027-40. doi: 10.1177/0886260507313967. PMID: 18292398.","82117","2019"
"flanagan2018_A","Mixed: Psychotherapy & pharmacotherapy","PTSD","PTSD",,"17","A","8",,"PE + oxytocin","Prolonged Exposure (PE) + oxytocin","PE augmented with oxytocin

PE: individual, manualized, trauma-focused CBT

Oxytocin: hypothalamic neuropeptide; self-administered intranasal spray 45 minutes prior to PE therapy (sessions 2 through 9)","Yes","TF","Yes","Other pharmacotherapy","No","Not Applicable","No","No","No","No","No","Individual","In Person","40 IU","90 minutes","Weekly","PE: 10, Oxytocin: 8",,"completed all 10 PE sessions","0.75",,"medication administration observed by research staff","1",,,,,,,,"Mixed","0","0.588","0.412","0.177",,"0.823","Mixed","combat-related, rape/sexual assault, accidents, terrorism/political violence/forced displacement, other (assault)","High","Flanagan JC, Sippel LM, Wahlquist A, et al. Augmenting prolonged exposure therapy for PTSD with intranasal oxytocin: a randomized, placebo-controlled pilot trial. J Psychiatr Res. 2018 Mar;98:64-9. doi: 10.1016/j.jpsychires.2017.12.014. PMID: 29294429.","49583","2019"
"flanagan2018_B","Mixed: Psychotherapy & pharmacotherapy","PTSD","PTSD",,"17","B","9",,"PE + placebo","Prolonged Exposure (PE) + placebo","PE with placebo augmentation

PE: individual, manualized, trauma-focused CBT

Placebo: matching placebo 45 minutes prior to PE therapy (sessions 2 through 9)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person",,"90 minutes","PE: weekly

Placebo: weekly","PE: 10, Placebo: 8","77.78%","completed all 10 PE sessions","0.77780000000000005",,"medication administration observed by research staff","1",,,,,,,,"Mixed","0","0.588","0.412","0.177",,"0.823","Mixed","combat-related, rape/sexual assault, accidents, terrorism/political violence/forced displacement, other (assault)","High","Flanagan JC, Sippel LM, Wahlquist A, et al. Augmenting prolonged exposure therapy for PTSD with intranasal oxytocin: a randomized, placebo-controlled pilot trial. J Psychiatr Res. 2018 Mar;98:64-9. doi: 10.1016/j.jpsychires.2017.12.014. PMID: 29294429.","49583","2019"
"foa2013_A","Psychotherapy","PTSD+SUD","PTSD+SUD","Not integrated","165","A","40",,"PE + naltrexone","Prolonged Exposure (PE) + naltrexone","Prolonged exposure with repeated imaginal exposures, processing the memory, and homework including in vivo exposure. Naltrexone starting dose given for a minimum of 3 days and titrated up within 1 week. All patients also received supportive counseling including medication management, adherence monitoring, and education about alcohol dependency.","Yes","TF","Yes","Other pharmacotherapy","No","Not Applicable","No","No","No","No","No","Individual","In Person","Start at 50 mg up to 100 mg","PE 90 minutes, counseling 30 to 45 minutes","Psychotherapy: weekly for 12 weeks then biweekly; Naltrexone: daily","24",,,,,"≥80% adherence to medication and attendance at supportive counseling. Naltrexone given with 100 mg riboflavin, and urine riboflavin tests were used to monitor medication compliance; pill counts also used","0.85",,,"6.18","3.86",,,,"Mixed","0","0.1152","0.8848","0.3455",,"0.6545","Mixed","Combat-related; Rape/sexual assault; Community/school violence; Other (not specified)","High","Foa EB, Yusko DA, McLean CP, et al. Concurrent naltrexone and prolonged exposure therapy for patients with comorbid alcohol dependence and PTSD: a randomized clinical trial. JAMA. 2013 Aug 7;310(5):488-95. doi: 10.1001/jama.2013.8268. PMID: 23925619.","40905","2020"
"foa2013_B","Psychotherapy","PTSD+SUD","PTSD+SUD","Not integrated","165","B","40",,"PE + placebo","Prolonged Exposure (PE) + placebo","Prolonged exposure with repeated imaginal exposures, processing the memory, and homework including in vivo exposure. Placebo identical to naltrexone given at starting dose for a minimum of 3 days and titrated up within 1 week. All patients also received supportive counseling including medication management, adherence monitoring, and education about alcohol dependency.","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","Start with placebo tablet identical to 50 mg naltrexone, titrate up to 100 mg","PE 90 minutes, counseling 30 to 45 minutes","Psychotherapy: weekly for 12 weeks then biweekly; Placebo: daily","24",,,,,"≥80% adherence to medication and attendance at supportive counseling. Placebo given with 100 mg riboflavin, and urine riboflavin tests were used to monitor medication compliance; pill counts also used","0.85",,,"6.48","3.49",,,,"Mixed","0","0.1152","0.8848","0.3455",,"0.6545","Mixed","Combat-related; Rape/sexual assault; Community/school violence; Other (not specified)","High","Foa EB, Yusko DA, McLean CP, et al. Concurrent naltrexone and prolonged exposure therapy for patients with comorbid alcohol dependence and PTSD: a randomized clinical trial. JAMA. 2013 Aug 7;310(5):488-95. doi: 10.1001/jama.2013.8268. PMID: 23925619.","40905","2020"
"foa2013_C","Psychotherapy","PTSD+SUD","SUD","Not integrated","165","C","42",,"Supportive counseling + naltrexone","Supportive counseling + naltrexone","Naltrexone starting dose given for a minimum of 3 days and titrated up within 1 week. All patients also received supportive counseling including medication management, adherence monitoring, and education about alcohol dependency.","Yes","Non-TF","Yes","Other pharmacotherapy","No","Not Applicable","No","No","No","No","No","Individual","In Person","Start at 50 mg up to 100 mg","30 to 45 minutes","Psychotherapy: weekly for 12 weeks then biweekly; Naltrexone: daily","24",,,,,"≥80% adherence to medication and attendance at supportive counseling. Naltrexone given with 100 mg riboflavin, and urine riboflavin tests were used to monitor medication compliance; pill counts also used","0.8571",,,,,,,,"Mixed","0","0.1152","0.8848","0.3455",,"0.6545","Mixed","Combat-related; Rape/sexual assault; Community/school violence; Other (not specified)","High","Foa EB, Yusko DA, McLean CP, et al. Concurrent naltrexone and prolonged exposure therapy for patients with comorbid alcohol dependence and PTSD: a randomized clinical trial. JAMA. 2013 Aug 7;310(5):488-95. doi: 10.1001/jama.2013.8268. PMID: 23925619.","40905","2020"
"foa2013_D","Psychotherapy","PTSD+SUD","SUD","Not integrated","165","D","43",,"Supportive counseling + placebo","Supportive counseling + placebo","Placebo identical to naltrexone starting dose given for a minimum of 3 days and titrated up within 1 week. All patients also received supportive counseling including medication management, adherence monitoring, and education about alcohol dependency.","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","Start with placebo tablet identical to 50 mg naltrexone, titrate up to 100 mg","Counseling 30 to 45 minutes","Psychotherapy: weekly for 12 weeks then biweekly; Placebo: daily","24",,,,,"≥80% adherence to medication and attendance at supportive counseling. Placebo given with 100 mg riboflavin, and urine riboflavin tests were used to monitor medication compliance; pill counts also used","0.8605",,,,,,,,"Mixed","0","0.1152","0.8848","0.3455",,"0.6545","Mixed","Combat-related; Rape/sexual assault; Community/school violence; Other (not specified)","High","Foa EB, Yusko DA, McLean CP, et al. Concurrent naltrexone and prolonged exposure therapy for patients with comorbid alcohol dependence and PTSD: a randomized clinical trial. JAMA. 2013 Aug 7;310(5):488-95. doi: 10.1001/jama.2013.8268. PMID: 23925619.","40905","2020"
"foa2017_A","Psychotherapy","PTSD+SUD","PTSD+SUD","Integrated","142","A","72",,"PE + smoking cessation counseling + varenicline","Prolonged Exposure (PE) + smoking cessation counseling + varenicline","Smoking cessation counseling (20 to 30 minutes) followed by PE (90 minutes) including imaginal exposure and in vivo exposure with weekly homework. Varenicline dose titrated, with 0.5 mg/day for 3 days, 1.0 mg/day for 4 days, then 2.0 mg/day through day 84. Medication initiated at baseline, and smoking quit date planned about one week later.","Yes","TF","Yes","Other pharmacotherapy","No","Not Applicable","No","No","No","No","No","Individual","In Person","Dose: 1.0 mg (after titration)","Session length: 110 to 120 minutes","Psychotherapy: weekly; Varenicline: twice daily","12",,,,,"percent of prescribed number of pills taken, verified by pill count and Timeline Follow Back Interview","0.945",,"8.3","3.50",,,,,"Community",,,"1","0.3944",,"0.6056","Mixed","Combat-related; Child sexual abuse; Rape/sexual assault; Accidents; Illness/medical procedure; Community/school violence; Natural or manmade disasters; Other (imprisonment, torture, other)","Medium","Foa EB, Asnaani A, Rosenfield D, et al. Concurrent varenicline and prolonged exposure for patients with nicotine dependence and PTSD: a randomized controlled trial. J Consult Clin Psychol. 2017 Sep;85(9):862-72. doi: 10.1037/ccp0000213. PMID: 28569519.","48569","2020"
"foa2017_B","Psychotherapy","PTSD+SUD","SUD","Not integrated","142","B","70",,"Smoking cessation counseling + varenicline","Smoking cessation counseling + varenicline","Smoking cessation counseling plus varenicline, dose titrated with 0.5 mg/day for 3 days, 1.0 mg/day for 4 days, then 2.0 mg/day through day 84. Medication initiated at baseline and smoking quit date planned about one week later.","Yes","Non-TF","Yes","Other pharmacotherapy","No","Not Applicable","No","No","No","No","No","Individual","In Person","Dose: 1.0 mg (after titration)","Session length: 20 to 30 minutes","Psychotherapy: weekly; Varenicline: twice daily","12",,,,,"percent of prescribed number of pills taken, verified by pill count and Timeline Follow Back Interview","0.951",,"9.2","3.71",,,,,"Community",,,"1","0.3944",,"0.6056","Mixed","Combat-related; Child sexual abuse; Rape/sexual assault; Accidents; Illness/medical procedure; Community/school violence; Natural or manmade disasters; Other (imprisonment, torture, other)","Medium","Foa EB, Asnaani A, Rosenfield D, et al. Concurrent varenicline and prolonged exposure for patients with nicotine dependence and PTSD: a randomized controlled trial. J Consult Clin Psychol. 2017 Sep;85(9):862-72. doi: 10.1037/ccp0000213. PMID: 28569519.","48569","2020"
"foa2018_D","Psychotherapy","PTSD","Control",,"370","D","40",,"Minimal contact","Minimal attention","Therapist call participants to ask about well-being, offer support as needed, and received contact information in case symptoms worsened.","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","Phone",,"10 to 15 minutes","Once weekly","4",,,,,,,,"3.54",,,,,,,,,,"0.1202",,"0.8798","Mixed","combat-related, other (not specified)","Medium","Foa EB, McLean CP, Zang Y, et al. Effect of prolonged exposure therapy delivered over 2 weeks vs 8 weeks vs present-centered therapy on PTSD symptom severity in military personnel: a randomized clinical trial. JAMA. 2018 Jan 23;319(4):354-64. doi: 10.1001/jama.2017.21242. PMID: 29362795.","49595","2020"
"foa2018_C","Psychotherapy","PTSD","PTSD",,"370","C","110",,"PCT","Present Centered Therapy (PCT)","Non-trauma-focused treatment focusing on current life problems that may or may not be PTSD-related.","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"90 minutes","Twice weekly for first and last weeks, once weekly for other weeks","8",,,,,,,,"9.10","2.53",,,,,,,,,"0.1202",,"0.8798","Mixed","combat-related, other (not specified)","Medium","Foa EB, McLean CP, Zang Y, et al. Effect of prolonged exposure therapy delivered over 2 weeks vs 8 weeks vs present-centered therapy on PTSD symptom severity in military personnel: a randomized clinical trial. JAMA. 2018 Jan 23;319(4):354-64. doi: 10.1001/jama.2017.21242. PMID: 29362795.","49595","2020"
"foa2018_A","Psychotherapy","PTSD","PTSD",,"370","A","110",,"Massed PE Therapy","Prolonged Exposure (PE)","CBT consisting of imaginal exposure followed by processing thoughts and feelings related to the imaginal exposure, in-vivo exposure, psychoeducation about PTSD, and controlled breathing training.","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,,"Once daily on weekdays","2",,,,,,,,"9.04","2.60",,,,,,,,,"0.1202",,"0.8798","Mixed","combat-related, other (not specified)","Medium","Foa EB, McLean CP, Zang Y, et al. Effect of prolonged exposure therapy delivered over 2 weeks vs 8 weeks vs present-centered therapy on PTSD symptom severity in military personnel: a randomized clinical trial. JAMA. 2018 Jan 23;319(4):354-64. doi: 10.1001/jama.2017.21242. PMID: 29362795.","49595","2020"
"foa2018_B","Psychotherapy","PTSD","PTSD",,"370","B","110",,"Spaced PE Therapy","Prolonged Exposure (PE)","CBT consisting of imaginal exposure followed by processing thoughts and feelings related to the imaginal exposure, in-vivo exposure, psychoeducation about PTSD, and controlled breathing training","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,,"Twice weekly for first and last weeks, once weekly for other weeks","8",,,,,,,,"8.59","2.68",,,,,,,,,"0.1202",,"0.8798","Mixed","combat-related, other (not specified)","Medium","Foa EB, McLean CP, Zang Y, et al. Effect of prolonged exposure therapy delivered over 2 weeks vs 8 weeks vs present-centered therapy on PTSD symptom severity in military personnel: a randomized clinical trial. JAMA. 2018 Jan 23;319(4):354-64. doi: 10.1001/jama.2017.21242. PMID: 29362795.","49595","2020"
"foa1991_A","Psychotherapy","PTSD","PTSD",,"55","A","17",,"SIT","Stress Inoculation Training (SIT)","Individual sessions with female therapist. Two sessions devoted to information gathering, description of treatment method and rationale, and explanation for origin of fear and anxiety. Seven sessions comprised of breathing exercises, deep muscle relaxation, thought stopping to counter ruminative or obsessive thinking, cognitive restructuring, guided self-dialogue, covert modeling, and role-playing.","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"90 minutes","Twice weekly","4.5",,,,,,,,,,,,,,"Community",,,"1","1",,"0","Rape/sexual assault",,"High","Foa EB, Rothbaum BO, Riggs DS, et al. Treatment of posttraumatic stress disorder in rape victims: a comparison between cognitive-behavioral procedures and counseling. J Consult Clin Psychol. 1991 Oct;59(5):715-23.  PMID: 1955605.","02437","2019"
"foa1991_B","Psychotherapy","PTSD","PTSD",,"55","B","14",,"PE","Prolonged Exposure (PE)","Individual sessions with female therapist. Two sessions devoted to information gathering, explanation of treatment rationale and treatment planning. Seven sessions comprised of imaginal exposure in which participants were instructed to imagine reliving the assault in vivid detail while describing it aloud, using present tense, and repeating for approximately 60 minutes of the session. Homework as at least once daily listening to tape-recorded narrative, with additional homework including in vivo exposure.","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"90 minutes","Twice weekly","4.5",,,,,,,,,,,,,,"Community",,,"1","1",,"0","Rape/sexual assault",,"High","Foa EB, Rothbaum BO, Riggs DS, et al. Treatment of posttraumatic stress disorder in rape victims: a comparison between cognitive-behavioral procedures and counseling. J Consult Clin Psychol. 1991 Oct;59(5):715-23.  PMID: 1955605.","02437","2019"
"foa1991_C","Psychotherapy","PTSD","PTSD",,"55","C","14",,"Supportive Counseling","Supportive counseling","Individual sessions with female therapist. Two sessions devoted to information gathering, explanation of treatment rationale and treatment planning. Seven sessions in which participants were taught a general problem-solving technique with therapists in unconditionally supportive role. Homework with diary-keeping of daily problems and attempts at problem solving. Participants were immediately redirected to focus on current daily problems if discussion of assault occurred.","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"90 minutes","Twice weekly","4.5",,,,,,,,,,,,,,"Community",,,"1","1",,"0","Rape/sexual assault",,"High","Foa EB, Rothbaum BO, Riggs DS, et al. Treatment of posttraumatic stress disorder in rape victims: a comparison between cognitive-behavioral procedures and counseling. J Consult Clin Psychol. 1991 Oct;59(5):715-23.  PMID: 1955605.","02437","2019"
"foa1991_D","Psychotherapy","PTSD","Control",,"55","D","10",,"Waitlist","Waitlist",,"No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","No","No","No",,,,,,"5",,,,,,,,,,,,,,"Community",,,"1","1",,"0","Rape/sexual assault",,"High","Foa EB, Rothbaum BO, Riggs DS, et al. Treatment of posttraumatic stress disorder in rape victims: a comparison between cognitive-behavioral procedures and counseling. J Consult Clin Psychol. 1991 Oct;59(5):715-23.  PMID: 1955605.","02437","2019"
"foa1999_A","Psychotherapy","PTSD","PTSD",,"96","A","25",,"PE","Prolonged Exposure (PE)","Individual treatment following manual; 2 sessions included information gathering, treatment rationale, construction of in vivo exposure hierarchy, and in vivo homework; remaining sessions included homework review, imaginal exposure, and homework assignment; homework to listen to tape recordings of imaginal exposure from sessions, and in vivo exposure.","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"120 minutes for 2 sessions
90 minutes for 7 sessions","Twice weekly","5",,"did not drop out of treatment","0.92",,,,,,,,,,,"Community",,,"1","1",,"0","Mixed","rape/sexual assault, community/school violence","Medium","Foa EB, Dancu CV, Hembree EA, et al. A comparison of exposure therapy, stress inoculation training, and their combination for reducing posttraumatic stress disorder in female assault victims. J Consult Clin Psychol. 1999;67(2):194.  PMID: 10224729.","09724","2019"
"foa1999_B","Psychotherapy","PTSD","PTSD",,"96","B","26",,"SIT","Stress Inoculation Training (SIT)","Individual treatment following manual, program adapted from Veronen and Kilpatrick (1983); 2 sessions included information gathering, breathing retraining, and treatment rationale and planning; remaining 7 sessions focused on coping skills for management of assault-related anxiety and postassault problems; coping skills included: deep muscle relaxation, cue-controlled and differential relaxation, thought stopping, cognitive restructuring, guided self-dialogue, covert modeling, and role-play. Homework to practice the coping skills to manage anxiety and fear in daily activities. Explicit in vivo homework instructions were omitted.","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"120 minutes for 2 sessions
90 minutes for 7 sessions","Twice weekly","5",,"did not drop out of treatment","0.73",,,,,,,,,,,"Community",,,"1","1",,"0","Mixed","rape/sexual assault, community/school violence","Medium","Foa EB, Dancu CV, Hembree EA, et al. A comparison of exposure therapy, stress inoculation training, and their combination for reducing posttraumatic stress disorder in female assault victims. J Consult Clin Psychol. 1999;67(2):194.  PMID: 10224729.","09724","2019"
"foa1999_C","Psychotherapy","PTSD","PTSD",,"96","C","30",,"PE + SIT","Prolonged Exposure (PE) + Stress Inoculation Training (SIT)","Individual treatment following manual; combination of PE and SIT included education, training on SIT coping skills, in vivo exposure, and imaginal exposure; homework assigned for exposure and coping skill practice","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"120 minutes for first 2 sessions, 90 minutes for remaining 7 sessions","Twice weekly","5",,"did not drop out of treatment","0.73",,,,,,,,,,,"Community",,,"1","1",,"0","Mixed","rape/sexual assault, community/school violence","Medium","Foa EB, Dancu CV, Hembree EA, et al. A comparison of exposure therapy, stress inoculation training, and their combination for reducing posttraumatic stress disorder in female assault victims. J Consult Clin Psychol. 1999;67(2):194.  PMID: 10224729.","09724","2019"
"foa1999_D","Psychotherapy","PTSD","Control",,"96","D","15",,"Waitlist","Waitlist","Waitlist participant were instructed to call if experiencing any problems; contacted once during the waiting period by a therapist to determine their current status.","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,,,,"5",,,,,,,,,,,,,,"Community",,,"1","1",,"0","Mixed","rape/sexual assault, community/school violence","Medium","Foa EB, Dancu CV, Hembree EA, et al. A comparison of exposure therapy, stress inoculation training, and their combination for reducing posttraumatic stress disorder in female assault victims. J Consult Clin Psychol. 1999;67(2):194.  PMID: 10224729.","09724","2019"
"foa2005_A","Psychotherapy","PTSD","PTSD",,"104","A","74",,"PE + CR","Prolonged Exposure (PE) plus cognitive restructuring","Sessions involved imaginal exposure and participants were taught to identify and challenge erroneous beliefs","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"≥90 minutes","Once a week","9 to 12",,"Attended ≥8 therapy sessions and completed a posttreatment assessment","0.595",,,,,,,,,,,"Community",,,"1","1",,"0","Mixed","rape/sexual assault, intimate partner violence, child sexual abuse","Medium","Foa EB, Hembree EA, Cahill SP, et al. Randomized trial of prolonged exposure for posttraumatic stress disorder with and without cognitive restructuring: outcome at academic and community clinics. J Consult Clin Psychol. 2005;73(5):953. doi: 10.1037/0022-006X.73.5.953. PMID: 16287395.","27946","2019"
"foa2005_B","Psychotherapy","PTSD","PTSD",,"104","B","79",,"PE","Prolonged Exposure (PE)","Each session began with reviewing homework and ended with assigning homework. Sessions involved imaginal exposure","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"≥90 minutes","Once weekly","9 to 12",,"Attended ≥ 8 therapy sessions and completed a posttreatment assessment","0.658",,,,,,,,,,,"Community",,,"1","1",,"0","Mixed","rape/sexual assault, intimate partner violence, child sexual abuse","Medium","Foa EB, Hembree EA, Cahill SP, et al. Randomized trial of prolonged exposure for posttraumatic stress disorder with and without cognitive restructuring: outcome at academic and community clinics. J Consult Clin Psychol. 2005;73(5):953. doi: 10.1037/0022-006X.73.5.953. PMID: 16287395.","27946","2019"
"foa2005_C","Psychotherapy","PTSD","Control",,"104","C","26",,"Waitlist","Waitlist","Participants informed their treatment will begin in 9 weeks","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,,,,"9",,,,,,,,,,,,,,"Community",,,"1","1",,"0","Mixed","rape/sexual assault, intimate partner violence, child sexual abuse","Medium","Foa EB, Hembree EA, Cahill SP, et al. Randomized trial of prolonged exposure for posttraumatic stress disorder with and without cognitive restructuring: outcome at academic and community clinics. J Consult Clin Psychol. 2005;73(5):953. doi: 10.1037/0022-006X.73.5.953. PMID: 16287395.","27946","2019"
"fonzo2017_A","Psychotherapy","PTSD","PTSD",,"66","A","36",,"PE","Prolonged Exposure (PE)","Manualized procedures according to Foa, Hembree, & Rothbaum 2007. Participants with adequate response to treatment, defined as <30% of PCL-C score at baseline (i.e. 70% reduction from baseline), were given the option to terminate treatment after Session 9. Nonresponders continued through Session 12","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"90 minutes","Once or twice weekly",,"9 to 12 sessions total",,,,,,,,,,,,,,,,,"0.6515",,"0.3485","Mixed","combat-related, illness/medical procedure, community/school violence, natural or manmade disasters, rape/sexual assault","Medium","Fonzo GA, Goodkind MS, Oathes DJ, et al. PTSD psychotherapy outcome predicted by brain activation during emotional reactivity and regulation. Am J Psychiatry. 2017 Dec 1;174(12):1163-74. doi: 10.1176/appi.ajp.2017.16091072. PMID: 28715908.","48700","2019"
"fonzo2017_B","Psychotherapy","PTSD","Control",,"66","B","30",,"Waitlist","Waitlist",,"No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,,,,"10",,,,,,,,,,,,,,,,,,"0.6515",,"0.3485","Mixed","combat-related, illness/medical procedure, community/school violence, natural or manmade disasters, rape/sexual assault","Medium","Fonzo GA, Goodkind MS, Oathes DJ, et al. PTSD psychotherapy outcome predicted by brain activation during emotional reactivity and regulation. Am J Psychiatry. 2017 Dec 1;174(12):1163-74. doi: 10.1176/appi.ajp.2017.16091072. PMID: 28715908.","48700","2019"
"forbes2012_A","Psychotherapy","PTSD","PTSD",,"59","A","30",,"CPT","Cognitive Processing Therapy (CPT)","Manualized treatment addressing key themes including safety, trust, power and control, self-esteem, and intimacy with cognitive therapy and written exposure","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"Session 1: 90 minutes
Sessions 2 to 12: 60  minutes","Biweekly","6","12 sessions total",,,,,,,"10.27","4.93",,,,,"Veteran","0","1","0","0.0339",,"0.9661","Combat-related (described as ""military-related"")",,"Medium","Forbes D, Lloyd D, Nixon RDV, et al. A multisite randomized controlled effectiveness trial of cognitive processing therapy for military-related posttraumatic stress disorder. J Anxiety Disord. 2012 Apr;26(3):442-52. doi: 10.1016/j.janxdis.2012.01.006. PMID: 22366446..","38353","2019"
"forbes2012_B","Psychotherapy","PTSD","PTSD",,"59","B","29",,"TAU","Psychotherapy as usual","Varied according to therapist: 14% psychoeducation and supportive counseling; 52% nontrauma-focused symptom management interventions; 34% CBT which included elements of exposure","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No",,"In Person",,,,"6",,,,,,,,"6.31","4.68",,,,,"Veteran","0","1","0","0.0339",,"0.9661","Combat-related (described as ""military-related"")",,"Medium","Forbes D, Lloyd D, Nixon RDV, et al. A multisite randomized controlled effectiveness trial of cognitive processing therapy for military-related posttraumatic stress disorder. J Anxiety Disord. 2012 Apr;26(3):442-52. doi: 10.1016/j.janxdis.2012.01.006. PMID: 22366446..","38353","2019"
"ford2018_A","Psychotherapy","PTSD","PTSD",,"31","A","17",,"Trauma Affect Regulation: Guide for Education and Therapy","Trauma Affect Regulation: Guide for Education and Therapy","Manualized therapy (Ford, 2015) including psychoeducation, eliciting day triggers for PTSD alarm reactions and teaching skills to inhibit impulsive emotional and behavioral reactions. Intervention teaches the ""Slow down, Orient Self-check"" skill and other skills to replace alarm reaction with emotional self-regulation.","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"75 to 90 minutes","Weekly","10",,"complete 80% of treatment sessions","0.7059",,,,,"7.65",,,,,,"Mixed",,,"0","0",,"1","Combat-related",,"High","Ford JD, Grasso DJ, Greene CA, et al. Randomized clinical trial pilot study of prolonged exposure versus present centred affect regulation therapy for PTSD and anger problems with male military combat veterans. Clin Psychol Psychother. 2018 Sep;25(5):641-9. doi: 10.1002/cpp.2194. PMID: 29687524.","50258","2019"
"ford2018_B","Psychotherapy","PTSD","PTSD",,"31","B","14",,"PE","Prolonged Exposure (PE)","Intervention according to manualized guidelines (Foa, Hembree, & Rothbaum, 2007), including psychoeducation, breathing retraining, imaginal and in vivo exposure","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"75 to 90 minutes","Weekly","10",,"complete 80% of treatment sessions","0.3571",,,,,"4.71",,,,,,"Mixed",,,"0","0",,"1","Combat-related",,"High","Ford JD, Grasso DJ, Greene CA, et al. Randomized clinical trial pilot study of prolonged exposure versus present centred affect regulation therapy for PTSD and anger problems with male military combat veterans. Clin Psychol Psychother. 2018 Sep;25(5):641-9. doi: 10.1002/cpp.2194. PMID: 29687524.","50258","2019"
"fortney2015_A","Collaborative care","PTSD","PTSD",,"265","A","133",,"Telemedicine Outreach for PTSD","Telemedicine Outreach for PTSD (TOP)","Off-site PTSD care team used telemedicine technology to support the PTSD treatment delivered by clinic providers. Specific components: Home-based telephone nurse care manager (e.g., symptom monitoring, education, medication adherence) and telephone pharmacist; clinic-based telepsychology and telepsychiatry service","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","No","No","Yes","Individual","Phone",,,,,"total followup 52 weeks",,"0.835",,"Pharmacologic component: patient self-report ≥80% adherence

Nonpharmacologic component: attended ≥8 CPT sessions",,"Pharmacologic: 59.41% first 6 months; 57.43% second 6 months; Nonpharmacologic: 27.1%",,,"CPT: 4.2 (5.4); Case manager encounters: 14.4 (NR)",,,,"Veteran",,"1",,"0.102",,"0.898","Combat-related",,"Medium","Fortney JC, Pyne JM, Kimbrell TA, et al. Telemedicine-based collaborative care for posttraumatic stress disorder: a randomized clinical trial. JAMA Psychiatry. 2015 Jan;72(1):58-67. doi: 10.1001/jamapsychiatry.2014.1575. PMID: 25409287.","43084","2019"
"fortney2015_B","Collaborative care","PTSD","Control",,"265","B","132",,"Usual care","Treatment as usual (TAU)","Care received at distant VA and local community-based outpatient clinic with no home-based or telemedicine support","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,,,,,"total followup 52 weeks",,,,"Pharmacologic component: patient self-report ≥80% adherence
Nonpharmacologic component: attended ≥8 CPT sessions",,"Pharmacologic: 67.01% first 6 months; 67.37% second 6 months; Nonpharmacologic: 5.3%","0.8","2.6",,,,,"Veteran",,"1",,"0.102",,"0.898","Combat-related",,"Medium","Fortney JC, Pyne JM, Kimbrell TA, et al. Telemedicine-based collaborative care for posttraumatic stress disorder: a randomized clinical trial. JAMA Psychiatry. 2015 Jan;72(1):58-67. doi: 10.1001/jamapsychiatry.2014.1575. PMID: 25409287.","43084","2019"
"franklin2017_A","Psychotherapy","PTSD","PTSD",,"27","A","12",,"Telehealth PE","Prolonged Exposure (PE)","PE therapy delivered via streaming-video calls using Tango (free application downloaded to the phone which uses the 3G network); no changes made to PE treatment other than mode of delivery. Participants loaned an iPhone 4 with service plans for duration of treatment.","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","Video",,,"Weekly","12","10 sessions total","completed 10 sessions within 12 weeks","0.30",,,,,,,,,,,"Veteran","0","1","0","0.074",,"0.926",,,"High","Franklin CL, Cuccurullo LA, Walton JL, et al. Face to face but not in the same place: a pilot study of prolonged exposure therapy. J Trauma Dissociation. 2017 Jan-Feb;18(1):116-30. doi: 10.1080/15299732.2016.1205704. PMID: 27348462.","50424","2019"
"franklin2017_B","Psychotherapy","PTSD","PTSD",,"27","B","7",,"PE delivered via computer-based teleconferencing","Prolonged Exposure (PE)","PE therapy delivered via computer-based teleconferencing equipment at rural VA community-based outpatient clinics; no changes made to PE treatment other than mode of delivery.","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","Video",,,"Weekly","12","10 sessions total","completed 10 sessions within 12 weeks","0.5714",,,,,,,,,,,"Veteran","0","1","0","0.074",,"0.926",,,"High","Franklin CL, Cuccurullo LA, Walton JL, et al. Face to face but not in the same place: a pilot study of prolonged exposure therapy. J Trauma Dissociation. 2017 Jan-Feb;18(1):116-30. doi: 10.1080/15299732.2016.1205704. PMID: 27348462.","50424","2019"
"franklin2017_C","Psychotherapy","PTSD","Control",,"27","C","8",,"TAU","Treatment as usual (TAU)","Allowed treatment: referring clinician's choice of therapy, excluding evidence-based psychotherapy for PTSD; therapies which occurred: supportive psychotherapy or medication management, typically provided by psychiatrists, masters'-level social workers, psychology interns/fellows, and psychologists at the community clinic.","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,,,,"12",,"remained in treatment for 12-week duration of the study","1",,,,,,,,,,,"Veteran","0","1","0","0.074",,"0.926",,,"High","Franklin CL, Cuccurullo LA, Walton JL, et al. Face to face but not in the same place: a pilot study of prolonged exposure therapy. J Trauma Dissociation. 2017 Jan-Feb;18(1):116-30. doi: 10.1080/15299732.2016.1205704. PMID: 27348462.","50424","2019"
"friedman2007_A","Pharmacotherapy","PTSD","PTSD",,"169","A","86",,"Sertraline","Sertraline","SSRI; started at 25 mg/day for 1 week, increased to 50 mg/day in week 2, weekly increases of 50 mg/day based on response and tolerability","No","Not Applicable","Yes","Antidepressant: SSRI","No","Not Applicable","No","No","No","No","No","Individual","In Person","Initiated at 25 mg, titrated to maximum 200 mg",,"Daily","12",,,,,,,,,,,"135 mg/day","61.9",,"Veteran","0","1","0","0.2282",,"0.7718","Mixed","combat-related, rape/sexual assault, accidents, community/school violence, other (injury, fire, seeing someone hurt or die, ""miscellaneous"")","Medium","Friedman MJ, Marmar CR, Baker DG, et al. Randomized, double-blind comparison of sertraline and placebo for posttraumatic stress disorder in a Department of Veterans Affairs setting. J Clin Psychiatry. 2007 May;68(5):711-20. PMID: 17503980.","29522","2019"
"friedman2007_B","Pharmacotherapy","PTSD","Control",,"169","B","83",,"Placebo","Placebo","Placebo matched sertraline","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person",,,"Daily","12",,,,,,,,,,,"172 mg/day equivalent","49.6",,"Veteran","0","1","0","0.2282",,"0.7718","Mixed","combat-related, rape/sexual assault, accidents, community/school violence, other (injury, fire, seeing someone hurt or die, ""miscellaneous"")","Medium","Friedman MJ, Marmar CR, Baker DG, et al. Randomized, double-blind comparison of sertraline and placebo for posttraumatic stress disorder in a Department of Veterans Affairs setting. J Clin Psychiatry. 2007 May;68(5):711-20. PMID: 17503980.","29522","2019"
"frommberger2004_A","Mixed: Psychotherapy & pharmacotherapy","PTSD","PTSD",,"21","A","11",,"Paroxetine","Paroxetine","SSRI; dose increased according to response and tolerability","No","Not Applicable","Yes","Antidepressant: SSRI","No","Not Applicable","No","No","No","No","No","Individual","In Person","20 to 50 mg; titration: 10 mg for 1 week then increased weekly in 10-mg increments",,"Daily","12",,,,,,,,,,,"28 mg/day",,,"Community",,,"1","0.5714",,"0.4286","Mixed","rape/sexual assault, accidents, community/school violence","High","Frommberger UH, Stieglitz R-D, Nyberg E, et al. Comparison between paroxetine and behaviour therapy in patients with posttraumatic stress disorder (PTSD): a pilot study. Int. J. Psychiatry Clin. Pract. 2004;8(1):19-24. doi: 10.1080/13651500310004803. PMID: 24937579.","27144","2019"
"frommberger2004_B","Mixed: Psychotherapy & pharmacotherapy","PTSD","PTSD",,"21","B","10",,"CBT","Trauma-focused cognitive behavioral therapy (TF-CBT)","CBT comprised psychoeducation,
behavioral assessment, relaxation training, stress inoculation training, exposure in sensu (prolonged exposure) and in vivo and cognitive restructuring. Methods and training provided by Edna Foa.","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,,"Weekly","12",,,,,,,,,,,,,,"Community",,,"1","0.5714",,"0.4286","Mixed","rape/sexual assault, accidents, community/school violence","High","Frommberger UH, Stieglitz R-D, Nyberg E, et al. Comparison between paroxetine and behaviour therapy in patients with posttraumatic stress disorder (PTSD): a pilot study. Int. J. Psychiatry Clin. Pract. 2004;8(1):19-24. doi: 10.1080/13651500310004803. PMID: 24937579.","27144","2019"
"frueh2007_A","Psychotherapy","PTSD","PTSD",,"38","A","17",,"Telehealth CBT","Cognitive behavioral therapy (CBT) without a trauma focus","Treatment specifically targeted social skills training (e.g., assertion, social communication, anger management), and activities to increase social participation","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","Video",,"90 minutes","Weekly","14",,,,,,,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"High","Frueh BC, Monnier J, Yim E, et al. A randomized trial of telepsychiatry for post-traumatic stress disorder. J. Telemed. Telecare. 2007 Apr 1;13(3):142-7. doi: 10.1258/135763307780677604. PMID: 17519056.","29644","2019"
"frueh2007_B","Psychotherapy","PTSD","PTSD",,"38","B","21",,"CBT in-person","Cognitive behavioral therapy (CBT) without a trauma focus","Treatment specifically targeted social skills training (e.g., assertion, social communication, anger management), and activities to increase social participation","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"90 minutes","Weekly","14",,,,,,,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"High","Frueh BC, Monnier J, Yim E, et al. A randomized trial of telepsychiatry for post-traumatic stress disorder. J. Telemed. Telecare. 2007 Apr 1;13(3):142-7. doi: 10.1258/135763307780677604. PMID: 17519056.","29644","2019"
"galovski2012_A","Psychotherapy","PTSD","PTSD",,"100","A","53",,"Modified CPT","Cognitive Processing Therapy (CPT)","Modified application of traditional CPT (Resick, Monson, & Chard, 2008); primary modifications: length of intervention individually tailored with conclusion based on predefined specified end-state criterion (4 to 18 possible sessions); up to 2 optional ""stressor sessions"" offered when a participant experienced a significant psychosocial stressor or emergency during the course of therapy, and participant's choice whether to use the stressor session.
End-state criterion for termination of treatment: PDS ≤20, BDI ≤18, agreement between the therapist and participant that treatment goals had been attained, and negative PTSD status on CAPS by blind rater.","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,,,,"4 to 18 sessions total","reached end-state criterion","0.7021",,,,,,,,,,,"Community",,,"1","0.69",,"0.31","Mixed","child sexual abuse, child physical abuse, rape/sexual assault, community/school violence, intimate partner violence","Medium","Galovski TE, Blain LM, Mott JM, et al. Manualized therapy for PTSD: flexing the structure of cognitive processing therapy. J Consult Clin Psychol. 2012 Dec;80(6):968-81. doi: 10.1037/a0030600. PMID: 23106761.","39611","2019"
"galovski2012_B","Psychotherapy","PTSD","Control",,"100","B","47",,"Symptom monitoring","Symptom monitoring","Daily monitoring of PTSD and depressive symptoms; 3 phone interviews for CAPS administration and inquiry into progress on symptom monitoring, overall symptom severity, and general distress but without cognitive therapy or other trauma-focused intervention.","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,,,,"10",,"completed treatment course","0.8409",,,,,,,,,,,"Community",,,"1","0.69",,"0.31","Mixed","child sexual abuse, child physical abuse, rape/sexual assault, community/school violence, intimate partner violence","Medium","Galovski TE, Blain LM, Mott JM, et al. Manualized therapy for PTSD: flexing the structure of cognitive processing therapy. J Consult Clin Psychol. 2012 Dec;80(6):968-81. doi: 10.1037/a0030600. PMID: 23106761.","39611","2019"
"galovski2016_A","Mixed: Psychotherapy & CIH","PTSD","PTSD",,"92","A","44",,"Sleep-directed hypnosis + CPT","Sleep-directed hypnosis followed by Cognitive Processing Therapy (CPT)","Sleep-directed hypnosis for 3 weeks followed by 12 weeks of CPT.

Scripted hypnosis targeting sleep impairment (no trauma-related material) with focus on sleep onset difficulty and mid-sleep awakening and inability to fall back to sleep; utilized psychoeducation, hypnotic trance using eye fixation technique, guided imagery and redirection of mental activity. Participants instructed to practice daily using audiotape of hypnosis session.

CPT targeting interpretations of the trauma itself and then current and future maladaptive and inaccurate beliefs about world, self and others; patients taught to identify, question, challenge and replace faulty assumptions and thoughts about traumatic event and its implications in their current life.","Yes","TF","No","Not Applicable","Yes","Clinical hypnosis","No","No","No","No","No","Individual","In Person",,"60 minutes","Weekly","15",,,,,,,,,,,,,,"Community",,,"1","1",,"0","Mixed","child sexual abuse, child physical abuse, rape/sexual assault, community/school violence, intimate partner violence","High","Galovski TE, Harik JM, Blain LM, et al. Augmenting cognitive processing therapy to improve sleep impairment in PTSD: a randomized controlled trial. J Consult Clin Psychol. 2016 Feb;84(2):167-77. doi: 10.1037/ccp0000059. PMID: 26689303.","44664","2019"
"galovski2016_B","Mixed: Psychotherapy & CIH","PTSD","PTSD",,"92","B","48",,"Sleep and symptom monitoring + CPT","Sleep and symptom monitoring followed by Cognitive Processing Therapy (CPT)","Sleep and symptom monitoring for 3 weeks followed by 12 weeks of CPT.

Daily monitoring of PTSD, depressive symptoms, and sleep, with weekly phone checks.

CPT targeting interpretations of the trauma itself and then current and future maladaptive and inaccurate beliefs about world, self and others; patients taught to identify, question, challenge and replace faulty assumptions and thoughts about traumatic event and its implications in their current life.","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person",,"Symptom monitoring: NA

CPT sessions: 60 minutes","Weekly","15",,,,,,,,,,,,,,"Community",,,"1","1",,"0","Mixed","child sexual abuse, child physical abuse, rape/sexual assault, community/school violence, intimate partner violence","High","Galovski TE, Harik JM, Blain LM, et al. Augmenting cognitive processing therapy to improve sleep impairment in PTSD: a randomized controlled trial. J Consult Clin Psychol. 2016 Feb;84(2):167-77. doi: 10.1037/ccp0000059. PMID: 26689303.","44664","2019"
"gamito2010_A","Psychotherapy","PTSD","PTSD",,"10","A","5",,"Virtual reality exposure therapy","Virtual reality exposure therapy (VRET)","Treatment includes psychoeducation for anxiety management and exposure to traumatic event through a Z800 head-mounted display (e-Magin Corp) that displays a footpath surrounded by dense vegetation where participants had to follow a column of virtual soldiers. Ambush, gun firing, motor, and waiting for evacuation near an injured soldier were added gradually each session","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,,,,"12 sessions total",,,,,,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"Medium","Gamito P, Oliveira J, Rosa P, et al. PTSD elderly war veterans: a clinical controlled pilot study. Cyberpsychol Behav Soc Netw. 2010 Feb;13(1):43-8. doi: 10.1089/cyber.2009.0237. PMID: 20528292.","33784","2019"
"gamito2010_B","Psychotherapy","PTSD","PTSD",,"10","B","2",,"Imaginal Exposure","Trauma-focused cognitive behavioral therapy (TF-CBT)","Treatment includes psychoeducation for anxiety management and imaginal exposure","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,,,,"12 sessions total",,,,,,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"Medium","Gamito P, Oliveira J, Rosa P, et al. PTSD elderly war veterans: a clinical controlled pilot study. Cyberpsychol Behav Soc Netw. 2010 Feb;13(1):43-8. doi: 10.1089/cyber.2009.0237. PMID: 20528292.","33784","2019"
"gamito2010_C","Psychotherapy","PTSD","Control",,"10","C","3",,"Waitlist","Waitlist",,"No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"Medium","Gamito P, Oliveira J, Rosa P, et al. PTSD elderly war veterans: a clinical controlled pilot study. Cyberpsychol Behav Soc Netw. 2010 Feb;13(1):43-8. doi: 10.1089/cyber.2009.0237. PMID: 20528292.","33784","2019"
"gapen2016_A","Complementary and integrative health (CIH)","PTSD","PTSD",,"23","A","12",,"Neurofeedback","Neurofeedback","EEG biofeedback with sensors placed at T3-T4. Training parameters followed flexible, principle-based manual with defined rules to adjust reward frequency and training time; reward frequency adjusted based on the participant's clinical response (number of over- or under-arousal symptoms); training time increased in 3-minute increments when participant reported positive change.","No","Not Applicable","No","Not Applicable","Yes","Relaxation","No","No","No","No","No","Individual","In Person","inhibit frequencies: 4 to 7 Hz and 22 to 36 Hz
reward frequency: 12 to 15 Hz","12 to 21 minutes","Twice weekly","20",,"completed 40 sessions","0.75",,,,,,,,,,,"Community",,,"1","0.6522",,"0.3478","Mixed","child physical abuse, child sexual abuse, child other abuse, other (not specified)","High","Gapen MA, van der Kolk BA, Hamlin E, et al. A pilot study of neurofeedback for chronic PTSD. Appl Psychophysiol Biofeedback. 2016 Sep;41(3):251-61. doi: 10.1007/s10484-015-9326-5. PMID: 26782083.","44803","2019"
"gapen2016_B","Complementary and integrative health (CIH)","PTSD","PTSD",,"23","B","11",,"Neurofeedback","Neurofeedback","EEG biofeedback with sensors placed at T4-P4. Training parameters followed flexible, principle-based manual; inhibit frequencies: 4-7 Hz and 22-36 Hz; reward frequency: initial 12-15 Hz, adjusted based on the participant's clinical response (number of over- or under-arousal symptoms); training time increased in 3-minute increments when participant reported positive change.","No","Not Applicable","No","Not Applicable","Yes","Relaxation","No","No","No","No","No","Individual","In Person","inhibit frequencies: 4 to 7 Hz and 22 to 36 Hz
reward frequency: 12 to 15 Hz","12 to 21 minutes","Twice weekly","20",,"completed 40 sessions","0.7273",,,,,,,,,,,"Community",,,"1","0.6522",,"0.3478","Mixed","child physical abuse, child sexual abuse, child other abuse, other (not specified)","High","Gapen MA, van der Kolk BA, Hamlin E, et al. A pilot study of neurofeedback for chronic PTSD. Appl Psychophysiol Biofeedback. 2016 Sep;41(3):251-61. doi: 10.1007/s10484-015-9326-5. PMID: 26782083.","44803","2019"
"gelkopf2013_A","Complementary and integrative health (CIH)","PTSD","PTSD",,"42","A","22",,"Nature Adventure Rehabilitation","Recreational therapy","Activity-based sport intervention (sailing) that seeks to empower participant, change negative self-image, enhance self-efficacy, hope, and the ability to enjoy life, to develop control over symptoms, and improve social and emotional regulation skills. Each session began with a summary of previous lesson, followed by sailing in a group and different sea-related activities. Session ends with a debrief and discussion of sailing-related and personal issues","No","Not Applicable","No","Not Applicable","Yes","Other physical activity and recreational therapies","No","No","No","No","No","Group","In Person",,"3 hours","Weekly","52",,,,,,,,,,">40/52",,,,"Veteran","0","1","0","0",,"1","Combat-related",,"High","Gelkopf M, Hasson-Ohayon I, Bikman M, et al. Nature adventure rehabilitation for combat-related posttraumatic chronic stress disorder: a randomized control trial. Psychiatry Res. 2013 Oct 30;209(3):485-93. doi: 10.1016/j.psychres.2013.01.026. PMID: 23541513.","40581","2019"
"gelkopf2013_B","Complementary and integrative health (CIH)","PTSD","Control",,"42","B","20",,"Waitlist","Waitlist",,"No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,,,,"52",,,,,,,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"High","Gelkopf M, Hasson-Ohayon I, Bikman M, et al. Nature adventure rehabilitation for combat-related posttraumatic chronic stress disorder: a randomized control trial. Psychiatry Res. 2013 Oct 30;209(3):485-93. doi: 10.1016/j.psychres.2013.01.026. PMID: 23541513.","40581","2019"
"geronilla2016_A","Psychotherapy","PTSD","PTSD",,"58","A","32",,"Emotional Freedom Technique","Emotional Freedom Technique (EFT)","Treatment followed The EFT Manual (Craig & Fowlie 1995; Church, 2013) where therapists guided participants through traumatic emotional events until emotional intensity reduces via office or telephone sessions or televideo conferencing calls. All participants received usual care by primary care provider","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"1 hour",,,"6 sessions total",,,,,,,,,,,,,"Veteran","0","1","0","0.1207",,"0.8793",,,"High","Geronilla L, Minewiser L, Mollon P, et al. EFT (Emotional Freedom Techniques) remediates PTSD and psychological symptoms in veterans: A randomized controlled replication trial. Energy Psychology. 2016;8(2):29.","1549292","2019"
"geronilla2016_B","Psychotherapy","PTSD","Control",,"58","B","26",,"TAU waitlist","Waitlist","Participants received usual care by primary care provider and completed a 30-day waiting period","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,,,,"4",,,,,,,,,,,,,,"Veteran","0","1","0","0.1207",,"0.8793",,,"High","Geronilla L, Minewiser L, Mollon P, et al. EFT (Emotional Freedom Techniques) remediates PTSD and psychological symptoms in veterans: A randomized controlled replication trial. Energy Psychology. 2016;8(2):29.","1549292","2019"
"gersons2000_A","Psychotherapy","PTSD","PTSD",,"44","A","22",,"Brief Eclectic Psychotherapy","Brief Eclectic Psychotherapy (BEP)","Individualized psychotherapy, consisting of psychoeducation, imaginary guidance, writing assignments and mementos, domain of meaning or integration, and a farewell ritual","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"60 minutes","Once a week","16",,,,,,,,,,,,,,"Community",,,"1","0.119",,"0.881","Other (occupational events)",,"Medium","Gersons BP, Carlier IV, Lamberts RD, et al. Randomized clinical trial of brief eclectic psychotherapy for police officers with posttraumatic stress disorder. J Trauma Stress. 2000 Apr;13(2):333-47. doi: 10.1023/A:1007793803627. PMID: 10838679..","15124","2019"
"gersons2000_B","Psychotherapy","PTSD","Control",,"44","B","20",,"Waitlist","Waitlist","Participants monitored by a nonassessor psychologist","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,,,,"16",,,,,,,,,,,,,,"Community",,,"1","0.119",,"0.881","Other (occupational events)",,"Medium","Gersons BP, Carlier IV, Lamberts RD, et al. Randomized clinical trial of brief eclectic psychotherapy for police officers with posttraumatic stress disorder. J Trauma Stress. 2000 Apr;13(2):333-47. doi: 10.1023/A:1007793803627. PMID: 10838679..","15124","2019"
"ghafoori2017_A","Psychotherapy","PTSD","PTSD",,"71","A","47",,"PE","Prolonged Exposure (PE)","Treatment delivered using manual; elements included: psychoeducation, breathing retraining, imaginal exposure with processing or discussion of the content during session, and in vivo exposure.","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"60 to 90 minutes","Weekly","12",,"completed 12 sessions","0.2766",,,,,"6.79","4.26",,,,,"Community",,,"1","0.831",,"0.169","Mixed","natural or manmade disaster, accidents, rape/sexual assault, community/school violence, illness/medical procedure, combat-related, terrorism/political violence/forced displacement","High","Ghafoori B, Hansen MC, Garibay E, et al. Feasibility of training frontline therapists in prolonged exposure: a randomized controlled pilot study of treatment of complex trauma in diverse victims of crime and violence. J Nerv Ment Dis. 2017 Apr;205(4):283-93. doi: 10.1097/NMD.0000000000000659. PMID: 28157725.","1523171","2019"
"ghafoori2017_B","Psychotherapy","PTSD","PTSD",,"71","B","24",,"PCT","Present Centered Therapy (PCT)","Treatment delivered using manual; content shared directed by client with therapist offering support with respect to trauma related memories; elements included: psychoeducation, breathing retraining, reviewing daily difficulties as a manifestation of PTSD related to trauma (without directive imaginal exposure).","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"60 to 90 minutes","Weekly","12",,"completed 12 sessions","0.3333",,,,,"8.67","4.02",,,,,"Community",,,"1","0.831",,"0.169","Mixed","natural or manmade disaster, accidents, rape/sexual assault, community/school violence, illness/medical procedure, combat-related, terrorism/political violence/forced displacement","High","Ghafoori B, Hansen MC, Garibay E, et al. Feasibility of training frontline therapists in prolonged exposure: a randomized controlled pilot study of treatment of complex trauma in diverse victims of crime and violence. J Nerv Ment Dis. 2017 Apr;205(4):283-93. doi: 10.1097/NMD.0000000000000659. PMID: 28157725.","1523171","2019"
"goldstein2018_A","Complementary and integrative health (CIH)","PTSD","PTSD",,"47","A","21",,"Integrative Exercise","Exercise","Combine aerobic and resistance exercise with yoga poses presented within a framework of mindfulness principles based on the Mindfulness-Based Stress Reduction and Mindful Breathing principles","No","Not Applicable","No","Not Applicable","Yes","Other physical activity and recreational therapies","No","No","No","No","No","Group","In Person",,"1 hour","3 times a week","12",,,,,,,,"17.38",,,,,,"Veteran",,"1",,"0.1915",,"0.8085",,,"Low","Goldstein LA, Mehling WE, Metzler TJ, et al. Veterans group exercise: a randomized pilot trial of an integrative exercise program for veterans with posttraumatic stress. J Affect Disord. 2018 Feb;227:345-52. doi: 10.1016/j.jad.2017.11.002. PMID: 29145076.","49403","2019"
"goldstein2018_B","Complementary and integrative health (CIH)","PTSD","Control",,"47","B","26",,"Waitlist","Waitlist","Participants could participate in Integrative Exercise after 12 weeks of waiting period","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,,,,"12",,,,,,,,,,,,,,"Veteran",,"1",,"0.1915",,"0.8085",,,"Low","Goldstein LA, Mehling WE, Metzler TJ, et al. Veterans group exercise: a randomized pilot trial of an integrative exercise program for veterans with posttraumatic stress. J Affect Disord. 2018 Feb;227:345-52. doi: 10.1016/j.jad.2017.11.002. PMID: 29145076.","49403","2019"
"golier2012_A","Pharmacotherapy","PTSD","PTSD",,"9","A",,,"Mifepristone","Mifepristone","Antiprogestogen","No","Not Applicable","Yes","Steroids","No","Not Applicable","No","No","No","No","No","Individual","In Person","600 mg",,"Daily at bedtime","1",,,,,,,,,,,,,,"Veteran","0","1","0",,,,"Combat-related",,"Medium","Golier JA, Caramanica K, Demaria R, et al. A pilot study of mifepristone in combat-related PTSD. Depress Res Treat. 2012;2012:393251. doi: 10.1155/2012/393251. PMID: 22611490.","39051","2019"
"golier2012_B","Pharmacotherapy","PTSD","Control",,"9","B",,,"Placebo","Placebo","Matched placebo","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,,"Daily at bedtime","1",,,,,,,,,,,,,,"Veteran","0","1","0",,,,"Combat-related",,"Medium","Golier JA, Caramanica K, Demaria R, et al. A pilot study of mifepristone in combat-related PTSD. Depress Res Treat. 2012;2012:393251. doi: 10.1155/2012/393251. PMID: 22611490.","39051","2019"
"gray2019a_A","Psychotherapy","PTSD","PTSD",,"74","A","37",,"Reconsolidation of Traumatic Memories","Reconsolidation of Traumatic Memories (RTM)","Brief, non-traumatizing trauma-focused CBT in which a consolidated trauma memory is reactivated using a brief narrative, then patients are presented with healthy dissociative distancing experiences and exercises to modify the perceptual structure of the memory","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"120 minutes",,"2","3 sessions",,,,,,,,,,,,,"Veteran","0","1","0","0",,"1","Mixed","MST, combat-related, rape/sexual assault, accidents, community/school violence, terrorism/political violence/forced displacement, other (not specified)","Medium","Gray R, Budden-Potts D, Bourke F. Reconsolidation of traumatic memories for PTSD: a randomized controlled trial of 74 male veterans. Psychother Res. 2017 Dec 14:1-19. doi: 10.1080/10503307.2017.1408973. PMID: 29241423.","49545","2020"
"gray2019a_B","Psychotherapy","PTSD","Control",,"74","B","37",,"Waitlist","Waitlist",,"No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,,,,"2",,,,,,,,,,,,,,"Veteran","0","1","0","0",,"1","Mixed","MST, combat-related, rape/sexual assault, accidents, community/school violence, terrorism/political violence/forced displacement, other (not specified)","Medium","Gray R, Budden-Potts D, Bourke F. Reconsolidation of traumatic memories for PTSD: a randomized controlled trial of 74 male veterans. Psychother Res. 2017 Dec 14:1-19. doi: 10.1080/10503307.2017.1408973. PMID: 29241423.","49545","2020"
"hall2019a_A","Complementary and integrative health (CIH)","PTSD","PTSD",,"54","A","36",,"Warrior Wellness","Exercise","Supervised community-based exercise training for older veterans; integrates cognitive behavioral strategies during exercise program, targeting 5 sources of self-efficacy: ""(1) self-monitoring and mastery experi- ence; (2) education of physiologic responses to exercise; (3) outcome expectations; (4) barriers to participation; and (5) modeling and social support"". Includes individual exercise prescription, with one-on-one and independent exercises which emphasized ""aerobic, strength, balance, and flexibility exercises. Modalities included body weight, free weight, cables, and exercise bands; treadmills and stationary bikes were used for aerobic training"".","No","Not Applicable","No","Not Applicable","Yes","Other physical activity and recreational therapies","No","No","No","No","No","Individual","In Person",,"60 to 90 minutes","3 times a week","12",,,,,,,,,,"82% (range 23 to 100%) (of participants who attended at least one session)",,,,"Veteran","0","1","0","0.9074",,"0.0926",,,"Medium","Hall KS, Morey MC, Bosworth HB, et al. Pilot randomized controlled trial of exercise training for older veterans with PTSD. J Behav Med. 2019 Jul 1doi: 10.1007/s10865-019-00073-w. PMID: 31264055.","52094","2020"
"hall2019a_B","Complementary and integrative health (CIH)","PTSD","Control",,"54","B","18",,"Waitlist","Waitlist","Continued usual care in VA clinics.","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,,,,"12",,,,,,,,,,,,,,"Veteran","0","1","0","0.9074",,"0.0926",,,"Medium","Hall KS, Morey MC, Bosworth HB, et al. Pilot randomized controlled trial of exercise training for older veterans with PTSD. J Behav Med. 2019 Jul 1doi: 10.1007/s10865-019-00073-w. PMID: 31264055.","52094","2020"
"hamner2019_B","Pharmacotherapy","PTSD","Control",,"24","B","15",,"Placebo augmentation","Placebo","Placebo augmentation to sertraline or paroxetine (open-label sertraline or paroxetine during phase 1 of study; see comments for phase 1 details).","No","Not Applicable","Yes","Antidepressant: SSRI","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","Comparable dosing to ziprasidone 120 to 160 mg",,"Twice daily in divided doses","8",,,,,,,,,,,,,"all individuals reached targeted dosing range","Veteran","0","1","0",,,,,,"High","Hamner MB, Hernandez-Tejada MA, Zuschlag ZD, et al. Ziprasidone augmentation of SSRI antidepressants in posttraumatic stress disorder: a randomized, placebo-controlled pilot study of augmentation therapy. J Clin Psychopharmacol. 2019 Mar/Apr;39(2):153-7. doi: 10.1097/JCP.0000000000001000. PMID: 30640209.","51867","2020"
"hamner2019_A","Pharmacotherapy","PTSD","PTSD",,"24","A","9",,"Ziprasidone augmentation","Ziprasidone augmentation","Ziprasidone augmentation to sertraline or paroxetine (open-label sertraline or paroxetine during phase 1 of study; see comments for phase 1 details).","No","Not Applicable","Yes","Mixed SSRI & antipsychotic","No","Not Applicable","No","No","No","No","No","Individual","In Person","120 to 160 mg total daily dose, as tolerated",,"Twice daily in divided doses","8",,,,,,,,,,,,,"all individuals reached targeted dosing range","Veteran","0","1","0",,,,,,"High","Hamner MB, Hernandez-Tejada MA, Zuschlag ZD, et al. Ziprasidone augmentation of SSRI antidepressants in posttraumatic stress disorder: a randomized, placebo-controlled pilot study of augmentation therapy. J Clin Psychopharmacol. 2019 Mar/Apr;39(2):153-7. doi: 10.1097/JCP.0000000000001000. PMID: 30640209.","51867","2020"
"hamner2009_A","Pharmacotherapy","PTSD","PTSD",,"29","A","16",,"Divalproex","Divalproex","Anticonvulsant","No","Not Applicable","Yes","Mood Stabilizer","No","Not Applicable","No","No","No","No","No","Individual","In Person","Started at 750 mg/day ""in divided doses"", increased by 250 mg every 3 to 4 days, titrated until positive clinical response or desired trough level (50 to 125 mcg/mL); mean daily dose range 500 to 1500 mg",,,"10",,,,,,,,,,,"1250 mg/day","327",,"Veteran","0","1","0","0.0345",,"0.9655","Mixed","combat-related, MST","High","Hamner MB, Faldowski RA, Robert S, et al. A preliminary controlled trial of divalproex in posttraumatic stress disorder. Ann Clin Psychiatry. 2009 Apr-Jun;21(2):89-94. PMID: 19439158.","33535","2019"
"hamner2009_B","Pharmacotherapy","PTSD","Control",,"29","B","13",,"Placebo","Placebo","Placebo","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person",,,,"10",,,,,,,,,,,,,,"Veteran","0","1","0","0.0345",,"0.9655","Mixed","combat-related, MST","High","Hamner MB, Faldowski RA, Robert S, et al. A preliminary controlled trial of divalproex in posttraumatic stress disorder. Ann Clin Psychiatry. 2009 Apr-Jun;21(2):89-94. PMID: 19439158.","33535","2019"
"hanling2016_A","Nonpharmacologic biological","PTSD","PTSD",,"42","A","27",,"Stellate Ganglion Block","Stellate ganglion block (SGB)","Injection of ropivacaine (a local anesthetic) at right C5 or C6 vertebra into the stellate ganglion - sympathetic nerve tissue of the neck.","No","Not Applicable","No","Not Applicable","No","Not Applicable","Yes","No","No","No","No","Individual","In Person","5 mL of 0.5% ropivacaine",,"Once or twice, depending on response","1","single injection, second injection after 3 months if needed",,,,,,,,,"66% received two injections","5 mL of 0.5% bupivacaine",,,"Mixed","0.881","0.119","0","0.1905",,"0.8095","Mixed","combat-related, other (noncombat unspecified)","Medium","Hanling SR, Hickey A, Lesnik I, et al. Stellate Ganglion Block for the treatment of posttraumatic stress disorder: a randomized, double-blind, controlled trial. Reg Anesth Pain Med. 2016 Jul-Aug;41(4):494-500. doi: 10.1097/aap.0000000000000402. PMID: 27187898.","46472","2019"
"hanling2016_B","Nonpharmacologic biological","PTSD","Control",,"42","B","15",,"Sham stellate ganglion block","Sham","Normal saline injected in soft tissues superficial to the anterior tubercle of C6","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","5 mL",,"Once","1",,"Received injection","1",,,,,,,,,,,"Mixed","0.881","0.119","0","0.1905",,"0.8095","Mixed","combat-related, other (noncombat unspecified)","Medium","Hanling SR, Hickey A, Lesnik I, et al. Stellate Ganglion Block for the treatment of posttraumatic stress disorder: a randomized, double-blind, controlled trial. Reg Anesth Pain Med. 2016 Jul-Aug;41(4):494-500. doi: 10.1097/aap.0000000000000402. PMID: 27187898.","46472","2019"
"harb2019_B","Psychotherapy","PTSD","PTSD",,"108","B","55",,"CBT-I","Cognitive Behavioral Therapy for Insomnia (CBT-I)","CBT-I: manualized therapy; ""included psychoeducation about sleep and post-traumatic sleep problems and the following elements of standard CBT-I: grounding, aimed at reducing arousal and/or disso- citation after waking from nightmares (session 1), progressive muscle relaxation and discussion of the relationship between daily stressors, sleep, and nightmares (session 2), sleep hygiene and setting a regular sleep schedule (session 3), stimulus control (session 4), reduction of cognitive hyperarousal (session 5), and relapse prevention (session 6)""; CBT-I did not include intentional sleep restriction, discussion of nightmare content, and did not teach any imagery rescripting techniques. Participants completed standard daily sleep diaries.","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"1 hour","Weekly","6",,,,,,,,,,,,,,"Veteran","0","1","0","0.139",,"0.861","Combat-related",,"Low","Harb GC, Cook JM, Phelps AJ, et al. Randomized controlled trial of imagery rehearsal for posttraumatic nightmares in combat veterans. J Clin Sleep Med. 2019 May 15;15(5):757-67. doi: 10.5664/jcsm.7770. PMID: 31053215.",,"2020"
"harb2019_A","Psychotherapy","PTSD","PTSD",,"108","A","53",,"IR + CBT-I","Imagery Rehearsal Training (IRT) + Cognitive Behavioral Therapy for Insomnia (CBT-I)","IR combined with CBT-I as manualized treatment; participants completed standard daily sleep diaries.
CBT-I ""included psychoeducation about sleep and post-traumatic sleep problems and the following elements of standard CBT-I: grounding, aimed at reducing arousal and/or disso- citation after waking from nightmares (session 1), progressive muscle relaxation and discussion of the relationship between daily stressors, sleep, and nightmares (session 2), sleep hygiene and setting a regular sleep schedule (session 3), stimulus control (session 4), reduction of cognitive hyperarousal (session 5), and relapse prevention (session 6)""; did not include intentional sleep restriction.
IR was incorporated in sessions 2-4 with identification and rescripting of a recurrent nightmare.","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"1 hour","Weekly","6",,,,,,,,,,,,,,"Veteran","0","1","0","0.139",,"0.861","Combat-related",,"Low","Harb GC, Cook JM, Phelps AJ, et al. Randomized controlled trial of imagery rehearsal for posttraumatic nightmares in combat veterans. J Clin Sleep Med. 2019 May 15;15(5):757-67. doi: 10.5664/jcsm.7770. PMID: 31053215.",,"2020"
"harris2018_A","Mixed: Psychotherapy & CIH","PTSD","PTSD",,"138","A","71",,"Building Spiritual Strength","Building Spiritual Strength","Manualized, spiritually integrated, group counseling intervention designed to facilitate resolution of spiritual distress","No","Not Applicable","No","Not Applicable","Yes","Spirituality","No","No","No","No","No","Group","In Person",,"2 hours","Weekly","8",,"completed ≥5 sessions","0.6056",,,,,"4.52","3.33",,,,,"Veteran","0","1","0","0.2391",,"0.7609","Mixed","combat-related, rape/sexual assault, accidents, illness/medical procedure, community/school violence, other (adverse childhood experiences, not specified)","Medium","Harris JI, Usset T, Voecks C, et al. Spiritually integrated care for PTSD: a randomized controlled trial of ‚Äö√Ñ√∫Building Spiritual Strength‚Äö√Ñ√π. Psychiatry Res. 2018 Jun 20;267:420-8. doi: 10.1016/j.psychres.2018.06.045. PMID: 29980120.","50585","2019"
"harris2018_B","Mixed: Psychotherapy & CIH","PTSD","PTSD",,"138","B","67",,"Group PCT","Present Centered Therapy (PCT)","Provides support and addresses participants' current problems but does not directly focus on the person's trauma-related memories or facilitate resolution of participants' spiritual distress","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Group","In Person",,"2 hour","Weekly","8",,"completed ≥5 sessions","0.6716",,,,,"4.78","3.34",,,,,"Veteran","0","1","0","0.2391",,"0.7609","Mixed","combat-related, rape/sexual assault, accidents, illness/medical procedure, community/school violence, other (adverse childhood experiences, not specified)","Medium","Harris JI, Usset T, Voecks C, et al. Spiritually integrated care for PTSD: a randomized controlled trial of ‚Äö√Ñ√∫Building Spiritual Strength‚Äö√Ñ√π. Psychiatry Res. 2018 Jun 20;267:420-8. doi: 10.1016/j.psychres.2018.06.045. PMID: 29980120.","50585","2019"
"henseldittmann2011_A","Psychotherapy","PTSD","PTSD",,"28","A","15",,"NET","Narrative Exposure Therapy (NET)","According to manual by Schauer et al. (2005), participant constructs a detailed chronological account of his/her biography. The therapist provides empathic understanding, active listening, congruency, and unconditional positive regard for the participant. The participant is encouraged to relive the emotions while narrating, and therapist links the experiences to episodic facts and contrasts the time and place of the memory with those of the present","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"90 minutes","NR (mean 9.82 [SD 3.55] days between sessions for overall study population)",,"10 sessions total, lasting mean 13 weeks for overall study population",,,,,,,,,,,,,"Community",,,"1",,,,"Terrorism/political violence/forced displacement",,"High","Hensel-Dittmann D, Schauer M, Ruf M, et al. Treatment of traumatized victims of war and torture: a randomized controlled comparison of narrative exposure therapy and stress inoculation training. Psychother Psychosom. 2011 Oct;80(6):345-52. doi: 10.1159/000327253. PMID: 21829046.","37590","2019"
"henseldittmann2011_B","Psychotherapy","PTSD","PTSD",,"28","B","13",,"SIT","Stress Inoculation Training (SIT)","Modified version includes breathing techniques, relaxation training, cognitive restructuring, thought stopping, guided self-dialogue, covert modeling, and role play","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"90 minutes","NR (mean 9.82 [SD 3.55] days between sessions for overall study population)",,"10 sessions total, lasting mean 13 weeks for overall study population",,,,,,,,,,,,,"Community",,,"1",,,,"Terrorism/political violence/forced displacement",,"High","Hensel-Dittmann D, Schauer M, Ruf M, et al. Treatment of traumatized victims of war and torture: a randomized controlled comparison of narrative exposure therapy and stress inoculation training. Psychother Psychosom. 2011 Oct;80(6):345-52. doi: 10.1159/000327253. PMID: 21829046.","37590","2019"
"herescolevy2002_A","Pharmacotherapy","PTSD","PTSD",,"11","A","10",,"D-cycloserine","D-cycloserine","Partial agonist at the NMDA receptor-associated glycine site; also used as broad spectrum antibiotic. Cross-over design with 2 weeks of washout between treatment periods.","No","Not Applicable","Yes","Other pharmacotherapy","No","Not Applicable","No","No","No","No","No","Individual","In Person","25 mg",,"Twice daily","4",,,,,,,,,,,,,,"Community",,,"1","0.1818",,"0.8182","Mixed","accidents, terrorism/political violence/forced displacement, other (physical abuse)","Medium","Heresco-Levy U, Kremer I, Javitt DC, et al. Pilot-controlled trial of D-cycloserine for the treatment of post-traumatic stress disorder. Int J Neuropsychopharmacol. 2002 Dec;5(4):301-7. doi: 10.1017/S1461145702003061. PMID: 12466030.","25345","2019"
"herescolevy2002_B","Pharmacotherapy","PTSD","Control",,"11","B","8",,"Placebo","Placebo","Matched placebo. Cross-over design with 2 weeks of washout between treatment periods.","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person",,,"Twice daily","4",,,,,,,,,,,,,,"Community",,,"1","0.1818",,"0.8182","Mixed","accidents, terrorism/political violence/forced displacement, other (physical abuse)","Medium","Heresco-Levy U, Kremer I, Javitt DC, et al. Pilot-controlled trial of D-cycloserine for the treatment of post-traumatic stress disorder. Int J Neuropsychopharmacol. 2002 Dec;5(4):301-7. doi: 10.1017/S1461145702003061. PMID: 12466030.","25345","2019"
"herescolevy2009_A","Pharmacotherapy","PTSD","PTSD",,"22","A","21",,"D-serine","D-serine","NMDA glutamate receptor agonist; cross-over design with 3 week washout period.","No","Not Applicable","Yes","Other pharmacotherapy","No","Not Applicable","No","No","No","No","No","Individual","In Person","30 mg/kg total daily dose; titration: initiated at 10 mg/kg, increased after 1 week to 20 mg/kg and after 2 weeks to 30 mg/kg",,"Daily (3 divided doses)","6",,,,,,,,,,,"2.45 g/day","0.3",,"Community",,,"1","0.1364",,"0.8636","Mixed","combat-related, accidents, terrorism/political violence/forced displacement, other (not specified)","Medium","Heresco-Levy U, Vass A, Bloch B, et al. Pilot controlled trial of D-serine for the treatment of post-traumatic stress disorder. Int J Neuropsychopharmacol. 2009 Oct;12(9):1275-82. doi: 10.1017/S1461145709000339. PMID: 19366490.","33582","2019"
"herescolevy2009_B","Pharmacotherapy","PTSD","Control",,"22","B","22",,"Placebo","Placebo","Placebo in capsule identical to active treatment with same dose escalation schedule; cross-over design with 3 week washout period.","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","30 mg/kg D-serine equivalent total daily dose; titration: initiated at 10 mg/kg, increased after 1 week to 20 mg/kg and after 2 weeks to 30 mg/kg",,"Daily","6",,,,,,,,,,,,,,"Community",,,"1","0.1364",,"0.8636","Mixed","combat-related, accidents, terrorism/political violence/forced displacement, other (not specified)","Medium","Heresco-Levy U, Vass A, Bloch B, et al. Pilot controlled trial of D-serine for the treatment of post-traumatic stress disorder. Int J Neuropsychopharmacol. 2009 Oct;12(9):1275-82. doi: 10.1017/S1461145709000339. PMID: 19366490.","33582","2019"
"hertzberg1999_A","Pharmacotherapy","PTSD","PTSD",,"15","A","11",,"Lamotrigine","Lamotrigine","Glutamate-inhibiting anticonvulsant with antidepressant properties; flexible dosing to achieve maximal response","No","Not Applicable","Yes","Mood Stabilizer","No","Not Applicable","No","No","No","No","No","Individual","In Person","50 to 500 mg; flexible dosing; titration: 25 mg for 2 weeks, 50 mg for 2 weeks, 100 mg for 1 week, then increased in 100-mg increments every 1 to 2 weeks with maximum dose of 500 mg; taper over last 2 weeks with 50% reduction each week",,"Daily","12",,,,,,,,,,,"380 mg/day (range 50 to 500 mg/day)",,,"Mixed","0","0.71","0.29","0.36",,"0.64","Mixed","combat-related, rape/sexual assault, other (abduction)","High","Hertzberg MA, Butterfield MI, Feldman ME, et al. A preliminary study of lamotrigine for the treatment of posttraumatic stress disorder. Biol psychiatry. 1999 May 1;45(9):1226-9. PMID: 10331117.","09744","2019"
"hertzberg1999_B","Pharmacotherapy","PTSD","Control",,"15","B","4",,"Placebo","Placebo","Placebo","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person",,,"Daily","12",,,,,,,,,,,,,,"Mixed","0","0.71","0.29","0.36",,"0.64","Mixed","combat-related, rape/sexual assault, other (abduction)","High","Hertzberg MA, Butterfield MI, Feldman ME, et al. A preliminary study of lamotrigine for the treatment of posttraumatic stress disorder. Biol psychiatry. 1999 May 1;45(9):1226-9. PMID: 10331117.","09744","2019"
"hertzberg2000_A","Pharmacotherapy","PTSD","PTSD",,"12","A","6",,"Fluoxetine","Fluoxetine","SSRI; flexible dosing with titration to maximal response or dose-limiting side effects","No","Not Applicable","Yes","Antidepressant: SSRI","No","Not Applicable","No","No","No","No","No","Individual","In Person","10 to 60 mg; titration: 10 mg for 1 week, then 20 mg for 2 weeks, then increased weekly in 10-mg increments with maximum daily dose of 60 mg",,"Daily","12",,,,,,,,,,,"48  mg/day (range 10 to 60  mg/day)",,,"Veteran","0","1","0","0",,"1","Combat-related",,"High","Hertzberg MA, Feldman ME, Beckham JC, et al. Lack of efficacy for fluoxetine in PTSD: a placebo controlled trial in combat veterans. Ann Clin Psychiatry. 2000 Jun;12(2):101-5. doi: 10.1023/A:1009076231175. PMID: 10907802.","22432","2019"
"hertzberg2000_B","Pharmacotherapy","PTSD","Control",,"12","B","6",,"Placebo","Placebo","Placebo","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person",,,"Daily","12",,,,,,,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"High","Hertzberg MA, Feldman ME, Beckham JC, et al. Lack of efficacy for fluoxetine in PTSD: a placebo controlled trial in combat veterans. Ann Clin Psychiatry. 2000 Jun;12(2):101-5. doi: 10.1023/A:1009076231175. PMID: 10907802.","22432","2019"
"hien2004_B","Psychotherapy","PTSD+SUD","SUD","Not integrated","96","B",,"34 completed at least one session and were randomized","Relapse Prevention","Relapse Prevention","Manualized individual therapy addressing substance abuse; ""does not directly address trauma-related symptoms.""","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"1 hour","Twice a week","12",,"attended ≥25% of all therapy sessions","0.7059",,,,,,,,,,,"Community",,,"1","1",,"0",,,"Medium","Hien DA, Cohen LR, Miele GM, et al. Promising treatments for women with comorbid PTSD and substance use disorders. Am J Psychiatry. 2004 Aug;161(8):1426-32. doi: 10.1176/appi.ajp.161.8.1426. PMID: 15285969.","26661","2020"
"hien2004_A","Psychotherapy","PTSD+SUD","PTSD+SUD","Integrated","96","A",,"41 attended at least one session and were analyzed","Seeking Safety","Seeking Safety","Manualized individual therapy; cognitive behavioral ""integrated treatment that addresses PTSD symptoms in the context of substance abuse.""","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"1 hour","Twice a week","12",,"attended ≥25% of all therapy sessions","0.6098",,,,,,,,,,,"Community",,,"1","1",,"0",,,"Medium","Hien DA, Cohen LR, Miele GM, et al. Promising treatments for women with comorbid PTSD and substance use disorders. Am J Psychiatry. 2004 Aug;161(8):1426-32. doi: 10.1176/appi.ajp.161.8.1426. PMID: 15285969.","26661","2020"
"hien2009_A","Psychotherapy","PTSD+SUD","PTSD+SUD","Integrated","353","A","176",,"Seeking Safety","Seeking Safety","Group therapy sessions following set structure; abbreviated to 12 sessions (full Seeking Safety treatment protocol is 25 sessions), each with a different topic; included topics: ""safety, taking back power from PTSD, when substances are in control, honesty, setting boundaries in relationships, compassion, healing from anger, cre- ating meaning, integrating the split self, taking good care of oneself, red and green flags, and detaching from emotional pain (grounding)."" All participants also had TAU for substance abuse at a community-based substance abuse treatment program which did not include trauma-focused treatments.","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Group","In Person",,"75 to 90 minutes","Twice a week","6",,"completed at least 6 treatment sessions (""at least minimal exposure"")","0.5852",,,,,"6.2","4.5",,,,,"Community",,,"1","1",,"0","Mixed","child physical abuse, child sexual abuse, rape/sexual assault, community/school violence, accidents, illness/medical procedure, other (""exposed to violent death"")","Medium","Hien DA, Wells EA, Jiang H, et al. Multisite randomized trial of behavioral interventions for women with co-occurring PTSD and substance use disorders. J Consult Clin Psychol. 2009 Aug;77(4):607-19. doi: 10.1037/a0016227. PMID: 19634955.","85825","2020"
"hien2009_B","Psychotherapy","PTSD+SUD","SUD","Not integrated","353","B","177",,"Women's Health Education","Women's Health Education","Group format with all sessions following the same format; intervention is ""psychoeducational, manualized health curriculum focused on topics such as understanding the female body, human sexual behavior, pregnancy and childbirth, sexually trans- mitted diseases, HIV, and AIDS""; no ""explicit focus or psychoeducation specific to substance abuse or trauma"". All participants also had TAU for substance abuse at a community-based substance abuse treatment program which did not include trauma-focused treatments.","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Group","In Person",,"75 to 90 minutes","Twice a week","6",,"completed at least 6 treatment sessions (""at least minimal exposure"")","0.5424",,,,,"6.0","4.3",,,,,"Community",,,"1","1",,"0","Mixed","child physical abuse, child sexual abuse, rape/sexual assault, community/school violence, accidents, illness/medical procedure, other (""exposed to violent death"")","Medium","Hien DA, Wells EA, Jiang H, et al. Multisite randomized trial of behavioral interventions for women with co-occurring PTSD and substance use disorders. J Consult Clin Psychol. 2009 Aug;77(4):607-19. doi: 10.1037/a0016227. PMID: 19634955.","85825","2020"
"hijazi2014_A","Psychotherapy","PTSD","PTSD",,"63","A","41",,"Brief NET","Narrative Exposure Therapy (NET)","Manualized treatment adapted for 3 sessions; intervention that fuses emotional processing, testimony, and expressive writing by helping people construct detailed narratives of their life stories with a focus on their traumatic experiences.","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"60 to 90 minutes","Weekly","3",,"completed all 3 sessions","0.951",,,,,,,,,,,"Community",,,"1","0.556",,"0.444","Mixed","terrorism/political violence/forced displacement, rape/sexual assault, combat-related","Medium","Hijazi AM, Lumley MA, Ziadni MS, et al. Brief narrative exposure therapy for posttraumatic stress in Iraqi refugees: a preliminary randomized clinical trial. J Trauma Stress. 2014 Jun;27(3):314-22. doi: 10.1002/jts.21922. PMID: 24866253.","42387","2019"
"hijazi2014_B","Psychotherapy","PTSD","Control",,"63","B","22",,"Waitlist","Waitlist","Waitlist","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.556",,"0.444","Mixed","terrorism/political violence/forced displacement, rape/sexual assault, combat-related","Medium","Hijazi AM, Lumley MA, Ziadni MS, et al. Brief narrative exposure therapy for posttraumatic stress in Iraqi refugees: a preliminary randomized clinical trial. J Trauma Stress. 2014 Jun;27(3):314-22. doi: 10.1002/jts.21922. PMID: 24866253.","42387","2019"
"hinton2009_A","Psychotherapy","PTSD","PTSD",,"24","A","12",,"Culturally sensitive CBT","Cognitive behavioral therapy (CBT) without a trauma focus","Manualized treatment according to Hinton et al. (2005) that includes muscle relaxation, guided imagery and mindfulness training, yoga-like stretching linked to self images of flexibility, cognitive restructuring, exercises used to teach emotional distancing and switching, and interceptive exposure","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Group","In Person",,,"Weekly","12",,,,,,,,,,,,,,"Community",,,"1","0.5833",,"0.4167","Terrorism/political violence/forced displacement",,"Medium","Hinton DE, Hofmann SG, Pollack MH, et al. Mechanisms of efficacy of CBT for Cambodian refugees with PTSD: improvement in emotion regulation and orthostatic blood pressure response. CNS Neurosci Ther. 2009 Fall;15(3):255-63. doi: 10.1111/j.1755-5949.2009.00100.x. PMID: 19691545.","33298","2019"
"hinton2009_B","Psychotherapy","PTSD","Control",,"24","B","12",,"Waitlist","Waitlist",,"No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,,,,"12",,,,,,,,,,,,,,"Community",,,"1","0.5833",,"0.4167","Terrorism/political violence/forced displacement",,"Medium","Hinton DE, Hofmann SG, Pollack MH, et al. Mechanisms of efficacy of CBT for Cambodian refugees with PTSD: improvement in emotion regulation and orthostatic blood pressure response. CNS Neurosci Ther. 2009 Fall;15(3):255-63. doi: 10.1111/j.1755-5949.2009.00100.x. PMID: 19691545.","33298","2019"
"hinton2011_A","Psychotherapy","PTSD","PTSD",,"24","A","12",,"Culturally adapted CBT","Cognitive behavioral therapy (CBT) without a trauma focus","Manualized group CBT with treatment culturally adapted for Latino patients.","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Group","In Person",,"1 hour","Weekly","14",,"completed treatment course","1",,,,,,,,,,,"Community",,,"1","1",,"0",,,"Medium","Hinton DE, Hofmann SG, Rivera E, et al. Culturally adapted CBT (CA-CBT) for Latino women with treatment-resistant PTSD: a pilot study comparing CA-CBT to applied muscle relaxation. Behav Res Ther. 2011 Apr;49(4):275-80. doi: 10.1016/j.brat.2011.01.005. PMID: 21333272.","36143","2019"
"hinton2011_B","Psychotherapy","PTSD","PTSD",,"24","B","12",,"Applied muscle relaxation","Relaxation","Manualized treatment; includes: psychoeducation about PTSD, anxiety, and panic; how those disorders produce somatic symptoms; how treatment can reduce anxiety and improve those disorders.","No","Not Applicable","No","Not Applicable","Yes","Relaxation","No","No","No","No","No","Group","In Person",,"1 hour","Weekly","14",,"completed treatment course","1",,,,,,,,,,,"Community",,,"1","1",,"0",,,"Medium","Hinton DE, Hofmann SG, Rivera E, et al. Culturally adapted CBT (CA-CBT) for Latino women with treatment-resistant PTSD: a pilot study comparing CA-CBT to applied muscle relaxation. Behav Res Ther. 2011 Apr;49(4):275-80. doi: 10.1016/j.brat.2011.01.005. PMID: 21333272.","36143","2019"
"hoffart2013_A","Psychotherapy","PTSD","PTSD",,"65","A","31",,"PE using imagery exposure","Prolonged Exposure (PE)","Manualized trauma-focused therapy following manual for PE using imagery exposure (Foa et al., 2007) adapted for inpatient setting; treatment included treatment rationale and psychoeducation, constructing exposure hierarchy, and imagery exposure (both entire memory and hot spots procedure).","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"90 minutes","Weekly","10",,"did not drop out and received therapy according to protocol","0.9677",,,,,,,,,,,"Community",,,"1","0.5846",,"0.4154","Mixed","combat-related, rape/sexual assault, accidents, community/school violence","Medium","Hoffart A, Øktedalen T, Langkaas TF, et al. Alliance and outcome in varying imagery procedures for PTSD: a study of within-person processes. J Couns Psychol. 2013 Oct;60(4):471-82. doi: 10.1037/a0033604. PMID: 23957768.","44042","2019"
"hoffart2013_B","Psychotherapy","PTSD","PTSD",,"65","B","34",,"PE using imagery rescripting","Prolonged Exposure (PE) with imagery rescripting","Manualized trauma-focused therapy following manual for PE using imagery rescripting (Smucker, 2005) adapted for inpatient setting; treatment included treatment rationale and psychoeducation, and 3 continuous phases of imagery rescripting: imagery reliving of the traumatic event, imagining current self entering the scene at the hot spot and bringing the situation to a solution, and imagining an interaction between the current self and the traumatized self back then.","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"90 minutes","Weekly","10",,"did not drop out and received therapy according to protocol","0.9118",,,,,,,,,,,"Community",,,"1","0.5846",,"0.4154","Mixed","combat-related, rape/sexual assault, accidents, community/school violence","Medium","Hoffart A, Øktedalen T, Langkaas TF, et al. Alliance and outcome in varying imagery procedures for PTSD: a study of within-person processes. J Couns Psychol. 2013 Oct;60(4):471-82. doi: 10.1037/a0033604. PMID: 23957768.","44042","2019"
"hogberg2007_A","Psychotherapy","PTSD","PTSD",,"24","A","13",,"EMDR","Eye Movement Desensitization and Reprocessing (EMDR)","Breathing and relaxation technique presented at beginning of each session. EMDR consists of therapist-guided psychotherapy designed to help shift negative thoughts and bodily distress to desired positive thoughts through sensory stimulations with rhythmic quality and left-right alternating character","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"90 minutes",,"8","5 sessions total",,,,,,,,,,,,,"Community",,,"1","0.2083",,"0.7917","Mixed","accidents, community/school violence","Medium","Hogberg G, Pagani M, Sundin O, et al. On treatment with eye movement desensitization and reprocessing of chronic post-traumatic stress disorder in public transportation workers--a randomized controlled trial. Nord J Psychiatry. 2007;61(1):54-61. doi:  10.1080/08039480601129408. PMID: 17365790.","38652","2019"
"hogberg2007_B","Psychotherapy","PTSD","Control",,"24","B","11",,"Waitlist","Waitlist",,"No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,,,,"8",,,,,,,,,,,,,,"Community",,,"1","0.2083",,"0.7917","Mixed","accidents, community/school violence","Medium","Hogberg G, Pagani M, Sundin O, et al. On treatment with eye movement desensitization and reprocessing of chronic post-traumatic stress disorder in public transportation workers--a randomized controlled trial. Nord J Psychiatry. 2007;61(1):54-61. doi:  10.1080/08039480601129408. PMID: 17365790.","38652","2019"
"hollifield2007_A","Mixed: Psychotherapy & CIH","PTSD","PTSD",,"84","A","29",,"Acupuncture","Acupuncture","Solid needles were placed into rationally
chosen points in subcutaneous tissue or muscle for a given period of time with manipulation. Sessions comprised of 15 to 20 minute interview; 2 to 5 minute pulse and tongue evaluation; 25 to 40 minute needle insertion, manipulation and retention; 2 minute ear-seed placement.","No","Not Applicable","No","Not Applicable","Yes","Acupuncture","No","No","No","No","No","Individual","In Person",,"1 hour","Twice weekly","12",,"completed treatment course","0.79",,,,,,,,,,,"Community",,,"1","0.6786",,"0.3214",,,"Medium","Hollifield M, Sinclair-Lian N, Warner TD, et al. Acupuncture for posttraumatic stress disorder: a randomized controlled pilot trial. J Nerv Ment Dis. 2007 Jun;195(6):504-13. doi: 10.1097/NMD.0b013e31803044f8. PMID: 17568299.","29609","2019"
"hollifield2007_B","Mixed: Psychotherapy & CIH","PTSD","PTSD",,"84","B","28",,"CBT","Trauma-focused cognitive behavioral therapy (TF-CBT)","Integrates 4 modalities that have direct and theoretical evidence of efficacy: psychoeducation, behavioral activation, activity planning, cognitive restructuring, imagery rehearsal, exposure and desensitization","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"2 hours","Once weekly","12",,,"0.84",,,,,,,,,,,"Community",,,"1","0.6786",,"0.3214",,,"Medium","Hollifield M, Sinclair-Lian N, Warner TD, et al. Acupuncture for posttraumatic stress disorder: a randomized controlled pilot trial. J Nerv Ment Dis. 2007 Jun;195(6):504-13. doi: 10.1097/NMD.0b013e31803044f8. PMID: 17568299.","29609","2019"
"hollifield2007_C","Mixed: Psychotherapy & CIH","PTSD","Control",,"84","C","27",,"Waitlist","Waitlist",,"No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,,,,"12",,"completed treatment course","0.88",,,,,,,,,,,"Community",,,"1","0.6786",,"0.3214",,,"Medium","Hollifield M, Sinclair-Lian N, Warner TD, et al. Acupuncture for posttraumatic stress disorder: a randomized controlled pilot trial. J Nerv Ment Dis. 2007 Jun;195(6):504-13. doi: 10.1097/NMD.0b013e31803044f8. PMID: 17568299.","29609","2019"
"hyer1996_A","Complementary and integrative health (CIH)","PTSD","PTSD",,"219","A","108",,"Outward Bound Experience adjunctive with TAU","Recreational therapy","TAU replaced by Outward Bound Experience for 1 week; remainder of TAU was not altered.

Outward Bound Experience: adventure experience comprised of: small group exercises focused on cooperation and trust; challenges that emphasize perseverance, self-reliance, and teamwork;  reflection with individual time for solitude, journal writing, and ""solo"" experiences; experiential tasks such as ropes course, hiking, rock climbing; group discussions functioning as debriefings of feeling and experiences, but without specific ""group therapy"" sessions or focus on war-trauma issues. 

TAU: specialized inpatient PTSD treatment program using multidisciplinary team approach, but differing by location. Location A: psychosocial emphasis with stress reduction treatment focus; treatment involves ongoing process group with up to 7 module groups on aspects of trauma coping; no psychopharmaceutical treatment is allowed. Location T: significant emphasis on processing war-related trauma issues in group setting and veteran involvement in therapeutic milieu (such as peer counseling); incorporates psychopharmaceutical treatments","No","Not Applicable","No","Not Applicable","Yes","Other physical activity and recreational therapies","No","No","No","No","No","Individual","In Person",,,"Daily during weekdays","1","overall inpatient treatment 11 to 14 weeks",,,,,,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"Medium","Hyer L, Boyd S, Scurfield R, et al. Effects of Outward Bound experience as an adjunct to inpatient PTSD treatment of war veterans. J Clin Psychol. 1996 May;52(3):263-78. doi: 10.1002/(SICI)1097-4679(199605)52:3<263::AID-JCLP3>3.0.CO;2-T. PMID: 8835688.","08065","2019"
"hyer1996_B","Complementary and integrative health (CIH)","PTSD","Control",,"219","B","111",,"TAU","Treatment as usual (TAU)","TAU: specialized inpatient PTSD treatment program using multidisciplinary team approach, but differing by location. Location A: psychosocial emphasis with stress reduction treatment focus; treatment involves ongoing process group with up to 7 module groups on aspects of trauma coping; no psychopharmaceutical treatment is allowed. Location T: significant emphasis on processing war-related trauma issues in group setting and veteran involvement in therapeutic milieu (such as peer counseling); incorporates psychopharmaceutical treatments","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,,,,"11 to 14",,,,,,,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"Medium","Hyer L, Boyd S, Scurfield R, et al. Effects of Outward Bound experience as an adjunct to inpatient PTSD treatment of war veterans. J Clin Psychol. 1996 May;52(3):263-78. doi: 10.1002/(SICI)1097-4679(199605)52:3<263::AID-JCLP3>3.0.CO;2-T. PMID: 8835688.","08065","2019"
"isserles2013_A","Nonpharmacologic biological","PTSD","PTSD",,"30","A","10",,"DTMS with traumatic experience","Transcranial magnetic stimualtion (TMS)","Direct transcranial magnetic stimulation after script-driven imagery of the traumatic experience immediately followed by a script-driven imagery of a neutral event","No","Not Applicable","No","Not Applicable","No","Not Applicable","Yes","No","No","No","No","Individual","In Person","20 Hz trains of 2 seconds each with 20 seconds inter-train interval for 42 trains, 1680 pulses total","20 minutes","3 times a week","4",,"received ≥8 treatment sessions","0.90",,,,,,,,,,,,,,,"0.2308",,"0.7692","Mixed","combat-related, other (not specified)","Medium","Isserles M, Shalev AY, Roth Y, et al. Effectiveness of deep transcranial magnetic stimulation combined with a brief exposure procedure in post-traumatic stress disorder--a pilot study. Brain Stimul. 2013 May;6(3):377-83. doi: 10.1016/j.brs.2012.07.008. PMID: 22921765.","39466","2019"
"isserles2013_B","Nonpharmacologic biological","PTSD","PTSD",,"30","B","10",,"DTMS with positive experience","Transcranial magnetic stimualtion (TMS)","DTMS after script-driven imagery of a positive experience immediately followed by a script-driven imagery of a neutral event","No","Not Applicable","No","Not Applicable","No","Not Applicable","Yes","No","No","No","No","Individual","In Person","20 Hz trains of 2 seconds each with 20 seconds inter-train interval for 42 trains, 1680 pulses total","20 minutes","Three times per week","4",,"received ≥ 8 treatment sessions","0.8",,,,,,,,,,,,,,,"0.2308",,"0.7692","Mixed","combat-related, other (not specified)","Medium","Isserles M, Shalev AY, Roth Y, et al. Effectiveness of deep transcranial magnetic stimulation combined with a brief exposure procedure in post-traumatic stress disorder--a pilot study. Brain Stimul. 2013 May;6(3):377-83. doi: 10.1016/j.brs.2012.07.008. PMID: 22921765.","39466","2019"
"isserles2013_C","Nonpharmacologic biological","PTSD","Control",,"30","C","10",,"DTMS with positive experience","Sham","DTMS after script-driven imagery of a positive experience immediately followed by a script-driven imagery of a neutral event.","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","20 Hz trains of 2 seconds each with 20 seconds inter-train interval for 42 trains, 1680 pulses total","20 minutes","Three times per week","4",,"received ≥ 8 treatment sessions","0.8",,,,,,,,,,,,,,,"0.2308",,"0.7692","Mixed","combat-related, other (not specified)","Medium","Isserles M, Shalev AY, Roth Y, et al. Effectiveness of deep transcranial magnetic stimulation combined with a brief exposure procedure in post-traumatic stress disorder--a pilot study. Brain Stimul. 2013 May;6(3):377-83. doi: 10.1016/j.brs.2012.07.008. PMID: 22921765.","39466","2019"
"ivarsson2014_A","Psychotherapy","PTSD","PTSD",,"62","A","31",,"CBT","Trauma-focused cognitive behavioral therapy (TF-CBT)","Guided internet-delivered CBT for PTSD: 8 text-based modules including validated components of ""psychoeducation, anxiety coping skills training, exposure, and cognitive restructuring"".","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","Technology Assisted",,,"Weekly","8",,"completed all modules","0.387",,,,,"5.1","3.2",,,,,"Community",,,"1","0.823",,"0.177","Mixed","intimate partner violence, accidents, illness/medical procedure, combat-related, natural or manmade disasters, community/school violence, other (torture, multiple stressors)","Medium","Ivarsson D, Blom M, Hesser H, et al. Guided internet-delivered cognitive behavior therapy for post-traumatic stress disorder: a randomized controlled trial. Internet Interv. 2014 March;1(1):33-40. doi: 10.1016/j.invent.2014.03.002.","44101","2019"
"ivarsson2014_B","Psychotherapy","PTSD","Control",,"62","B","31",,"Minimal support control","Internet control intervention","Minimal support, delayed treatment control; non-passive condition comprised of voluntary participation in internet-delivered weekly sets of general questions regarding well-being, stress, and sleep. Treatment with guided internet-delivered CBT for PTSD offered after collection of post-treatment measures.","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","Technology Alone",,,"Weekly (voluntary)","8",,,,,,,,,,,,,,"Community",,,"1","0.823",,"0.177","Mixed","intimate partner violence, accidents, illness/medical procedure, combat-related, natural or manmade disasters, community/school violence, other (torture, multiple stressors)","Medium","Ivarsson D, Blom M, Hesser H, et al. Guided internet-delivered cognitive behavior therapy for post-traumatic stress disorder: a randomized controlled trial. Internet Interv. 2014 March;1(1):33-40. doi: 10.1016/j.invent.2014.03.002.","44101","2019"
"jacob2014_A","Psychotherapy","PTSD","PTSD",,"76","A","38",,"NET","Narrative Exposure Therapy (NET) + Interpersonal Psychotherapy (IPT)","Combined NET with IPT. First treatment session consists of psychoeducation. NET consists of the therapist recording participant's story in writing while seeking to reactivate the associated thoughts and emotions and raise the participant's awareness of his/her concomitant bodily responses. The IPT portion targets symptoms of depression and grief related to the losses and to raise awareness about major current problems","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"90 to 150 minutes","Weekly","8",,,,,,,,,,,,,,"Community",,,"1","0.9211",,"0.0789","Mixed","rape/sexual assault, terrorism/political violence/forced displacement","Medium","Jacob N, Neuner F, Maedl A, et al. Dissemination of psychotherapy for trauma spectrum disorders in postconflict settings: a randomized controlled trial in Rwanda. Psychother Psychosom. 2014 Nov;83(6):354-63. doi: 10.1159/000365114. PMID: 25323203.","43991","2019"
"jacob2014_B","Psychotherapy","PTSD","Control",,"76","B","38",,"Waitlist","Waitlist",,"No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,,,,"8",,,,,,,,,,,,,,"Community",,,"1","0.9211",,"0.0789","Mixed","rape/sexual assault, terrorism/political violence/forced displacement","Medium","Jacob N, Neuner F, Maedl A, et al. Dissemination of psychotherapy for trauma spectrum disorders in postconflict settings: a randomized controlled trial in Rwanda. Psychother Psychosom. 2014 Nov;83(6):354-63. doi: 10.1159/000365114. PMID: 25323203.","43991","2019"
"jak2019_A","Psychotherapy","PTSD","PTSD",,"100","A","49",,"CPT","Cognitive Processing Therapy (CPT)","Standard CPT without trauma narrative; included education about PTSD symptoms and treatment, a brief ""Impact Statement"" and identification of distorted thoughts (""stuck points""), learning connection between thoughts and feelings, and challenging distorted thoughts and stuck points.","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"60 to 75 minutes","Weekly","12",,"completed all 12 treatment sessions","0.49",,,,,"7.39","4.92",,,,,"Veteran","0","1","0","0.11",,"0.89",,,"Low","Jak AJ, Jurick S, Crocker LD, et al. SMART-CPT for veterans with comorbid post-traumatic stress disorder and history of traumatic brain injury: a randomised controlled trial. J Neurol Neurosurg Psychiatry. 2019 Mar;90(3):333-41. doi: 10.1136/jnnp-2018-319315. PMID: 30554135.","51464","2020"
"jak2019_B","Psychotherapy","PTSD","PTSD",,"100","B","51",,"SMART-CPT","Cognitive Processing Therapy (CPT) adapted for traumatic brain injury (TBI)","A hybrid treatment with adapted CPT components plus elements from CogSMART; adaptations were focused on TBI and cognitive complaints including psychoeducation and compensatory strategies.","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"60 to 75 minutes","Weekly","12",,"completed all 12 treatment sessions","0.569",,,,,"8.53","4.51",,,,,"Veteran","0","1","0","0.11",,"0.89",,,"Low","Jak AJ, Jurick S, Crocker LD, et al. SMART-CPT for veterans with comorbid post-traumatic stress disorder and history of traumatic brain injury: a randomised controlled trial. J Neurol Neurosurg Psychiatry. 2019 Mar;90(3):333-41. doi: 10.1136/jnnp-2018-319315. PMID: 30554135.","51464","2020"
"jensen1994_A","Psychotherapy","PTSD","PTSD",,"25","A","13",,"EMDR","Eye Movement Desensitization and Reprocessing (EMDR)","Treatment included 1 history-taking session and 2 EMDR sessions. Therapist instructs the participant to visualize a picture of the traumatic scene and concentrate on previously identified negative statement associated with the trauma. Then the participant simultaneously focus on  the physical sensation of anxiety and visually track therapist's finger as it moves rapidly back-and-forth, inducing saccadic eye movement. Saccades were elicited continuously until subjective units of distress reached 0.","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,,,"1.43",,,,,,,,,,,,,,"Veteran","0","1","0","0",,"1",,,"High","Jensen JA. An investigation of Eye Movement Desensitization Reprocessing (EMD/R) as a treatment for posttraumatic stress disorder (PTSD) symptoms of Vietnam combat veterans. Behav Ther. 1994 Spring;25(2):311-25. doi: 10.1016/S0005-7894(05)80290-4.","04669","2019"
"jensen1994_B","Psychotherapy","PTSD","Control",,"25","B","12",,"Control","Control","Participants informed of their group assignment and given a list of local alternative treatment sites","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,,,,"2.5",,,,,,,,,,,,,,"Veteran","0","1","0","0",,"1",,,"High","Jensen JA. An investigation of Eye Movement Desensitization Reprocessing (EMD/R) as a treatment for posttraumatic stress disorder (PTSD) symptoms of Vietnam combat veterans. Behav Ther. 1994 Spring;25(2):311-25. doi: 10.1016/S0005-7894(05)80290-4.","04669","2019"
"jespersen2012_A","Complementary and integrative health (CIH)","PTSD","PTSD",,"19","A","10",,"Relaxation music at bedtime","Relaxation","Hour-long music from MusiCure series played through speakers around special pillow","No","Not Applicable","No","Not Applicable","Yes","Relaxation","No","No","No","No","No","Individual","Technology Alone",,"Participant's choice of 15, 30, 60, or 120 minutes","Daily","3",,,,,,,,,,,,,,"Community",,,"1","0.6","completers only","0.4",,,"High","Jespersen KV, Vuust P. The effect of relaxation music listening on sleep quality in traumatized refugees: a pilot study. J Music Ther. 2012;49(2):205-29.  PMID: 26753218.","1548481","2019"
"jespersen2012_B","Complementary and integrative health (CIH)","PTSD","Control",,"19","B","9",,"Ergonomic pillow","Ergonomic pillow","Same ergonomic pillow as treatment group without music","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","Technology Alone",,,"Daily","3",,,,,,,,,,,,,,"Community",,,"1","0.6","completers only","0.4",,,"High","Jespersen KV, Vuust P. The effect of relaxation music listening on sleep quality in traumatized refugees: a pilot study. J Music Ther. 2012;49(2):205-29.  PMID: 26753218.","1548481","2019"
"jindani2015_A","Complementary and integrative health (CIH)","PTSD","PTSD",,"80","A","59",,"Kundalini Yoga","Yoga","Comprehensive yoga style which incorporates traditional elements of yoga practice including postures and physical exercises, breathing techniques, meditation, cultivation of mind-body awareness, and deep relaxation. The general class structure was active warm-up and loosening exercises, yoga postures and exercises, deep supine relaxation, yoga breathing techniques, meditation, and discussion of the physical, psychological, and philosophical principles of yoga; daily home practice of 15 minutes. The program integrated guidelines for trauma sensitive yoga.","No","Not Applicable","No","Not Applicable","Yes","Yoga","No","No","No","No","No","Group","In Person",,"90 minutes","Weekly","8",,"completed treatment course","0.4925",,,,,,,,,,,"Community",,,"1","0.8875",,"0.1125","Mixed","rape/sexual assault, child sexual abuse, intimate partner violence, terrorism/political violence/forced displacement, illness/medical procedure, accidents, other (emotional abuse, systemic discrimination, compassion fatigue)","High","Jindani FA, Turner N, Khalsa SBS. A yoga intervention for posttraumatic stress: a preliminary randomized control trial. Evid Based Complement Alternat Med. 2015;2015:351746. doi: 10.1155/2015/351746. PMID: 26366179.","48111","2019"
"jindani2015_B","Complementary and integrative health (CIH)","PTSD","Control",,"80","B","21",,"Waitlist","Waitlist",,"No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,,,,"8",,"completed treatment course","1",,,,,,,,,,,"Community",,,"1","0.8875",,"0.1125","Mixed","rape/sexual assault, child sexual abuse, intimate partner violence, terrorism/political violence/forced displacement, illness/medical procedure, accidents, other (emotional abuse, systemic discrimination, compassion fatigue)","High","Jindani FA, Turner N, Khalsa SBS. A yoga intervention for posttraumatic stress: a preliminary randomized control trial. Evid Based Complement Alternat Med. 2015;2015:351746. doi: 10.1155/2015/351746. PMID: 26366179.","48111","2019"
"johnson2011_A","Other mixed","PTSD","PTSD",,"70","A","35",,"Helping to Overcome PTSD through Empowerment","Helping to Overcome PTSD through Empowerment","Participants provided with an ""empowerment toolbox"" that includes an exhaustive list of positive coping strategies regarding safety and empowerment, managing symptoms, and improving relationships. Core modules included engagement and goal setting, psychoeducation about abuse and PTSD, safety planning, establishing trust, cognitive restructuring, managing triggers, self-soothing, establishing boundaries, anger management, and establishing long-term support. Participants who left shelter prior to completing 12 sessions were referred to treatment in community","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","No","Yes","No","Individual","In Person",,"1 to 1.5 hours","Up to twice weekly","8","12 sessions total","attending ≥5 sessions","0.6286",,,,,"6.8","4.3",,,,,"Community",,,"1","1",,"0","Intimate partner violence",,"Medium","Johnson DM, Zlotnick C, Perez SK. Cognitive behavioral treatment of PTSD in residents of battered women's shelters: results of a randomized clinical trial. J Consult Clin Psychol. 2011 Aug;79(4):542-51. doi: 10.1037/a0023822. PMID: 21787052.","37002","2019"
"johnson2011_B","Other mixed","PTSD","Control",,"70","B","35",,"Standard shelter service","Standard shelter service","Provided referrals to treatment in community","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,,,,"12",,,,,,,,,,,,,,"Community",,,"1","1",,"0","Intimate partner violence",,"Medium","Johnson DM, Zlotnick C, Perez SK. Cognitive behavioral treatment of PTSD in residents of battered women's shelters: results of a randomized clinical trial. J Consult Clin Psychol. 2011 Aug;79(4):542-51. doi: 10.1037/a0023822. PMID: 21787052.","37002","2019"
"johnson2018_A","Complementary and integrative health (CIH)","PTSD","PTSD",,"29","A","15",,"Therapeutic horseback riding","Therapeutic horseback riding","Program with aw primary goal of rehabilitation, includes basic horsemanship skills and completing tasks on horseback.","No","Not Applicable","No","Not Applicable","Yes","Other physical activity and recreational therapies","No","No","No","No","No","Individual","In Person",,"60 minutes","Weekly","6",,,,,,,,,,,,,,"Veteran",,"1",,,,,,,"High","Johnson RA, Albright DL, Marzolf JR, et al. Effects of therapeutic horseback riding on post-traumatic stress disorder in military veterans. Mil Med Res. 2018 Jan;5(1):3. doi: 10.1186/s40779-018-0149-6. PMID: 29502529.","49720","2019"
"johnson2018_B","Complementary and integrative health (CIH)","PTSD","Control",,"29","B","14",,"Waitlist","Waitlist","6-week waiting period","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,,,,"6",,,,,,,,,,,,,,"Veteran",,"1",,,,,,,"High","Johnson RA, Albright DL, Marzolf JR, et al. Effects of therapeutic horseback riding on post-traumatic stress disorder in military veterans. Mil Med Res. 2018 Jan;5(1):3. doi: 10.1186/s40779-018-0149-6. PMID: 29502529.","49720","2019"
"jung2013_A","Psychotherapy","PTSD","PTSD",,"34","A","17",,"CR and Imagery Modification","Cognitive restructuring and imagery modification","Participants instructed to research skin cell rebuilding to see that dermal cells in trauma-related body region have been rebuilt completely since last contact with perpetrator. Then therapist confronts patient with her own ideas on contamination, and develop an idiosyncratic imagery representing the process of skin or cell renewal.","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"First session 90 minutes, second session 50 minutes","Weekly","2",,,,,,,,,,,,,,"Community",,,"1","1",,"0","Child sexual abuse",,"Medium","Jung K, Steil R. A randomized controlled trial on cognitive restructuring and imagery modification to reduce the feeling of being contaminated in adult survivors of childhood sexual abuse suffering from posttraumatic stress disorder. Psychother Psychosom. 2013 Jun;82(4):213-20. doi: 10.1159/000348450. PMID: 23712073.","41611","2019"
"jung2013_B","Psychotherapy","PTSD","Control",,"34","B","17",,"Waitlist","Waitlist",,"No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,,,,"2",,,,,,,,,,,,,,"Community",,,"1","1",,"0","Child sexual abuse",,"Medium","Jung K, Steil R. A randomized controlled trial on cognitive restructuring and imagery modification to reduce the feeling of being contaminated in adult survivors of childhood sexual abuse suffering from posttraumatic stress disorder. Psychother Psychosom. 2013 Jun;82(4):213-20. doi: 10.1159/000348450. PMID: 23712073.","41611","2019"
"kaplan1996_A","Pharmacotherapy","PTSD","PTSD",,"17","A",,,"Inositol","Inositol","Glucose isomer that ""can affect the function of several neurotransmitters including serotonin;"" given in powder form, patients instructed to take in juice or tea.","No","Not Applicable","Yes","Supplement","No","Not Applicable","No","No","No","No","No","Individual","In Person","6 grams (2 teaspoons)",,"Twice daily","4",,,,,,,,,,,,,,"Community",,,"1","0.3846",,"0.6154","Mixed","combat-related, accidents, community/school violence, other (not specified)","High","Kaplan Z, Amir M, Swartz M, et al. Inositol treatment of post-traumatic stress disorder. Anxiety. 1996;2(1):51-2. doi: 10.1002/(SICI)1522-7154(1996)2:1<51::AID-ANXI8>3.0.CO;2-G. PMID: 9160600.","06980","2019"
"kaplan1996_B","Pharmacotherapy","PTSD","Control",,"17","B",,,"Placebo","Placebo","Glucose; in powder form of similar taste and texture to inositol; patients
instructed to take two teaspoons twice a day in juice or tea (12 grams/day).","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","12 grams",,"Daily","4",,,,,,,,,,,,,,"Community",,,"1","0.3846",,"0.6154","Mixed","combat-related, accidents, community/school violence, other (not specified)","High","Kaplan Z, Amir M, Swartz M, et al. Inositol treatment of post-traumatic stress disorder. Anxiety. 1996;2(1):51-2. doi: 10.1002/(SICI)1522-7154(1996)2:1<51::AID-ANXI8>3.0.CO;2-G. PMID: 9160600.","06980","2019"
"karatzias2019_A","Psychotherapy","PTSD","PTSD",,"29","A","15",,"EMDR","Eye Movement Desensitization and Reprocessing (EMDR)","Eight-phase treatment protocol which includes components of affect management, psychoeducation, assessment of distressing memory components, bilateral stimulation to reach Subjective Units of Discomfort Scale score of 0 and Validity of Cognition Scale score of 7, and re-evaluation. The bilateral stimulation included standard light bar, tactile and auditory stimulus in order to accommodate the participants' disabilities.","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"1 hour",,,"up to 8 sessions",,,,,,,"3.1","2.15",,,,,,,,,"0.62",,"0.38",,,"Medium","Karatzias T, Brown M, Taggart L, et al. A mixed-methods, randomized controlled feasibility trial of Eye Movement Desensitization and Reprocessing (EMDR) plus Standard Care (SC) versus SC alone for DSM-5 Posttraumatic Stress Disorder (PTSD) in adults with intellectual disabilities. J Appl Res Intellect Disabil. 2019 Jul;32(4):806-18. doi: 10.1111/jar.12570. PMID: 30714684.","52277","2020"
"karatzias2019_B","Psychotherapy","PTSD","Control",,"29","B","14",,"Standard care","Treatment as usual (TAU)","Continuation of participants' usual psychological, psychiatric and medical care","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person",,,,,,,,,,,,,,,,,,,,,,"0.62",,"0.38",,,"Medium","Karatzias T, Brown M, Taggart L, et al. A mixed-methods, randomized controlled feasibility trial of Eye Movement Desensitization and Reprocessing (EMDR) plus Standard Care (SC) versus SC alone for DSM-5 Posttraumatic Stress Disorder (PTSD) in adults with intellectual disabilities. J Appl Res Intellect Disabil. 2019 Jul;32(4):806-18. doi: 10.1111/jar.12570. PMID: 30714684.","52277","2020"
"karatzias2011_A","Psychotherapy","PTSD","PTSD",,"46","A","23",,"Emotional Freedom Technique","Emotional Freedom Technique (EFT)","Therapist lightly stimulate endpoints of traditional acupuncture meridians on the face, upper body, and hands, while patients focus on the traumatic event","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"1 hour",,,"maximum 8 sessions",,,,,,,"3.8","2.6",,,,,"Community",,,"1","0.5652",,"0.4348","Mixed","accidents, community/school violence, other (not specified)","High","Karatzias A, Power KG, Brown KW, et al. A controlled comparison of the effectiveness and efficiency of two psychological therapies for posttraumatic stress disorder: Eye Movement Desensitization and Reprocessing vs. Emotional Freedom Techniques. J. Nerv. Ment. Dis. 2011 Jun;199(6):372-8. doi: 10.1097/NMD.0b013e31821cd262. PMID: 21629014.","36614","2019"
"karatzias2011_B","Psychotherapy","PTSD","PTSD",,"46","B","23",,"EMDR","Eye Movement Desensitization and Reprocessing (EMDR)","According to manual by Shapiro (2001, 2002) in which therapist utilizes bilateral stimulation while participant's attention is directed toward the traumatic event until Subjective Unit of Discomfort Scale reaches 0","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"1 hour",,,"up to 8 sessions",,,,,,,"3.7","2.3",,,,,"Community",,,"1","0.5652",,"0.4348","Mixed","accidents, community/school violence, other (not specified)","High","Karatzias A, Power KG, Brown KW, et al. A controlled comparison of the effectiveness and efficiency of two psychological therapies for posttraumatic stress disorder: Eye Movement Desensitization and Reprocessing vs. Emotional Freedom Techniques. J. Nerv. Ment. Dis. 2011 Jun;199(6):372-8. doi: 10.1097/NMD.0b013e31821cd262. PMID: 21629014.","36614","2019"
"katz1994_A","Pharmacotherapy","PTSD","PTSD",,"64","A","33",,"Brofaromine","Brofaromine","MAOI; 2-week placebo run-in, responders excluded; titrated to maximum 3 tablets (150 mg) based on physician's judgment of best dose","No","Not Applicable","Yes","Antidepressant: MAOI","No","Not Applicable","No","No","No","No","No","Individual","In Person","50 to 150 mg (total daily dose); titration: initiated at 50 mg/day, maximum daily dose of 150 mg",,"Twice daily","up to 14",,,,,,,,,,,"Modal dose 2 tablets (100 mg/day)",,,"Community",,,"1","0.2444",,"0.7556","Mixed","combat-related, rape/sexual assault, accidents, community/school violence, other (not specified)","High","Katz RJ, Lott MH, Arbus P, et al. Pharmacotherapy of post-traumatic stress disorder with a novel psychotropic. Anxiety. 1994;1(4):169-74.  PMID: 9160569.","05306","2019"
"katz1994_B","Pharmacotherapy","PTSD","Control",,"64","B","31",,"Placebo","Placebo","After single-blind 2-week placebo run-in, responders excluded; double-blind phase started with one tablet/day identical to active treatment, titrated to maximum 3 tablets based on physician's judgment of best dose","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person",,,"Daily","up to 14",,,,,,,,,,,,,"Modal dose = 2 tablets","Community",,,"1","0.2444",,"0.7556","Mixed","combat-related, rape/sexual assault, accidents, community/school violence, other (not specified)","High","Katz RJ, Lott MH, Arbus P, et al. Pharmacotherapy of post-traumatic stress disorder with a novel psychotropic. Anxiety. 1994;1(4):169-74.  PMID: 9160569.","05306","2019"
"katz2014_A","Psychotherapy","PTSD","PTSD",,"51","A","17",,"Holographic reprocessing","Holographic reprocessing","Integrative treatment focusing on underlying causes or patterns of unfulfilling or abusive relationships rather than specific events. Practiced in 3 steps: 1) identifying patterns, 2) cognitive shifts and holistic reappraisals, and 3) reprocessing using imagery. Treatment included 2 to 4 reprocessing procedures.","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,,,,"10 sessions total",,"0.9412",,,,,,,,,,,"Veteran","0","1","0","1",,"0","Mixed","MST, rape/sexual assault, child sexual abuse, intimate partner violence","High","Katz LS, Douglas S, Zaleski K, et al. Comparing holographic reprocessing and prolonged exposure for women veterans with sexual trauma: a pilot randomized trial. J Contemp Psychother. 2014 Mar;44(1):9-19. doi: 10.1007/s10879-013-9248-6.","1548483","2019"
"katz2014_B","Psychotherapy","PTSD","PTSD",,"51","B","17",,"PE","Prolonged Exposure (PE)","Therapy followed protocol by Foa et al. 2007; PE uses in vivo and imaginal exposure to enable patients to ""confront their fears and anxieties, repair a fragmented narrative, and desensitize to memories of trauma.""","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,,,,"10 sessions total","completed treatment course","0.5882",,,,,,,,,,,"Veteran","0","1","0","1",,"0","Mixed","MST, rape/sexual assault, child sexual abuse, intimate partner violence","High","Katz LS, Douglas S, Zaleski K, et al. Comparing holographic reprocessing and prolonged exposure for women veterans with sexual trauma: a pilot randomized trial. J Contemp Psychother. 2014 Mar;44(1):9-19. doi: 10.1007/s10879-013-9248-6.","1548483","2019"
"katz2014_C","Psychotherapy","PTSD","PTSD",,"51","C","17",,"Person-centered therapy","Person centered Therapy","Treatment followed Rogerian supportive therapy and focuses on providing support and discussing and understanding here-and-now issues that are generated by patients; treatment included supportive listening, relaxation training, and problem solving.","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,,,,"10 sessions total","completed treatment course","0.6471",,,,,,,,,,,"Veteran","0","1","0","1",,"0","Mixed","MST, rape/sexual assault, child sexual abuse, intimate partner violence","High","Katz LS, Douglas S, Zaleski K, et al. Comparing holographic reprocessing and prolonged exposure for women veterans with sexual trauma: a pilot randomized trial. J Contemp Psychother. 2014 Mar;44(1):9-19. doi: 10.1007/s10879-013-9248-6.","1548483","2019"
"keane1989_A","Psychotherapy","PTSD","PTSD",,"24","A","11",,"Implosive therapy","Implosive Therapy","Treatment following therapy manual; included relaxation therapy, flooding, integration of new information or emotions evoked from imagery just presented, and intersession homework; primary focus of therapy is gradual presentation of stimulus and response of traumatic memory in the context of a supportive clinical relationship.","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"90 minutes",,,"14 to 16 total sessions",,,,,,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"High","Keane TM, Fairbank JA, Caddell JM, et al. Implosive (flooding) therapy reduces symptoms of PTSD in Vietnam combat veterans. Behav Ther. 1989 Spring;20(2):245-60. doi: 10.1016/S0005-7894(89)80072-3.","01015","2019"
"keane1989_B","Psychotherapy","PTSD","Control",,"24","B","13",,"Waitlist","Waitlist","Waitlist participants were not prohibited from obtaining or continuing psychiatric treatment during the waiting period.","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,,,,"12","minimum 3 months, average 4.5 months",,,,,,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"High","Keane TM, Fairbank JA, Caddell JM, et al. Implosive (flooding) therapy reduces symptoms of PTSD in Vietnam combat veterans. Behav Ther. 1989 Spring;20(2):245-60. doi: 10.1016/S0005-7894(89)80072-3.","01015","2019"
"kearney2016_A","Complementary and integrative health (CIH)","PTSD","PTSD",,"55","A","26",,"MBSR + TAU","Mindfulness-based stress reduction (MBSR)","MBSR: Group course with ""instruction on mindfulness meditation practices, including body scan meditation, breathing meditation, gentle yoga, walking meditation, and loving-kindness meditation"", between-session home practice meditation using audio CD, and other homework.
TAU: continuation of ""treatment as usual without intervention from the study team""","No","Not Applicable","No","Not Applicable","Yes","Meditation","No","No","No","No","No","Group","In Person",,"2.5 hours (plus single 7-hour session)","Weekly","8",,"attended ≥4 classes","0.73",,,,,"5.7",,,,,,"Veteran","0","1","0","0.1455",,"0.8545",,,"Medium","Kearney DJ, Simpson TL, Malte CA, et al. Mindfulness-based stress reduction in addition to usual care is associated with improvements in pain, fatigue, and cognitive failures among veterans with Gulf War illness. Am J Med. 2016 Feb;129(2):204-14. doi: 10.1016/j.amjmed.2015.09.015. PMID: 26519614.","45996","2020"
"kearney2016_B","Complementary and integrative health (CIH)","PTSD","Control",,"55","B","29",,"TAU","Treatment as usual (TAU)","Continuation of ""treatment as usual without intervention from the study team"".","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person",,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0.1455",,"0.8545",,,"Medium","Kearney DJ, Simpson TL, Malte CA, et al. Mindfulness-based stress reduction in addition to usual care is associated with improvements in pain, fatigue, and cognitive failures among veterans with Gulf War illness. Am J Med. 2016 Feb;129(2):204-14. doi: 10.1016/j.amjmed.2015.09.015. PMID: 26519614.","45996","2020"
"kearney2013_A","Complementary and integrative health (CIH)","PTSD","PTSD",,"47","A","25",,"MBSR","Mindfulness-based stress reduction (MBSR)","Mindfulness-based stress reduction following format developed by Kabat-Zinn, including mindfulness exercises, attentional skills, daily meditation and yoga","No","Not Applicable","No","Not Applicable","Yes","Meditation","No","No","No","No","No","Group","In Person",,"2.5 hours weekly plus
7 hours on 1 Saturday","Once weekly, plus 1 Saturday session","8",,"≥4 sessions","0.84",,,,,"7","2",,,,,"Veteran",,"1",,"0.2128",,"0.7872",,,"Medium","Kearney DJ, McDermott K, Malte C, et al. Effects of participation in a mindfulness program for veterans with posttraumatic stress disorder: a randomized controlled pilot study. J Clin Psychol. 2013 Jan;69(1):14-27. doi: 10.1002/jclp.21911. PMID: 22930491.","39341","2019"
"kearney2013_B","Complementary and integrative health (CIH)","PTSD","Control",,"47","B","22",,"TAU","Treatment as usual (TAU)","Usual care without intervention from the study team","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,,,,"8",,,,,,,,,,,,,,"Veteran",,"1",,"0.2128",,"0.7872",,,"Medium","Kearney DJ, McDermott K, Malte C, et al. Effects of participation in a mindfulness program for veterans with posttraumatic stress disorder: a randomized controlled pilot study. J Clin Psychol. 2013 Jan;69(1):14-27. doi: 10.1002/jclp.21911. PMID: 22930491.","39341","2019"
"kehleforbes2019_A","Psychotherapy","PTSD+SUD","PTSD+SUD","Integrated","183","A","95",,"Integrated MET + PE","Integrated Motivational Enhancement Therapy (MET) + Prolonged Exposure (PE)","Integrated MET and PE, in which all sessions included components of both therapies. MET: ""evidence-based, structured adaptation of motivational interviewing that encourages change through the structured assessment and feedback of SUD behaviors"". PE: ""evidence-based psychotherapy for PTSD that includes in vivo (exposure to trauma-related safe situations, objects, or people that cause distress and are avoided) and imaginal (revisiting and processing of the trauma memory) exposure"".","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"90 minutes","Weekly","16",,"attended ≥12 sessions","0.2316",,,,,"8.35","4.15",,,,,"Veteran","0","1","0","0.0765",,"0.9235",,,"Medium","Kehle-Forbes SM, Chen S, Polusny MA, et al. A randomized controlled trial evaluating integrated versus phased application of evidence-based psychotherapies for military veterans with comorbid PTSD and substance use disorders. Drug Alcohol Depend. 2019 Dec 1;205:107647. doi: 10.1016/j.drugalcdep.2019.107647. PMID: 31675546.",,"2020"
"kehleforbes2019_B","Psychotherapy","PTSD+SUD","PTSD+SUD","Not integrated","183","B","88",,"Phased MET + PE","Phased Motivational Enhancement Therapy (MET) + Prolonged Exposure (PE)","Phased MET and PE. Sessions 1-4: MET content (plus health education content to balance time with integrated MET plus PE arm); sessions 5-16: PE (12 session course) with ""brief SUD-check in at the beginning of each treatment session"" (issues raised were addressed as needed using MET framework). MET: ""evidence-based, structured adaptation of motivational interviewing that encourages change through the structured assessment and feedback of SUD behaviors"". PE: ""evidence-based psychotherapy for PTSD that includes in vivo (exposure to trauma-related safe situations, objects, or people that cause distress and are avoided) and imaginal (revisiting and processing of the trauma memory) exposure"".","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"90 minutes","Weekly","16",,"attended ≥12 sessions","0.3636",,,,,"9.16","4.55",,,,,"Veteran","0","1","0","0.0765",,"0.9235",,,"Medium","Kehle-Forbes SM, Chen S, Polusny MA, et al. A randomized controlled trial evaluating integrated versus phased application of evidence-based psychotherapies for military veterans with comorbid PTSD and substance use disorders. Drug Alcohol Depend. 2019 Dec 1;205:107647. doi: 10.1016/j.drugalcdep.2019.107647. PMID: 31675546.",,"2020"
"kent2011_A","Psychotherapy","PTSD","PTSD",,"39","A","20",,"Resilience-oriented treatment","Resilience-oriented treatment","Manualized intervention fostering resilience resources (e.g., awareness of positive emotions; social connectedness) that individuals are encouraged to draw on in later sessions when they revisit traumatic episodes or experience PTSD symptoms. Week 1 = introduction to concept of resilience; weeks 2-3 = attention to bodily sensations as sources of vitality and engagement; weeks 4-7 = building positive emotional experiences and social bonds; weeks 8-10 = revisiting stressors and traumas while tapping into positive emotional resources and social bonds developed in earlier sessions; weeks 11-12 = developing a plan to sustain change.","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Group","In Person",,"90 minutes","Weekly","12",,,,,,,,"9.75","2.24",,,,,"Veteran","0","1","0","0.33",,"0.67","Mixed","combat-related, child physical abuse, child other abuse, rape/sexual assault, accidents, community/school violence","Medium","Kent M, Davis MC, Stark SL, et al. A resilience-oriented treatment for posttraumatic stress disorder: results of a preliminary randomized clinical trial. J Trauma Stress. 2011 Oct;24(5):591-5. doi: 10.1002/jts.20685. PMID: 21898603.","85582","2019"
"kent2011_B","Psychotherapy","PTSD","Control",,"39","B","19",,"Waitlist","Waitlist",,"No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0.33",,"0.67","Mixed","combat-related, child physical abuse, child other abuse, rape/sexual assault, accidents, community/school violence","Medium","Kent M, Davis MC, Stark SL, et al. A resilience-oriented treatment for posttraumatic stress disorder: results of a preliminary randomized clinical trial. J Trauma Stress. 2011 Oct;24(5):591-5. doi: 10.1002/jts.20685. PMID: 21898603.","85582","2019"
"kip2013_A","Psychotherapy","PTSD","PTSD",,"57","A","29",,"Accelerated Resolution Therapy","Accelerated Resolution Therapy (ART)","Intervention involves imaginal exposure where participants were asked to recall the traumatic event while focusing on physiological sensations, thoughts, and emotions while engaging in clinician-directed eye movements. Second phase is imagery rescripting where participant is instructed to visualize their traumatic scene and imagine changing the imagery and sensory components of the scene to anything they choose","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"60 to 75 minutes",,"2","2 to 5 sessions total",,,,,,,"3.6","1.1",,,,,"Mixed","0.2982","0.7018","0","0.193",,"0.807","Mixed","MST, combat-related, community/school violence","Medium","Kip KE, Rosenzweig L, Hernandez DF, et al. Randomized controlled trial of Accelerated Resolution Therapy (ART) for symptoms of combat-related post-traumatic stress disorder (PTSD). Mil Med. 2013 Dec;178(12):1298-309. doi: 10.7205/MILMED-D-13-00298. PMID: 24306011.","88001","2019"
"kip2013_B","Psychotherapy","PTSD","Control",,"57","B","28",,"Attention Control","Fitness/career assessment and planning","Fitness or career assessment and planning","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person",,"1 hour",,"2","2 sessions total",,,,,,,"1.71",,,,,,"Mixed","0.2982","0.7018","0","0.193",,"0.807","Mixed","MST, combat-related, community/school violence","Medium","Kip KE, Rosenzweig L, Hernandez DF, et al. Randomized controlled trial of Accelerated Resolution Therapy (ART) for symptoms of combat-related post-traumatic stress disorder (PTSD). Mil Med. 2013 Dec;178(12):1298-309. doi: 10.7205/MILMED-D-13-00298. PMID: 24306011.","88001","2019"
"knaevelsrud2015_A","Psychotherapy","PTSD","PTSD",,"159","A","79",,"Interapy","Trauma-focused cognitive behavioral therapy (TF-CBT)","A Dutch Internet-based CBT manual translated into Arabic and culturally adapted. Interapy consists of writing activities that include self-confrontation with traumatic event, cognitive restructuring, and social sharing. Therapists provided individually written feedback and instructions on writing assignments","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","Technology Assisted",,"45 minutes","Twice weekly","5",,,,,,,,,,,,,,"Community",,,"1","0.7233",,"0.2767","Mixed","terrorism/political violence/forced displacement, rape/sexual assault, community/school violence","High","Knaevelsrud C, Brand J, Lange A, et al. Web-based psychotherapy for posttraumatic stress disorder in war-traumatized Arab patients: randomized controlled trial. J Med Internet Res. 2015 Mar 20;17(3):e71. doi: 10.2196/jmir.3582. PMID: 25799024.","46782","2019"
"knaevelsrud2015_B","Psychotherapy","PTSD","Control",,"159","B","80",,"Waitlist","Waitlist","Participants did not receive intervention during 6-week waiting period","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,,,,"6",,,,,,,,,,,,,,"Community",,,"1","0.7233",,"0.2767","Mixed","terrorism/political violence/forced displacement, rape/sexual assault, community/school violence","High","Knaevelsrud C, Brand J, Lange A, et al. Web-based psychotherapy for posttraumatic stress disorder in war-traumatized Arab patients: randomized controlled trial. J Med Internet Res. 2015 Mar 20;17(3):e71. doi: 10.2196/jmir.3582. PMID: 25799024.","46782","2019"
"knaevelsrud2017_A","Psychotherapy","PTSD","PTSD",,"94","A","47",,"Integrative Testimonial Therapy","Trauma-focused cognitive behavioral therapy (TF-CBT)","Internet-based structured CBT with writing assignments that focused on resource-oriented biographical reconstruction, moderated exposure, and cognitive reconstruction. Therapists provided feedback and instructions based on a disordered-specific CBT manual.","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","Technology Assisted",,"45 minutes","Twice weekly","6",,,,,,,,,,,,,,"Community",,,"1","0.6489",,"0.3511","Terrorism/political violence/forced displacement",,"Medium","Knaevelsrud C, Böttche M, Pietrzak RH, et al. Efficacy and feasibility of a therapist-guided internet-based intervention for older persons with childhood traumatization: a randomized controlled trial. Am J Geriatr Psychiatry. 2017 Aug;25(8):878-88. doi: 10.1016/j.jagp.2017.02.024. PMID: 28365000.","47282","2019"
"knaevelsrud2017_B","Psychotherapy","PTSD","Control",,"94","B","47",,"Waitlist","Waitlist","Waitlist","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,,,,"6",,,,,,,,,,,,,,"Community",,,"1","0.6489",,"0.3511","Terrorism/political violence/forced displacement",,"Medium","Knaevelsrud C, Böttche M, Pietrzak RH, et al. Efficacy and feasibility of a therapist-guided internet-based intervention for older persons with childhood traumatization: a randomized controlled trial. Am J Geriatr Psychiatry. 2017 Aug;25(8):878-88. doi: 10.1016/j.jagp.2017.02.024. PMID: 28365000.","47282","2019"
"koochaki2018_A","Psychotherapy","PTSD","PTSD",,"90","A","45",,"CBT for PTSD + routine care counseling","Cognitive behavioral therapy (CBT) without a trauma focus","CBT for PTSD: 6 group sessions covering topics such as psychological aspects of feelings and thoughts, signs of stress and coping techniques, and problem-solving skills.
Routine care counseling: 8 group sessions covering routine infant care.","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Group","In Person",,"40 to 60 minutes","CBT for PTSD: NR; Routine care counseling: twice a week",,"total 6 sessions of CBT plus 8 sessions of routine care counseling","attend all sessions","0.9333",,,,,,,,,,,,,,,"1",,"0","Illness/medical procedure",,"Medium","Koochaki M, Mahmoodi Z, Esmaelzadeh–Saeieh S, et al. Effects of cognitive-behavioral counseling on posttraumatic stress disorder in mothers with infants hospitalized at neonatal intensive care units: a randomized controlled trial. Iran J Psychiatry Behav Sci. 2018;12(4):e65159. doi: 10.5812/ijpbs.65159.",,"2020"
"koochaki2018_B","Psychotherapy","PTSD","Control",,"90","B","45",,"PTSD educational packet + routine care counseling","PTSD educational packet + routine care counseling","PTSD educational packet: contained information on the same topics covered in the CBT for PTSD intervention; psychological aspects of feelings and thoughts, signs of stress and coping techniques, and problem-solving skills.
Routine care counseling: 8 group sessions covering routine infant care.","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Group","In Person",,"40 to 60 minutes","Twice a week","4",,"attend all sessions","0.8667",,,,,,,,,,,,,,,"1",,"0","Illness/medical procedure",,"Medium","Koochaki M, Mahmoodi Z, Esmaelzadeh–Saeieh S, et al. Effects of cognitive-behavioral counseling on posttraumatic stress disorder in mothers with infants hospitalized at neonatal intensive care units: a randomized controlled trial. Iran J Psychiatry Behav Sci. 2018;12(4):e65159. doi: 10.5812/ijpbs.65159.",,"2020"
"kosten1991_A","Pharmacotherapy","PTSD","PTSD",,"60","A","19",,"Phenelzine","Phenelzine","MAO-I antidepressant; dose titrated to achieve ≥85% platelet MAO inhibition with blood tested at week 2 and one week following any dosage changes, unless limited by side effects","No","Not Applicable","Yes","Antidepressant: MAOI","No","Not Applicable","No","No","No","No","No","Individual","In Person","15 to 75 mg; titration: initiated at 15 mg, increased to target maximum dose of 60 to 75 mg with ≥85% platelet MAO inhibition",,"Daily","8",,,,,,,,,,,"68 mg/day (4.5 tablets)","20",,"Veteran","0","1","0","0",,"1","Combat-related",,"Medium","Kosten TR, Frank JB, Dan E, et al. Pharmacotherapy for posttraumatic stress disorder using phenelzine or imipramine. J Nerv Ment Dis. 1991;179(6):366-70. PMID: 2051152.","02658","2019"
"kosten1991_B","Pharmacotherapy","PTSD","PTSD",,"60","B","23",,"Imipramine","Imipramine","TCA; dose titrated to attain blood levels >150 ng/ml after a week on stable dose, with blood tested at week 2 and one week following any dosage changes, unless limited by side effects","No","Not Applicable","Yes","Antidepressant: TCA","No","Not Applicable","No","No","No","No","No","Individual","In Person","50 to 300 mg; titration: 50 mg initial dose increased to achieve blood levels >150 ng/ml after 1 week of stable dosing, with maximum dose of 300 mg",,"Daily","8",,,,,,,,,,,"225 mg/day (4.5 tablets)","55",,"Veteran","0","1","0","0",,"1","Combat-related",,"Medium","Kosten TR, Frank JB, Dan E, et al. Pharmacotherapy for posttraumatic stress disorder using phenelzine or imipramine. J Nerv Ment Dis. 1991;179(6):366-70. PMID: 2051152.","02658","2019"
"kosten1991_C","Pharmacotherapy","PTSD","Control",,"60","C","18",,"Placebo","Placebo","Placebo pills; dose (number of pills) adjusted by nonblind physician monitoring blood levels in other intervention arms","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person",,,"Daily","8",,,,,,,,,,,"4.4 tablets/day","1.4",,"Veteran","0","1","0","0",,"1","Combat-related",,"Medium","Kosten TR, Frank JB, Dan E, et al. Pharmacotherapy for posttraumatic stress disorder using phenelzine or imipramine. J Nerv Ment Dis. 1991;179(6):366-70. PMID: 2051152.","02658","2019"
"kozel2019_A","Other mixed","PTSD","PTSD",,"35","A","17",,"rTMS 1 Hz","Transcranial magnetic stimualtion (TMS)","rTMS positioned over the dorsolateral prefrontal cortex; stimulus was 1 Hz frequency, continuous for 40 minutes with total of 2400 pulses per session and total pulses over all sessions (including taper) was 86,400. Treatment outcomes were assessed at the end of 6 weeks of rTMS (30 sessions); there was an additional 3-week taper period with 6 sessions (3 in week 1, 2 in week 2, and 1 in week 3).","No","Not Applicable","No","Not Applicable","No","Not Applicable","Yes","No","No","No","No","Individual","In Person","Dose: 1 Hz continuous","Session length: 40 minutes","5 days per week","6",,"completed 30 sessions","0.8235",,,,,,,,,,,"Veteran","0","1","0","0.2857",,"0.7143",,,"Medium","Kozel FA, Van Trees K, Larson V, et al. One hertz versus ten hertz repetitive TMS treatment of PTSD: a randomized clinical trial. Psychiatry Res. 2019 Mar;273:153-62. doi: 10.1016/j.psychres.2019.01.004. PMID: 30641346.","51540","2020"
"kozel2019_B","Other mixed","PTSD","PTSD",,"35","B","18",,"rTMS 10 Hz","Transcranial magnetic stimualtion (TMS)","rTMS positioned over the dorsolateral prefrontal cortex; stimulus was 10 Hz frequency, 4 seconds on and 36 seconds off for 40 minutes with total of 2400 pulses per session and total pulses over all sessions (including taper) was 86,400. Treatment outcomes were assessed at the end of 6 weeks of rTMS (30 sessions); there was an additional 3-week taper period with 6 sessions (3 in week 1, 2 in week 2, and 1 in week 3).","No","Not Applicable","No","Not Applicable","No","Not Applicable","Yes","No","No","No","No","Individual","In Person","Dose: 10 Hz, 4 seconds on and 36 seconds off","Session length: 40 minutes","5 days per week","6",,"completed 30 sessions","0.7222",,,,,,,,,,,"Veteran","0","1","0","0.2857",,"0.7143",,,"Medium","Kozel FA, Van Trees K, Larson V, et al. One hertz versus ten hertz repetitive TMS treatment of PTSD: a randomized clinical trial. Psychiatry Res. 2019 Mar;273:153-62. doi: 10.1016/j.psychres.2019.01.004. PMID: 30641346.","51540","2020"
"kozel2018_A","Other mixed","PTSD","PTSD",,"103","A","54",,"rTMS + CPT","Transcranial magnetic stimulation (TMS) + Cognitive Processing Therapy (CPT)","TMS coil positioned over the right dorsolateral prefrontal cortex.

CPT according to Resick and Schnicke (1992), a trauma-focused therapy that elicit memories of traumatic events and directly confronting conflicts and maladaptive beliefs associated with the memories","Yes","TF","No","Not Applicable","No","Not Applicable","Yes","No","No","No","No","Individual","In Person","1-Hz at 110% motor threshold, 1800 pulses per treatment","rTMS: 30 minutes
CPT: 60 minutes","rTMS: once

CPT: weekly","12",,,,,,,,,,,,,,"Veteran","0","1","0",,,,"Combat-related",,"Medium","Kozel FA, Motes MA, Didehbani N, et al. Repetitive TMS to augment cognitive processing therapy in combat veterans of recent conflicts with PTSD: a randomized clinical trial. J Affect Disord. 2018 Mar 15;229:506-14. doi: 10.1016/j.jad.2017.12.046. PMID: 29351885.","49858","2019"
"kozel2018_B","Other mixed","PTSD","Control",,"103","B","46",,"Sham rTMS + CPT","Cognitive Processing Therapy (CPT) + sham","Sham TMS coil positioned over the right dorsolateral prefrontal cortex. CPT according to Resick and Schnicke (1992), a trauma-focused therapy that elicit memories of traumatic events and directly confronting conflicts and maladaptive beliefs associated with the memories","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person",,"rTMS: 30 minutes

CPT: 60 minutes","rTMS: once

CPT: weekly","12",,,,,,,,,,,,,,"Veteran","0","1","0",,,,"Combat-related",,"Medium","Kozel FA, Motes MA, Didehbani N, et al. Repetitive TMS to augment cognitive processing therapy in combat veterans of recent conflicts with PTSD: a randomized clinical trial. J Affect Disord. 2018 Mar 15;229:506-14. doi: 10.1016/j.jad.2017.12.046. PMID: 29351885.","49858","2019"
"krakow2000_A","Psychotherapy","PTSD","PTSD",,"169","A","87",,"Imagery rehearsal","Imagery Rehearsal Training (IRT)","Manual-based cognitive-imagery approach where participants practice pleasant imagery exercise, learn about cognitive-behavioral tools to deal with unpleasant images, and use imagery-rehearsal technique on a single nightmare. Participants rehearse a new dream daily","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"Two 3-hour sessions, one 1-hour followup session","First 2 sessions weekly, then followup 3 weeks later","6",,,,,,,,,,,,,,"Community","0","0","1","1",,"0","Mixed","child physical abuse, child sexual abuse, rape/sexual assault, accidents, community/school violence, natural or manmade disasters","High","Krakow BJ, Hollifield M, Schrader R, et al. A controlled study of imagery rehearsal for chronic nightmares in sexual assault survivors with PTSD: a preliminary report. Journal of Traumatic Stress. 2000 Oct;13(4):589-609. doi: 10.1023/A:1007854015481. PMID: 11109233.","15539","2020"
"krakow2000_B","Psychotherapy","PTSD","Control",,"169","B","82",,"Waitlist","Waitlist",,"No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,,,,"24",,,,,,,,,,,,,,"Community","0","0","1","1",,"0","Mixed","child physical abuse, child sexual abuse, rape/sexual assault, accidents, community/school violence, natural or manmade disasters","High","Krakow BJ, Hollifield M, Schrader R, et al. A controlled study of imagery rehearsal for chronic nightmares in sexual assault survivors with PTSD: a preliminary report. Journal of Traumatic Stress. 2000 Oct;13(4):589-609. doi: 10.1023/A:1007854015481. PMID: 11109233.","15539","2020"
"krupnick2008_A","Psychotherapy","PTSD","PTSD",,"48","A","32",,"IPT","Interpersonal Psychotherapy (IPT)","Intervention adapted into group format that begins with developing group cohesion, addressing relationship disputes, social deficits, role transitions, and relationship losses. Last 3 sessions focus on anticipating future problems and identifying relationship triggers that could reactivate PTSD symptoms","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Group","In Person",,"2 hours",,,"16 sessions total",,,,,,,,,,,,,"Community",,,"1","1",,"0","Mixed","child physical abuse, child sexual abuse, other (interpersonal trauma)","High","Krupnick JL, Green BL, Stockton P, et al. Group interpersonal psychotherapy for low-income women with posttraumatic stress disorder. Psychother Res. 2008 Sep;18(5):497-507. doi: 10.1080/10503300802183678. PMID: 18816001.","32335","2019"
"krupnick2008_B","Psychotherapy","PTSD","Control",,"48","B","16",,"Waitlist","Waitlist",,"No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,,,,,,,,,,,,,,,,,,"Community",,,"1","1",,"0","Mixed","child physical abuse, child sexual abuse, other (interpersonal trauma)","High","Krupnick JL, Green BL, Stockton P, et al. Group interpersonal psychotherapy for low-income women with posttraumatic stress disorder. Psychother Res. 2008 Sep;18(5):497-507. doi: 10.1080/10503300802183678. PMID: 18816001.","32335","2019"
"krupnick2017_A","Psychotherapy","PTSD","PTSD",,"34","A","18",,"Warriors Internet Recovery & Education + TAU","Trauma-focused cognitive behavioral therapy (TF-CBT)","Adjunct writing exercises through an online portal using principles of prolonged exposure and cognitive therapy. Therapist provides general response and specific instructions for subsequent writing session.","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","Technology Assisted",,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0.0882",,"0.9118","Mixed","MST, combat-related","High","Krupnick JL, Green BL, Amdur RL, et al. An internet-based writing intervention for PTSD in veterans: a feasibility and pilot effectiveness trial. Psychol Trauma. 2017 Jul;9(4):461-70. doi: 10.1037/tra0000176. PMID: 27607767.","45679","2019"
"krupnick2017_B","Psychotherapy","PTSD","Control",,"34","B","16",,"TAU","Treatment as usual (TAU)",,"No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,,,,,,,,,,,,,,,,,,"Veteran","0","1","0","0.0882",,"0.9118","Mixed","MST, combat-related","High","Krupnick JL, Green BL, Amdur RL, et al. An internet-based writing intervention for PTSD in veterans: a feasibility and pilot effectiveness trial. Psychol Trauma. 2017 Jul;9(4):461-70. doi: 10.1037/tra0000176. PMID: 27607767.","45679","2019"
"krystal2011_A","Pharmacotherapy","PTSD","PTSD",,"296","A","147",,"Risperidone augmentation","Risperidone augmentation","Second-generation antipsychotic; augmentation of antidepressants with or without psychotherapy; titrated over 4 weeks, with further optional 1 mg increase determined by treating investigators (blinded to study medication status).","No","Not Applicable","Yes","Antipsychotic","No","Not Applicable","No","No","No","No","No","Individual","In Person","1 to 4 mg; titration: initiated at 1 mg and increased in 1-mg increments weekly to 3 mg with optional increase by 1 mg to maximum of 4 mg after 4 weeks",,"Daily at bedtime","24",,,,,,,,,,,"2.74 mg",,,"Veteran","0","1","0","0.09",,"0.91","Mixed","combat-related, other (physical or sexual abuse)","Low","Krystal JH, Rosenheck RA, Cramer JA, et al. Adjunctive risperidone treatment for antidepressant-resistant symptoms of chronic military service-related PTSD: a randomized trial. JAMA. 2011;306(5):493-502. doi: 10.1001/jama.2011.1080. PMID: 21813427.","36863","2019"
"krystal2011_B","Pharmacotherapy","PTSD","Control",,"296","B","149",,"Placebo","Placebo","Matching tablets. Initiated at 1 tablet orally at bedtime and increased by 1 tablet per week to a dose of 3 tablets at bedtime. After participants received study medication for 4 weeks, investigators who were blinded to study medication status and were treating patients had the option of further increasing the dose by 1 tablet.","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","Equivalent of 1 to 4 mg in placebo tablets",,"Daily at bedtime","24",,,,,,,,,,,"3.35 mg equivalent",,,"Veteran","0","1","0","0.09",,"0.91","Mixed","combat-related, other (physical or sexual abuse)","Low","Krystal JH, Rosenheck RA, Cramer JA, et al. Adjunctive risperidone treatment for antidepressant-resistant symptoms of chronic military service-related PTSD: a randomized trial. JAMA. 2011;306(5):493-502. doi: 10.1001/jama.2011.1080. PMID: 21813427.","36863","2019"
"kubany2004_A","Psychotherapy","PTSD","PTSD",,"107","A","46",,"Cognitive trauma therapy","Trauma-focused cognitive behavioral therapy (TF-CBT)","Therapy components include trauma history exploration, psychoeducation regarding exposure technique, solution-oriented attitude, coping strategies, cognitive therapy for trauma-related guilt, training on self-advocacy and empowerment","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"1.5 hours (median)","Twice weekly","4 to 5.5",,"Completed all sessions","0.77",,,,,"9.5","1.6","Completers only",,,,,,,,"1",,"0","Intimate partner violence",,"Medium","Kubany ES, Hill EE, Owens JA, et al. Cognitive trauma therapy for battered women with PTSD (CTT-BW). J Consult Clin Psychol. 2004 Feb;72(1):3-18. doi: 10.1037/0022-006x.72.1.3. PMID: 14756610.","26300","2019"
"kubany2004_B","Psychotherapy","PTSD","Control",,"107","B","40",,"Waitlist","Waitlist","Therapy delayed for 6 weeks","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,,,,"6",,,,,,,,,,,,,,,,,,"1",,"0","Intimate partner violence",,"Medium","Kubany ES, Hill EE, Owens JA, et al. Cognitive trauma therapy for battered women with PTSD (CTT-BW). J Consult Clin Psychol. 2004 Feb;72(1):3-18. doi: 10.1037/0022-006x.72.1.3. PMID: 14756610.","26300","2019"
"kuckertz2014_A","Nonpharmacologic cognitive","PTSD","PTSD",,"37","A","20",,"Attention Bias Modification","Attention bias modification (ABM)","Each trial began with a fixation cross that appeared in the center of the computer screen for 500 millisecond The fixation cross then disappeared and was replaced by a word pair consisting of one threat and one neutral word, presented vertically in the center of the screen for 500 millisecond, with one word directly above the other. The words then disappeared and a probe (either the letter ‘E’ or the letter ‘F’) appeared in the location of one of the two words. Participants were instructed to decide whether the probe replacing the word was an ‘E’ or an ‘F’ and press the corresponding mouse button (left mouse button for ‘E’ and right mouse button for ‘F’). The letter probe remained on the screen until the participant responded. Response latencies for each participant to identify the probe were recorded from the time the probe was presented to the time participants responded. Following each response, there was a 500 millisecond interval where participants saw a blank screen before the next trial began with a fixation cross. Each session consisted of 384 trials: 48 pre-session, 288 training or control sessions, and 48 post-sessions.","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","Yes","No","No","No","Individual","In Person",,,"Daily","2",,,,,,,,"6.67","5.25",,,,,"Active Duty Military","1","0","0","0.069",,"0.931",,,"Medium","Kuckertz JM, Amir N, Boffa JW, et al. The effectiveness of an attention bias modification program as an adjunctive treatment for post-traumatic stress disorder. Behav Res Ther. 2014 Dec;63:25-35. doi: 10.1016/j.brat.2014.09.002. PMID: 25277496.","43075","2019"
"kuckertz2014_B","Nonpharmacologic cognitive","PTSD","Control",,"37","B","17",,"Attention Control Condition","Attention bias modification (ABM)","Identical to the Attention Bias Modification procedure with the exception that the probe replaced the threat and neutral words with equal frequency.","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","Yes","No","No","No","Individual","In Person",,,"Daily","2",,,,,,,,"7.24","5.72",,,,,"Active Duty Military","1","0","0","0.069",,"0.931",,,"Medium","Kuckertz JM, Amir N, Boffa JW, et al. The effectiveness of an attention bias modification program as an adjunctive treatment for post-traumatic stress disorder. Behav Res Ther. 2014 Dec;63:25-35. doi: 10.1016/j.brat.2014.09.002. PMID: 25277496.","43075","2019"
"lang2019_A","Complementary and integrative health (CIH)","PTSD","PTSD",,"37","A","17",,"Compassion meditation","Compassion meditation","Adaptation of Cognitively-Based Compassion Training (CBCT®), with exercises to stabilize attention, develop present-moment
awareness, and foster compassion toward self and others. Group sessions led by a clinical psychologist, with individual daily meditation assignments.","No","Not Applicable","No","Not Applicable","Yes","Meditation","No","No","No","No","No","Group","In Person",,"90 minutes","Weekly","10",,"attended ≥6 group sessions",,,"for daily meditation practice, total minutes of practice recorded divided by total minutes of practice assigned",,,"7.3","3.0","Total minutes of practice: 689.5 (423.1), an average of 75.5% of assigned practice",,,,"Veteran","0","1","0","0.25",,"0.75","Mixed","combat-related; Accidents; Community/ school violence; Other (sudden violent death, causing serious harm to another)","Medium","Lang AJ, Malaktaris AL, Casmar P, et al. Compassion meditation for posttraumatic stress disorder in veterans: a randomized proof of concept study. J Trauma Stress. 2019 Apr;32(2):299-309. doi: 10.1002/jts.22397. PMID: 30929283.","51896","2020"
"lang2019_B","Complementary and integrative health (CIH)","PTSD","PTSD",,"37","B","20",,"Veteran.calm","Veteran.calm","Psychoeducation about PTSD, rationale for relaxation, relaxation training including progressive muscle relaxation, and sleep hygiene. Group sessions led by a graduate student in clinical psychology, with individual daily meditation practice between sessions.","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Group","In Person",,"90 minutes","Weekly","10",,"attended ≥6 group sessions",,,"for daily meditation practice, total minutes of practice recorded divided by total minutes of practice assigned",,,"6.7","3.5","Total minutes of practice: 524.6 (236.4), an average of 49.6% of assigned practice",,,,"Veteran","0","1","0","0.25",,"0.75","Mixed","combat-related; Accidents; Community/ school violence; Other (sudden violent death, causing serious harm to another)","Medium","Lang AJ, Malaktaris AL, Casmar P, et al. Compassion meditation for posttraumatic stress disorder in veterans: a randomized proof of concept study. J Trauma Stress. 2019 Apr;32(2):299-309. doi: 10.1002/jts.22397. PMID: 30929283.","51896","2020"
"langkaas2017_A","Psychotherapy","PTSD","PTSD",,"65","A","34",,"Imagery Rescription","Imagery rescripting","Imagery-based cognitive restructuring consisting of imaginal exposure, mastery imagery, and self-calming/self-nurturing imagery, with psychoeducation about trauma and in vivo exposure","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"90 to 120 minutes","Weekly","10",,,,,,,,,,,,,,"Community",,,"1","0.5846",,"0.4154","Mixed","rape/sexual assault, accidents, community/school violence, other (war-related)","Medium","Langkaas TF, Hoffart A, Øktedalen T, et al. Exposure and non-fear emotions: a randomized controlled study of exposure-based and rescripting-based imagery in PTSD treatment. Behav Res Ther. 2017 Oct;97:33-42. doi: 10.1016/j.brat.2017.06.007. PMID: 28689041.","48570","2019"
"langkaas2017_B","Psychotherapy","PTSD","PTSD",,"65","B","33",,"PE","Prolonged Exposure (PE)","Trauma-focused CBT","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"90 to 120 minutes","Weekly","10",,,,,,,,,,,,,,"Community",,,"1","0.5846",,"0.4154","Mixed","rape/sexual assault, accidents, community/school violence, other (war-related)","Medium","Langkaas TF, Hoffart A, Øktedalen T, et al. Exposure and non-fear emotions: a randomized controlled study of exposure-based and rescripting-based imagery in PTSD treatment. Behav Res Ther. 2017 Oct;97:33-42. doi: 10.1016/j.brat.2017.06.007. PMID: 28689041.","48570","2019"
"lee2002_A","Psychotherapy","PTSD","PTSD",,"27","A","12",,"SIT with PE","Stress Inoculation Training (SIT) plus Prolonged Exposure (PE)","Based on Foa 1991 but reduced sessions by excluding session containing thought stopping and condensing content of first three sessions into two. Sessions included assessment, controlled breathing, education, prolonged exposure, and coping skills.","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"90 minutes","Weekly","7",,,,,,,,,,,,,,"Mixed","0",,,"0.4583",,"0.5417","Mixed","combat-related, rape/sexual assault, accidents, other (murder)","High","Lee CW, Gavriel H, Drummond PD, et al. Treatment of PTSD: stress inoculation training with prolonged exposure compared to EMDR. J Clin Psychol. 2002 Sep;58(9):1071-89. doi: 10.1002/jclp.10039. PMID: 12209866.","24570","2019"
"lee2002_B","Psychotherapy","PTSD","PTSD",,"27","B","12",,"EMDR","Eye Movement Desensitization and Reprocessing (EMDR)","Full standard 8-phase intervention as described in Shapiro 1995. Included preparation, target memory and desensitization, debriefing, and re-evaluation.","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"90 minutes","weekly","7",,,,,,,,,,,,,,"Mixed","0",,,"0.4583",,"0.5417","Mixed","combat-related, rape/sexual assault, accidents, other (murder)","High","Lee CW, Gavriel H, Drummond PD, et al. Treatment of PTSD: stress inoculation training with prolonged exposure compared to EMDR. J Clin Psychol. 2002 Sep;58(9):1071-89. doi: 10.1002/jclp.10039. PMID: 12209866.","24570","2019"
"lely2019_A","Psychotherapy","PTSD","PTSD",,"33","A","18",,"NET","Narrative Exposure Therapy (NET)","Standardized individual treatment following manual, based on trauma-focused CBT and incorporating components of testimonial therapy. ""Session one is dedicated to psychoeducation and treatment planning. In session two, the therapist and the participant create a visual timeline of traumatic and supporting experiences and select the events for exposure. Sessions three to ten are dedicated to imaginal exposure. The last session allows for receiving the documented narration, focusing on the future and saying goodbye.""","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"90 minutes","Every 1 to 2 weeks",,"Mean (SD): 19.00 (8.31) (total 11 sessions)",,"0.7778",,,,,,,,,,,"Community","0","0","1","0.2727",,"0.7273","Mixed","intimate partner violence, terrorism/political violence/forced displacement, other (unspecified child abuse, persecution)","Medium","Lely JCG, Knipscheer JW, Moerbeek M, et al. Randomised controlled trial comparing narrative exposure therapy with present-centred therapy for older patients with post-traumatic stress disorder. Br J Psychiatry. 2019 Jun;214(6):369-77. doi: 10.1192/bjp.2019.59. PMID: 30957736.",,"2020"
"lely2019_B","Psychotherapy","PTSD","PTSD",,"33","B","15",,"PCT","Present Centered Therapy (PCT)","Individual, non-trauma-focused therapy following PCT protocol; includes psychoeducation and homework, ""targeting current maladaptive relational patterns by including problem-solving techniques, and helps patients to focus on the ‘here and now’.""","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"90 minutes","Every 1 to 2 weeks",,"Mean (SD): 19.00 (8.78) (total 11 sessions)",,"0.80",,,,,,,,,,,"Community","0","0","1","0.2727",,"0.7273","Mixed","intimate partner violence, terrorism/political violence/forced displacement, other (unspecified child abuse, persecution)","Medium","Lely JCG, Knipscheer JW, Moerbeek M, et al. Randomised controlled trial comparing narrative exposure therapy with present-centred therapy for older patients with post-traumatic stress disorder. Br J Psychiatry. 2019 Jun;214(6):369-77. doi: 10.1192/bjp.2019.59. PMID: 30957736.",,"2020"
"leong2020_C","Nonpharmacologic biological","PTSD","Control",,"31","C","10",,"Sham rTMS","Sham","Sham rTMS with either 1-Hz or 10-Hz sham stimulation using a Magstim D70 model 3950-00 device, identical in appearance and producing a similar sound and vibration as the active coil, targeting the right DLPFC","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","Intensity: Sham 1 or 10 Hz for 37.5 minutes",,"Daily on weekdays","2",,,,,,,,,,,,,,"Community","0","0","1","0.8276",,"0.1724","Mixed","Rape/sexual assault; Other (exposure to actual or threatened death or serious injury, and witnessing such incidents)","High","Leong K, Chan P, Ong L, et al. A Randomized Sham-controlled Trial of 1-Hz and 10-Hz Repetitive Transcranial Magnetic Stimulation (rTMS) of the Right Dorsolateral Prefrontal Cortex in Civilian Post-traumatic Stress Disorder. Can J Psychiatry. 2020 May 07:706743720923064. doi: https://dx.doi.org/10.1177/0706743720923064. PMID: 32379487.",,"2020"
"leong2020_B","Nonpharmacologic biological","PTSD","PTSD",,"31","B","10",,"High-frequency rTMS","Transcranial magnetic stimualtion (TMS)","10-Hz rTMS with 3,000 pulses over 37.5 minutes, targeting the right DLPFC using Magstim Super Rapid2 model 3910-00 device","No","Not Applicable","No","Not Applicable","No","Not Applicable","Yes","No","No","No","No","Individual","In Person","Intensity: 10 Hz for 37.5 minutes",,"Daily on weekdays","2",,,,,,,,,,,,,,"Community","0","0","1","0.8276",,"0.1724","Mixed","Rape/sexual assault; Other (exposure to actual or threatened death or serious injury, and witnessing such incidents)","High","Leong K, Chan P, Ong L, et al. A Randomized Sham-controlled Trial of 1-Hz and 10-Hz Repetitive Transcranial Magnetic Stimulation (rTMS) of the Right Dorsolateral Prefrontal Cortex in Civilian Post-traumatic Stress Disorder. Can J Psychiatry. 2020 May 07:706743720923064. doi: https://dx.doi.org/10.1177/0706743720923064. PMID: 32379487.",,"2020"
"leong2020_A","Nonpharmacologic biological","PTSD","PTSD",,"31","A","11",,"Low-frequency repetitive transcranial magnetic stimulation (rTMS)","Transcranial magnetic stimualtion (TMS)","One-Hz rTMS with 2,250 pulses over 37.5 minutes, targeting the right dorsolateral prefrontal cortex (DLPFC) using Magstim Super Rapid2 model 3910-00 device","No","Not Applicable","No","Not Applicable","No","Not Applicable","Yes","No","No","No","No","Individual","In Person","Intensity: 1 Hz for 37.5 minutes",,"Daily on weekdays","2",,,,,,,,,,,,,,"Community","0","0","1","0.8276",,"0.1724","Mixed","Rape/sexual assault; Other (exposure to actual or threatened death or serious injury, and witnessing such incidents)","High","Leong K, Chan P, Ong L, et al. A Randomized Sham-controlled Trial of 1-Hz and 10-Hz Repetitive Transcranial Magnetic Stimulation (rTMS) of the Right Dorsolateral Prefrontal Cortex in Civilian Post-traumatic Stress Disorder. Can J Psychiatry. 2020 May 07:706743720923064. doi: https://dx.doi.org/10.1177/0706743720923064. PMID: 32379487.",,"2020"
"lewis2017_A","Other mixed","PTSD","PTSD",,"42","A","21",,"Internet-based guided self-help","Internet-based guided self-help","Interactive online program and therapist guidance. Online program consisted of 8 modules covering psychoeducation, grounding, relaxation and anxiety management, behavioral reactivation, imaginal and in-vivo exposure, cognitive therapy, and relapse prevention. Therapist guidance (face-to-face or telephone) for support, monitoring, motivation, and problem-solving; brief check-ins between appointments.","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","No","Yes","No","Individual","Technology Assisted",,"Session length: therapist 30 minutes (initial appointment 1 hour)","Therapist guidance every 2 weeks, brief check-in weekly","8",,"completed all 8 modules",,,,,,,,,,,,"Community",,,"1","0.595",,"0.405","Mixed","accidents, illness/medical procedure, rape/sexual assault, terrorism/political violence/forced displacement, community/school violence","Medium","Lewis CE, Farewell D, Groves V, et al. Internet-based guided self-help for posttraumatic stress disorder (PTSD): randomized controlled trial. Depress Anxiety. 2017 Jun;34(6):555-65. doi: 10.1002/da.22645. PMID: 28557299.","48301","2019"
"lewis2017_B","Other mixed","PTSD","Control",,"42","B","21",,"Delayed treatment","Waitlist","Waiting period during which there was no therapist contact","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,,,,"8",,,,,,,,,,,,,,"Community",,,"1","0.595",,"0.405","Mixed","accidents, illness/medical procedure, rape/sexual assault, terrorism/political violence/forced displacement, community/school violence","Medium","Lewis CE, Farewell D, Groves V, et al. Internet-based guided self-help for posttraumatic stress disorder (PTSD): randomized controlled trial. Depress Anxiety. 2017 Jun;34(6):555-65. doi: 10.1002/da.22645. PMID: 28557299.","48301","2019"
"li2017_A","Pharmacotherapy","PTSD","PTSD",,"72","A","36",,"Sertraline","Sertraline","SSRI, fixed-dose","No","Not Applicable","Yes","Antidepressant: SSRI","No","Not Applicable","No","No","No","No","No","Individual","In Person","135 mg",,"Daily","12",,,,,,,,,,,,,,"Mixed","0.375",,"0.625","0.125",,"0.875","Mixed","combat-related, other (chemical burn)","Low","Li W, Ma YB, Yang Q, et al. Effect and safety of sertraline for treat posttraumatic stress disorder: a multicenter randomised controlled study. Int. J. Psychiatry Clin. Pract. 2017 Jun;21(2):151-5. doi: 10.1080/13651501.2017.1291838. PMID: 28266242.","49934","2019"
"li2017_B","Pharmacotherapy","PTSD","Control",,"72","B","36",,"Placebo","Placebo","Placebo matched to sertraline (3 tablets)","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person",,,"Daily","12",,,,,,,,,,,,,,"Mixed","0.375",,"0.625","0.125",,"0.875","Mixed","combat-related, other (chemical burn)","Low","Li W, Ma YB, Yang Q, et al. Effect and safety of sertraline for treat posttraumatic stress disorder: a multicenter randomised controlled study. Int. J. Psychiatry Clin. Pract. 2017 Jun;21(2):151-5. doi: 10.1080/13651501.2017.1291838. PMID: 28266242.","49934","2019"
"lindauer2005_A","Psychotherapy","PTSD","PTSD",,"24","A","12",,"BEP","Brief Eclectic Psychotherapy (BEP)","Following manual by Gersons et al. 2004, includes psychoeducation, imaginal exposure, writing tasks and memorabilia, meaning and integration, and farewell ritual","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"45 to 60 minutes","Weekly","16",,,,,,,,,,,,,,"Community","0","0","1","0.5417",,"0.4583","Mixed","combat-related, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (unspecified)","Medium","Lindauer RJ, Gersons BP, van Meijel EP, et al. Effects of brief eclectic psychotherapy in patients with posttraumatic stress disorder: randomized clinical trial. Journal of traumatic stress. 2005 Jun;18(3):205-12. doi: 10.1002/jts.20029. PMID: 16281214.","19181","2020"
"lindauer2005_B","Psychotherapy","PTSD","Control",,"24","B","12",,"Waitlist","Waitlist",,"No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,,,,"16",,,,,,,,,,,,,,"Community","0","0","1","0.5417",,"0.4583","Mixed","combat-related, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (unspecified)","Medium","Lindauer RJ, Gersons BP, van Meijel EP, et al. Effects of brief eclectic psychotherapy in patients with posttraumatic stress disorder: randomized clinical trial. Journal of traumatic stress. 2005 Jun;18(3):205-12. doi: 10.1002/jts.20029. PMID: 16281214.","19181","2020"
"lindley2007_A","Pharmacotherapy","PTSD","PTSD",,"40","A","20",,"Topiramate","Topiramate","Anticonvulsant","No","Not Applicable","Yes","Mood Stabilizer","No","Not Applicable","No","No","No","No","No","Individual","In Person","25 to 100 mg (total daily dose 50 to 200 mg); titration: initiated at 25 mg twice a day and increased weekly by 50 mg/day as tolerated with maximum dose of 200 mg/day",,"Twice daily","7",,,,,,,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"High","Lindley SE, Carlson EB, Hill K. A randomized, double-blind, placebo-controlled trial of augmentation topiramate for chronic combat-related posttraumatic stress disorder. J Clin Psychopharmacol. 2007 Dec;27(6):677-81. doi: 10.1097/jcp.0b013e31815a43ee. PMID: 18004136..","50965","2019"
"lindley2007_B","Pharmacotherapy","PTSD","Control",,"40","B","20",,"Placebo","Placebo","Placebo","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person",,,,"7",,,,,,,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"High","Lindley SE, Carlson EB, Hill K. A randomized, double-blind, placebo-controlled trial of augmentation topiramate for chronic combat-related posttraumatic stress disorder. J Clin Psychopharmacol. 2007 Dec;27(6):677-81. doi: 10.1097/jcp.0b013e31815a43ee. PMID: 18004136..","50965","2019"
"littleton2016_A","Other mixed","PTSD","PTSD",,"87","A","46",,"From Survivor to Thriver","From Survivor to Thriver","Online interactive program providing psychoeducation, distress management strategies, healthy coping skills, and cognitive behavioral techniques through video, written description of skills, and written examples modeling the skills","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","No","Yes","No","Individual","Technology Assisted",,,,"14",,"completed baseline online questionnaires and logged in to assigned program at least once","0.8478",,,,,,,,,,,"Community",,,"1","1",,"0","Mixed","child sexual abuse, child physical abuse, rape/sexual assault, intimate partner violence","High","Littleton HL, Grills AE, Kline KD, et al. The From Survivor to Thriver program: RCT of an online therapist-facilitated program for rape-related PTSD. J Anxiety Disord. 2016 Oct;43:41-51. doi: 10.1016/j.janxdis.2016.07.010. PMID: 27513363.","45583","2019"
"littleton2016_B","Other mixed","PTSD","Control",,"87","B","41",,"Psychoeducation website","Psychoeducation","Written information providing same psychoeducation, distress management strategies, and healthy coping skills as From Survivor to Thriver program","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","No","Yes","No","Individual","Technology Alone",,,,"14",,"completed baseline online questionnaires and logged in to assigned program at least once","0.8537",,,,,,,,,,,"Community",,,"1","1",,"0","Mixed","child sexual abuse, child physical abuse, rape/sexual assault, intimate partner violence","High","Littleton HL, Grills AE, Kline KD, et al. The From Survivor to Thriver program: RCT of an online therapist-facilitated program for rape-related PTSD. J Anxiety Disord. 2016 Oct;43:41-51. doi: 10.1016/j.janxdis.2016.07.010. PMID: 27513363.","45583","2019"
"litz2012_A","Mixed: Psychotherapy & pharmacotherapy","PTSD","PTSD",,"26","A","13",,"D-cycloserine + brief exposure therapy","D-cycloserine plus imaginal exposure","Partial NMDA receptor agonist, given 50 minutes before exposure therapy in sessions 2 through 5. Patients in both treatment arms received therapy; 4 of 6 total sessions included 50 minutes of imaginal exposure focused on most distressing war trauma memory.","Yes","TF","Yes","Other pharmacotherapy","No","Not Applicable","No","No","No","No","No","Individual","In Person","Session length: 60 to 90 minutes

Dose: 50 mg",,"Psychotherapy: NR

D-cycloserine: NR","Psychotherapy: NR (6 sessions total), D-cycloserine: NR (4 doses total, at sessions 2 through 5)",,,,,,,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"Medium","Litz BT, Salters-Pedneault K, Steenkamp MM, et al. A randomized placebo-controlled trial of D-cycloserine and exposure therapy for posttraumatic stress disorder. J Psychiatr Res. 2012;46(9):1184-90. doi: 10.1016/j.jpsychires.2012.05.006. PMID: 22694905.","38885","2019"
"litz2012_B","Mixed: Psychotherapy & pharmacotherapy","PTSD","Control",,"26","B","13",,"Placebo + brief exposure therapy","Imaginal exposure (experimental paradigm)","Placebo pill given 50 minutes before exposure therapy. Patients in both treatment arms received therapy; of 6 total sessions, four included 50-minute imaginal exposure focused on most distressing war trauma memory.","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","Session length: 60 to 90 minutes

Dose: NA",,"Psychotherapy: 6 sessions, interval NR

Placebo: 4 doses, sessions 2 through 5","NR (6 sessions)",,,,,,,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"Medium","Litz BT, Salters-Pedneault K, Steenkamp MM, et al. A randomized placebo-controlled trial of D-cycloserine and exposure therapy for posttraumatic stress disorder. J Psychiatr Res. 2012;46(9):1184-90. doi: 10.1016/j.jpsychires.2012.05.006. PMID: 22694905.","38885","2019"
"liu2019_B","Psychotherapy","PTSD","PTSD",,"207","B","104",,"CPT in person","Cognitive Processing Therapy (CPT)","In-person CPT; therapy followed manual used by the VA (for CPT-C or cognitive-only version) which doesn't include written account of the trauma. ""Per protocol, participants were educated about PTSD symptoms, cognitive theory, and treatment goals; wrote about how traumatic experiences have influenced thoughts and beliefs about themselves, others, and the world; identified problematic thoughts (‘stuck points’) related to the traumatic event; learned how these thoughts influence emotions; and learned to challenge distorted thoughts and identify more balanced alternative thoughts.""","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"60 minutes","Weekly","12",,"completed ≥9 sessions","0.6538",,,,,"9.7","4.0",,,,,"Veteran","0","1","0","0.226",,"0.774","Mixed","combat-related, rape/sexual assault, accidents, community/school violence, other (unspecified type of child abuse, ""unexpected death"", ""others"")","High","Liu L, Thorp SR, Moreno L, et al. Videoconferencing psychotherapy for veterans with PTSD: results from a randomized controlled non-inferiority trial. J Telemed Telecare. 2019 Jun 19doi: 10.1177/1357633X19853947. PMID: 31216210.",,"2020"
"liu2019_A","Psychotherapy","PTSD","PTSD",,"207","A","103",,"CPT by videoconference","Cognitive Processing Therapy (CPT)","Participant used videoconference equipment at a community-based outpatient clinic and the therapist was located at another VA site. CPT followed manual used by the VA (for CPT-C or cognitive-only version) which doesn't include written account of the trauma. ""Per protocol, participants were educated about PTSD symptoms, cognitive theory, and treatment goals; wrote about how traumatic experiences have influenced thoughts and beliefs about themselves, others, and the world; identified problematic thoughts (‘stuck points’) related to the traumatic event; learned how these thoughts influence emotions; and learned to challenge distorted thoughts and identify more balanced alternative thoughts.""","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","Video",,"60 minutes","Weekly","12",,"completed ≥9 sessions","0.7573",,,,,"8.9","4.5",,,,,"Veteran","0","1","0","0.226",,"0.774","Mixed","combat-related, rape/sexual assault, accidents, community/school violence, other (unspecified type of child abuse, ""unexpected death"", ""others"")","High","Liu L, Thorp SR, Moreno L, et al. Videoconferencing psychotherapy for veterans with PTSD: results from a randomized controlled non-inferiority trial. J Telemed Telecare. 2019 Jun 19doi: 10.1177/1357633X19853947. PMID: 31216210.",,"2020"
"ludascher2015_A","Pharmacotherapy","PTSD","PTSD",,"30","A","30",,"Hydrocortisone","Hydrocortisone","Corticosteroid","No","Not Applicable","Yes","Steroids","No","Not Applicable","No","No","No","No","No","Individual","In Person","10 mg",,"Once daily","1",,,,,,,,,,,,,,"Community",,,"1","1",,"0","Mixed","child sexual abuse, rape/sexual assault, child physical abuse, child other abuse","High","Ludascher P, Schmahl C, Feldmann RE, Jr., et al. No evidence for differential dose effects of hydrocortisone on intrusive memories in female patients with complex post-traumatic stress disorder--a randomized, double-blind, placebo-controlled, crossover study. J Psychopharmacol. 2015 Oct;29(10):1077-84. doi: 10.1177/0269881115592339. PMID: 26152322.","49607","2019"
"ludascher2015_B","Pharmacotherapy","PTSD","PTSD",,"30","B","30",,"Hydrocortisone","Hydrocortisone","Corticosteroid","No","Not Applicable","Yes","Steroids","No","Not Applicable","No","No","No","No","No","Individual","In Person","30 mg",,"Once daily","1",,,,,,,,,,,,,,"Community",,,"1","1",,"0","Mixed","child sexual abuse, rape/sexual assault, child physical abuse, child other abuse","High","Ludascher P, Schmahl C, Feldmann RE, Jr., et al. No evidence for differential dose effects of hydrocortisone on intrusive memories in female patients with complex post-traumatic stress disorder--a randomized, double-blind, placebo-controlled, crossover study. J Psychopharmacol. 2015 Oct;29(10):1077-84. doi: 10.1177/0269881115592339. PMID: 26152322.","49607","2019"
"ludascher2015_C","Pharmacotherapy","PTSD","Control",,"30","C","30",,"Placebo","Placebo",,"No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person",,,"Once daily","1",,,,,,,,,,,,,,"Community",,,"1","1",,"0","Mixed","child sexual abuse, rape/sexual assault, child physical abuse, child other abuse","High","Ludascher P, Schmahl C, Feldmann RE, Jr., et al. No evidence for differential dose effects of hydrocortisone on intrusive memories in female patients with complex post-traumatic stress disorder--a randomized, double-blind, placebo-controlled, crossover study. J Psychopharmacol. 2015 Oct;29(10):1077-84. doi: 10.1177/0269881115592339. PMID: 26152322.","49607","2019"
"maguen2017_A","Psychotherapy","PTSD","PTSD",,"33","A","17",,"Impact of Killing","Impact of Killing","Cognitive-behavioral intervention incorporating self-forgiveness, existential, gestalt, and relational theories to reduce mental health symptoms and functional impairment associated with killing in a war.","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"60 to 90 minutes","Weekly","6 to 8",,"Full participation in all content outlined in 6 sessions, completion of all between-session assignments, and completion of outcome measures","0.8824",,,,,,,,,,,"Veteran",,"1",,"0",,"1","Combat-related",,"Medium","Maguen S, Burkman KM, Madden E, et al. Impact of killing in war: a randomized, controlled pilot trial. J Clin Psychol. 2017 Sep;73(9):997-1012. doi: 10.1002/jclp.22471. PMID: 28294318.","47285","2019"
"maguen2017_B","Psychotherapy","PTSD","Control",,"33","B","16",,"TAU","Treatment as usual (TAU)","TAU includes medication management, brief case management visits, and supportive group psychotherapy. Participants were prohibited from enrolling in individual psychotherapy or cognitive-behaviorally based group psychotherapy.","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,,,,"6",,,,,,,,,,,,,,"Veteran",,"1",,"0",,"1","Combat-related",,"Medium","Maguen S, Burkman KM, Madden E, et al. Impact of killing in war: a randomized, controlled pilot trial. J Clin Psychol. 2017 Sep;73(9):997-1012. doi: 10.1002/jclp.22471. PMID: 28294318.","47285","2019"
"mahabir2016_A","Pharmacotherapy","PTSD","PTSD",,"41","A","20",,"Propranolol","Propranolol","Beta-adrenergic receptor antagonist","No","Not Applicable","Yes","Antiadrenergic","No","Not Applicable","No","No","No","No","No","Individual","In Person","1 mg/kg",,"Once (single dose)","1",,,,,,,,,,,,,,"Community",,,"1","0.7317",,"0.2683","Mixed","accidents, rape/sexual assault, combat-related, community/school violence, other (non-specified)","Medium","Mahabir M, Ashbaugh AR, Saumier D, et al. Propranolol's impact on cognitive performance in post-traumatic stress disorder. J Affect Disord. 2016 Mar 1;192:98-103. doi: 10.1016/j.jad.2015.11.051. PMID: 26707354.","46886","2019"
"mahabir2016_B","Pharmacotherapy","PTSD","Control",,"41","B","21",,"Placebo","Placebo","Placebo","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person",,,"Once (single dose)",,,,,,,,,,,,,,,"Community",,,"1","0.7317",,"0.2683","Mixed","accidents, rape/sexual assault, combat-related, community/school violence, other (non-specified)","Medium","Mahabir M, Ashbaugh AR, Saumier D, et al. Propranolol's impact on cognitive performance in post-traumatic stress disorder. J Affect Disord. 2016 Mar 1;192:98-103. doi: 10.1016/j.jad.2015.11.051. PMID: 26707354.","46886","2019"
"maieritsch2016_A","Psychotherapy","PTSD","PTSD",,"90","A","45",,"CPT via Telehealth","Cognitive Processing Therapy (CPT)","CPT provided over video teleconference","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","Video",,"50 minutes","Once or twice weekly",,"10 sessions total","completed 10 sessions",,,,,,,,,,,,"Veteran",,"1",,"0.067",,"0.933","Mixed","MST, combat-related, community/school violence","High","Maieritsch KP, Smith TL, Hessinger JD, et al. Randomized controlled equivalence trial comparing videoconference and in person delivery of cognitive processing therapy for PTSD. J Telemed Telecare. 2016 Jun;22(4):238-43. doi: 10.1177/1357633x15596109. PMID: 26231819.","45182","2019"
"maieritsch2016_B","Psychotherapy","PTSD","PTSD",,"90","B","45",,"CPT","Cognitive Processing Therapy (CPT)","In-person sessions","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"50 minutes","1 to 2 times weekly",,"10 sessions total","10 sessions",,,,,,,,,,,,"Veteran",,"1",,"0.067",,"0.933","Mixed","MST, combat-related, community/school violence","High","Maieritsch KP, Smith TL, Hessinger JD, et al. Randomized controlled equivalence trial comparing videoconference and in person delivery of cognitive processing therapy for PTSD. J Telemed Telecare. 2016 Jun;22(4):238-43. doi: 10.1177/1357633x15596109. PMID: 26231819.","45182","2019"
"manteghi2014_A","Pharmacotherapy","PTSD","PTSD",,"40","A","20",,"Citalopram + baclofen","Citalopram + baclofen","Citalopram: SSRI; baclofen: GABA-B agonist","No","Not Applicable","Yes","Mixed","No","Not Applicable","No","No","No","No","No","Individual","In Person","Citalopram: 60 mg; titrated from 10 mg to 60 mg

Baclofen: 40 mg; started at 10 mg titrated up to 40 mg",,"Once daily

3 times daily","8",,,,,,,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"Medium","Manteghi AA, Hebrani P, Mortezania M, et al. Baclofen add-on to citalopram in treatment of posttraumatic stress disorder. J Clin Psychopharmacol. 2014 Apr;34(2):240-3. doi: 10.1097/jcp.0000000000000089. PMID: 24525635.","42065","2019"
"manteghi2014_B","Pharmacotherapy","PTSD","Control",,"40","B","20",,"Citalopram + placebo","Citalopram + placebo","SSRI plus placebo","No","Not Applicable","Yes","Antidepressant: SSRI","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","10 mg/day titrated up to 60 mg/day",,"Once daily citalopram and three time a day for placebo","8",,,,,,,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"Medium","Manteghi AA, Hebrani P, Mortezania M, et al. Baclofen add-on to citalopram in treatment of posttraumatic stress disorder. J Clin Psychopharmacol. 2014 Apr;34(2):240-3. doi: 10.1097/jcp.0000000000000089. PMID: 24525635.","42065","2019"
"marcus1997_A","Psychotherapy","PTSD","PTSD",,"67","A",,,"EMDR","Eye Movement Desensitization and Reprocessing (EMDR)","Individual psychotherapy according to Shapiro (1995), includes history taking and treatment planning, assessment of target trauma, desensitization of the targeted trauma, installation of positive cognition, body scan to identify residual disturbing body sensations or affect, and EMDR closure. Treatment was offered until individual no long met DSM-III-R criteria for PTSD or study ended. Participants also received TAU, including medication visits and group therapy.","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"50 minutes",,,,,,,,,,,,,,,,"Community",,,"1","0.791",,"0.209","Mixed","rape/sexual assault, accidents, illness/medical procedure, community/school violence, natural or manmade disaster","High","Marcus SV, Marquis P, Sakai CE. Controlled study of treatment of PTSD using EMDR in an HMO setting. Psychotherapy (Chic). 1997;34(3):307-15. doi: 10.1037/h0087791.","09960","2019"
"marcus1997_B","Psychotherapy","PTSD","Control",,"67","B",,,"Standard care","Treatment as usual (TAU)","Individuals received individual psychotherapy (cognitive, psychodynamic, or behavior), medication, and/or group therapy","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,,"Individual therapy: 50 minutes

Medication visits: 30 to 45 minutes

Group therapy: 90 minutes",,,,,,,,,,,,,,,,"Community",,,"1","0.791",,"0.209","Mixed","rape/sexual assault, accidents, illness/medical procedure, community/school violence, natural or manmade disaster","High","Marcus SV, Marquis P, Sakai CE. Controlled study of treatment of PTSD using EMDR in an HMO setting. Psychotherapy (Chic). 1997;34(3):307-15. doi: 10.1037/h0087791.","09960","2019"
"margolies2013_A","Psychotherapy","PTSD","PTSD",,"40","A","20",,"CBT-I + IRT","Cognitive Behavioral Therapy for Insomnia (CBT-I) + Imagery Rehearsal Training (IRT)","Treatment includes CBT-I following Morin & Epsie 2003 protocol, imaginal rehearsal of new dream, and stimulus control following Bootzin & Epstine 2000.","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"60 minutes","Weekly","6","4 sessions",,,,,,,,,,,,,"Veteran","0","1","0","0.10",,"0.9",,,"High","Margolies SO, Rybarczyk B, Vrana SR, et al. Efficacy of a cognitive-behavioral treatment for insomnia and nightmares in Afghanistan and Iraq veterans with PTSD. Journal of Clinical Psychology. 2013 Oct;69(10):1026-42. doi: 10.1002/jclp.21970. PMID: 23629959.","40515","2020"
"margolies2013_B","Psychotherapy","PTSD","Control",,"40","B","20",,"Waitlist","Waitlist",,"No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,,,,"6",,,,,,,,,,,,,,"Veteran","0","1","0","0.10",,"0.9",,,"High","Margolies SO, Rybarczyk B, Vrana SR, et al. Efficacy of a cognitive-behavioral treatment for insomnia and nightmares in Afghanistan and Iraq veterans with PTSD. Journal of Clinical Psychology. 2013 Oct;69(10):1026-42. doi: 10.1002/jclp.21970. PMID: 23629959.","40515","2020"
"markowitz2015a_A","Psychotherapy","PTSD","PTSD",,"110","A","38",,"PE","Prolonged Exposure (PE)","Patients narrate an increasingly detailed trauma narrative (imaginal exposure) and confront trauma reminders (in vivo exposure) to extinguish fear responses","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"90 minutes","Weekly for 7 weeks, then 3 sessions over next 7 weeks","14",,"completed PE","0.7105",,,,,"8.3","3.1",,,,,"Community",,,"1","0.7",,"0.3","Mixed","rape/sexual assault, other (child abuse unspecified, interpersonal, not specified)","Medium","Markowitz JC, Petkova E, Neria Y, et al. Is exposure necessary? A randomized clinical trial of interpersonal psychotherapy for PTSD. Am J Psychiatry. 2015 May;172(5):430-40. doi: 10.1176/appi.ajp.2014.14070908. PMID: 25677355.","43409","2019"
"markowitz2015a_B","Psychotherapy","PTSD","PTSD",,"110","B","40",,"Interpersonal Psychotherapy","Interpersonal Psychotherapy (IPT)","Addresses not trauma but its interpersonal aftermath, and assigns no homework. The first half of Interpersonal Psychotherapy emphasized affective attunement, recognizing, naming, and expressing one’s feelings in non-trauma-related interpersonal situations; the remainder addressed typical Interpersonal Psychotherapy problem areas (e.g., role disputes, transitions) not trauma but its interpersonal aftermath, and assigns no homework. The first half of Interpersonal Psychotherapy emphasized affective attunement, recognizing, naming, and expressing one’s feelings in non-trauma-related interpersonal situations; the remainder addressed typical Interpersonal Psychotherapy problem areas (e.g., role disputes, transitions)","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"50 minutes","Weekly","14",,"completed interpersonal therapy","0.85",,,,,"12.6","3.4",,,,,"Community",,,"1","0.7",,"0.3","Mixed","rape/sexual assault, other (child abuse unspecified, interpersonal, not specified)","Medium","Markowitz JC, Petkova E, Neria Y, et al. Is exposure necessary? A randomized clinical trial of interpersonal psychotherapy for PTSD. Am J Psychiatry. 2015 May;172(5):430-40. doi: 10.1176/appi.ajp.2014.14070908. PMID: 25677355.","43409","2019"
"markowitz2015a_C","Psychotherapy","PTSD","PTSD",,"110","C","32",,"Relaxation Therapy","Relaxation","Highly scripted, induces progressive muscle and mental relaxation","No","Not Applicable","No","Not Applicable","Yes","Relaxation","No","No","No","No","No","Individual","In Person",,"90 minutes for weekly session, 30 minutes for final session","Weekly for 7 weeks, then 3 sessions over next 7 weeks","14",,"completed therapy","0.6563",,,,,"7.8","3.5",,,,,"Community",,,"1","0.7",,"0.3","Mixed","rape/sexual assault, other (child abuse unspecified, interpersonal, not specified)","Medium","Markowitz JC, Petkova E, Neria Y, et al. Is exposure necessary? A randomized clinical trial of interpersonal psychotherapy for PTSD. Am J Psychiatry. 2015 May;172(5):430-40. doi: 10.1176/appi.ajp.2014.14070908. PMID: 25677355.","43409","2019"
"marks1998_A","Psychotherapy","PTSD","PTSD",,"87","A","23",,"Exposure Therapy","Trauma-focused cognitive behavioral therapy (TF-CBT)","Sessions 1-5: Patients asked to talk in first-person and present-tense about their experience; then rewind and 'hold' on memory of trauma until distress reduced. Homework involved listening to parts of their audiotaped description for 1 hour daily, noting peak distress before, during, and after listening sessions in diary. Sessions 6-10: Prolonged live exposure to stimuli; exposure repeated and accompanied by therapist. Homework involved live exposure for 1 hour daily, recording distress levels in diaries.","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"90 minutes","Usually weekly","10",,"completed 10 sessions","0.87",,,,,,,,,,,"Community",,,"1","0.36",,"0.64","Mixed","combat-related, rape/sexual assault, accidents, community/school violence, terrorism/political violence/forced displacement","Medium","Marks I, Lovell K, Noshirvani H, et al. Treatment of posttraumatic stress disorder by exposure and/or cognitive restructuring: a controlled study. Arch Gen Psychiatry. 1998 Apr;55(4):317-25.  PMID: 9554427.","09640","2019"
"marks1998_B","Psychotherapy","PTSD","PTSD",,"87","B","19",,"CR","Cognitive restructuring","Patients taught to identify dysfunctional thoughts, develop rational alternatives, and re-appraise beliefs about themselves, their trauma, and the world. Homework involved use of daily thought records.","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"90 minutes","Usually weekly","10",,"completed 10 sessions","0.947",,,,,,,,,,,"Community",,,"1","0.36",,"0.64","Mixed","combat-related, rape/sexual assault, accidents, community/school violence, terrorism/political violence/forced displacement","Medium","Marks I, Lovell K, Noshirvani H, et al. Treatment of posttraumatic stress disorder by exposure and/or cognitive restructuring: a controlled study. Arch Gen Psychiatry. 1998 Apr;55(4):317-25.  PMID: 9554427.","09640","2019"
"marks1998_C","Psychotherapy","PTSD","PTSD",,"87","C","24",,"Exposure combined with CR","Trauma-focused cognitive behavioral therapy (TF-CBT)","First half of sessions involved imaginal exposure, then cognitive restructuring; second half of sessions involved in vivo exposure, then cognitive restructuring (45 minutes of exposure therapy, followed by 15 minute break, followed by 45 minutes of cognitive restructuring therapy). Homework involved one hour of daily exposure and cognitive tasks.","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"105 minutes","Usually weekly","10",,"completed 10 sessions","0.792",,,,,,,,,,,"Community",,,"1","0.36",,"0.64","Mixed","combat-related, rape/sexual assault, accidents, community/school violence, terrorism/political violence/forced displacement","Medium","Marks I, Lovell K, Noshirvani H, et al. Treatment of posttraumatic stress disorder by exposure and/or cognitive restructuring: a controlled study. Arch Gen Psychiatry. 1998 Apr;55(4):317-25.  PMID: 9554427.","09640","2019"
"marks1998_D","Psychotherapy","PTSD","PTSD",,"87","D","21",,"Relaxation","Relaxation","Patients taught to relax. Homework involved listening to relaxation tape daily and to record anxiety in daily diary.","No","Not Applicable","No","Not Applicable","Yes","Relaxation","No","No","No","No","No","Individual","In Person",,"90 minutes","Usually weekly","10",,"completed 10 sessions","0.952",,,,,,,,,,,"Community",,,"1","0.36",,"0.64","Mixed","combat-related, rape/sexual assault, accidents, community/school violence, terrorism/political violence/forced displacement","Medium","Marks I, Lovell K, Noshirvani H, et al. Treatment of posttraumatic stress disorder by exposure and/or cognitive restructuring: a controlled study. Arch Gen Psychiatry. 1998 Apr;55(4):317-25.  PMID: 9554427.","09640","2019"
"marshall2001_A","Pharmacotherapy","PTSD","PTSD",,"563","A","187",,"Paroxetine (flexible dose)","Paroxetine","SSRI; started at 20 mg/day, received 30 mg/day during week 2, 40 mg/day from start of week 3; followed 1-week placebo run-in to assess compliance","No","Not Applicable","Yes","Antidepressant: SSRI","No","Not Applicable","No","No","No","No","No","Individual","In Person","40 mg; titration: 20 mg/day for 1 week, then 30 mg/day for 1 week, then 40 mg/day for remainder",,"Daily","12",,,,,,,,,,,,,,"Community",,,"1","0.6842",,"0.3158","Mixed","combat-related, rape/sexual assault, accidents, community/school violence, other (serious injury, witnessing injury or death)","Medium","Marshall RD, Beebe KL, Oldham M, et al. Efficacy and safety of paroxetine treatment for chronic PTSD: a fixed-dose, placebo-controlled study. Am J Psychiatry. 2001;158(12):1982-8. doi: 10.1176/appi.ajp.158.12.1982. PMID: 11729013.","23882","2019"
"marshall2001_B","Pharmacotherapy","PTSD","PTSD",,"563","B","188",,"Paroxetine (fixed dose)","Paroxetine","SSRI, fixed-dose; followed 1-week placebo run-in to assess compliance","No","Not Applicable","Yes","Antidepressant: SSRI","No","Not Applicable","No","No","No","No","No","Individual","In Person","20 mg",,"Daily","12",,,,,,,,,,,,,,"Community",,,"1","0.6842",,"0.3158","Mixed","combat-related, rape/sexual assault, accidents, community/school violence, other (serious injury, witnessing injury or death)","Medium","Marshall RD, Beebe KL, Oldham M, et al. Efficacy and safety of paroxetine treatment for chronic PTSD: a fixed-dose, placebo-controlled study. Am J Psychiatry. 2001;158(12):1982-8. doi: 10.1176/appi.ajp.158.12.1982. PMID: 11729013.","23882","2019"
"marshall2001_C","Pharmacotherapy","PTSD","Control",,"563","C","188",,"Placebo","Placebo","1-week placebo run-in to assess compliance, followed by placebo treatment after randomization","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person",,,"Daily","12",,,,,,,,,,,,,,"Community",,,"1","0.6842",,"0.3158","Mixed","combat-related, rape/sexual assault, accidents, community/school violence, other (serious injury, witnessing injury or death)","Medium","Marshall RD, Beebe KL, Oldham M, et al. Efficacy and safety of paroxetine treatment for chronic PTSD: a fixed-dose, placebo-controlled study. Am J Psychiatry. 2001;158(12):1982-8. doi: 10.1176/appi.ajp.158.12.1982. PMID: 11729013.","23882","2019"
"marshall2007_A","Pharmacotherapy","PTSD","PTSD",,"63","A","25",,"Paroxetine (flexible dose)","Paroxetine","SSRI, initiated at 10 mg daily. If patients remained symptomatic, dosage was increased to 20 mg for weeks 2 and 3, 40mg daily for weeks 4–6, and 60 mg daily for weeks 7–10 as tolerated. Followed 1-week single-blind placebo run-in period, with responders excluded from the study.","No","Not Applicable","Yes","Antidepressant: SSRI","No","Not Applicable","No","No","No","No","No","Individual","In Person","10 mg titrated to maximum 60 mg",,"Daily","10",,,,,,,,,,,"40.4 mg","17.7",,"Community",,,"1","0.6731",,"0.3269","Mixed","rape/sexual assault, accidents, community/school violence, other (witnessing events, fire)","High","Marshall RD, Lewis-Fernández R, Blanco C, et al. A controlled trial of paroxetine for chronic PTSD, dissociation, and interpersonal problems in mostly minority adults. Depress Anxiety. 2007;24(2):77-84. doi: 10.1002/da.20176. PMID: 16892419.","29847","2019"
"marshall2007_B","Pharmacotherapy","PTSD","Control",,"63","B","27",,"Placebo","Placebo","Placebo","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person",,,"Daily","10",,,,,,,,,,,"43.2 mg equivalent","17.3",,"Community",,,"1","0.6731",,"0.3269","Mixed","rape/sexual assault, accidents, community/school violence, other (witnessing events, fire)","High","Marshall RD, Lewis-Fernández R, Blanco C, et al. A controlled trial of paroxetine for chronic PTSD, dissociation, and interpersonal problems in mostly minority adults. Depress Anxiety. 2007;24(2):77-84. doi: 10.1002/da.20176. PMID: 16892419.","29847","2019"
"martenyi2002_A","Pharmacotherapy","PTSD","PTSD",,"301","A","226",,"Fluoxetine","Fluoxetine","SSRI antidepressant; dose could be increased in 20-mg increments at each of 3 titration points based on predefined response criteria","No","Not Applicable","Yes","Antidepressant: SSRI","No","Not Applicable","No","No","No","No","No","Individual","In Person","Initiated at 20 mg, titrated to maximum 80 mg",,"Daily","12",,,,,"Determined by direct questioning and medication counts; noncompliant if missed >4 consecutive days, >10 total days, or if ratio of capsules taken to those prescribed was <0.8 or >1.2",,"97%-100% at all timepoints for each group",,,,"57 mg/day",,,"Mixed","0","0.4817","0.5183","0.19",,"0.81","Mixed","combat-related, other (""victim of war or witness of war event,"" ""witness of another person's death"")","Medium","Martenyi F, Brown EB, Zhang H, et al. Fluoxetine versus placebo in posttraumatic stress disorder. J Clin Psychiatry. 2002;63(3):199-206.  PMID: 11926718","24911","2019"
"martenyi2002_B","Pharmacotherapy","PTSD","Control",,"301","B","75",,"Placebo","Placebo","Placebo","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person",,,"Daily","12",,,,,"Determined by direct questioning and medication counts; noncompliant if missed >4 consecutive days, >10 total days, or if ratio of capsules taken to those prescribed was <0.8 or >1.2",,"97%-100% at all timepoints for each group",,,,,,,"Mixed","0","0.4817","0.5183","0.19",,"0.81","Mixed","combat-related, other (""victim of war or witness of war event,"" ""witness of another person's death"")","Medium","Martenyi F, Brown EB, Zhang H, et al. Fluoxetine versus placebo in posttraumatic stress disorder. J Clin Psychiatry. 2002;63(3):199-206.  PMID: 11926718","24911","2019"
"martenyi2007_A","Pharmacotherapy","PTSD","PTSD",,"411","A","163",,"Fluoxetine","Fluoxetine","SSRI, fixed-dose (no titration)","No","Not Applicable","Yes","Antidepressant: SSRI","No","Not Applicable","No","No","No","No","No","Individual","In Person","20 mg",,"Daily","12",,,,,,,,,,,,,,,,,,"0.7153",,"0.2847","Mixed","combat-related, rape/sexual assault, intimate partner violence, accidents, other (incest, witnessed a death)","Medium","Martenyi F, Brown EB, Caldwell CD. Failed efficacy of fluoxetine in the treatment of posttraumatic stress disorder: results of a fixed-dose, placebo-controlled study. J Clin Psychopharmacol. 2007;27(2):166-70. doi: 10.1097/JCP.0b013e31803308ce. PMID: 17414240.","29532","2019"
"martenyi2007_B","Pharmacotherapy","PTSD","PTSD",,"411","B","160",,"Fluoxetine","Fluoxetine","SSRI, initiated at 20 mg and increased to 40 mg after 2 weeks","No","Not Applicable","Yes","Antidepressant: SSRI","No","Not Applicable","No","No","No","No","No","Individual","In Person","40 mg; titration: initiated at 20 mg, titrated to 40 mg",,"Daily","12",,,,,,,,,,,,,,,,,,"0.7153",,"0.2847","Mixed","combat-related, rape/sexual assault, intimate partner violence, accidents, other (incest, witnessed a death)","Medium","Martenyi F, Brown EB, Caldwell CD. Failed efficacy of fluoxetine in the treatment of posttraumatic stress disorder: results of a fixed-dose, placebo-controlled study. J Clin Psychopharmacol. 2007;27(2):166-70. doi: 10.1097/JCP.0b013e31803308ce. PMID: 17414240.","29532","2019"
"martenyi2007_C","Pharmacotherapy","PTSD","Control",,"411","C","88",,"Placebo","Placebo",,"No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person",,,"Daily","12",,,,,,,,,,,,,,,,,,"0.7153",,"0.2847","Mixed","combat-related, rape/sexual assault, intimate partner violence, accidents, other (incest, witnessed a death)","Medium","Martenyi F, Brown EB, Caldwell CD. Failed efficacy of fluoxetine in the treatment of posttraumatic stress disorder: results of a fixed-dose, placebo-controlled study. J Clin Psychopharmacol. 2007;27(2):166-70. doi: 10.1097/JCP.0b013e31803308ce. PMID: 17414240.","29532","2019"
"mathew2011_A","Pharmacotherapy","PTSD","PTSD",,"47","A","22",,"GR205171 investigational drug","GR205171 investigational drug","Investigational neurokinin-1 receptor antagonist, fixed-dose; followed 2-week placebo lead-in","No","Not Applicable","Yes","Other pharmacotherapy","No","Not Applicable","No","No","No","No","No","Individual","In Person","5 mg",,"Daily","8",,,,,"determined by capsule counts","0.982",,,,,,,,"Community",,,"1","0.5897",,"0.4103","Mixed","combat-related, rape/sexual assault, accidents, community/school violence, other (unexpected death)","Medium","Mathew SJ, Vythilingam M, Murrough JW, et al. A selective neurokinin-1 receptor antagonist in chronic PTSD: a randomized, double-blind, placebo-controlled, proof-of-concept trial. Eur. Neuropsychopharmacol. 2011;21(3):221-9. doi: 10.1016/j.euroneuro.2010.11.012. PMID: 21194898.","35587","2019"
"mathew2011_B","Pharmacotherapy","PTSD","Control",,"47","B","25",,"Placebo","Placebo","Placebo capsules identical to active drug; double-blind period followed 2-week placebo lead-in","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person",,,"Daily","8",,,,,"determined by capsule counts","0.977",,,,,,,,"Community",,,"1","0.5897",,"0.4103","Mixed","combat-related, rape/sexual assault, accidents, community/school violence, other (unexpected death)","Medium","Mathew SJ, Vythilingam M, Murrough JW, et al. A selective neurokinin-1 receptor antagonist in chronic PTSD: a randomized, double-blind, placebo-controlled, proof-of-concept trial. Eur. Neuropsychopharmacol. 2011;21(3):221-9. doi: 10.1016/j.euroneuro.2010.11.012. PMID: 21194898.","35587","2019"
"maxwell2016_A","Psychotherapy","PTSD","PTSD",,"18","A","9",,"Group memory specificity training","Memory specificity training","Group therapy following manual; sessions are directed toward teaching how to retrieve specific memories rather than over general memories, based on cue words of negative, positive, and neutral emotion levels; group interactions involved sharing examples and asking questions; homework assignments involved cue words and were reviewed at each session.","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Group","In Person",,"90 minutes","Weekly","6",,"attended ≥4 sessions","0.8889",,,,,"5.38",,,,,,"Community",,,"1","0.8125",,"0.1875","Mixed","rape/sexual assault, child sexual abuse, child physical abuse, accidents, community/school violence, other (military-related, not specified)","Medium","Maxwell K, Callahan JL, Holtz P, et al. Comparative study of group treatments for posttraumatic stress disorder. Psychotherapy (Chic). 2016 Dec;53(4):433-45. doi: 10.1037/pst0000032. PMID: 26390014.","50402","2019"
"maxwell2016_B","Psychotherapy","PTSD","PTSD",,"18","B","9",,"Group CPT","Cognitive Processing Therapy (CPT)","Group therapy following manual by Resick et al. 2010; group members write down, in great detail, their experience of their traumatic event, and refer back to this direct account throughout treatment; sessions involved psychoeducation, writing and sharing an impact statement, discussing the meaning of their trauma, Socratic questioning of ""stuck points"", reading full trauma account, challenging assumptions and problematic beliefs, and behavioral assignments.","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Group","In Person",,"90 minutes","Biweekly","6",,"attended ≥8  sessions","0.8889",,,,,"10.37",,,,,,"Community",,,"1","0.8125",,"0.1875","Mixed","rape/sexual assault, child sexual abuse, child physical abuse, accidents, community/school violence, other (military-related, not specified)","Medium","Maxwell K, Callahan JL, Holtz P, et al. Comparative study of group treatments for posttraumatic stress disorder. Psychotherapy (Chic). 2016 Dec;53(4):433-45. doi: 10.1037/pst0000032. PMID: 26390014.","50402","2019"
"mccall2018_B","Pharmacotherapy","PTSD","Control",,"20","B","10",,"Placebo","Placebo","Placebo identical to prazosin","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person",,,"Once daily at bedtime","8",,,,,,,,,,,"7.6 mg","5.3 mg",,"Mixed","0","0.10","0.90","0.85",,"0.15","Mixed","combat-related, other (not specified)","High","McCall WV, Pillai A, Case D, et al. A pilot, randomized clinical trial of bedtime doses of prazosin versus placebo in suicidal posttraumatic stress disorder patients with nightmares. J Clin Psychopharmacol. 2018 Dec;38(6):618-21. doi: 10.1097/JCP.0000000000000968. PMID: 30335633.","51299","2020"
"mccall2018_A","Pharmacotherapy","PTSD","PTSD",,"20","A","10",,"Prazosin","Prazosin","Dose increased on Day 3 and Weeks 2 through 6. Treatment directed at nightmares thought to contribute to suicidality.","No","Not Applicable","Yes","Antiadrenergic","No","Not Applicable","No","No","No","No","No","Individual","In Person","Prazosin initiated at 1 mg and titrated up to a maximum dose of 20 mg for men and 10 mg for women",,"Once daily at bedtime","8",,,,,,"0.91",,,,,"5.5 mg","3.5 mg",,"Mixed","0","0.10","0.90","0.85",,"0.15","Mixed","combat-related, other (not specified)","High","McCall WV, Pillai A, Case D, et al. A pilot, randomized clinical trial of bedtime doses of prazosin versus placebo in suicidal posttraumatic stress disorder patients with nightmares. J Clin Psychopharmacol. 2018 Dec;38(6):618-21. doi: 10.1097/JCP.0000000000000968. PMID: 30335633.","51299","2020"
"mcdonagh2005_A","Psychotherapy","PTSD","PTSD",,"74","A","29",,"CBT","Trauma-focused cognitive behavioral therapy (TF-CBT)","Manualized, modified version of treatment developed by Foa et al., 1999; primary components of prolonged exposure, in vivo exposure, and cognitive restructuring; additional components included psychoeducation, breathing retraining, and homework.","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"1.5 to 2 hours","Approximately once a week",,"14 sessions total","completed treatment course","0.5862",,,,,,,,,,,"Community",,,"1","1",,"0","Child sexual abuse",,"Medium","McDonagh A, Friedman MJ, McHugo GJ, et al. Randomized trial of cognitive-behavioral therapy for chronic posttraumatic stress disorder in adult female survivors of childhood sexual abuse. J Consult Clin Psychol. 2005 Jun;73(3):515-24. doi: 10.1037/0022-006X.73.3.515. PMID: 15982149.","27712","2019"
"mcdonagh2005_B","Psychotherapy","PTSD","PTSD",,"74","B","22",,"PCT","Present Centered Therapy (PCT)","Manualized, collaborative therapeutic intervention with focus on here-and-now problem-solving; main elements include psychoeducation, training in problem solving, and journal writing.","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"1.5 to 2 hours","approximately once a week",,"14 sessions total","completed treatment course","0.9091",,,,,,,,,,,"Community",,,"1","1",,"0","Child sexual abuse",,"Medium","McDonagh A, Friedman MJ, McHugo GJ, et al. Randomized trial of cognitive-behavioral therapy for chronic posttraumatic stress disorder in adult female survivors of childhood sexual abuse. J Consult Clin Psychol. 2005 Jun;73(3):515-24. doi: 10.1037/0022-006X.73.3.515. PMID: 15982149.","27712","2019"
"mcdonagh2005_C","Psychotherapy","PTSD","Control",,"74","C","23",,"Waitlist","Waitlist","Waitlist; participants were contacted after randomization and encouraged to seek additional phone contact as needed during waiting period and were offered help seeking treatment as usual in the community (none requested such help).","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,,,,"14",,"completed treatment course","0.8696",,,,,,,,,,,"Community",,,"1","1",,"0","Child sexual abuse",,"Medium","McDonagh A, Friedman MJ, McHugo GJ, et al. Randomized trial of cognitive-behavioral therapy for chronic posttraumatic stress disorder in adult female survivors of childhood sexual abuse. J Consult Clin Psychol. 2005 Jun;73(3):515-24. doi: 10.1037/0022-006X.73.3.515. PMID: 15982149.","27712","2019"
"mcfall2010_A","Mixed: Psychotherapy & pharmacotherapy","PTSD+SUD","PTSD+SUD","Integrated","943","A","472",,"Integrated Care","Integrated care","Tobacco cessation counseling and optional  cessation medication integrated into participant's ongoing PTSD treatment. Tobacco cessation counseling delivered in individual sessions using treatment manual; core sessions included ""tobacco use education, behavioral skills for quitting smoking, setting a quit date..., and relapse prevention""; follow-up visits and booster sessions in which clinicians ""assessed tobacco use, reinforced abstinence and relapse prevention, and re-applied cessation treatment to continued smokers."" Cessation medication following algorithm for ""standard prescribing practices for nicotine replacement therapy, bupropion, and varenicline"".
 and addressing  Psychotherapy addressing specific PTSD symptoms dynamically related to smoking relapse

Tobacco cessation counseling sessions  

Cessation mediation","Yes","Non-TF","Yes","Other pharmacotherapy","No","Not Applicable","No","No","No","No","No","Individual","In Person",,,"Weekly for 8 sessions, then monthly",,"≥8 total sessions [5 core sessions + 3 follow-up sessions + as needed booster sessions]",,,,,,,,,"median 8 (IQR 4 to 12)",,,,"Veteran","0","1","0","0.0636",,"0.9364","Other (""related to military service"")",,"Medium","McFall ME, Saxon AJ, Malte CA, et al. Integrating tobacco cessation into mental health care for posttraumatic stress disorder: a randomized controlled trial. JAMA. 2010 Dec 8;304(22):2485-93. doi: 10.1001/jama.2010.1769. PMID: 21139110.","35450","2020"
"mcfall2010_B","Mixed: Psychotherapy & pharmacotherapy","PTSD+SUD","SUD","Not integrated","943","B","471",,"Smoking Cessation Clinic","Smoking cessation","Specialized cessation clinic (VA standard of care) that following smoking cessation practice guidelines; ""provided treatment within 6 weeks of referral, prescribed cessation medications directly or through patients' primary care provider"", and provided cessation treatment sessions.","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,,,,,,,,,,,,,"median 1 (IQR 0 to 4)",,,,"Veteran","0","1","0","0.0636",,"0.9364","Other (""related to military service"")",,"Medium","McFall ME, Saxon AJ, Malte CA, et al. Integrating tobacco cessation into mental health care for posttraumatic stress disorder: a randomized controlled trial. JAMA. 2010 Dec 8;304(22):2485-93. doi: 10.1001/jama.2010.1769. PMID: 21139110.","35450","2020"
"mcgovern2011_B","Psychotherapy","PTSD+SUD","PTSD+SUD","Not integrated","53","B","21",,"Individual Addiction Counseling + Standard Care","Addiction Counseling","Individual addiction counseling: manual guided therapy targeting substance use only, ""designed to be integrated into an addiction treatment or methadone maintenance programs""; consists of 5 modules: treatment initiation; early abstinence; maintaining abstinence; recovery; termination.
Standard care: intensive outpatient program or methadone maintenance","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,,"Weekly",,"8 to 12 weeks (10 to 12 sessions)","≥75% of sessions","1",,,,,,,,,,,"Community","0","0","1","0.566",,"0.434","Mixed","child physical abuse, child sexual abuse, rape/sexual assault, community/school violence, accidents","Medium","McGovern MP, Lambert-Harris C, Alterman AI, et al. A randomized controlled trial comparing integrated cognitive behavioral therapy versus individual addiction counseling for co-occurring substance use and posttraumatic stress disorders. J Dual Diagn. 2011 Jan 1;7(4):207-27. doi: 10.1080/15504263.2011.620425. PMID: 22383864.","85821","2020"
"mcgovern2011_A","Psychotherapy","PTSD+SUD","PTSD+SUD","Integrated","53","A","32",,"Integrated CBT + Standard Care","Integrated Cognitive Behavioral Therapy (ICBT)","Integrated CBT: manualized individual therapy for PTSD and SUD, crisis/relapse prevention, breathing retraining, PTSD symptom education, PTSD associated symptoms, cognitive restructuring, generalization training
Standard care: intensive outpatient program or methadone maintenance","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"45 to 50 minutes","Weekly",,"8 to 12 weeks (12 to 14 sessions)","≥75% of sessions","0.696",,,,,,,,,,,"Community","0","0","1","0.566",,"0.434","Mixed","child physical abuse, child sexual abuse, rape/sexual assault, community/school violence, accidents","Medium","McGovern MP, Lambert-Harris C, Alterman AI, et al. A randomized controlled trial comparing integrated cognitive behavioral therapy versus individual addiction counseling for co-occurring substance use and posttraumatic stress disorders. J Dual Diagn. 2011 Jan 1;7(4):207-27. doi: 10.1080/15504263.2011.620425. PMID: 22383864.","85821","2020"
"mcgovern2015_B","Psychotherapy","PTSD+SUD","PTSD+SUD","Not integrated","221","B","75",,"Individual Addiction Counseling + Standard Care","Addiction Counseling","Individual addiction counseling: manual guided individual therapy focused only on substance use and recovery (doesn't directly address PTSD); modules included: treatment initiation, early abstinence, maintaining abstinence, and recovery; adaptation of ""individual drug counseling (IDC) from the NIDA Cocaine Collaborative Study and Twelve-Step facilitation (TSF) from the NIAAA Project Match"".
Standard care: intensive outpatient program, includes individual and group therapy and medication management.","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"45 to 50 minutes","Weekly",,"10 to 12 weeks",,,,,,,,,,,,,"Community","0","0","1","0.593",,"0.407","Mixed","child sexual abuse, community/school violence, other (not specified)","Medium","McGovern MP, Lambert-Harris C, Xie H, et al. A randomized controlled trial of treatments for co-occurring substance use disorders and post-traumatic stress disorder. Addiction. 2015 Jul;110(7):1194-204. doi: 10.1111/add.12943. PMID: 25846251.","44027","2020"
"mcgovern2015_A","Psychotherapy","PTSD+SUD","PTSD+SUD","Integrated","221","A","73",,"Integrated CBT + Standard Care","Integrated Cognitive Behavioral Therapy (ICBT)","Integrated CBT: manualized individual therapy for PTSD and SUD; 3 main components are: education, mindful relaxation, and flexible thinking.
Standard care: intensive outpatient program, includes individual and group therapy and medication management","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"45 to 50 minutes","Weekly",,"8 to 12 weeks",,,,,,,,,,,,,"Community","0","0","1","0.593",,"0.407","Mixed","child sexual abuse, community/school violence, other (not specified)","Medium","McGovern MP, Lambert-Harris C, Xie H, et al. A randomized controlled trial of treatments for co-occurring substance use disorders and post-traumatic stress disorder. Addiction. 2015 Jul;110(7):1194-204. doi: 10.1111/add.12943. PMID: 25846251.","44027","2020"
"mcgovern2015_C","Psychotherapy","PTSD+SUD","Control","Not integrated","221","C","73",,"Standard Care","Treatment as usual (TAU)","Standard care: intensive outpatient program, includes individual and group therapy and medication management","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Control","No","No","Individual","In Person",,"Varied (9-12 hours per week of individual and group therapy)","Varied (daily to weekly)",,"6 to 8 weeks (followed by 12 weeks continuing care group)",,,,,,,,,,,,,"Community","0","0","1","0.593",,"0.407","Mixed","child sexual abuse, community/school violence, other (not specified)","Medium","McGovern MP, Lambert-Harris C, Xie H, et al. A randomized controlled trial of treatments for co-occurring substance use disorders and post-traumatic stress disorder. Addiction. 2015 Jul;110(7):1194-204. doi: 10.1111/add.12943. PMID: 25846251.","44027","2020"
"mcguirestanbury2020_A","Psychotherapy","PTSD","PTSD",,"20","A","10",,"EMDR","Eye Movement Desensitization and Reprocessing (EMDR)","Target memories selected and saccadic eye movements used to desensitize, substituting positive for negative beliefs and eliminating negative body sensations","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"Session length: 90 minutes","Twice weekly","6",,,"1",,,,,"12",,,,,,"Community",,,"1",,,,"Mixed","Rape/sexual assault; Intimate partner violence; Accidents; Community/school violence; Natural or manmade disasters; Other (childhood trauma, not specified)","Medium","McGuire Stanbury TM, Drummond PD, Laugharne J, et al. Comparative Efficiency of EMDR and Prolonged Exposure in Treating Posttraumatic Stress Disorder: A Randomized Trial. Journal of EMDR Practice and Research. 2020;14(1):2-12. doi: 10.1891/1933-3196.14.1.2.",,"2020"
"mcguirestanbury2020_B","Psychotherapy","PTSD","PTSD",,"20","B","10",,"PE","Prolonged Exposure (PE)","Included initial trauma interview and breathing retraining; in vivo exposure homework; and imaginal exposure during treatment sessions","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"Session length: 90 minutes","Twice weekly","6",,,"1",,,,,"12",,,,,,"Community",,,"1",,,,"Mixed","Rape/sexual assault; Intimate partner violence; Accidents; Community/school violence; Natural or manmade disasters; Other (childhood trauma, not specified)","Medium","McGuire Stanbury TM, Drummond PD, Laugharne J, et al. Comparative Efficiency of EMDR and Prolonged Exposure in Treating Posttraumatic Stress Disorder: A Randomized Trial. Journal of EMDR Practice and Research. 2020;14(1):2-12. doi: 10.1891/1933-3196.14.1.2.",,"2020"
"mclay2011_A","Psychotherapy","PTSD","PTSD",,"20","A","10",,"Virtual reality-graded exposure therapy","Virtual reality exposure therapy (VRET)","Manualized treatment; initial sessions focused on rationale for therapy, meditation and attentional control with autonomic control using biofeedback (J&J Engineering Biofeedback system), skill practice during trauma recall, and discussion of PTSD symptoms; remaining sessions focused on exposure using virtual reality simulation with three-dimensional visual scenarios and relevant sounds, and cognitive restructuring conducted at the end of each session.","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,,"Up to twice weekly","10","up to 20 sessions total",,,,,,,"8.8",,"SD range 4 to 20",,,,"Active Duty Military","1","0","0","0.05",,"0.95","Combat-related",,"High","McLay RN, Wood DP, Webb-Murphy JA, et al. A randomized, controlled trial of virtual reality-graded exposure therapy for post-traumatic stress disorder in active duty service members with combat-related post-traumatic stress disorder. Cyberpsychol Behav Soc Netw. 2011 Apr;14(4):223-9. doi: 10.1089/cyber.2011.0003. PMID: 21332375.","36339","2019"
"mclay2011_B","Psychotherapy","PTSD","Control",,"20","B","10",,"TAU","Treatment as usual (TAU)","TAU included any of the regular services available at the Naval Medical Center San Diego and Naval Hospital Camp Pendleton, including PTSD treatment with medication and/or therapy (individual and/or group).","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person",,,,"10",,,,,,,,,,,,,,"Active Duty Military","1","0","0","0.05",,"0.95","Combat-related",,"High","McLay RN, Wood DP, Webb-Murphy JA, et al. A randomized, controlled trial of virtual reality-graded exposure therapy for post-traumatic stress disorder in active duty service members with combat-related post-traumatic stress disorder. Cyberpsychol Behav Soc Netw. 2011 Apr;14(4):223-9. doi: 10.1089/cyber.2011.0003. PMID: 21332375.","36339","2019"
"mclay2017_A","Psychotherapy","PTSD","PTSD",,"81","A","43",,"Virtual reality exposure therapy","Virtual reality exposure therapy (VRET)","In vivo exposure using virtual reality with computer-simulation and head-mounted display with optional vibration and smells; this exposure combined with participant recounting traumatic experience wile confronting simulated aspects of that trauma in virtual reality with increasing intensity throughout therapy; homework for confronting real life stresses in vivo; cognitive reframing, discussion, and symptom monitoring at each session.","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"90 minutes","Up to twice weekly","9","up to 18 sessions total",,,,,,,"10.28",,,,,,"Active Duty Military","1","0","0","0.037",,"0.963","Combat-related",,"Medium","McLay RN, Baird A, Webb-Murphy J, et al. A randomized, head-to-head study of virtual reality exposuretherapy for posttraumatic stress disorder. Cyberpsychol Behav Soc Netw. 2017 Apr;20(4):218-24. doi: 10.1089/cyber.2016.0554. PMID: 28394217.","36339","2019"
"mclay2017_B","Psychotherapy","PTSD","Control",,"81","B","38",,"Control exposure therapy","Exposure therapy","Exposure therapy following the same protocol as virtual reality exposure therapy but without virtual reality headset or other immersive technology; instead still images were viewed on standard computer screen for participant to focus on during in-session exposure.","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"90 minutes","Up to twice weekly","9","up to 18 sessions total",,,,,,,"9.24",,,,,,"Active Duty Military","1","0","0","0.037",,"0.963","Combat-related",,"Medium","McLay RN, Baird A, Webb-Murphy J, et al. A randomized, head-to-head study of virtual reality exposuretherapy for posttraumatic stress disorder. Cyberpsychol Behav Soc Netw. 2017 Apr;20(4):218-24. doi: 10.1089/cyber.2016.0554. PMID: 28394217.","36339","2019"
"mcrae2004_A","Pharmacotherapy","PTSD","PTSD",,"37","A","18",,"Nefazodone","Nefazodone","Atypical antidepressant; titrated based on response and tolerability with adjustments at least weekly","No","Not Applicable","Yes","Antidepressant: Other","No","Not Applicable","No","No","No","No","No","Individual","In Person","Initiated at 50 mg, titrated to target dose 300 mg",,"Twice daily","12",,,,,"counted returned medication, counseled nonadherent patients",,,,,,"463 mg/day",,,"Community",,,"1","0.7692",,"0.2308","Mixed","child physical abuse, child sexual abuse, rape/sexual assault, accidents, community/school violence, other (not specified)","High","McRae AL, Brady KT, Mellman TA, et al. Comparison of nefazodone and sertraline for the treatment of posttraumatic stress disorder. Depress Anxiety. 2004;19(3):190-6. doi: 10.1002/da.20008. PMID: 15129422.","26720","2019"
"mcrae2004_B","Pharmacotherapy","PTSD","PTSD",,"37","B","19",,"Sertraline","Sertraline","SSRI; titrated based on response and tolerability with adjustments at least weekly","No","Not Applicable","Yes","Antidepressant: SSRI","No","Not Applicable","No","No","No","No","No","Individual","In Person","Initiated at 25 mg, titrated to target dose 100 mg",,"Twice daily","12",,,,,"counted returned medication, counseled nonadherent patients",,,,,,"153 mg/day",,,"Community",,,"1","0.7692",,"0.2308","Mixed","child physical abuse, child sexual abuse, rape/sexual assault, accidents, community/school violence, other (not specified)","High","McRae AL, Brady KT, Mellman TA, et al. Comparison of nefazodone and sertraline for the treatment of posttraumatic stress disorder. Depress Anxiety. 2004;19(3):190-6. doi: 10.1002/da.20008. PMID: 15129422.","26720","2019"
"meredith2016_A","Collaborative care","PTSD","PTSD",,"404","A","206",,"Collaborative Care","Collaborative care","Care manager provided active patient education and engagement using NIMH PTSD brochures and motivational interviewing and community resource support and facilitated continuity of care via ≥ 15 phone or in-person contacts. Also, Primary Care Clinician education about trauma, PTSD and evidence-based psychopharmacology, including 2-hour training onsite and 2 booster training sessions via Webcast; laminated medication guide; patients provided with NIMH brochure","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","No","No","Yes","Individual","Mixed",,,"As needed","52",,,,,,,,"4.2",,,,,,"Community",,,"1","0.8056",,"0.1944",,,"Medium","Meredith LS, Eisenman DP, Han B, et al. Impact of collaborative care for underserved patients with PTSD in primary care: a randomized controlled trial. J Gen Intern Med. 2016 May;31(5):509-17. doi: 10.1007/s11606-016-3588-3. PMID: 26850413.","44675","2019"
"meredith2016_B","Collaborative care","PTSD","Control",,"404","B","198",,"Minimally Enhanced Usual Care","Minimally enhanced usual care","Primary Care Clinician education about trauma, PTSD and evidence-based psychopharmacology, including 2-hour training onsite and 2 booster training sessions via Webcast; laminated medication guide; patients provided with NIMH brochure.","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","Mixed",,,,"52",,,,,,,,,,,,,,"Community",,,"1","0.8056",,"0.1944",,,"Medium","Meredith LS, Eisenman DP, Han B, et al. Impact of collaborative care for underserved patients with PTSD in primary care: a randomized controlled trial. J Gen Intern Med. 2016 May;31(5):509-17. doi: 10.1007/s11606-016-3588-3. PMID: 26850413.","44675","2019"
"mills2012_A","Psychotherapy","PTSD+SUD","PTSD+SUD","Integrated","103","A","55",,"COPE + Usual Treatment","Concurrent Treatment for PTSD and Substance Use Disorder Using Prolonged Exposure (COPE)","COPE: modified version of Concurrent Treatment of PTSD and Cocaine Dependence. ""The version of COPE used in present study represents an integration of existing evidence-based manualized CBT interventions for PTSD and substance dependence... Treatment components include motivational enhancement and CBT for substance use (sessions 1-4 and throughout); psychoeducation relating to both disorders and their interaction (sessions 1-4); in vivo exposure (sessions 5-12); imaginal exposure (sessions 6-12); and cognitive therapy for PTSD (sessions 8-12). The final session (session 13) is dedicated to providing a review of the treatment, devising an after-care plan, and termination of therapy.""
Usual Treatment: participants could engage in usual treatment for substance dependence ""currently available in the community, including outpatient counseling, inpatient or outpatient detoxification, residential rehabilitation, and pharmacotherapies (e.g.,, methadone, buprenorphine, buprenorphine plus naloxone, naltrexone).""","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"COPE: 90 minutes; Usual Treatment: NR","COPE: weekly; Usual Treatment: NR","13",,"attended all 13 sessions","0.182",,,,,,,"median 5 (range 0 to 13)",,,,"Community",,,"1","0.621",,"0.379","Mixed","combat-related, child sexual abuse, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, terrorism/political violence/forced displacement, other (not specified)","Medium","Mills KL, Teesson M, Back SE, et al. Integrated exposure-based therapy for co-occurring posttraumatic stress disorder and substance dependence: a randomized controlled trial. JAMA. 2012 Aug 15;308(7):690-9. doi: 10.1001/jama.2012.9071. PMID: 22893166..","39123","2020"
"mills2012_B","Psychotherapy","PTSD+SUD","SUD","Not integrated","103","B","48",,"Usual Treatment","Treatment as usual (TAU)","Usual treatment for substance dependence ""currently available in the community, including outpatient counseling, inpatient or outpatient detoxification, residential rehabilitation, and pharmacotherapies (e.g.,, methadone, buprenorphine, buprenorphine plus naloxone, naltrexone).""","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person",,,,,,,,,,,,,,,,,,"Community",,,"1","0.621",,"0.379","Mixed","combat-related, child sexual abuse, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, terrorism/political violence/forced displacement, other (not specified)","Medium","Mills KL, Teesson M, Back SE, et al. Integrated exposure-based therapy for co-occurring posttraumatic stress disorder and substance dependence: a randomized controlled trial. JAMA. 2012 Aug 15;308(7):690-9. doi: 10.1001/jama.2012.9071. PMID: 22893166..","39123","2020"
"mithoefer2011_A","Mixed: Psychotherapy & pharmacotherapy","PTSD","PTSD",,"23","A","15",,"MDMA-assisted psychotherapy","MDMA-assisted psychotherapy","Psychotherapy with concomitant MDMA administration: 2 MDMA-assisted sessions, 11 non-drug psychotherapy sessions with option of additional integration sessions as needed.","Yes","Non-TF","Yes","Psychostimulant","No","Not Applicable","No","No","No","No","No","Individual","In Person","MDMA dose: 125 mg, optional supplemental dose of 62.5 mg

Session length: psychotherapy 90 minutes, MDMA-assisted psychotherapy sessions 8 to 10 hours with overnight stay",,"MDMA: Monthly

Psychotherapy: Weekly","18",,"received allocated intervention","0.80",,,,,,,,,,,"Community",,,"1","0.85",,"0.15","Mixed","combat-related, child physical abuse, child sexual abuse, child other abuse, rape/sexual assault, community/school violence, other (family violence)","Medium","Mithoefer MC, Wagner MT, Mithoefer AT, et al. The safety and efficacy of ±3,4-psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study. [Erratum appears in J Psychopharmacol. 2011;25(6):852.] J Psychopharmacol. 2010 June;25(4):439-52. doi: 10.1177/0269881110378371.","35036","2019"
"mithoefer2011_B","Mixed: Psychotherapy & pharmacotherapy","PTSD","PTSD",,"23","B","8",,"Placebo-assisted psychotherapy","Trauma-focused psychotherapy","Psychotherapy with concomitant placebo (lactose) administration: 2 psychotherapy sessions with placebo administration, 11 non-drug psychotherapy sessions with option of additional integration sessions as needed.","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","Dose: NA

Psychotherapy: 90 minutes

Placebo-assisted psychotherapy sessions: 8 to 10 hours with overnight stay",,"Placebo: Monthly

Psychotherapy: Weekly","18",,"received allocated intervention","1",,,,,,,,,,,"Community",,,"1","0.85",,"0.15","Mixed","combat-related, child physical abuse, child sexual abuse, child other abuse, rape/sexual assault, community/school violence, other (family violence)","Medium","Mithoefer MC, Wagner MT, Mithoefer AT, et al. The safety and efficacy of ±3,4-psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study. [Erratum appears in J Psychopharmacol. 2011;25(6):852.] J Psychopharmacol. 2010 June;25(4):439-52. doi: 10.1177/0269881110378371.","35036","2019"
"mithoefer2018_A","Mixed: Psychotherapy & pharmacotherapy","PTSD","PTSD",,"26","A","12",,"MDMA-assisted psychotherapy","MDMA-assisted psychotherapy","MDMA, a psychoactive compound scheduled in the U.S. as a drug of abuse (ecstasy), and also used as an adjunct to psychotherapy. Patients received both MDMA-assisted ""non-directive or client-directed"" therapy sessions, following a treatment manual with a male or female co-therapy team, and additional non-drug therapy sessions.","Yes","Non-TF","Yes","Psychostimulant","No","Not Applicable","No","No","No","No","No","Individual","In Person","Session length: MDMA sessions 8 hours, nondrug sessions 90 minutes

Dose: 125 mg (followed 1.5 to 2 hours later by an optional supplemental dose of half the initial dose)",,"Every 3 to 5 weeks",,,,,,,,,,,,,,,"Mixed","0","0.8462","0.1538","0.2692",,"0.7308","Mixed","combat-related, other (firefighter/police officer)","High","Mithoefer MC, Mithoefer AT, Feduccia AA, et al. 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in military veterans, firefighters, and police officers: a randomised, double-blind, dose-response, phase 2 clinical trial. Lancet Psychiatry. 2018 Jun;5(6):486-97. doi: 10.1016/S2215-0366(18)30135-4. PMID: 29728331.","50277","2019"
"mithoefer2018_B","Mixed: Psychotherapy & pharmacotherapy","PTSD","PTSD",,"26","B","7",,"MDMA-assisted psychotherapy","MDMA-assisted psychotherapy","MDMA, a psychoactive compound scheduled in the U.S. as a drug of abuse (ecstasy), and also used as an adjunct to psychotherapy. Patient received both MDMA-assisted ""non-directive or client-directed"" therapy sessions, following a treatment manual with a male or female co-therapy team, and additional non-drug therapy sessions.","Yes","Non-TF","Yes","Psychostimulant","No","Not Applicable","No","No","No","No","No","Individual","In Person","Session length: MDMA sessions 8 hours, non-drug sessions 90 minutes

Dose: 75 mg  (followed 1.5 to 2 hours later by an optional supplemental dose of half the initial dose, but NR on final cumulative dose)",,"Every 3 to 5 weeks",,,,,,,,,,,,,,,"Mixed","0","0.8462","0.1538","0.2692",,"0.7308","Mixed","combat-related, other (firefighter/police officer)","High","Mithoefer MC, Mithoefer AT, Feduccia AA, et al. 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in military veterans, firefighters, and police officers: a randomised, double-blind, dose-response, phase 2 clinical trial. Lancet Psychiatry. 2018 Jun;5(6):486-97. doi: 10.1016/S2215-0366(18)30135-4. PMID: 29728331.","50277","2019"
"mithoefer2018_C","Mixed: Psychotherapy & pharmacotherapy","PTSD","PTSD",,"26","C","7",,"Low-dose MDMA-assisted psychotherapy","MDMA-assisted psychotherapy","MDMA used as an active control, as an adjunct to psychotherapy. Patients  received both MDMA-assisted ""non-directive or client-directed"" therapy sessions, following a treatment manual with a male or female co-therapy team, and additional non-drug therapy sessions.","Yes","Non-TF","Yes","Psychostimulant","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","Session length: MDMA sessions 8 hours, non-drug sessions 90 minutes

Dose: 30 mg  (followed 1.5 to 2 hours later by an optional supplemental dose of half the initial dose)",,"Every 3 to 5 weeks",,,,,,,,,,,,,,,"Mixed","0","0.8462","0.1538","0.2692",,"0.7308","Mixed","combat-related, other (firefighter/police officer)","High","Mithoefer MC, Mithoefer AT, Feduccia AA, et al. 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in military veterans, firefighters, and police officers: a randomised, double-blind, dose-response, phase 2 clinical trial. Lancet Psychiatry. 2018 Jun;5(6):486-97. doi: 10.1016/S2215-0366(18)30135-4. PMID: 29728331.","50277","2019"
"miyahira2012_A","Psychotherapy","PTSD","PTSD",,"42","A","29",,"CBT with virtual reality exposure","Virtual reality exposure therapy (VRET)","Manualized CBT treatment protocol with virtual reality exposure showing combat environment","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,,"Twice weekly","5",,,,,,,,,,,,,,"Active Duty Military","1","0","0",,,,"Combat-related",,"High","Miyahira SD, Folen RA, Hoffman HG, et al. The effectiveness of VR exposure therapy for PTSD in returning warfighters. Stud Health Technol Inform. 2012;181:128-32.  PMID: 22954842.","43675","2019"
"miyahira2012_B","Psychotherapy","PTSD","Control",,"42","B","13",,"Minimal attention","Minimal attention","Brief telephone contacts","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","Phone",,,"Once every 2 weeks","5",,,,,,,,,,,,,,"Active Duty Military","1","0","0",,,,"Combat-related",,"High","Miyahira SD, Folen RA, Hoffman HG, et al. The effectiveness of VR exposure therapy for PTSD in returning warfighters. Stud Health Technol Inform. 2012;181:128-32.  PMID: 22954842.","43675","2019"
"monson2006_A","Psychotherapy","PTSD","PTSD",,"60","A","30",,"CPT","Cognitive Processing Therapy (CPT)","CPT according to Resick (2001), CBT with primary focus on cognitive interventions and includes exposure to traumatic memory through writing and reading accounts","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,,"Twice weekly","6",,,,,,,,,,,,,,"Veteran","0","1","0","0.1",,"0.9","Other (military-related)",,"Medium","Monson CM, Schnurr PP, Resick PA, et al. Cognitive processing therapy for veterans with military-related posttraumatic stress disorder. J Consult Clin Psychol. 2006 Oct;74(5):898-907. doi: 10.1037/0022-006X.74.5.898. PMID: 17032094.","28862","2019"
"monson2006_B","Psychotherapy","PTSD","Control",,"60","B","30",,"Waitlist","Waitlist",,"No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,,,,"6",,,,,,,,,,,,,,"Veteran","0","1","0","0.1",,"0.9","Other (military-related)",,"Medium","Monson CM, Schnurr PP, Resick PA, et al. Cognitive processing therapy for veterans with military-related posttraumatic stress disorder. J Consult Clin Psychol. 2006 Oct;74(5):898-907. doi: 10.1037/0022-006X.74.5.898. PMID: 17032094.","28862","2019"
"monson2012a_A","Psychotherapy","PTSD","PTSD",,"80","A","20",,"Cognitive Behavioral Couple Therapy","Cognitive Behavioral Conjoint Therapy (CBCT)","Includes 3 phases that include both in- and out-of-session exercises. Phase I: establishing rationale for therapy and relationship safety. Phase 2: Avoidance. Phase 3: Influence of trauma on relationship trust, control, emotional closeness, and physical intimacy","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Couple","In Person",,,"Twice weekly for phases 1 and 2, weekly during phase 3.","12",,,,,,,,,,,,,,"Mixed",,"0.225","0.775","0.75",,"0.25","Mixed","rape/sexual assault, child sexual abuse, accidents, illness/medical procedure, combat-related, community/school violence, other (not specified)","Medium","Monson CM, Fredman SJ, Macdonald A, et al. Effect of cognitive-behavioral couple therapy for PTSD: a randomized controlled trial. JAMA. 2012 Aug 15;308(7):700-9. doi: 10.1001/jama.2012.9307. PMID: 22893167.","39124","2019"
"monson2012a_B","Psychotherapy","PTSD","Control",,"80","B","20",,"Waitlist","Waitlist","Wait for 3 months before receiving treatment","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,,,,"12",,,,,,,,,,,,,,"Mixed",,"0.225","0.775","0.75",,"0.25","Mixed","rape/sexual assault, child sexual abuse, accidents, illness/medical procedure, combat-related, community/school violence, other (not specified)","Medium","Monson CM, Fredman SJ, Macdonald A, et al. Effect of cognitive-behavioral couple therapy for PTSD: a randomized controlled trial. JAMA. 2012 Aug 15;308(7):700-9. doi: 10.1001/jama.2012.9307. PMID: 22893167.","39124","2019"
"moradi2014_A","Psychotherapy","PTSD","PTSD",,"24","A","12",,"Group memory specificity training","Memory specificity training","Training group sessions following manual; aim of treatment is to enhance the specificity with which participants retrieve personal events from their autobiographical memory; uses concepts of specific vs over general memories; sessions involve training using neutral, positive, and negative cues, recall exercises and homework.","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Group","In Person",,"1 hour","Weekly","4",,,,,,,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"Medium","Moradi AR, Moshirpanahi S, Parhon H, et al. A pilot randomized controlled trial investigating the efficacy of Memory Specificity Training in improving symptoms of posttraumatic stress disorder. Behav Res Ther. 2014 May;56:68-74. doi: 10.1016/j.brat.2014.03.002. PMID: 24705337.","46541","2019"
"moradi2014_B","Psychotherapy","PTSD","Control",,"24","B","12",,"Control","Assessment","No additional contact.","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,,,,"4",,,,,,,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"Medium","Moradi AR, Moshirpanahi S, Parhon H, et al. A pilot randomized controlled trial investigating the efficacy of Memory Specificity Training in improving symptoms of posttraumatic stress disorder. Behav Res Ther. 2014 May;56:68-74. doi: 10.1016/j.brat.2014.03.002. PMID: 24705337.","46541","2019"
"morath2014_A","Psychotherapy","PTSD","PTSD",,"34","A","17",,"NET","Narrative Exposure Therapy (NET)","Trauma-focused treatment according to Schauer et al. (2011)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"90 minutes","Weekly","12",,,,,,,,,,,,,,"Community",,,"1","0.7",,"0.3","Terrorism/political violence/forced displacement",,"Medium","Morath J, Gola H, Sommershof A, et al. The effect of trauma-focused therapy on the altered T cell distribution in individuals with PTSD: evidence from a randomized controlled trial. J Psychiatr Res. 2014 Jul;54:1-10. doi: 10.1016/j.jpsychires.2014.03.016. PMID: 24726027.","49697","2019"
"morath2014_B","Psychotherapy","PTSD","Control",,"34","B","17",,"Waitlist","Waitlist",,"No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,,,,"32",,,,,,,,,,,,,,"Community",,,"1","0.7",,"0.3","Terrorism/political violence/forced displacement",,"Medium","Morath J, Gola H, Sommershof A, et al. The effect of trauma-focused therapy on the altered T cell distribution in individuals with PTSD: evidence from a randomized controlled trial. J Psychiatr Res. 2014 Jul;54:1-10. doi: 10.1016/j.jpsychires.2014.03.016. PMID: 24726027.","49697","2019"
"morland2019_B","Psychotherapy","PTSD","PTSD",,"175","B","58",,"Home-based telehealth PE","Prolonged Exposure (PE)","Individual PE delivered by home-based telehealth; includes psychoeducation, breathing retraining, imaginal and in vivo exposure. Number of sessions dependent on treatment response - early responders ""could graduate before attending 15 sessions if they completed six or seven sessions of PE and had PCL‐5 scores <21 for two consecutive sessions"" or PCL-5 score <30 (cutoff score for PCL-5 revised during study).","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","Video",,"90 minutes","Once a week",,"6 to 15","completed ≥8 sessions","0.621",,,,,"8.3","4.96",,,,,"Veteran","0","1","0","0.251",,"0.749",,,"Medium","Morland L, Mackintosh MA, Glassman L, et al. Home-based delivery of variable length prolonged exposure therapy: a comparison of clinical efficacy between service modalities. 2019 Dec 24. doi: 10.1002/da.22979. PMID: 31872563.",,"2020"
"morland2019_A","Psychotherapy","PTSD","PTSD",,"175","A","58",,"In-home in-person PE","Prolonged Exposure (PE)","In-home-in-person individual PE; includes psychoeducation, breathing retraining, imaginal and in vivo exposure. Number of sessions dependent on treatment response - early responders ""could graduate before attending 15 sessions if they completed six or seven sessions of PE and had PCL‐5 scores <21 for two consecutive sessions"" or PCL-5 score <30 (cutoff score for PCL-5 revised during study).","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"90 minutes","Once a week",,"6 to 15","completed ≥8 sessions","0.793",,,,,"9.8","5.00",,,,,"Veteran","0","1","0","0.251",,"0.749",,,"Medium","Morland L, Mackintosh MA, Glassman L, et al. Home-based delivery of variable length prolonged exposure therapy: a comparison of clinical efficacy between service modalities. 2019 Dec 24. doi: 10.1002/da.22979. PMID: 31872563.",,"2020"
"morland2019_C","Psychotherapy","PTSD","PTSD",,"175","C","59",,"Office-based telehealth PE","Prolonged Exposure (PE)","Individual PE delivered in office-based telehealth; includes psychoeducation, breathing retraining, imaginal and in vivo exposure. Number of sessions dependent on treatment response - early responders ""could graduate before attending 15 sessions if they completed six or seven sessions of PE and had PCL‐5 scores <21 for two consecutive sessions"" or PCL-5 score <30 (cutoff score for PCL-5 revised during study).","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","Video",,"90 minutes","Once a week",,"6 to 15","completed ≥8 sessions","0.458",,,,,"7.0","4.55",,,,,"Veteran","0","1","0","0.251",,"0.749",,,"Medium","Morland L, Mackintosh MA, Glassman L, et al. Home-based delivery of variable length prolonged exposure therapy: a comparison of clinical efficacy between service modalities. 2019 Dec 24. doi: 10.1002/da.22979. PMID: 31872563.",,"2020"
"morland2014_A","Psychotherapy","PTSD","PTSD",,"125","A","61",,"Group CPT-cognitive only delivered via videoteleconferencing","Cognitive Processing Therapy (CPT)","Variant of CPT that excludes the written trauma narrative. Modified version includes psychoeducation, skill building exercises, and practice strategies to restructure thoughts","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Group","Video",,"90 minutes","Twice weekly","6",,"attended >10 sessions","0.7541",,,,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"Low","Morland LA, Mackintosh M-A, Greene CJ, et al. Cognitive processing therapy for posttraumatic stress disorder delivered to rural veterans via telemental health: a randomized noninferiority clinical trial. J Clin Psychiatry. 2014;75(5):470-6. doi: 10.4088/JCP.13m08842. PMID: 24922484.","42407","2019"
"morland2014_B","Psychotherapy","PTSD","PTSD",,"125","B","64",,"In person group CPT-cognitive only","Cognitive Processing Therapy (CPT)","Variant of CPT that excludes the written trauma narrative. Modified version includes psychoeducation, skill building exercises, and practice strategies to restructure thoughts","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Group","In Person",,"90 minutes","Twice weekly","6",,"attended >10 sessions","0.7813",,,,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"Low","Morland LA, Mackintosh M-A, Greene CJ, et al. Cognitive processing therapy for posttraumatic stress disorder delivered to rural veterans via telemental health: a randomized noninferiority clinical trial. J Clin Psychiatry. 2014;75(5):470-6. doi: 10.4088/JCP.13m08842. PMID: 24922484.","42407","2019"
"morland2015_A","Psychotherapy","PTSD","PTSD",,"126","A","63",,"CPT by video teleconferencing","Cognitive Processing Therapy (CPT)","Individual manualized cognitive processing therapy delivered by video teleconferencing","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","Video",,"90 minutes","Once or twice weekly",,"12 sessions total","attended 10 or more sessions","0.762",,"number of assignments completed",,,,,,,,,"Mixed",,"0.17","0.83","1",,"0",,,"Medium","Morland LA, Mackintosh MA, Rosen CS, et al. Telemedicine versus in-person delivery of cognitive processing therapy for women with posttraumatic stress disorder: a randomized noninferiority trial. Depress Anxiety. 2015 Nov;32(11):811-20. doi: 10.1002/da.22397. PMID: 26243685.","44260","2019"
"morland2015_B","Psychotherapy","PTSD","PTSD",,"126","B","63",,"CPT","Cognitive Processing Therapy (CPT)","Individual manualized cognitive processing therapy delivered in person","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"90 minutes","Once or twice weekly",,"12 sessions total","attended 10 or more sessions","0.794",,,,,"10.3",,,,,,"Mixed",,"0.17","0.83","1",,"0",,,"Medium","Morland LA, Mackintosh MA, Rosen CS, et al. Telemedicine versus in-person delivery of cognitive processing therapy for women with posttraumatic stress disorder: a randomized noninferiority trial. Depress Anxiety. 2015 Nov;32(11):811-20. doi: 10.1002/da.22397. PMID: 26243685.","44260","2019"
"mueser2008_A","Psychotherapy","PTSD","PTSD",,"108","A","54",,"CBT","Trauma-focused cognitive behavioral therapy (TF-CBT)","Program includes psychoeducation, breathing retraining, and cognitive restructuring","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,,,"16 to 24","12 to 16 sessions total","completed ≥6 sessions","0.8148",,,,,,,,,,,"Community",,,"1","0.787",,"0.213","Mixed","combat-related, child physical abuse, child sexual abuse, rape/sexual assault, accidents, community/school violence, other (not specified)","Medium","Mueser KT, Rosenberg SD, Xie HY, et al. A randomized controlled trial of cognitive-behavioral treatment for posttraumatic stress disorder in severe mental illness. J Consult Clin Psychol. 2008 Apr;76(2):259-71. doi: 10.1037/0022-006X.76.2.259. PMID: 18377122.","30794","2019"
"mueser2008_B","Psychotherapy","PTSD","Control",,"108","B","54",,"TAU","Treatment as usual (TAU)",,"No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,,,,"16 to 24",,,,,,,,,,,,,,"Community",,,"1","0.787",,"0.213","Mixed","combat-related, child physical abuse, child sexual abuse, rape/sexual assault, accidents, community/school violence, other (not specified)","Medium","Mueser KT, Rosenberg SD, Xie HY, et al. A randomized controlled trial of cognitive-behavioral treatment for posttraumatic stress disorder in severe mental illness. J Consult Clin Psychol. 2008 Apr;76(2):259-71. doi: 10.1037/0022-006X.76.2.259. PMID: 18377122.","30794","2019"
"mueser2015_A","Psychotherapy","PTSD","PTSD",,"201","A","104",,"CBT for severe mental illness","Trauma-focused cognitive behavioral therapy (TF-CBT)","CBT program including breath retraining and cognitive restructuring","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,,,"12 to 16",,"completing ≥ 6 sessions","0.6442",,,,,,,,,,,"Community",,,"1","0.6866",,"0.3134",,,"High","Mueser KT, Gottlieb JD, Xie H, et al. Evaluation of cognitive restructuring for post-traumatic stress disorder in people with severe mental illness. Br J Psychiatry. 2015 Jun;206(6):501-8. doi: 10.1192/bjp.bp.114.147926. PMID: 25858178.","43698","2019"
"mueser2015_B","Psychotherapy","PTSD","PTSD",,"201","B","97",,"Brief Treatment","Psychoeducation","Includes breathing retraining and educational components of the CBT program","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,,,"3",,"completing ≥ 2 sessions","0.8557",,,,,,,,,,,"Community",,,"1","0.6866",,"0.3134",,,"High","Mueser KT, Gottlieb JD, Xie H, et al. Evaluation of cognitive restructuring for post-traumatic stress disorder in people with severe mental illness. Br J Psychiatry. 2015 Jun;206(6):501-8. doi: 10.1192/bjp.bp.114.147926. PMID: 25858178.","43698","2019"
"nacasch2011_A","Psychotherapy","PTSD","PTSD",,"30","A","15",,"PE","Prolonged Exposure (PE)","Trauma-focused individual therapy; sessions included: psychoeducation about trauma and related symptoms, treatment rationale and description, breathing retraining, in vivo exposure, imaginal exposure, and discussion/processing, as well as in vivo homework assignments between sessions.","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"90 to 120 minutes","Weekly",,"9 to 15 sessions total",,,,,,,"11","2.9",,,,,"Veteran","0","1","0","0.0667",,"0.9333","Mixed","combat-related, terrorism/political violence","Medium","Nacasch N, Foa EB, Huppert JD, et al. Prolonged exposure therapy for combat- and terror-related posttraumatic stress disorder: a randomized control comparison with treatment as usual. J Clin Psychiatry. 2011 Sep;72(9):1174-80. doi: 10.4088/JCP.09m05682blu. PMID: 21208581.","35512","2019"
"nacasch2011_B","Psychotherapy","PTSD","Control",,"30","B","15",,"TAU","Treatment as usual (TAU)","Usual treatment with nondirective, psychodynamically oriented therapy and/or medication and counseling; therapy delivered by the same therapists as the PE intervention and was not focused on the traumatic event.","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,,"1 hour","Weekly",,,,,,,,,,,,,,,"Veteran","0","1","0","0.0667",,"0.9333","Mixed","combat-related, terrorism/political violence","Medium","Nacasch N, Foa EB, Huppert JD, et al. Prolonged exposure therapy for combat- and terror-related posttraumatic stress disorder: a randomized control comparison with treatment as usual. J Clin Psychiatry. 2011 Sep;72(9):1174-80. doi: 10.4088/JCP.09m05682blu. PMID: 21208581.","35512","2019"
"nacasch2015_A","Psychotherapy","PTSD","PTSD",,"39","A","20",,"PE","Prolonged Exposure (PE)","Short-duration PE therapy according to treatment manual for PE (Foa et al., 2007), with imaginal exposure portion limited to 20 minutes of a 60-minute session. The first 2 sessions (pre-randomization) included treatment rationale, information gathering about trauma history, most disturbing trauma, breathing retraining, construction of in vivo exposure hierarchy and homework assignments. Remaining sessions (postrandomization) included homework review, imaginal exposure for 20 minutes followed by processing, and assignment of in vivo exposure homework.","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"Session length: 60 minutes
Imaginal exposure portion: 20 minutes",,,"10 to 15 sessions total","Supervisor and therapist agreed that the patient's self-reported symptoms of PTSD remained low and stable (minimum 10, maximum 15 sessions)","1",,,,,"13.60","2.23",,,,,"Veteran","0","1","0","0.3846",,"0.6154","Mixed","combat-related, rape/sexual assault, child sexual abuse, community/school violence, terrorism/political violence/forced displacement, accidents","Medium","Nacasch N, Huppert JD, Su Y-J, et al. Are 60-minute prolonged exposure sessions with 20-minute imaginal exposure to traumatic memories sufficient to successfully treat PTSD? A randomized nonininferiority clinical trial. Behav Ther. 2015 May;46(3):328-41. doi: 10.1016/j.beth.2014.12.002. PMID: 25892169.","43927","2019"
"nacasch2015_B","Psychotherapy","PTSD","PTSD",,"39","B","19",,"PE","Prolonged Exposure (PE)","Long-duration (typical) PE therapy according to treatment manual for PE (Foa et al., 2007), with imaginal exposure portion of 40 minutes and a 90-minute session. The first 2 sessions (prerandomization) included treatment rationale, information gathering about trauma history, most disturbing trauma, breathing retraining, construction of in vivo exposure hierarchy and homework assignments. Remaining sessions (postrandomization) included homework review, imaginal exposure for 40 minutes followed by processing, and assignment of in vivo exposure homework.","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"Session length: 90 minutes
Imaginal exposure portion: 40 minutes",,,"10 to 15 sessions total","Supervisor and therapist agreed that the patient's self-reported symptoms of PTSD remained low and stable (minimum 10, maximum 15 sessions)","0.9474",,,,,"13.21","2.59",,,,,"Veteran","0","1","0","0.3846",,"0.6154","Mixed","combat-related, rape/sexual assault, child sexual abuse, community/school violence, terrorism/political violence/forced displacement, accidents","Medium","Nacasch N, Huppert JD, Su Y-J, et al. Are 60-minute prolonged exposure sessions with 20-minute imaginal exposure to traumatic memories sufficient to successfully treat PTSD? A randomized nonininferiority clinical trial. Behav Ther. 2015 May;46(3):328-41. doi: 10.1016/j.beth.2014.12.002. PMID: 25892169.","43927","2019"
"najavits2018_A","Psychotherapy","PTSD+SUD","PTSD+SUD","Integrated","52","A","26",,"Creating Change","Creating Change","Individual, past-focused cognitive-behavioral therapy for PTSD/SUD; covered 17 topics relevant to both PTSD and SUD. Both interventions included ""a check-in, inspirational quotation, handouts, and check-out""; participants also allowed to ""attend nonstudy therapies and supports including 12-step self-help groups, except for current PTSD or PTSD/SUD evidence-based therapy models.""","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"1 hour","Weekly","17",,,,,,,,"11.42","5.36",,,,,"Veteran","0","1","0","0.2692",,"0.7308","Mixed","combat-related, rape/sexual assault, other (NR)","Medium","Najavits LM, Krinsley K, Waring ME, et al. A randomized controlled trial for veterans with PTSD and substance use disorder: creating change versus seeking safety. Subst Use Misuse. 2018 Sep 19;53(11):1788-800. doi: 10.1080/10826084.2018.1432653. PMID: 29461920.","49779","2020"
"najavits2018_B","Psychotherapy","PTSD+SUD","PTSD+SUD","Integrated","52","B","26",,"Seeking Safety","Seeking Safety","Individual, present-focused cognitive-behavioral therapy for PTSD/SUD; 17 of the 25 topics in Seeking Safety were used in order to keep dose of therapy the same between interventions (the 17 topics were same for all participants). Both interventions included ""a check-in, inspirational quotation, handouts, and check-out""; participants also allowed to ""attend nonstudy therapies and supports including 12-step self-help groups, except for current PTSD or PTSD/SUD evidence-based therapy models.""","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"1 hour","Weekly","17",,,,,,,,"11.62","5.36",,,,,"Veteran","0","1","0","0.2692",,"0.7308","Mixed","combat-related, rape/sexual assault, other (NR)","Medium","Najavits LM, Krinsley K, Waring ME, et al. A randomized controlled trial for veterans with PTSD and substance use disorder: creating change versus seeking safety. Subst Use Misuse. 2018 Sep 19;53(11):1788-800. doi: 10.1080/10826084.2018.1432653. PMID: 29461920.","49779","2020"
"nam2013_A","Nonpharmacologic biological","PTSD","PTSD",,"18","A","9",,"rTMS","Transcranial magnetic stimualtion (TMS)","Low-frequency rTMS to the right prefrontal cortex","No","Not Applicable","No","Not Applicable","No","Not Applicable","Yes","No","No","No","No","Individual","In Person","1 Hz at 100% motor threshold, 18,000 pulses total","20 minutes","Daily","2.14",,,,,,,,,,,,,,"Community",,,"1","0.625",,"0.375","Mixed","intimate partner violence, accidents, community/school violence","Medium","Nam D-H, Pae C-U, Chae J-H. Low-frequency, repetitive transcranial magnetic stimulation for the treatment of patients with posttraumatic stress disorder: a double-blind, sham-controlled study. Clin Psychopharmacol Neurosci. 2013 Aug;11(2):96-102. doi: 10.9758/cpn.2013.11.2.96. PMID: 24023554.","46490","2019"
"nam2013_B","Nonpharmacologic biological","PTSD","Control",,"18","B","9",,"Sham rTMS","Sham","Identical rTMS treatment except lateral wing of coil raised 90 degrees off the head, with edge of medial wing of the coil still touching scalp.","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"20 minutes","daily","2.14",,,,,,,,,,,,,,"Community",,,"1","0.625",,"0.375","Mixed","intimate partner violence, accidents, community/school violence","Medium","Nam D-H, Pae C-U, Chae J-H. Low-frequency, repetitive transcranial magnetic stimulation for the treatment of patients with posttraumatic stress disorder: a double-blind, sham-controlled study. Clin Psychopharmacol Neurosci. 2013 Aug;11(2):96-102. doi: 10.9758/cpn.2013.11.2.96. PMID: 24023554.","46490","2019"
"naylor2015_A","Pharmacotherapy","PTSD","PTSD",,"16","A",,,"Aripiprazole augmentation","Aripiprazole","Second-generation antipsychotic augmentation; all patients also continued baseline antidepressant treatment for PTSD. Following a 2-week placebo lead-in, aripiprazole 5 mg/day taken for 2 weeks, 5 to 10 mg/day for 2 weeks, 5 to 15 mg/day for 2 weeks, and finally 5 to 20 mg/day taken for 2 weeks.","No","Not Applicable","Yes","Antipsychotic","No","Not Applicable","No","No","No","No","No","Individual","In Person","Initiated at 5 mg, titrated to maximum 20 mg",,"Daily","8",,,,,,,,,,,"10.0 mg/day",,,"Veteran","0","1","0","0.3571",,"0.6429","Combat-related",,"High","Naylor JC, Kilts JD, Bradford DW, et al. A pilot randomized placebo-controlled trial of adjunctive aripiprazole for chronic PTSD in US military veterans resistant to antidepressant treatment. Int. Clin Psychopharmacol. 2015;30(3):167-74. doi: 10.1097/YIC.0000000000000061. PMID: 25647451.","46407","2019"
"naylor2015_B","Pharmacotherapy","PTSD","Control",,"16","B",,,"Placebo augmentation","Placebo","Augmentation with placebo capsules identical to active drug; all patients also continued baseline antidepressant treatment for PTSD. Double-blind treatment followed a 2-week placebo lead-in.","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person",,,"Daily","8",,,,,,,,,,,,,,"Veteran","0","1","0","0.3571",,"0.6429","Combat-related",,"High","Naylor JC, Kilts JD, Bradford DW, et al. A pilot randomized placebo-controlled trial of adjunctive aripiprazole for chronic PTSD in US military veterans resistant to antidepressant treatment. Int. Clin Psychopharmacol. 2015;30(3):167-74. doi: 10.1097/YIC.0000000000000061. PMID: 25647451.","46407","2019"
"neuner2008_A","Psychotherapy","PTSD","PTSD",,"277","A","111",,"NET","Narrative Exposure Therapy (NET)","Carried out according to manual by Schauer et al. (2005). Participants construct a chronological account of his own biography. Then the counselor discussed traumatic experiences with focus on current emotional, physiological, cognitive, and behavioral reactions to the experience until habituation of the emotional reactions","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"1 to 2 hours","Twice weekly",,"6 sessions total",,,,,,,,,,,,,"Community",,,"1","0.5126",,"0.4874","Terrorism/political violence/forced displacement",,"Medium","Neuner F, Onyut PL, Ertl V, et al. Treatment of posttraumatic stress disorder by trained lay counselors in an African refugee settlement: a randomized controlled trial. J Consult Clin Psychol. 2008 Aug;76(4):686-94. doi: 10.1037/0022-006X.76.4.686. PMID: 18665696.","31216","2019"
"neuner2008_B","Psychotherapy","PTSD","PTSD",,"277","B","111",,"Trauma counseling","Trauma counseling","Counselors address psychological and social needs expressed by the participant by relating current problems to past traumatic experiences. Counselors can use narrative exposure of traumatic events as part of therapy, but is not required","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"1 to 2 hours","Twice weekly",,"6 sessions total",,,,,,,,,,,,,"Community",,,"1","0.5126",,"0.4874","Terrorism/political violence/forced displacement",,"Medium","Neuner F, Onyut PL, Ertl V, et al. Treatment of posttraumatic stress disorder by trained lay counselors in an African refugee settlement: a randomized controlled trial. J Consult Clin Psychol. 2008 Aug;76(4):686-94. doi: 10.1037/0022-006X.76.4.686. PMID: 18665696.","31216","2019"
"neuner2008_C","Psychotherapy","PTSD","Control",,"277","C","55",,"Waitlist","Waitlist",,"No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","No","No","No",,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.5126",,"0.4874","Terrorism/political violence/forced displacement",,"Medium","Neuner F, Onyut PL, Ertl V, et al. Treatment of posttraumatic stress disorder by trained lay counselors in an African refugee settlement: a randomized controlled trial. J Consult Clin Psychol. 2008 Aug;76(4):686-94. doi: 10.1037/0022-006X.76.4.686. PMID: 18665696.","31216","2019"
"neuner2010_A","Psychotherapy","PTSD","PTSD",,"32","A","16",,"NET","Narrative Exposure Therapy (NET)","Intervention according to manual by Schauer et al. (2005) containing psychoeducation and participants narrating their biography","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"NR (mean 120 minutes)","Once or twice weekly",,"terminated at therapist's discretion",,,,,,,"8.79","3.77",,,,,"Community",,,"1","0.3125",,"0.6875","Terrorism/political violence/forced displacement",,"Medium","Neuner F, Kurreck S, Ruf M, et al. Can asylum-seekers with posttraumatic stress disorder be successfully treated? A randomized controlled pilot study. Cogn Behav Ther. 2010;39(2):81-91. doi: 10.1080/16506070903121042. PMID: 19816834.","33877","2019"
"neuner2010_B","Psychotherapy","PTSD","Control",,"32","B","16",,"TAU","Treatment as usual (TAU)","Participants encouraged to continue their current treatment or were referred to institutions of public mental health care","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","No","No","No",,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.3125",,"0.6875","Terrorism/political violence/forced displacement",,"Medium","Neuner F, Kurreck S, Ruf M, et al. Can asylum-seekers with posttraumatic stress disorder be successfully treated? A randomized controlled pilot study. Cogn Behav Ther. 2010;39(2):81-91. doi: 10.1080/16506070903121042. PMID: 19816834.","33877","2019"
"neylan2006_A","Pharmacotherapy","PTSD","PTSD",,"63","A","29",,"Guanfacine","Guanfacine","Centrally acting alpha-2 receptor agonist","No","Not Applicable","Yes","Antiadrenergic","No","Not Applicable","No","No","No","No","No","Individual","In Person","0.5 mg at week 1, titrated by 0.5 mg per week up to 1 to 3 mg",,"Once daily","8",,,,,"assessed by pill count",,,,,,"2.4 mg/day","0.7",,"Veteran","0","1","0",,,,,,"Medium","Neylan TC, Lenoci M, Samuelson KW, et al. No improvement of posttraumatic stress disorder symptoms with guanfacine treatment. Am J Psychiatry. 2006 Dec;163(12):2186-8. doi: 10.1176/appi.ajp.163.12.2186. PMID: 17151174.","28964","2019"
"neylan2006_B","Pharmacotherapy","PTSD","Control",,"63","B","34",,"Placebo","Placebo","Placebo","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person",,,"Once daily","8",,,,,"assessed by pill count",,,,,,,,,"Veteran","0","1","0",,,,,,"Medium","Neylan TC, Lenoci M, Samuelson KW, et al. No improvement of posttraumatic stress disorder symptoms with guanfacine treatment. Am J Psychiatry. 2006 Dec;163(12):2186-8. doi: 10.1176/appi.ajp.163.12.2186. PMID: 17151174.","28964","2019"
"nidich2018_B","Mixed: Psychotherapy & CIH","PTSD","PTSD",,"202","B","68",,"PE","Prolonged Exposure (PE)","Trauma-focused behavioural treatment with graduated exposure to imaginal and in-vivo trauma experiences delivered Individually. Homework involved listening to imaginal and engaging in in-vivo exposures.","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"90 minutes","Weekly","12",,"≥8 sessions","0.6176",,,,,"8.2","3.7",,,,,"Veteran","0","1","0","0.1683",,"0.8317","Mixed","MST; Combat-related; Illness/medical procedure; Natural or manmade disasters; Other (life-threatening or serious injury; life-threatening illness)","Low","Nidich S, Mills PJ, Rainforth M, et al. Non-trauma-focused meditation versus exposure therapy in veterans with post-traumatic stress disorder: a randomised controlled trial. Lancet Psychiatry. 2018 Dec;5(12):975-86. doi: 10.1016/S2215-0366(18)30384-5. PMID: 30449712.","51386","2020"
"nidich2018_C","Mixed: Psychotherapy & CIH","PTSD","Control",,"202","C","66",,"PTSD health education","PTSD health education","Health education specific to PTSD veterans, including symptoms, negative coping behaviors, and healthy lifestyle. Group sessions fostered social support and personal expression","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Group","In Person",,"90 minutes","Weekly","12",,"≥8 sessions","0.6515",,,,,"7.9","3.6",,,,,"Veteran","0","1","0","0.1683",,"0.8317","Mixed","MST; Combat-related; Illness/medical procedure; Natural or manmade disasters; Other (life-threatening or serious injury; life-threatening illness)","Low","Nidich S, Mills PJ, Rainforth M, et al. Non-trauma-focused meditation versus exposure therapy in veterans with post-traumatic stress disorder: a randomised controlled trial. Lancet Psychiatry. 2018 Dec;5(12):975-86. doi: 10.1016/S2215-0366(18)30384-5. PMID: 30449712.","51386","2020"
"nidich2018_A","Mixed: Psychotherapy & CIH","PTSD","PTSD",,"202","A","68",,"Transcendental meditation","Transcendental meditation","Sitting meditation with eyes closed to quiet thoughts; PTSD symptoms not specifically addressed. Meditation technique taught in 5 sessions on consecutive days in a group format with lectures and some one-on-one instruction. Seven group maintenance sessions taught over the rest of the 3-month period. Home practice of two 20-minute daily sessions encouraged.","No","Not Applicable","No","Not Applicable","Yes","Meditation","No","No","No","No","No",,,,"Instructor sessions: 90 minutes","Daily for 5 days then on average every 11 days (""gradually spaced"")","12",,"≥8 sessions","0.75",,,,,"9.0","4.3",,,,,"Veteran","0","1","0","0.1683",,"0.8317","Mixed","MST; Combat-related; Illness/medical procedure; Natural or manmade disasters; Other (life-threatening or serious injury; life-threatening illness)","Low","Nidich S, Mills PJ, Rainforth M, et al. Non-trauma-focused meditation versus exposure therapy in veterans with post-traumatic stress disorder: a randomised controlled trial. Lancet Psychiatry. 2018 Dec;5(12):975-86. doi: 10.1016/S2215-0366(18)30384-5. PMID: 30449712.","51386","2020"
"nijdam2012_A","Psychotherapy","PTSD","PTSD",,"140","A","70",,"Brief eclectic psychotherapy","Brief Eclectic Psychotherapy (BEP)","Psychoeducation, imaginal exposure, cognitive restructuring and writing assignments","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"45 to 60 minutes","Weekly","16",,"completed treatment course","0.643",,,,,"14.7","4.5",,,,,"Community",,,"1","0.564",,"0.436","Mixed","rape/sexual assault, accidents, natural or manmade disasters, community/school violence, other (war-related)","Medium","Nijdam MJ, Gersons BP, Reitsma JB, et al. Brief eclectic psychotherapy v. Eye Movement Desensitization and Reprocessing therapy for post-traumatic stress disorder: randomised controlled trial. Br J Psychiatry. 2012 Mar;200(3):224-31. doi: 10.1192/bjp.bp.111.099234. PMID: 22322458.","38273","2019"
"nijdam2012_B","Psychotherapy","PTSD","PTSD",,"140","B","70",,"EMDR","Eye Movement Desensitization and Reprocessing (EMDR)","During EMDR therapy, the most distressing images of the traumatic event are identified and processed consecutively. After the patient has focused on an image with the corresponding negative cognition, the most distressing emotion and the bodily location of the emotion, the patient is continuously asked to follow the therapist’s finger making saccadic movements in alternation with the patient’s own associations.","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"90 minutes","Weekly","16",,"completed treatment course","0.714",,,,,"6.5","3.8",,,,,"Community",,,"1","0.564",,"0.436","Mixed","rape/sexual assault, accidents, natural or manmade disasters, community/school violence, other (war-related)","Medium","Nijdam MJ, Gersons BP, Reitsma JB, et al. Brief eclectic psychotherapy v. Eye Movement Desensitization and Reprocessing therapy for post-traumatic stress disorder: randomised controlled trial. Br J Psychiatry. 2012 Mar;200(3):224-31. doi: 10.1192/bjp.bp.111.099234. PMID: 22322458.","38273","2019"
"niles2012_A","Complementary and integrative health (CIH)","PTSD","PTSD",,"33","A","17",,"Mindfulness","Mindfulness","2 in-person sessions and 6 phone sessions; participants given Mindfulness Handbook which covered mindfulness topics: defining mindfulness, noticing sensations, noticing thoughts and emotions, beginners' mind, choice, patience, and continuing to practice; in-person sessions included mindfulness exercises; participants instructed to practice with guided mindfulness exercises on provided CD and track practice.","No","Not Applicable","No","Not Applicable","Yes","Meditation","No","No","No","No","No","Individual","Mixed",,"Session length: 45-minute in-person sessions and 20-minute phone sessions","Weekly","8",,"Attended intervention and post-treatment assessment","0.76",,"Self-reported proportion of assigned readings completed and the amount of unguided practice",,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"High","Niles BL, Klunk-Gillis J, Ryngala DJ, et al. Comparing mindfulness and psychoeducation treatments for combat-related PTSD using a telehealth approach. Psychol Trauma. 2012 Sep;4(5):538-47. doi: 10.1037/a0026161","37920","2019"
"niles2012_B","Complementary and integrative health (CIH)","PTSD","Control",,"33","B","16",,"Psychoeducation","Psychoeducation","2 in-person sessions and 6 telephone sessions; participants given PTSD Education Handbook complementing treatment and providing education on issues of trust, safety, self-care, relationships and trauma, coping and healing, change, and moving forward; treatment focused on educating participants on how PTSD may affect their lives, and encouraged reflection and gave suggestions on positive coping without specific coping techniques (no relaxation exercises or behavioral activation).","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","No","Yes","No","Individual","Mixed",,"Session length: 45-minute in-person sessions and 20-minute phone sessions","Weekly","8",,"Attended intervention and post-treatment assessment","0.88",,"Self-reported proportion of assigned readings completed",,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"High","Niles BL, Klunk-Gillis J, Ryngala DJ, et al. Comparing mindfulness and psychoeducation treatments for combat-related PTSD using a telehealth approach. Psychol Trauma. 2012 Sep;4(5):538-47. doi: 10.1037/a0026161","37920","2019"
"noohi2017_A","Complementary and integrative health (CIH)","PTSD","PTSD",,"30","A","15",,"Neurofeedback","Neurofeedback","Treatment followed the alpha/theta protocol by El-Hage, Quide, Radua & Olff (2013) where participants relax with eyes closed. Participants asked to recall positive memory to increase cerebral theta waves. Feedback consisted of audio of river waves representing alpha waves and ocean waves representing theta waves","No","Not Applicable","No","Not Applicable","Yes","Relaxation","No","No","No","No","No","Individual","In Person",,"30 to 40 minutes","4 sessions per week","6","25 sessions total",,,,,,,,,,,,,"Community",,,"1","0",,"1","Combat-related",,"High","Noohi S, Miraghaie AM, Arabi A, et al. Effectiveness of neuro-feedback treatment with alpha/theta method on PTSD symptoms and their executing function. Biomed Res. 2017;28(5):2019-27.","47468","2019"
"noohi2017_B","Complementary and integrative health (CIH)","PTSD","Control",,"30","B","15",,"Control","Control",,"No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,,,,,,,,,,,,,,,,,,"Community",,,"1","0",,"1","Combat-related",,"High","Noohi S, Miraghaie AM, Arabi A, et al. Effectiveness of neuro-feedback treatment with alpha/theta method on PTSD symptoms and their executing function. Biomed Res. 2017;28(5):2019-27.","47468","2019"
"nordbrandt2020_A","Complementary and integrative health (CIH)","PTSD","PTSD",,"318","A","105",,"Basic body awareness therapy + TAU","Exercise","Basic body awareness therapy: manualized physical exercise with ""slow, guided movements while standing, sitting and lying down, aiming at normalising and improving balance, muscle tension, free breathing and awareness."" Participants also encouraged to do exercises as homework.
TAU: interdisciplinary treatmen with medical doctor and psychologist; medical doctor focused on pharmacological treatment as needed and psychoeducation; psychologist followed manual for treatment - ""individual flexible CBT with elements of acceptance and commitment therapy, stress management and mindfulness.""","No","Not Applicable","No","Not Applicable","Yes","Other physical activity and recreational therapies","No","No","No","No","No","Individual","In Person",,"1 hour","Weekly","20",,"≥10 physiotherapy sessions","0.60",,,,,"10",,,,,,"Community","0","0","1","0.528",,"0.472","Mixed","combat-related, rape/sexual assault, terrorism/political violence/forced dsplacement, other (""violence from relatives"")","Medium","Nordbrandt MS, Sonne C, Mortensen EL, et al. Trauma-affected refugees treated with basic body awareness therapy or mixed physical activity as augmentation to treatment as usual-A pragmatic randomised controlled trial. PLoS ONE [Electronic Resource]. 2020;15(3):e0230300. doi: https://dx.doi.org/10.1371/journal.pone.0230300. PMID: 32163509.",,"2020"
"nordbrandt2020_B","Complementary and integrative health (CIH)","PTSD","PTSD",,"318","B","109",,"Mixed physical activity + TAU","Exercise","Mixed physical activity: followed manual; ""bsic exercises focusing on improving strength, endurance, balance and coordination, using simple tools such as water bottles, bicycle, resistance bands, grocery bags etc."" (tools selected which would allow participants to practice exercises at home). Participants also encouraged to do exercises as homework.
TAU: interdisciplinary treatmen with medical doctor and psychologist; medical doctor focused on pharmacological treatment as needed and psychoeducation; psychologist followed manual for treatment - ""individual flexible CBT with elements of acceptance and commitment therapy, stress management and mindfulness.""","No","Not Applicable","No","Not Applicable","Yes","Other physical activity and recreational therapies","No","No","No","No","No","Individual","In Person",,"2 hours","Twice weekly","20",,"≥10 physiotherapy sessions","0.5596",,,,,"10",,,,,,"Community","0","0","1","0.528",,"0.472","Mixed","combat-related, rape/sexual assault, terrorism/political violence/forced dsplacement, other (""violence from relatives"")","Medium","Nordbrandt MS, Sonne C, Mortensen EL, et al. Trauma-affected refugees treated with basic body awareness therapy or mixed physical activity as augmentation to treatment as usual-A pragmatic randomised controlled trial. PLoS ONE [Electronic Resource]. 2020;15(3):e0230300. doi: https://dx.doi.org/10.1371/journal.pone.0230300. PMID: 32163509.",,"2020"
"nordbrandt2020_C","Complementary and integrative health (CIH)","PTSD","Control",,"318","C","104",,"TAU","Treatment as usual (TAU)","Interdisciplinary treatmen with medical doctor and psychologist; medical doctor focused on pharmacological treatment as needed and psychoeducation; psychologist followed manual for treatment - ""individual flexible CBT with elements of acceptance and commitment therapy, stress management and mindfulness.""","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person",,"1 hour","Weekly","20",,,"1",,,,,,,,,,,"Community","0","0","1","0.528",,"0.472","Mixed","combat-related, rape/sexual assault, terrorism/political violence/forced dsplacement, other (""violence from relatives"")","Medium","Nordbrandt MS, Sonne C, Mortensen EL, et al. Trauma-affected refugees treated with basic body awareness therapy or mixed physical activity as augmentation to treatment as usual-A pragmatic randomised controlled trial. PLoS ONE [Electronic Resource]. 2020;15(3):e0230300. doi: https://dx.doi.org/10.1371/journal.pone.0230300. PMID: 32163509.",,"2020"
"norman2019_A","Psychotherapy","PTSD+SUD","PTSD+SUD","Integrated","119","A","63",,"Concurrent Treatment for PTSD and Substance Use Disorder Prolonged Exposure (COPE)","Concurrent Treatment for PTSD and Substance Use Disorder Using Prolonged Exposure (COPE)","Integrated prolonged exposure with cognitive behavioral relapse prevention skills for SUD, includes in vivo and imaginal exposure","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"90 minutes","1-2 times per week",,"6-24","completed ≥12 sessions","0.3175",,,,,"8.4","4.6",,,,,"Veteran","0","1","0","0.1008",,"0.8992","Mixed","combat-related, rape/sexual assault, accidents, community/school violence, natural or manmade disasters","Medium","Norman SB, Trim R, Haller M, et al. Efficacy of integrated exposure therapy vs integrated coping skills therapy for comorbid posttraumatic stress disorder and alcohol use disorder: a randomized clinical trial. JAMA Psychiatry. 2019 Apr 24;76(8):791-9. doi: 10.1001/jamapsychiatry.2019.0638. PMID: 31017639.","52065","2020"
"norman2019_B","Psychotherapy","PTSD+SUD","PTSD+SUD","Integrated","119","B","56",,"Seeking Safety (SS)","Seeking Safety","Cognitive behavioral and interpersonal techniques and case management","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"90 minutes","1-2 times per week",,"6-24","completed ≥12 sessions","0.6607",,,,,"11.4","4.8",,,,,"Veteran","0","1","0","0.1008",,"0.8992","Mixed","combat-related, rape/sexual assault, accidents, community/school violence, natural or manmade disasters","Medium","Norman SB, Trim R, Haller M, et al. Efficacy of integrated exposure therapy vs integrated coping skills therapy for comorbid posttraumatic stress disorder and alcohol use disorder: a randomized clinical trial. JAMA Psychiatry. 2019 Apr 24;76(8):791-9. doi: 10.1001/jamapsychiatry.2019.0638. PMID: 31017639.","52065","2020"
"numata2014_A","Pharmacotherapy","PTSD","PTSD",,"43","A","21",,"Saikokeishikankyoto","Saikokeishikankyoto","Traditional Japanese-Chinese herbal formula containing a mixture of 7 dried herbs each registered in the Pharmacopoeia of Japan version 15","No","Not Applicable","No","Not Applicable","Yes","Natural products","No","No","No","No","No","Individual","In Person","2.5 grams (contains 1.17 grams herb extract)",,"3 times daily","2",,,,,,,,,,,,,,"Community",,,"1","0.4884",,"0.5116","Natural or manmade disasters",,"Medium","Numata T, GunFan S, Takayama S, et al. Treatment of posttraumatic stress disorder using the traditional Japanese herbal medicine saikokeishikankyoto: a randomized, observer-blinded, controlled trial in survivors of the great East Japan earthquake and tsunami. Evid Based Complement Alternat Med. 2014;2014:683293. doi: 10.1155/2014/683293. PMID: 24790634.","46973","2019"
"numata2014_B","Pharmacotherapy","PTSD","Control",,"43","B","22",,"Control","Control","""control""","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person",,,,"2",,,,,,,,,,,,,,"Community",,,"1","0.4884",,"0.5116","Natural or manmade disasters",,"Medium","Numata T, GunFan S, Takayama S, et al. Treatment of posttraumatic stress disorder using the traditional Japanese herbal medicine saikokeishikankyoto: a randomized, observer-blinded, controlled trial in survivors of the great East Japan earthquake and tsunami. Evid Based Complement Alternat Med. 2014;2014:683293. doi: 10.1155/2014/683293. PMID: 24790634.","46973","2019"
"oehen2013_A","Mixed: Psychotherapy & pharmacotherapy","PTSD","PTSD",,"14","A","9",,"MDMA-assisted psychotherapy","MDMA-assisted psychotherapy","MDMA is a psychoactive compound [Schedule 1 in the U.S. as a drug of abuse (ecstasy]). MDMA was given as an adjunct to psychotherapy. Patients received MDMA-assisted psychotherapy, music therapy and ""body work"" (e.g. hand-holding) with 2 therapists present over an 8-hour period, followed by non-drug therapy sessions the following day, and at one- and two-weeks post MDMA treatment.","Yes","Non-TF","Yes","Psychostimulant","No","Not Applicable","No","No","No","No","No","Individual","In Person","Session length: MDMA sessions 8 hours, NR for non-drug sessions

Dose: 187.5 mg (125 mg followed 2.5 hours later by 62.5 mg)",,"Interval between MDMA sessions NR; one non-drug session the morning after each MDMA-assisted session, followed by 2 non-drug sessions one week apart",,,,,,,,,,,,,,,"Community",,,"1","0.8333",,"0.1667","Mixed","child sexual abuse, rape/sexual assault, accidents, illness/medical procedure","High","Oehen P, Traber R, Widmer V, et al. A randomized, controlled pilot study of MDMA (±3,4-Methylenedioxymethamphetamine)-assisted psychotherapy for treatment of resistant, chronic post-traumatic stress disorder (PTSD). J Psychopharmacol. 2013 Jan;27(1):40-52. doi: 10.1177/0269881112464827. PMID: 23118021.","41195","2019"
"oehen2013_B","Mixed: Psychotherapy & pharmacotherapy","PTSD","PTSD",,"14","B","5",,"Low-dose MDMA-assisted psychotherapy","MDMA-assisted psychotherapy","Low-dose MDMA used as an ""active placebo"" to maintain blinding ""since MDMA's effects can be easily discerned by both subjects and investigators."" Chosen dose expected ""to produce minimal, but detectable subjective effects,"" but no significant therapeutic effect. Low-dose MDMA was given as an adjunct to psychotherapy. Patients received low-dose MDMA-assisted psychotherapy, music therapy and ""body work"" (e.g. hand-holding) with 2 therapists present over an 8-hour period, followed by non-drug therapy sessions the following day, and at one- and two-weeks post MDMA treatment.","Yes","Non-TF","Yes","Psychostimulant","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","Session length: MDMA sessions 8 hours, NR for non-drug sessions

Dose: 37.5 mg (25 mg followed 2.5 hours later by 12.5 mg)",,"Interval between MDMA sessions NR; one non-drug session the morning after each MDMA-assisted session, followed by 2 non-drug sessions one week apart",,,,,,,,,,,,,,,"Community",,,"1","0.8333",,"0.1667","Mixed","child sexual abuse, rape/sexual assault, accidents, illness/medical procedure","High","Oehen P, Traber R, Widmer V, et al. A randomized, controlled pilot study of MDMA (±3,4-Methylenedioxymethamphetamine)-assisted psychotherapy for treatment of resistant, chronic post-traumatic stress disorder (PTSD). J Psychopharmacol. 2013 Jan;27(1):40-52. doi: 10.1177/0269881112464827. PMID: 23118021.","41195","2019"
"önder2006_A","Pharmacotherapy","PTSD","PTSD",,"103","A","38",,"Fluoxetine","Fluoxetine","SSRI; flexible dosing, single dose in the morning; if no response at week 8, dose increased from 20 to 40 mg","No","Not Applicable","Yes","Antidepressant: SSRI","No","Not Applicable","No","No","No","No","No","Individual","In Person","Initiated at 20 mg, could be increased to 40 mg",,"Once daily","12",,,,,,,,,,,"27.4 mg/day","9.8",,"Community",,,"1","0.5049",,"0.4951","Natural or manmade disasters",,"High","Önder E, Tural Ü, Aker AT. A comparative study of fluoxetine, moclobemide, and tianeptine in the treatment of posttraumatic stress disorder following an earthquake. Eur Psychiatry. 2006 Apr;21(3):174-9. doi: 10.1016/j.eurpsy.2005.03.007. PMID: 15964747.","28188","2019"
"önder2006_B","Pharmacotherapy","PTSD","PTSD",,"103","B","35",,"Moclobemide","Moclobemide","MAOI Antidepressant; flexible dosing, daily dose divided between 8 am and 8 pm; if no response at week 8, increased from 450 mg to 900 mg","No","Not Applicable","Yes","Antidepressant: MAOI","No","Not Applicable","No","No","No","No","No","Individual","In Person","Initiated at 450 mg, could be increased to 900 mg",,"Daily, divided","12",,,,,,,,,,,"565.7 mg/day","115.5",,"Community",,,"1","0.5049",,"0.4951","Natural or manmade disasters",,"High","Önder E, Tural Ü, Aker AT. A comparative study of fluoxetine, moclobemide, and tianeptine in the treatment of posttraumatic stress disorder following an earthquake. Eur Psychiatry. 2006 Apr;21(3):174-9. doi: 10.1016/j.eurpsy.2005.03.007. PMID: 15964747.","28188","2019"
"önder2006_C","Pharmacotherapy","PTSD","PTSD",,"103","C","30",,"Tianeptine","Tianeptine","Atypical antidepressant; flexible dosing, daily dose divided between 8 am, 4 pm, and 11 pm; if no response at 8 weeks, increased from 37.5 to 50 mg","No","Not Applicable","Yes","Antidepressant: Other","No","Not Applicable","No","No","No","No","No","Individual","In Person","Initiated at 37.5 mg, could be increased to 50 mg",,"Daily, divided","12",,,,,,,,,,,"41.3 mg","5.8",,"Community",,,"1","0.5049",,"0.4951","Natural or manmade disasters",,"High","Önder E, Tural Ü, Aker AT. A comparative study of fluoxetine, moclobemide, and tianeptine in the treatment of posttraumatic stress disorder following an earthquake. Eur Psychiatry. 2006 Apr;21(3):174-9. doi: 10.1016/j.eurpsy.2005.03.007. PMID: 15964747.","28188","2019"
"orang2018_A","Psychotherapy","PTSD","PTSD",,"45","A","24",,"NET","Narrative Exposure Therapy (NET)","Psychoeducation in the first session, then treatment proceeds with ""lifeline"" exercise where patient chronologically narrates her life using stones to mark traumatic events and flowers to mark joyful events. Therapists also provided consultation on safety issues and current violence.","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"120-150 minutes",,,"12-24",,,,,,,"11.88","1.76",,,,,"Community","0","0","1","1",,"0","Intimate partner violence",,"High","Orang T, Ayoughi S, Moran JK, et al. The efficacy of narrative exposure therapy in a sample of Iranian women exposed to ongoing intimate partner violence-a randomized controlled trial. Clin Psychol Psychother. 2018 Nov;25(6):827-41. doi: 10.1002/cpp.2318. PMID: 30079583.",,"2020"
"orang2018_B","Psychotherapy","PTSD","PTSD",,"45","B","21",,"TAU","Supportive counseling","Psychoeducation and supportive counseling individually tailored to each patient, including life skill training, cognitive-behavioral techniques, acceptance and commitment therapy, improvement of self-knowledge, and involvement of violent husbands as needed.","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"90 to 120 minutes",,,"12-24",,,,,,,"10.88","1.16",,,,,"Community","0","0","1","1",,"0","Intimate partner violence",,"High","Orang T, Ayoughi S, Moran JK, et al. The efficacy of narrative exposure therapy in a sample of Iranian women exposed to ongoing intimate partner violence-a randomized controlled trial. Clin Psychol Psychother. 2018 Nov;25(6):827-41. doi: 10.1002/cpp.2318. PMID: 30079583.",,"2020"
"otalora2018_C","Mixed: Psychotherapy & pharmacotherapy","PTSD","Control",,"28","C","6",,"Psychotherapy + control dose MDMA","MDMA-assisted psychotherapy","Manualized therapy developed for use with psychedelics; followed patients' process with no agenda or solutions offered. Three preparatory sessions followed by two eight-hour MDMA sessions (with overnight observation), each drug session followed by three non-drug integrative sessions over one month and daily phone contact for a week.","Yes","Non-TF","Yes","Psychostimulant","No","Not Applicable","No","No","No","No","No","Individual","In Person","Dose: 40 mg + 20 mg available supplemental dose","Preparatory sessions: 90 minutes; MDMA sessions: 8 hours; Integrative sessions: NR","Preparatory sessions: interval NR; MDMA sessions: one month apart; Integrative sessions: ~10 days apart",,,,,,,,,,,,,,,"Community","0","0","1","0.679",,"0.321","Mixed","Combat-related; Child physical abuse; Child sexual abuse; Accidents; Community/school violence; Other (ritual abuse, witnessing a crime)","Medium","Ot'alora GM, Grigsby J, Poulter B, et al. 3,4-methylenedioxymethamphetamine-assisted psychotherapy for treatment of chronic posttraumatic stress disorder: a randomized phase 2 controlled trial. J Psychopharmacol. 2018 Dec;32(12):1295-307. doi: 10.1177/0269881118806297. PMID: 30371148.","51494","2020"
"otalora2018_A","Mixed: Psychotherapy & pharmacotherapy","PTSD","PTSD",,"28","A","13",,"Psychotherapy + higher-dose MDMA","MDMA-assisted psychotherapy","Manualized therapy developed for use with psychedelics; followed patients' process with no agenda or solutions offered. Three preparatory sessions followed by two eight-hour MDMA sessions (with overnight observation), each drug session followed by three non-drug integrative sessions over one month and daily phone contact for a week.","Yes","Non-TF","Yes","Psychostimulant","No","Not Applicable","No","No","No","No","No","Individual","In Person","Dose: 125 mg + 62.5 mg available supplemental dose","Preparatory sessions: 90 minutes; MDMA sessions: 8 hours; Integrative sessions: NR","Preparatory sessions: interval NR; MDMA sessions: one month apart; Integrative sessions: ~10 days apart",,,,,,,,,,,,,,,"Community","0","0","1","0.679",,"0.321","Mixed","Combat-related; Child physical abuse; Child sexual abuse; Accidents; Community/school violence; Other (ritual abuse, witnessing a crime)","Medium","Ot'alora GM, Grigsby J, Poulter B, et al. 3,4-methylenedioxymethamphetamine-assisted psychotherapy for treatment of chronic posttraumatic stress disorder: a randomized phase 2 controlled trial. J Psychopharmacol. 2018 Dec;32(12):1295-307. doi: 10.1177/0269881118806297. PMID: 30371148.","51494","2020"
"otalora2018_B","Mixed: Psychotherapy & pharmacotherapy","PTSD","PTSD",,"28","B","9",,"Psychotherapy + lower-dose MDMA","MDMA-assisted psychotherapy","Manualized therapy developed for use with psychedelics; followed patients' process with no agenda or solutions offered. Three preparatory sessions followed by two eight-hour MDMA sessions (with overnight observation), each drug session followed by three non-drug integrative sessions over one month and daily phone contact for a week.","Yes","Non-TF","Yes","Psychostimulant","No","Not Applicable","No","No","No","No","No","Individual","In Person","Dose: 100 mg + 50 mg available supplemental dose","Preparatory sessions: 90 minutes; MDMA sessions: 8 hours; Integrative sessions: NR","Preparatory sessions: interval NR; MDMA sessions: one month apart; Integrative sessions: ~10 days apart",,,,,,,,,,,,,,,"Community","0","0","1","0.679",,"0.321","Mixed","Combat-related; Child physical abuse; Child sexual abuse; Accidents; Community/school violence; Other (ritual abuse, witnessing a crime)","Medium","Ot'alora GM, Grigsby J, Poulter B, et al. 3,4-methylenedioxymethamphetamine-assisted psychotherapy for treatment of chronic posttraumatic stress disorder: a randomized phase 2 controlled trial. J Psychopharmacol. 2018 Dec;32(12):1295-307. doi: 10.1177/0269881118806297. PMID: 30371148.","51494","2020"
"padala2006_A","Pharmacotherapy","PTSD","PTSD",,"20","A","11",,"Risperidone","Risperidone","Initiated at 1 mg/day, increase weekly by up to 1 mg/day to target dose of 4 to 6 mg/day","No","Not Applicable","Yes","Antipsychotic","No","Not Applicable","No","No","No","No","No","Individual","In Person","4 to 6 mg total daily dose",,"Twice daily","10",,,,,,,,,,,"2.62 mg",,,"Community",,,"1","1",,"0","Mixed","rape/sexual assault, intimate partner violence, child physical abuse, community/school violence, other (violent death of a loved one)","High","Padala PR, Madison J, Monnahan M, et al. Risperidone monotherapy for post-traumatic stress disorder related to sexual assault and domestic abuse in women. Int Clin Psychopharmacol. 2006 Sep;21(5):275-80. PMID: 16877898.","50966","2019"
"padala2006_B","Pharmacotherapy","PTSD","Control",,"20","B","9",,"Placebo","Placebo","Placebo","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person",,,"Twice daily","10",,,,,,,,,,,,,,"Community",,,"1","1",,"0","Mixed","rape/sexual assault, intimate partner violence, child physical abuse, community/school violence, other (violent death of a loved one)","High","Padala PR, Madison J, Monnahan M, et al. Risperidone monotherapy for post-traumatic stress disorder related to sexual assault and domestic abuse in women. Int Clin Psychopharmacol. 2006 Sep;21(5):275-80. PMID: 16877898.","50966","2019"
"panahi2011_A","Pharmacotherapy","PTSD","PTSD",,"70","A","35",,"Sertraline","Sertraline","SSRI; patients visited every 2 weeks by a psychiatrist who adjusted dose based on response and adverse effects","No","Not Applicable","Yes","Antidepressant: SSRI","No","Not Applicable","No","No","No","No","No","Individual","In Person","Initiated at 50 mg, titrated to maximum 200 mg",,"Daily","10",,,,,,,,,,,"140 mg/day","33",,"Mixed","0.6857","0.3143","0","0",,"1","Combat-related",,"Low","Panahi Y, Moghaddam BR, Sahebkar A, et al. A randomized, double-blind, placebo-controlled trial on the efficacy and tolerability of sertraline in Iranian veterans with post-traumatic stress disorder. Psychol Med. 2011;41(10):2159-66. doi: 10.1017/S0033291711000201. PMID: 21349225.","36061","2019"
"panahi2011_B","Pharmacotherapy","PTSD","Control",,"70","B","35",,"Placebo","Placebo","Placebo matched to active treatment","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person",,,"Daily","10",,,,,,,,,,,"131 mg equivalent","29",,"Mixed","0.6857","0.3143","0","0",,"1","Combat-related",,"Low","Panahi Y, Moghaddam BR, Sahebkar A, et al. A randomized, double-blind, placebo-controlled trial on the efficacy and tolerability of sertraline in Iranian veterans with post-traumatic stress disorder. Psychol Med. 2011;41(10):2159-66. doi: 10.1017/S0033291711000201. PMID: 21349225.","36061","2019"
"paunovic2001_A","Psychotherapy","PTSD","PTSD",,"20","A",,,"Exposure therapy","Exposure therapy","Patients were exposed to anxiety-provoking trauma-related images and situations until habituated to each.","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"60 to 120 minutes","Weekly","16 to 20",,,,,,,,,,,,,,"Community",,,"1","0.1875",,"0.8125","Mixed","combat-related, rape/sexual assault, accidents, community/school violence, terrorism/political violence/forced displacement, other (exposure to toxic substance)","High","Paunovic N, Öst L-G. Cognitive-behavior therapy vs exposure therapy in the treatment of PTSD in refugees. Behav Res Ther. 2001 Oct;39(10):1183-97. doi: 10.1016/S0005-7967(00)00093-0. PMID: 11579988.","07357","2019"
"paunovic2001_B","Psychotherapy","PTSD","PTSD",,"20","B",,,"CBT","Trauma-focused cognitive behavioral therapy (TF-CBT)","Flexible combination of exposure, cognitive therapy, and controlled breathing.","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"60 to 120 minutes","Weekly","16 to 20",,,,,,,,,,,,,,"Community",,,"1","0.1875",,"0.8125","Mixed","combat-related, rape/sexual assault, accidents, community/school violence, terrorism/political violence/forced displacement, other (exposure to toxic substance)","High","Paunovic N, Öst L-G. Cognitive-behavior therapy vs exposure therapy in the treatment of PTSD in refugees. Behav Res Ther. 2001 Oct;39(10):1183-97. doi: 10.1016/S0005-7967(00)00093-0. PMID: 11579988.","07357","2019"
"perezdandieu2014_A","Psychotherapy","PTSD","PTSD+SUD","Not integrated","12","A","6",,"EMDR + TAU","Eye Movement Desensitization and Reprocessing (EMDR)","EMDR follows protocol according to Shapiro (2005), which involves participant isolating a visual representation of a traumatic memory, holding the memory, negative statement, evoked emotion, and area of body where the emotion is experienced while visually follow clinician's fingers for a set of 25 eye movements. All participants also received standard treatment for addiction, including clinical interviews, baclofen administration, anxiolytics/antidepressants administration, heroin substitution therapy, medications for PTSD treatment, and psychoeducation","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,,"Three sessions in first month, followed by monthly sessions","26","8 sessions total",,,,,,,,,,,,,"Community",,,"1","1",,"0","Mixed","other (sexual abuse, physical abuse or physical threatening or negligence, emotional abuse)","High","Perez-Dandieu B, Tapia G. Treating trauma in addiction with EMDR: a pilot study. J Psychoactive Drugs. 2014 Oct-Dec;46(4):303-9. doi: 10.1080/02791072.2014.921744. PMID: 25188700.","1548480","2019"
"perezdandieu2014_B","Psychotherapy","PTSD","Control",,"12","B","6",,"TAU","Treatment as usual (TAU)","Clinical interviews, baclofen administration, anxiolytics/antidepressants administration, heroin substitution therapy, medications for PTSD treatment, and psychoeducation","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person",,,,"26",,,,,,,,,,,,,,"Community",,,"1","1",,"0","Mixed","other (sexual abuse, physical abuse or physical threatening or negligence, emotional abuse)","High","Perez-Dandieu B, Tapia G. Treating trauma in addiction with EMDR: a pilot study. J Psychoactive Drugs. 2014 Oct-Dec;46(4):303-9. doi: 10.1080/02791072.2014.921744. PMID: 25188700.","1548480","2019"
"petrakis2016_B","Pharmacotherapy","PTSD+SUD","Control","Not integrated","96","B","46",,"Placebo","Placebo","Placebo","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person",,,"Daily","12",,,,,"remained on study medication for 12 weeks","0.5217",,,,,,,,"Veteran","0","1","0","0.0625",,"0.9375",,,"High","Petrakis IL, Desai N, Gueorguieva R, et al. Prazosin for veterans with posttraumatic stress disorder and comorbid alcohol dependence: a clinical trial. Alcohol Clin Exp Res. 2016 Jan;40(1):178-86. doi: 10.1111/acer.12926. PMID: 26683790.","44663","2020"
"petrakis2016_A","Pharmacotherapy","PTSD+SUD","PTSD+SUD","Not integrated","96","A","50",,"Prazosin","Prazosin","Alpha-1 adrenergic receptor inverse agonist. Initiated at 2 mg/day, titrated over 2 weeks up to 16 mg/day","No","Not Applicable","Yes","Antiadrenergic","No","Not Applicable","No","No","No","No","No","Individual","In Person","Initiated at 2 mg, titrated over 2 weeks up to 16 mg",,"Daily","12",,,,,"remained on study medication for 12 weeks","0.60",,,,,"14.5 mg/day","3.14 mg/day",,"Veteran","0","1","0","0.0625",,"0.9375",,,"High","Petrakis IL, Desai N, Gueorguieva R, et al. Prazosin for veterans with posttraumatic stress disorder and comorbid alcohol dependence: a clinical trial. Alcohol Clin Exp Res. 2016 Jan;40(1):178-86. doi: 10.1111/acer.12926. PMID: 26683790.","44663","2020"
"petrakis2012_A","Pharmacotherapy","PTSD+SUD","PTSD+SUD","Not integrated","88","A","22",,"Paroxetine + naltrexone","Paroxetine + naltrexone","Paroxetine: SSRI; naltrexone: opioid antagonist","No","Not Applicable","Yes","Mixed","No","Not Applicable","No","No","No","No","No","Individual","In Person","Paroxetine initiated at 10 mg, titrated over 2 weeks to 40 mg

Naltrexone initiated at 25 mg for 1 day then 50 mg for rest of treatment",,"Daily

Daily","12",,,,,"monitored by pill count",,,,,,,,,"Mixed","0","0.9205","0.0795","0.0909",,"0.9091",,,"Medium","Petrakis IL, Ralevski E, Desai N, et al. Noradrenergic vs serotonergic antidepressant with or without naltrexone for veterans with PTSD and comorbid alcohol dependence. Neuropsychopharmacology. 2012 Mar;37(4):996-1004. doi: 10.1038/npp.2011.283. PMID: 22089316.","36777","2019"
"petrakis2012_B","Pharmacotherapy","PTSD+SUD","PTSD",,"88","B","20",,"Paroxetine + placebo","Paroxetine + placebo","SSRI","No","Not Applicable","Yes","Antidepressant: SSRI","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","Paroxetine initiated at 10 mg/day, titrated over 2 weeks to 40 mg/day.",,"Daily","12",,,,,"monitored by pill count",,,,,,,,,"Mixed","0","0.9205","0.0795","0.0909",,"0.9091",,,"Medium","Petrakis IL, Ralevski E, Desai N, et al. Noradrenergic vs serotonergic antidepressant with or without naltrexone for veterans with PTSD and comorbid alcohol dependence. Neuropsychopharmacology. 2012 Mar;37(4):996-1004. doi: 10.1038/npp.2011.283. PMID: 22089316.","36777","2019"
"petrakis2012_C","Pharmacotherapy","PTSD+SUD","PTSD+SUD","Not integrated","88","C","22",,"Desipramine + naltrexone","Desipramine + naltrexone","TCA plus opioid antagonist","No","Not Applicable","Yes","Mixed","No","Not Applicable","No","No","No","No","No","Individual","In Person","Desipramine initiated at 25 mg/day, titrated over 2 weeks to 200 mg/day. Naltrexone initiated at 25 mg/day for first day then 50 mg/day for rest of treatment.",,"Daily","12",,,,,"monitored by pill count",,,,,,,,,"Mixed","0","0.9205","0.0795","0.0909",,"0.9091",,,"Medium","Petrakis IL, Ralevski E, Desai N, et al. Noradrenergic vs serotonergic antidepressant with or without naltrexone for veterans with PTSD and comorbid alcohol dependence. Neuropsychopharmacology. 2012 Mar;37(4):996-1004. doi: 10.1038/npp.2011.283. PMID: 22089316.","36777","2019"
"petrakis2012_D","Pharmacotherapy","PTSD+SUD","PTSD",,"88","D","24",,"Desipramine + placebo","Desipramine + placebo","TCA","No","Not Applicable","Yes","Antidepressant: TCA","No","Not Applicable","No","No","No","No","No","Individual","In Person","Desipramine initiated at 25 mg/day, titrated over 2 weeks to 200 mg/day",,"Daily","12",,,,,"monitored by pill count",,,,,,,,,"Mixed","0","0.9205","0.0795","0.0909",,"0.9091",,,"Medium","Petrakis IL, Ralevski E, Desai N, et al. Noradrenergic vs serotonergic antidepressant with or without naltrexone for veterans with PTSD and comorbid alcohol dependence. Neuropsychopharmacology. 2012 Mar;37(4):996-1004. doi: 10.1038/npp.2011.283. PMID: 22089316.","36777","2019"
"philip2019a_B","Nonpharmacologic biological","PTSD","Control",,"50","B","25",,"Sham intermittent theta-burst transcranial magnetic stimulation","Sham","Sham treatment; used separate coils for sham stimulation using a Magstim Rapid 2+1 system.","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","Dose: NR (sham treatment)","Session length: 9.5 minutes","Daily (weekdays)","2","total 10 sessions","completed allocated intervention per protocol","0.92",,,,,,,,,,,"Veteran","0","1","0","0.16",,"0.84","Mixed","combat-related, rape/sexual assault, accidents, illness/medical procedure, community/school violence, natural or manmade disasters, terrorism/political violence/forced displacement, other (unspecified childhood trauma, ""serious injury, harm, or death you caused to someone else"", ""other very stressful event/experiences"")","Medium","Philip NS, Barredo J, Aiken E, et al. Theta-burst transcranial magnetic stimulation for posttraumatic stress disorder. Am J Psychiatry. 2019 Jun 24;176(11):939-48. doi: 10.1176/appi.ajp.2019.18101160. PMID: 31230462.","52101","2020"
"philip2019a_A","Nonpharmacologic biological","PTSD","PTSD",,"50","A","25",,"Intermittent theta-burst transcranial magnetic stimulation","Transcranial magnetic stimualtion (TMS)","Intermittent theta-burst transcranial magnetic stimulation to right dorsolateral prefrontal cortex at 80% motor threshold (1800 pulses, 9.5 minutes) using a Magstim Rapid 2+1 system.","No","Not Applicable","No","Not Applicable","No","Not Applicable","Yes","No","No","No","No","Individual","In Person","Dose: 1800 pulses at 80% of active motor threshold","Session length: 9.5 minutes","Daily (weekdays)","2","total 10 sessions","completed allocated intervention per protocol","0.96",,,,,,,,,,,"Veteran","0","1","0","0.16",,"0.84","Mixed","combat-related, rape/sexual assault, accidents, illness/medical procedure, community/school violence, natural or manmade disasters, terrorism/political violence/forced displacement, other (unspecified childhood trauma, ""serious injury, harm, or death you caused to someone else"", ""other very stressful event/experiences"")","Medium","Philip NS, Barredo J, Aiken E, et al. Theta-burst transcranial magnetic stimulation for posttraumatic stress disorder. Am J Psychiatry. 2019 Jun 24;176(11):939-48. doi: 10.1176/appi.ajp.2019.18101160. PMID: 31230462.","52101","2020"
"philip2019b_B","Nonpharmacologic biological","PTSD","Control",,"23","B","13",,"Sham synchronized TMS","Sham","Sham synchronized TMS was identical to active synchronized TMS except it did not use rotating magnets. Sham stimulation followed by optional unblinded synchronized TMS for another 4 weeks, delivered on a separate device from the one used for blinded stimulation.","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person",,,"5 times a week",,"blinded: 4 weeks; optional unblinded: 4 weeks",,,,,,,,,,,,,"Veteran","0","1","0","0.22",,"0.78",,,"High","Philip NS, Aiken EE, Kelley ME, et al. Synchronized transcranial magnetic stimulation for posttraumatic stress disorder and comorbid major depression. Brain Stimulation. 2019 Sep-Oct;12(5):1335-7. doi: http://dx.doi.org/10.1016/j.brs.2019.06.010. PMID: 31204205.","1511859","2020"
"philip2019b_A","Nonpharmacologic biological","PTSD","PTSD",,"23","A","10",,"Synchronized TMS","Transcranial magnetic stimualtion (TMS)","Active synchronized TMS for 4 weeks. Optional unblinded synchronized TMS for another 4 weeks, delivered on a separate device from the one used for blinded stimulation.","No","Not Applicable","No","Not Applicable","No","Not Applicable","Yes","No","No","No","No","Individual","In Person",,,"5 times a week",,"blinded: 4 weeks; optional unblinded: 4 weeks",,,,,,,,,,,,,"Veteran","0","1","0","0.22",,"0.78",,,"High","Philip NS, Aiken EE, Kelley ME, et al. Synchronized transcranial magnetic stimulation for posttraumatic stress disorder and comorbid major depression. Brain Stimulation. 2019 Sep-Oct;12(5):1335-7. doi: http://dx.doi.org/10.1016/j.brs.2019.06.010. PMID: 31204205.","1511859","2020"
"polak2015_A","Psychotherapy","PTSD","PTSD",,"8","A","4",,"Trauma-focused CBT with breathing biofeedback","Trauma-focused cognitive behavioral therapy (TF-CBT) with breathing biofeedback","CBT following model developed by Foa et al (1995) that included imaginal and in vivo exposure, psychoeducation, and anxiety management. A device measures breathing frequency and provides immediate feedback (sound) when breathing frequency is outside preprogrammed frequency","Yes","TF","No","Not Applicable","No","Not Applicable","Yes","No","No","No","No","Individual","In Person",,,"Weekly",,"flexible number of sessions until subjective units of distress‚ ≤30",,,,,,,,,"median 7.5 (range 6 to 11)",,,,"Community",,,"1","0.75",,"0.25","Mixed","accidents, other (sexual or physical abuse)","High","Polak AR, Witteveen AB, Denys D, et al. Breathing biofeedback as an adjunct to exposure in cognitive behavioral therapy hastens the reduction of PTSD symptoms: a pilot study. Appl Psychophysiol Biofeedback. 2015 Mar;40(1):25-31. doi: 10.1007/s10484-015-9268-y. PMID: 25750106.","47793","2019"
"polak2015_B","Psychotherapy","PTSD","PTSD",,"8","B","4",,"Trauma-focused CBT","Trauma-focused cognitive behavioral therapy (TF-CBT)","CBT following model developed by Foa et al (1995) that included imaginal and in vivo exposure, psychoeducation, and anxiety management","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,,"Weekly",,"flexible number of sessions until subjective units of distress‚ ≤30",,,,,,,,,"median 8.0 (range 5 to 18)",,,,"Community",,,"1","0.75",,"0.25","Mixed","accidents, other (sexual or physical abuse)","High","Polak AR, Witteveen AB, Denys D, et al. Breathing biofeedback as an adjunct to exposure in cognitive behavioral therapy hastens the reduction of PTSD symptoms: a pilot study. Appl Psychophysiol Biofeedback. 2015 Mar;40(1):25-31. doi: 10.1007/s10484-015-9268-y. PMID: 25750106.","47793","2019"
"polusny2015_A","Mixed: Psychotherapy & CIH","PTSD","PTSD",,"116","A","58",,"MBSR","Mindfulness-based stress reduction (MBSR)","Program teaches participants to attend to the present moment (immediate emotional and physical states) in a nonjudgmental and accepting way. Sessions include didactic training and formal practice in 3 meditation techniques: body scan, sitting meditation, and mindful yoga. Intervention modified to include PTSD psychoeducation.","No","Not Applicable","No","Not Applicable","Yes","Meditation","No","No","No","No","No","Group","In Person",,"Weekly session: 2.5 hours

Retreat: 6.5 hours","8 weekly sessions plus 1 daylong retreat","9",,"completed ≥7 sessions","0.7759",,,,,"6.96","2.6",,,,,"Veteran","0","1","0","0.1552",,"0.8448","Mixed","combat-related, rape/sexual assault, illness/medical procedure, community/school violence, natural or manmade disaster, other (not specified)","Medium","Polusny MA, Erbes CR, Thuras P, et al. Mindfulness-based stress reduction for posttraumatic stress disorder among veterans: a randomized clinical trial. JAMA. 2015 Aug 4;314(5):456-65. doi: 10.1001/jama.2015.8361. PMID: 26241597.","44257","2019"
"polusny2015_B","Mixed: Psychotherapy & CIH","PTSD","PTSD",,"116","B","58",,"PCT","Present Centered Therapy (PCT)","Therapy focuses on current life problems as manifestations of PTSD. Therapists are nondirective and encourage patients to provide each other with support, problem solving, and validation","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Group","In Person",,"1.5 hour","Weekly","9",,"completed ≥7 sessions","0.931",,,,,"8.08","1.8",,,,,"Veteran","0","1","0","0.1552",,"0.8448","Mixed","combat-related, rape/sexual assault, illness/medical procedure, community/school violence, natural or manmade disaster, other (not specified)","Medium","Polusny MA, Erbes CR, Thuras P, et al. Mindfulness-based stress reduction for posttraumatic stress disorder among veterans: a randomized clinical trial. JAMA. 2015 Aug 4;314(5):456-65. doi: 10.1001/jama.2015.8361. PMID: 26241597.","44257","2019"
"popiel2015_A","Mixed: Psychotherapy & pharmacotherapy","PTSD","PTSD",,"228","A","114",,"PE","Prolonged Exposure (PE)","Treatment according to manual by Foa, Hembree & Rothbaum, 2007 and Foa, Rothbaum, Riggs, & Murdock 1991","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","90 minutes",,"Weekly","12",,,,,,,,"8.6","3.5",,,,,"Community",,,"1","0.2368",,"0.7632","Accidents",,"High","Popiel A, Zawadzki B, Praglowska E, et al. Prolonged exposure, paroxetine and the combination in the treatment of PTSD following a motor vehicle accident. A randomized clinical trial - the ""TRAKT"" study. J Behav Ther Exp Psychiatry. 2015 Sep;48:17-26. doi: 10.1016/j.jbtep.2015.01.002. PMID: 25677254.","45183","2019"
"popiel2015_B","Mixed: Psychotherapy & pharmacotherapy","PTSD","PTSD",,"228","B","57",,"Paroxetine","Paroxetine","SSRI","No","Not Applicable","Yes","Antidepressant: SSRI","No","Not Applicable","No","No","No","No","No","Individual","In Person","20 mg/day achieved over 3 to 7 days",,"Daily","12",,,,,,,,,,,,,,"Community",,,"1","0.2368",,"0.7632","Accidents",,"High","Popiel A, Zawadzki B, Praglowska E, et al. Prolonged exposure, paroxetine and the combination in the treatment of PTSD following a motor vehicle accident. A randomized clinical trial - the ""TRAKT"" study. J Behav Ther Exp Psychiatry. 2015 Sep;48:17-26. doi: 10.1016/j.jbtep.2015.01.002. PMID: 25677254.","45183","2019"
"popiel2015_C","Mixed: Psychotherapy & pharmacotherapy","PTSD","PTSD",,"228","C","57",,"PE + paroxetine","Prolonged Exposure (PE) + paroxetine","PE protocol according to Foa, Hembree & Rothbaum, 2007 and Foa, Rothbaum, Riggs, & Murdock, 1991; plus SSRI","Yes","TF","Yes","Antidepressant: SSRI","No","Not Applicable","No","No","No","No","No","Individual","In Person","Session length: 90 minutes

Doses: 20 mg/day",,"Psychotherapy: weekly

SSRI: daily","12",,,,,,,,"8.0","3.4",,,,,"Community",,,"1","0.2368",,"0.7632","Accidents",,"High","Popiel A, Zawadzki B, Praglowska E, et al. Prolonged exposure, paroxetine and the combination in the treatment of PTSD following a motor vehicle accident. A randomized clinical trial - the ""TRAKT"" study. J Behav Ther Exp Psychiatry. 2015 Sep;48:17-26. doi: 10.1016/j.jbtep.2015.01.002. PMID: 25677254.","45183","2019"
"possemato2016_A","Other mixed","PTSD","PTSD",,"20","A","10",,"PTSD Coach mobile application with clinician support","PTSD Coach mobile application","Self-management app with psychoeducation, symptom monitoring, coping skills, and links to social support and professional resources with clinician support","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","No","Yes","No","Individual","Technology Assisted",,"20 minutes","Biweekly","8",,"attended all coaching sessions","1",,,,,"4","0",,,,,"Veteran","0","1","0","0.05",,"0.95","Other (military-related)",,"High","Possemato K, Kuhn E, Johnson E, et al. Using PTSD Coach in primary care with and without clinician support: a pilot randomized controlled trial. General hospital psychiatry. 2016 Jan-Feb;38:94-8. doi: 10.1016/j.genhosppsych.2015.09.005. PMID: 26589765.","44682","2019"
"possemato2016_B","Other mixed","PTSD","PTSD",,"20","B","10",,"PTSD Coach mobile application without clinician support","PTSD Coach mobile application","Self-management app with psychoeducation, symptom monitoring, coping skills, and links to social support and professional resources","No","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","Yes","No","Individual","Technology Alone",,,,"8",,"attended all coaching sessions","1",,,,,,,,,,,"Veteran","0","1","0","0.05",,"0.95","Other (military-related)",,"High","Possemato K, Kuhn E, Johnson E, et al. Using PTSD Coach in primary care with and without clinician support: a pilot randomized controlled trial. General hospital psychiatry. 2016 Jan-Feb;38:94-8. doi: 10.1016/j.genhosppsych.2015.09.005. PMID: 26589765.","44682","2019"
"power2002_A","Psychotherapy","PTSD","PTSD",,"105","A","39",,"EMDR","Eye Movement Desensitization and Reprocessing (EMDR)","Patient's attention is directed to an external stimulus while they simultaneously concentrate on an identified source of emotional disturbance. External stimuli used included bilateral saccadic eye movements or alternating hand taps. When distress had sufficiently reduced on the part of the patient negative belief statements were replaced by preferred belief statements and saccadic eye movements or hand taps","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"90 minutes","Weekly","10",,,,,,,,"4.2",,,,,,"Community",,,"1","0.4167","completers only","0.5833","Mixed","accidents, rape/sexual assault, community/school violence, other (traumatic death, not specified)","High","Power K, McGoldrick T, Brown K, et al. A controlled comparison of Eye Movement Desensitization and Reprocessing versus exposure plus cognitive restructuring versus waiting list in the treatment of post‚Äö√Ñ√™traumatic stress disorder. Clin Psychol Psychother. 2002 Sep/Oct;9(5):299-318. doi: 10.1002/cpp.341.
.","25144","2019"
"power2002_B","Psychotherapy","PTSD","PTSD",,"105","B","37",,"Exposure + cognitive restructuring","Trauma-focused cognitive behavioral therapy (TF-CBT)","Imaginal exposure sessions which were audio-taped. Therapists facilitated this process by prompting, questioning and encouraging. Patients were provided with audio-tape copies and asked to listen to the recording at least once per day as homework.","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"90 minutes","Weekly","10",,,,,,,,"6.4",,,,,,"Community",,,"1","0.4167","completers only","0.5833","Mixed","accidents, rape/sexual assault, community/school violence, other (traumatic death, not specified)","High","Power K, McGoldrick T, Brown K, et al. A controlled comparison of Eye Movement Desensitization and Reprocessing versus exposure plus cognitive restructuring versus waiting list in the treatment of post‚Äö√Ñ√™traumatic stress disorder. Clin Psychol Psychother. 2002 Sep/Oct;9(5):299-318. doi: 10.1002/cpp.341.
.","25144","2019"
"power2002_C","Psychotherapy","PTSD","Control",,"105","C","29",,"Waitlist","Waitlist",,"No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,,,,"10",,,,,,,,,,,,,,"Community",,,"1","0.4167","completers only","0.5833","Mixed","accidents, rape/sexual assault, community/school violence, other (traumatic death, not specified)","High","Power K, McGoldrick T, Brown K, et al. A controlled comparison of Eye Movement Desensitization and Reprocessing versus exposure plus cognitive restructuring versus waiting list in the treatment of post‚Äö√Ñ√™traumatic stress disorder. Clin Psychol Psychother. 2002 Sep/Oct;9(5):299-318. doi: 10.1002/cpp.341.
.","25144","2019"
"powers2015_A","Psychotherapy","PTSD","PTSD",,"9","A",,,"PE + exercise","Prolonged Exposure (PE) + exercise","Participants completed a 30-minute bout of moderate-intensity treadmill exercise (70% of age-predicted HRmax) immediately prior to each PE session. PE was manualized treatment program including education about trauma; breathing retraining: prolonged and repeated imaginal exposure to the trauma memories; prolonged and repeated in vivo exposure to safe situations; assignment of homework; and monitoring compliance of homework assignments.","Yes","TF","No","Not Applicable","Yes","Other physical activity and recreational therapies","No","No","No","No","No","Individual","In Person",,"90 minutes","Weekly","12",,,,,,,,,,,,,,"Community",,,"1","0.8889",,"0.1111",,,"High","Powers MB, Medina JL, Burns S, et al. Exercise augmentation of exposure therapy for PTSD: rationale and pilot efficacy data. Cogn Behav Ther. 2015;44(4):314-27. doi: 10.1080/16506073.2015.1012740. PMID: 25706090.","43517","2019"
"powers2015_B","Psychotherapy","PTSD","PTSD",,"9","B",,,"PE","Prolonged Exposure (PE)","PE was manualized treatment program including education about trauma; breathing retraining: prolonged and repeated imaginal exposure to the trauma memories; prolonged and repeated in vivo exposure to safe situations; assignment of homework; and monitoring compliance of homework assignments.","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"90 minutes","Weekly","12",,,,,,,,,,,,,,"Community",,,"1","0.8889",,"0.1111",,,"High","Powers MB, Medina JL, Burns S, et al. Exercise augmentation of exposure therapy for PTSD: rationale and pilot efficacy data. Cogn Behav Ther. 2015;44(4):314-27. doi: 10.1080/16506073.2015.1012740. PMID: 25706090.","43517","2019"
"quinones2015_A","Mixed: Psychotherapy & CIH","PTSD","PTSD",,"100","A","50",,"Yoga + supportive therapy","Yoga + supportive therapy","Satyananda yoga includes postures, breathing techniques, deep relaxation, and meditation. Supportive therapy provided by trained psychologist and follows mandatory ordinary assistance protocol designed by Agencia Colombiana para la Reintegracion for reintegrating individuals","Yes","Non-TF","No","Not Applicable","Yes","Yoga","No","No","No","No","No","Individual","In Person",,"1 hour","Satyananda yoga: twice weekly

Supportive therapy: once monthly","16",,,,,,,,,,,,,,"Community",,,"1","0.27",,"0.73","Combat-related",,"High","Quinones N, Maquet YG, Velez DM, et al. Efficacy of a Satyananda yoga intervention for reintegrating adults diagnosed with posttraumatic stress disorder. Int J Yoga Therap. 2015;25(1):89-99. doi: 10.17761/1531-2054-25.1.89. PMID: 26667292.","44694","2019"
"quinones2015_B","Mixed: Psychotherapy & CIH","PTSD","Control",,"100","B","50",,"Waitlist + supportive therapy","Supportive counseling","Wait list for yoga with monthly appointment with a trained psychologist following the mandatory ordinary assistance protocol designed by Agencia Colombiana para la Reintegracion for reintegrating individuals.","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person",,,"Once monthly","16",,,,,,,,,,,,,,"Community",,,"1","0.27",,"0.73","Combat-related",,"High","Quinones N, Maquet YG, Velez DM, et al. Efficacy of a Satyananda yoga intervention for reintegrating adults diagnosed with posttraumatic stress disorder. Int J Yoga Therap. 2015;25(1):89-99. doi: 10.17761/1531-2054-25.1.89. PMID: 26667292.","44694","2019"
"raeolmsted2019_B","Nonpharmacologic biological","PTSD","Control",,"113","B","39",,"Sham SGB","Sham","Two sham right-sided SGB treatments, with normal saline injected into musculature anterolateral to the anterior tubercle of C6, performed at 0 and 2 weeks with outcomes measured at 8 weeks","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","1 to 2 mL of normal saline",,"Twice separated by 2 weeks","2",,,,,,,,,,,,,,"Active Duty Military","1","0","0","0.115",,"0.885",,,"Medium","Rae Olmsted KL, Bartoszek M, Mulvaney S, et al. Effect of Stellate Ganglion Block Treatment on Posttraumatic Stress Disorder Symptoms: A Randomized Clinical Trial. JAMA Psychiatry. 2019 Nov 6:1-9. doi: https://dx.doi.org/10.1001/jamapsychiatry.2019.3474. PMID: 31693083.",,"2020"
"raeolmsted2019_A","Nonpharmacologic biological","PTSD","PTSD",,"113","A","74",,"SGB","Stellate ganglion block (SGB)","Two right-sided SGB treatments, with ropivicaine injected into ganglion site at level of C6 anterior tubercle, performed at 0 and 2 weeks with outcomes measured at 8 weeks","No","Not Applicable","No","Not Applicable","No","Not Applicable","Yes","No","No","No","No","Individual","In Person","7 to 10 mL of 0.5% ropivacaine",,"Twice separated by 2 weeks","2",,,,,,,,,,,,,,"Active Duty Military","1","0","0","0.115",,"0.885",,,"Medium","Rae Olmsted KL, Bartoszek M, Mulvaney S, et al. Effect of Stellate Ganglion Block Treatment on Posttraumatic Stress Disorder Symptoms: A Randomized Clinical Trial. JAMA Psychiatry. 2019 Nov 6:1-9. doi: https://dx.doi.org/10.1001/jamapsychiatry.2019.3474. PMID: 31693083.",,"2020"
"ramaswamy2016_A","Pharmacotherapy","PTSD","PTSD",,"30","A","15",,"Ziprasidone","Ziprasidone","Atypical antipsychotic; dose increased in increments of 20 mg twice daily","No","Not Applicable","Yes","Antipsychotic","No","Not Applicable","No","No","No","No","No","Individual","In Person","Initiated at 20 mg, titrated to maximum 80 mg",,"Twice daily","9",,,,,,,,,,,,,,"Community",,,"1","0.8667",,"0.1333","Mixed","rape/sexual assault, community/school violence, other (not specified)","High","Ramaswamy S, Driscoll D, Smith LM, et al. Failed efficacy of ziprasidone in the treatment of post-traumatic stress disorder. Contemp Clin Trials Commun. 2016 Dec;2:1-5. doi: 10.1016/j.conctc.2015.12.003. PMID: 29736440.","1551835","2019"
"ramaswamy2016_B","Pharmacotherapy","PTSD","Control",,"30","B","15",,"Placebo","Placebo","Placebo","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person",,,,"9",,,,,,,,,,,,,,"Community",,,"1","0.8667",,"0.1333","Mixed","rape/sexual assault, community/school violence, other (not specified)","High","Ramaswamy S, Driscoll D, Smith LM, et al. Failed efficacy of ziprasidone in the treatment of post-traumatic stress disorder. Contemp Clin Trials Commun. 2016 Dec;2:1-5. doi: 10.1016/j.conctc.2015.12.003. PMID: 29736440.","1551835","2019"
"ramaswamy2017_A","Pharmacotherapy","PTSD","PTSD",,"59","A","29",,"Vilazodone","Vilazodone","SSRI and partial agonist of 5-HT1A receptor; 10 mg/day on days 1 to 7, 20 mg/day on days 8 to 14, 40 mg/day weeks 3 through 12, with the option to adjust dose based on response and tolerability; tapered off vilazodone over weeks 13 and 14, no treatment week 15","No","Not Applicable","Yes","Other pharmacotherapy","No","Not Applicable","No","No","No","No","No","Individual","In Person","Initiated at 10 mg/day, increased to maximum 40 mg/day",,"Once daily","12",,,,,"counts of returned medications",,,,,,,,,"Veteran","0","1","0","0.0339",,"0.9661","Combat-related",,"Medium","Ramaswamy S, Driscoll D, Reist C, et al. A double-blind, placebo-controlled randomized trial of vilazodone in the treatment of posttraumatic stress disorder and comorbid depression. Prim Care Companion CNS Disord. 2017 Aug 24;19(4):17m02138. doi: 10.4088/PCC.17m02138. PMID: 28858440.","49046","2019"
"ramaswamy2017_B","Pharmacotherapy","PTSD","Control",,"59","B","30",,"Placebo","Placebo","Matched active treatment","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person",,,"Once daily","12",,,,,"counts of returned medications",,,,,,,,,"Veteran","0","1","0","0.0339",,"0.9661","Combat-related",,"Medium","Ramaswamy S, Driscoll D, Reist C, et al. A double-blind, placebo-controlled randomized trial of vilazodone in the treatment of posttraumatic stress disorder and comorbid depression. Prim Care Companion CNS Disord. 2017 Aug 24;19(4):17m02138. doi: 10.4088/PCC.17m02138. PMID: 28858440.","49046","2019"
"raskind2003_A","Pharmacotherapy","PTSD","PTSD",,"10","A","10",,"Prazosin","Prazosin","Alpha-1 adrenergic receptor antagonist; 1 mg/day for 3 days, 2 mg/day for 4 days, then based on response and tolerability increased to 4 mg/day for 7 days, 6 mg/day for 7 days, and then 10 mg/day.","No","Not Applicable","Yes","Antiadrenergic","No","Not Applicable","No","No","No","No","No","Individual","In Person","Initiated at 1 mg and titrated to maximum 10 mg",,"Daily","9",,,,,,,,,,,"9.5 mg/day","0.5",,"Veteran","0","1","0","0",,"1","Combat-related",,"Medium","Raskind MA, Peskind ER, Kanter ED, et al. Reduction of nightmares and other PTSD symptoms in combat veterans by prazosin: a placebo-controlled study. Am J Psychiatry. 2003 Feb;160(2):371-3. doi: 10.1176/appi.ajp.160.2.371. PMID: 12562588.","25442","2019"
"raskind2003_B","Pharmacotherapy","PTSD","Control",,"10","B","10",,"Placebo","Placebo","Placebo","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,,"Daily","9",,,,,,,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"Medium","Raskind MA, Peskind ER, Kanter ED, et al. Reduction of nightmares and other PTSD symptoms in combat veterans by prazosin: a placebo-controlled study. Am J Psychiatry. 2003 Feb;160(2):371-3. doi: 10.1176/appi.ajp.160.2.371. PMID: 12562588.","25442","2019"
"raskind2007_A","Pharmacotherapy","PTSD","PTSD",,"40","A","20",,"Prazosin","Prazosin","Alpha-1 adrenergic receptor antagonist; 1 mg for 3 days, 2 mg through day 7, then titrated based on response and tolerability to 4 mg through day 14, 6 mg through day 21, 10 mg through day 28, 15 mg after 28-day visit.","No","Not Applicable","Yes","Antiadrenergic","No","Not Applicable","No","No","No","No","No","Individual","In Person","Initiated at 1 mg, titrated to maximum 15 mg",,"Daily","8",,,,,,,,,,,"13 mg","3",,"Veteran","0","1","0","0.05",,"0.95","Combat-related",,"Medium","Raskind MA, Peskind ER, Hoff DJ, et al. A parallel group placebo controlled study of prazosin for trauma nightmares and sleep disturbance in combat veterans with post-traumatic stress disorder. Biol Psychiatry. 2007 Apr 15;61(8):928-34. doi: 10.1016/j.biopsych.2006.06.032. PMID: 17069768.","29403","2019"
"raskind2007_B","Pharmacotherapy","PTSD","Control",,"40","B","20",,"Placebo","Placebo","Placebo capsules indistinguishable from prazosin","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person",,,"Daily","8",,,,,,,,,,,"14 mg equivalent","2",,"Veteran","0","1","0","0.05",,"0.95","Combat-related",,"Medium","Raskind MA, Peskind ER, Hoff DJ, et al. A parallel group placebo controlled study of prazosin for trauma nightmares and sleep disturbance in combat veterans with post-traumatic stress disorder. Biol Psychiatry. 2007 Apr 15;61(8):928-34. doi: 10.1016/j.biopsych.2006.06.032. PMID: 17069768.","29403","2019"
"raskind2013_A","Pharmacotherapy","PTSD","PTSD",,"67","A","32",,"Prazosin","Prazosin","Alpha-1 adrenergic receptor antagonist; titrated for up to 6 weeks based on response and tolerability, with a lower morning dose and higher bedtime dose, and separate titration schedules for men and women with lower doses for women","No","Not Applicable","Yes","Antiadrenergic","No","Not Applicable","No","No","No","No","No","Individual","In Person","Initiated at 1 mg for both men and women, titrated to maximum 25 mg for men and 12 mg for women",,"Daily (divided into smaller morning and larger bedtime doses)","15",,,,,,,,,,,"Bedtime dose 15.6 mg for men and 7.0 mg for women. Midmorning dose 4.0 mg for men and 1.7 mg for women.","Bedtime dose (6.0) mg for men and (3.5) mg for women. Midmorning dose (1.4) mg for men and (0.5) mg for women.",,"Mixed","0.9701","0.0299","0","0.1493",,"0.8507","Combat-related",,"Medium","Raskind MA, Peterson K, Williams T, et al. A trial of prazosin for combat trauma PTSD with nightmares in active-duty soldiers returned from Iraq and Afghanistan. Am J Psychiatry. 2013 Sep;170(9):1003-10. doi: 10.1176/appi.ajp.2013.12081133. PMID: 23846759.","41028","2019"
"raskind2013_B","Pharmacotherapy","PTSD","Control",,"67","B","35",,"Placebo","Placebo","Capsules indistinguishable from the 3 active drug capsules (1 mg, 2 mg, 5 mg); titration period for both placebo and active arms","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person",,,"Daily (morning and bedtime)","15",,,,,,,,,,,"Bedtime dose 18.8 mg for men and 10.0 mg for women. Midmorning dose 4.8 mg for men and 2.0 mg for women.","Bedtime dose (3.3) mg for men and (0.0) mg for women. Midmorning dose (0.8) mg for men and (0.0) mg for women.",,"Mixed","0.9701","0.0299","0","0.1493",,"0.8507","Combat-related",,"Medium","Raskind MA, Peterson K, Williams T, et al. A trial of prazosin for combat trauma PTSD with nightmares in active-duty soldiers returned from Iraq and Afghanistan. Am J Psychiatry. 2013 Sep;170(9):1003-10. doi: 10.1176/appi.ajp.2013.12081133. PMID: 23846759.","41028","2019"
"raskind2018_A","Pharmacotherapy","PTSD","PTSD",,"304","A","152",,"Prazosin","Prazosin","Alpha-1 adrenergic receptor antagonist; titrated based on response and tolerability, with a lower morning dose and higher bedtime dose, and separate titration schedules for men and women with lower doses for women. After the first 10 weeks, other pharmacologic therapies (except prazosin, trazodone, or psychostimulants) or psychotherapeutic treatments could be added, discontinued, or modified by treating clinicians.","No","Not Applicable","Yes","Adrenergic","No","Not Applicable","No","No","No","No","No","Individual","In Person","Initiated at 1 mg for both men and women, titrated to maximum 20 mg for men and 12 mg for women",,"Daily (divided into smaller morning and larger bedtime doses)","26",,,,,,,,,,,"14.8 mg/day","6.1",,"Veteran","0","1","0","0.023",,"0.977","Combat-related",,"Medium","Raskind MA, Peskind ER, Chow B, et al. Trial of prazosin for post-traumatic stress disorder in military veterans. N Engl J Med. 2018 Feb 8;378(6):507-17. doi: 10.1056/NEJMoa1507598. PMID: 29414272.","49659","2019"
"raskind2018_B","Pharmacotherapy","PTSD","Control",,"304","B","152",,"Placebo","Placebo","Capsules identical to the 3 active drug capsules (1 mg, 2 mg, 5 mg); titration period for both placebo and active arms. After the first 10 weeks, other pharmacologic therapies (except prazosin, trazodone, or psychostimulants) or psychotherapeutic treatments could be added, discontinued, or modified by treating clinicians.","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person",,,"Daily (morning and bedtime)","26",,,,,,,,,,,"16.4 mg/day","5.9",,"Veteran","0","1","0","0.023",,"0.977","Combat-related",,"Medium","Raskind MA, Peskind ER, Chow B, et al. Trial of prazosin for post-traumatic stress disorder in military veterans. N Engl J Med. 2018 Feb 8;378(6):507-17. doi: 10.1056/NEJMoa1507598. PMID: 29414272.","49659","2019"
"rasmusson2017_A","Pharmacotherapy","PTSD","PTSD",,"112","A","59",,"Ganaxolone","Ganaxolone","Investigational anxiolytic and anticonvulsant; biweekly dose escalations by 200 mg twice daily, based on tolerability","No","Not Applicable","Yes","Steroids","No","Not Applicable","No","No","No","No","No","Individual","In Person","Initiated at 200 mg, titrated to maximum 600 mg",,"Twice daily","6",,,,,"counted returned supplies; and compared plasma trough levels of ganaxolone to predicted therapeutic levels (≥20 ng/mL)","0.6471",,,,,,,,"Mixed",,,"0.125","0.2143",,"0.7857","Mixed","combat-related, child physical abuse, child sexual abuse, child other abuse","Medium","Rasmusson AM, Marx CE, Jain S, et al. A randomized controlled trial of ganaxolone in posttraumatic stress disorder. Psychopharmacology (Berl). 2017;234(15):2245-57. doi: 10.1007/s00213-017-4649-y. PMID: 28667510.","48368","2019"
"rasmusson2017_B","Pharmacotherapy","PTSD","Control",,"112","B","53",,"Placebo","Placebo","Gelatin capsules identical to those containing ganaxolone","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person",,,"Twice daily","6",,,,,"counted returned supplies",,,,,,,,,"Mixed",,,"0.125","0.2143",,"0.7857","Mixed","combat-related, child physical abuse, child sexual abuse, child other abuse","Medium","Rasmusson AM, Marx CE, Jain S, et al. A randomized controlled trial of ganaxolone in posttraumatic stress disorder. Psychopharmacology (Berl). 2017;234(15):2245-57. doi: 10.1007/s00213-017-4649-y. PMID: 28667510.","48368","2019"
"rauch2019_B","Psychotherapy","PTSD","PTSD",,"223","B","74",,"PE + placebo","Prolonged Exposure (PE) + placebo","Prolonged exposure therapy sessions included psychoeducation, imaginal exposure to traumatic memories, discussion, and in vivo exposure homework. Placebo titrated with last dose increase at 10 weeks.","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"Session length: 90 minutes","Psychotherapy: 13 sessions over 24 weeks; Placebo: daily","24",,"completion defined by adherence",,,"completing all 13 sessions and taking sertraline at week 24","0.463","defined for both interventions together",,,,"197.4 mg","11.3 mg",,"Mixed",,,"0","0.13",,"0.87","Combat-related",,"Medium","Rauch SAM, Kim HM, Powell C, et al. Efficacy of prolonged exposure therapy, sertraline hydrochloride, and their combination among combat veterans with posttraumatic stress disorder: a randomized clinical trial. JAMA Psychiatry. 2019 Feb 1;76(2):117-26. doi: 10.1001/jamapsychiatry.2018.3412. PMID: 30516797.","51290","2020"
"rauch2019_A","Psychotherapy","PTSD","PTSD",,"223","A","75",,"PE + sertraline","Prolonged Exposure (PE) + sertraline","Prolonged exposure therapy sessions included psychoeducation, imaginal exposure to traumatic memories, discussion, and in vivo exposure homework. Sertraline titrated with last dose increase at 10 weeks.","Yes","TF","Yes","Antidepressant: SSRI","No","Not Applicable","No","No","No","No","No","Individual","In Person","Dose: sertraline adjusted between 50 and 200 mg","Session length: 90 minutes","Psychotherapy: 13 sessions over 24 weeks; Sertraline: daily","24",,"completion defined by adherence",,,"completing all 13 sessions and taking sertraline at week 24","0.536","defined for both interventions together",,,,"171.6 mg","45.0 mg",,"Mixed",,,"0","0.13",,"0.87","Combat-related",,"Medium","Rauch SAM, Kim HM, Powell C, et al. Efficacy of prolonged exposure therapy, sertraline hydrochloride, and their combination among combat veterans with posttraumatic stress disorder: a randomized clinical trial. JAMA Psychiatry. 2019 Feb 1;76(2):117-26. doi: 10.1001/jamapsychiatry.2018.3412. PMID: 30516797.","51290","2020"
"rauch2019_C","Psychotherapy","PTSD","PTSD",,"223","C","74",,"Sertraline","Sertraline","Sertraline titrated with last dose increase at 10 weeks. Enhanced medication management ending at week 12 provided to balance time, psychoeducation, and clinician support compared with PE therapy groups","No","Not Applicable","Yes","Antidepressant: SSRI","No","Not Applicable","No","No","No","No","No","Individual","In Person","50 to 100 mg",,"Daily","24",,,,,"taking sertraline at week 24","0.732",,,,,"170.7 mg","46.9 mg",,"Mixed",,,"0","0.13",,"0.87","Combat-related",,"Medium","Rauch SAM, Kim HM, Powell C, et al. Efficacy of prolonged exposure therapy, sertraline hydrochloride, and their combination among combat veterans with posttraumatic stress disorder: a randomized clinical trial. JAMA Psychiatry. 2019 Feb 1;76(2):117-26. doi: 10.1001/jamapsychiatry.2018.3412. PMID: 30516797.","51290","2020"
"rauch2015_A","Psychotherapy","PTSD","PTSD",,"36","A","18",,"PE","Prolonged Exposure (PE)","Manualized therapy including psychoeducation, imaginal exposure, in vivo exposure, and emotional processing.","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"80 minutes",,"10 to 12",,"completed ≥7 sessions","0.6111",,,,,,,,,,,"Veteran","0","1","0","0.0833",,"0.9167",,,"High","Rauch SAM, King AP, Abelson JL, et al. Biological and symptom changes in posttraumatic stress disorder treatment: a randomized clinical trial. Depress Anxiety. 2015 Mar;32(3):204-12. doi: 10.1002/da.22331. PMID: 25639570.","43645","2019"
"rauch2015_B","Psychotherapy","PTSD","PTSD",,"36","B","18",,"PCT","Present Centered Therapy (PCT)","Therapy following the Shea manual (Schnurr 2007), with psychoeducation (2 sessions) and discussion of current experience of PTSD symptoms and coping (remaining sessions).","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"80 minutes",,"10 to 12",,"completed ≥7 sessions","0.8333",,,,,,,,,,,"Veteran","0","1","0","0.0833",,"0.9167",,,"High","Rauch SAM, King AP, Abelson JL, et al. Biological and symptom changes in posttraumatic stress disorder treatment: a randomized clinical trial. Depress Anxiety. 2015 Mar;32(3):204-12. doi: 10.1002/da.22331. PMID: 25639570.","43645","2019"
"ready2018_A","Psychotherapy","PTSD","PTSD",,"81","A","41",,"Group-based exposure therapy","Exposure therapy","Treatment involves creation of group cohesion, improving coping skills, imaginal and in vivo exposure exercises, and guided imagery exercise","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Group","In Person",,"4 hours","Twice weekly","16",,,,,,,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"Medium","Ready DJ, Mascaro N, Wattenberg MS, et al. A controlled study of group-based exposure therapy with Vietnam-era veterans. J Loss Trauma. 2018;23(6):439-57. doi: 10.1080/15325024.2018.1485268. PMID: 133654049.",,"2020"
"ready2018_B","Psychotherapy","PTSD","PTSD",,"81","B","40",,"PCGT","Present Centered Therapy (PCT)","Sessions focus on current problems related to PTSD symptoms and problem-solving","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Group","In Person",,"90-minute session","Twice weekly; Booster session once every 3 weeks","16","Booster sessions: 6",,,,,,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"Medium","Ready DJ, Mascaro N, Wattenberg MS, et al. A controlled study of group-based exposure therapy with Vietnam-era veterans. J Loss Trauma. 2018;23(6):439-57. doi: 10.1080/15325024.2018.1485268. PMID: 133654049.",,"2020"
"ready2010_A","Psychotherapy","PTSD","PTSD",,"11","A","6",,"Virtual reality exposure  therapy","Virtual reality exposure therapy (VRET)","Therapist provided trauma-related stimuli in a gradual manner through a virtual reality environment. Participants were asked to give a Subjective Units of Distress Scale every 5 minutes and to scan their body to report levels of tension.","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"90 minutes",,,"10 sessions total",,,,,,,"8.67","3.27",,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"High","Ready DJ, Gerardi RJ, Backscheider AG, et al. Comparing virtual reality exposure therapy to present-centered therapy with 11 U.S. Vietnam veterans with PTSD. Cyberpsychol Behav Soc Netw. 2010 Feb;13(1):49-54.  PMID: 20528293.","34258","2019"
"ready2010_B","Psychotherapy","PTSD","PTSD",,"11","B","5",,"PCT","Present Centered Therapy (PCT)","Supportive therapy involving psychoeducation, teaching problem-solving techniques, and helping participants through a focus on problems occurring in their lives","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"90 minutes",,,"10 sessions total",,,,,,,"8.00","4.47",,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"High","Ready DJ, Gerardi RJ, Backscheider AG, et al. Comparing virtual reality exposure therapy to present-centered therapy with 11 U.S. Vietnam veterans with PTSD. Cyberpsychol Behav Soc Netw. 2010 Feb;13(1):49-54.  PMID: 20528293.","34258","2019"
"reeve2020_A","Complementary and integrative health (CIH)","PTSD","PTSD",,"40","A","20",,"Healing Touch + Standard of care","Healing Touch","Each session included healing touch using two protocols: biofield treatment, and amygdala treatment. Participants also received standard of care during both phases.","No","Not Applicable","No","Not Applicable","Yes","Other physical activity and recreational therapies","No","No","No","No","No","Individual","In Person",,"1 hour","Weekly","10",,,,,,,,,,,,,,"Veteran","0","1","0",,,,,,"High","Reeve K, et al. Examining the impact of a Healing Touch intervention to reduce posttraumatic stress disorder symptoms in combat veterans. Psychological Trauma: Theory, Research, Practice, and Policy. 2020. doi: 10.1037/tra0000591.",,"2020"
"reeve2020_B","Complementary and integrative health (CIH)","PTSD","Control",,"40","B","20",,"Standard of care","Treatment as usual (TAU)","Medication and psychotherapy delivered by the subjects regular practitioners and a variety of other interventions, such as relaxation training, meditation, archery, or yoga.","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person",,,,,,,,,,,,,,,,,,"Veteran","0","1","0",,,,,,"High","Reeve K, et al. Examining the impact of a Healing Touch intervention to reduce posttraumatic stress disorder symptoms in combat veterans. Psychological Trauma: Theory, Research, Practice, and Policy. 2020. doi: 10.1037/tra0000591.",,"2020"
"reger2016_B","Psychotherapy","PTSD","PTSD",,"162","B","54",,"PE","Prolonged Exposure (PE)","Manualized intervention according to Foa et al. (2007), includes psychoeducation, breathing retraining, repeated and prolonged imaginal exposure to traumatic memory, cognitive and emotional processing of traumatic material, and in vivo exposure to safe but feared situations","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"90 minutes","Once or twice weekly","5","10 sessions total","completed 10 sessions","0.5926",,,,,"7.50","3.46",,,,,"Active Duty Military","1","0","0","0.037",,"0.963","Combat-related",,"Medium","Reger GM, Koenen-Woods P, Zetocha K, et al. Randomized controlled trial of prolonged exposure using imaginal exposure vs. virtual reality exposure in active duty soldiers with deployment-related posttraumatic stress disorder (PTSD). J Consult Clin. Psychol. 2016 Nov;84(11):946-59. doi: 10.1037/ccp0000134. PMID: 27606699.","45485","2020"
"reger2016_A","Psychotherapy","PTSD","PTSD",,"162","A","54",,"PE with virtual reality exposure","Prolonged Exposure (PE) with virtual reality exposure","Intervention follow PE treatment protocol according to Foa et al. (2007) with traumatic memory shown through virtual reality headset. While wearing headset, patient verbally describe the events.","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"90 minutes","Once or twice weekly","5","10 sessions total","completed 10 sessions","0.5556",,,,,"7.11","3.58",,,,,"Active Duty Military","1","0","0","0.037",,"0.963","Combat-related",,"Medium","Reger GM, Koenen-Woods P, Zetocha K, et al. Randomized controlled trial of prolonged exposure using imaginal exposure vs. virtual reality exposure in active duty soldiers with deployment-related posttraumatic stress disorder (PTSD). J Consult Clin. Psychol. 2016 Nov;84(11):946-59. doi: 10.1037/ccp0000134. PMID: 27606699.","45485","2020"
"reger2016_C","Psychotherapy","PTSD","Control",,"162","C","54",,"Waitlist minimal attention","Waitlist",,"No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,,,,"5",,"completing 5-week waiting period","0.8704",,,,,,,,,,,"Active Duty Military","1","0","0","0.037",,"0.963","Combat-related",,"Medium","Reger GM, Koenen-Woods P, Zetocha K, et al. Randomized controlled trial of prolonged exposure using imaginal exposure vs. virtual reality exposure in active duty soldiers with deployment-related posttraumatic stress disorder (PTSD). J Consult Clin. Psychol. 2016 Nov;84(11):946-59. doi: 10.1037/ccp0000134. PMID: 27606699.","45485","2020"
"reich2004_A","Pharmacotherapy","PTSD","PTSD",,"21","A","12",,"Risperidone","Risperidone","Atypical antipsychotic","No","Not Applicable","Yes","Antipsychotic","No","Not Applicable","No","No","No","No","No","Individual","In Person","0.5 mg for 3 days, then 1 mg/day after 3 days, then increase weekly by up to 1 mg/day to 4 mg/day.  Could increase to maximum of 8 mg/day after week 5",,"Daily at bedtime initially, then could be 2 or 3 times daily","8",,,,,,,,,,,"overall 1.41 mg, mean 2.05 mg at week 8",,,"Community","0","0","1","1",,"0","Mixed","child physical abuse, child sexual abuse, child other abuse","Medium","Reich DB, Winternitz S, Hennen J, et al. A preliminary study of risperidone in the treatment of posttraumatic stress disorder related to childhood abuse in women. J Clin Psychiatry. 2004 Dec;65(12):1601-6. PMID: 15641864.","27284","2019"
"reich2004_B","Pharmacotherapy","PTSD","Control",,"21","B","9",,"Control","Placebo","Placebo","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person",,,"Once daily at bedtime initially, then up to 2 or 3 times daily","8",,,,,,,,,,,,,,"Community","0","0","1","1",,"0","Mixed","child physical abuse, child sexual abuse, child other abuse","Medium","Reich DB, Winternitz S, Hennen J, et al. A preliminary study of risperidone in the treatment of posttraumatic stress disorder related to childhood abuse in women. J Clin Psychiatry. 2004 Dec;65(12):1601-6. PMID: 15641864.","27284","2019"
"reinhardt2018_A","Complementary and integrative health (CIH)","PTSD","PTSD",,"51","A","26",,"Kripalu yoga","Yoga","Group yoga sessions comprised of centering and breathing exercises, body warm-ups, physical poses, breath work, moving meditation, and relaxation; participants asked to practice yoga for 15 minutes daily.","No","Not Applicable","No","Not Applicable","Yes","Yoga","No","No","No","No","No","Group","In Person",,"90 minutes","Twice weekly","10",,,"0.3846",,,,,,,,,,,"Mixed",,,"0","0.1176",,"0.8824",,,"High","Reinhardt KM, Noggle Taylor JJ, Johnston J, et al. Kripalu yoga for military veterans With PTSD: a randomized trial. J Clin Psychol. 2018 Jan;74(1):93-108. doi: 10.1002/jclp.22483. PMID: 28524358.","48190","2019"
"reinhardt2018_B","Complementary and integrative health (CIH)","PTSD","Control",,"51","B","25",,"Control","Assessment","No treatment; participants completed assessments as a group (except CAPS, completed individually).","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Group","In Person",,,,"10",,"completed treatment course","0.84",,,,,,,,,,,"Mixed",,,"0","0.1176",,"0.8824",,,"High","Reinhardt KM, Noggle Taylor JJ, Johnston J, et al. Kripalu yoga for military veterans With PTSD: a randomized trial. J Clin Psychol. 2018 Jan;74(1):93-108. doi: 10.1002/jclp.22483. PMID: 28524358.","48190","2019"
"resick2015_A","Psychotherapy","PTSD","PTSD",,"108","A","56",,"CPT-Cognitive only version","Cognitive Processing Therapy (CPT)","Trauma-focused cognitive therapy where patients learn to label events, thoughts, and subsequent emptions while therapist uses Socratic questioning to help patients examine the facts and context, and develop new, more balanced thinking about traumatic events","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Group","In Person",,"90 minutes","Twice weekly","6",,,,,,,,"8.4","3.5",,,,,"Active Duty Military","1","0","0","0.0741",,"0.9259","Mixed","combat-related, child sexual abuse","Medium","Resick PA, Wachen JS, Mintz J, et al. A randomized clinical trial of group cognitive processing therapy compared with group present-centered therapy for PTSD among active duty military personnel. J Consult Clin Psychol. 2015 Dec;83(6):1058-68. doi: 10.1037/ccp0000016. PMID: 25939018.","43929","2020"
"resick2015_B","Psychotherapy","PTSD","PTSD",,"108","B","52",,"PCT","Present Centered Therapy (PCT)","Therapists help patients manage current symptoms through problem solving, directing discussion of trauma back to present time","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Group","In Person",,"90 minutes","Twice weekly","6",,,,,,,,"9.8","2.3",,,,,"Active Duty Military","1","0","0","0.0741",,"0.9259","Mixed","combat-related, child sexual abuse","Medium","Resick PA, Wachen JS, Mintz J, et al. A randomized clinical trial of group cognitive processing therapy compared with group present-centered therapy for PTSD among active duty military personnel. J Consult Clin Psychol. 2015 Dec;83(6):1058-68. doi: 10.1037/ccp0000016. PMID: 25939018.","43929","2020"
"resick2002_A","Psychotherapy","PTSD","PTSD",,"171","A","62",,"CPT","Cognitive Processing Therapy (CPT)","Manualized therapy including cognitive therapy and exposure in the form of writing and reading about the traumatic event","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"60 minutes for initial session, all others 90 minutes","Twice weekly","6",,"completed all 12 sessions","0.6613",,,,,,,,,,,"Community",,,"1","1",,"0","Mixed","child sexual abuse, rape/sexual assault","Medium","Resick PA, Nishith P, Weaver TL, et al. A comparison of cognitive-processing therapy with prolonged exposure and a waiting condition for the treatment of chronic posttraumatic stress disorder in female rape victims. J Consult Clin Psychol. 2002 Aug;70(4):867-79.  PMID: 12182270.","14652","2019"
"resick2002_B","Psychotherapy","PTSD","PTSD",,"171","B","62",,"PE","Prolonged Exposure (PE)","Includes education-rationale, breathing retraining, behavioral exposures, and imaginal exposures","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"60 minutes for initial session, all others 90 minutes","Twice weekly","6",,"completed all 12 sessions","0.6452",,,,,,,,,,,"Community",,,"1","1",,"0","Mixed","child sexual abuse, rape/sexual assault","Medium","Resick PA, Nishith P, Weaver TL, et al. A comparison of cognitive-processing therapy with prolonged exposure and a waiting condition for the treatment of chronic posttraumatic stress disorder in female rape victims. J Consult Clin Psychol. 2002 Aug;70(4):867-79.  PMID: 12182270.","14652","2019"
"resick2002_C","Psychotherapy","PTSD","Control",,"171","C","47",,"Waitlist with minimal attention","Minimal attention","Participants were encouraged to call therapist for client-centered telephone counseling","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","Phone",,,,"6",,"completed treatment course","0.8511",,,,,,,,,,,"Community",,,"1","1",,"0","Mixed","child sexual abuse, rape/sexual assault","Medium","Resick PA, Nishith P, Weaver TL, et al. A comparison of cognitive-processing therapy with prolonged exposure and a waiting condition for the treatment of chronic posttraumatic stress disorder in female rape victims. J Consult Clin Psychol. 2002 Aug;70(4):867-79.  PMID: 12182270.","14652","2019"
"resick2008_A","Psychotherapy","PTSD","PTSD",,"162","A","56",,"CPT","Cognitive Processing Therapy (CPT)","Manualized therapy that teaches skill of recognizing and challenging dysfunctional cognitions","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"60 minutes","Twice weekly","6",,"completed all 12 sessions","0.48",,,,,,,,,,,"Community",,,"1","1",,"0","Mixed","child physical abuse, child sexual abuse, rape/sexual assault, intimate partner violence","Medium","Resick PA, Galovski TE, Uhlmansiek MOB, et al. A randomized clinical trial to dismantle components of cognitive processing therapy for posttraumatic stress disorder in female victims of interpersonal violence. J Consult Clin Psychol. 2008 Apr;76(2):243-58. doi: 10.1037/0022-006X.76.2.243. PMID: 18377121.","30597","2019"
"resick2008_B","Psychotherapy","PTSD","PTSD",,"162","B","51",,"Written account","Written narrative exposure","Exposure-focused component of CPT where patients wrote about index event and discussed emotional response regarding event, but did not include cognitive therapy or challenge to client's dysfunctional statements","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"60 minutes for initial 2 sessions, 2 hours for remaining sessions","Twice weekly for first week, then weekly","6","7 sessions total","completed all 7 sessions","0.57",,,,,,,,,,,"Community",,,"1","1",,"0","Mixed","child physical abuse, child sexual abuse, rape/sexual assault, intimate partner violence","Medium","Resick PA, Galovski TE, Uhlmansiek MOB, et al. A randomized clinical trial to dismantle components of cognitive processing therapy for posttraumatic stress disorder in female victims of interpersonal violence. J Consult Clin Psychol. 2008 Apr;76(2):243-58. doi: 10.1037/0022-006X.76.2.243. PMID: 18377121.","30597","2019"
"resick2008_C","Psychotherapy","PTSD","PTSD",,"162","C","55",,"CPT-cognitive therapy","Cognitive Processing Therapy (CPT)","Identical to manualized CPT but without written account component","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"60 minutes","Twice weekly","6",,"completed all 12 sessions","0.55",,,,,,,,,,,"Community",,,"1","1",,"0","Mixed","child physical abuse, child sexual abuse, rape/sexual assault, intimate partner violence","Medium","Resick PA, Galovski TE, Uhlmansiek MOB, et al. A randomized clinical trial to dismantle components of cognitive processing therapy for posttraumatic stress disorder in female victims of interpersonal violence. J Consult Clin Psychol. 2008 Apr;76(2):243-58. doi: 10.1037/0022-006X.76.2.243. PMID: 18377121.","30597","2019"
"resick2017_A","Psychotherapy","PTSD","PTSD",,"268","A","133",,"Group CPT","Cognitive Processing Therapy (CPT)","Trauma-focused cognitive therapy in groups of 8 to 10 participants; cognitive-only version following manual developed for military and veterans and incorporating special considerations for military population; one individual meeting with therapist prior to treatment to review trauma history; therapy aim to teach patients to recognize and challenge dysfunctional cognitions (stuck points) about the traumatic event(s) and current thoughts about themselves, others, and the world. Participants who missed 4 sessions were dropped from group treatment.","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Group","In Person",,"90 minutes","Twice weekly","6",,"completed ≥9 sessions","0.5489",,,,,,,,,,,"Active Duty Military","1","0","0","0.09",,"0.91","Mixed","combat-related, rape/sexual assault, accidents, community/school violence, other (noncombat death)","Medium","Resick PA, Wachen JS, Dondanville KA, et al. Effect of group vs individual cognitive processing therapy in active-duty military seeking treatment for posttraumatic stress disorder: a randomized clinical trial. JAMA Psychiatry. 2017 Jan;74(1):28-36.  PMID: 27893032.","45949","2019"
"resick2017_B","Psychotherapy","PTSD","PTSD",,"268","B","135",,"Individual CPT","Cognitive Processing Therapy (CPT)","Individual trauma-focused cognitive therapy; cognitive-only version following manual developed for military and veterans and incorporating special considerations for military population; therapy aim to teach patients to recognize and challenge dysfunctional cognitions (stuck points) about the traumatic event(s) and current thoughts about themselves, others, and the world. Participants who couldn't complete treatment in 3 months for reasons other than military assignments had treatment ended.","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"60 minutes","Twice weekly","6",,"completed ≥9 sessions","0.6074",,,,,,,,,,,"Active Duty Military","1","0","0","0.09",,"0.91","Mixed","combat-related, rape/sexual assault, accidents, community/school violence, other (noncombat death)","Medium","Resick PA, Wachen JS, Dondanville KA, et al. Effect of group vs individual cognitive processing therapy in active-duty military seeking treatment for posttraumatic stress disorder: a randomized clinical trial. JAMA Psychiatry. 2017 Jan;74(1):28-36.  PMID: 27893032.","45949","2019"
"richards1994_A","Psychotherapy","PTSD","PTSD",,"14","A","7",,"Imaginal exposure followed by live exposure","Exposure therapy","Imaginal exposure involved patients reliving their traumatic memories until anxiety is reduced. Live exposure involved patients re-entering trauma-related situations that they had been avoiding.","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"60 minutes","Weekly","8","4 sessions each of imaginal and live exposure",,,,,,,,,,,,,"Community",,,"1","0.6923","(completers only)","0.3077","Mixed","rape/sexual assault, accidents, community/school violence, natural or manmade disasters","High","Richards DA, Lovell K, Marks IM. Post-traumatic stress disorder: evaluation of a behavioral treatment program. J Trauma Stress. 1994 Oct;7(4):669-80. doi: 10.1007/BF02103014. PMID: 7820356.","12187","2019"
"richards1994_B","Psychotherapy","PTSD","PTSD",,"14","B","7",,"Live exposure followed by imaginal exposure","Exposure therapy","Imaginal exposure involved patients reliving their traumatic memories until anxiety is reduced. Live exposure involved patients re-entering trauma-related situations that they had been avoiding.","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"60 minutes","Weekly","8","4 sessions each of imaginal and live exposure",,,,,,,,,,,,,"Community",,,"1","0.6923","(completers only)","0.3077","Mixed","rape/sexual assault, accidents, community/school violence, natural or manmade disasters","High","Richards DA, Lovell K, Marks IM. Post-traumatic stress disorder: evaluation of a behavioral treatment program. J Trauma Stress. 1994 Oct;7(4):669-80. doi: 10.1007/BF02103014. PMID: 7820356.","12187","2019"
"robjant2019_A","Psychotherapy","PTSD","PTSD",,"92","A","46",,"Adapted FORNET","Narrative Exposure Therapy (NET)","Individual + group therapy sessions; adapted version expanded group component to ""maximize the focus on behaviour change away from ongoing perpetration of violence within the community, and to increase the emphasis on peer support"". Individual sessions involved construction of lifeline, exploration of traumatic events (act of perpetrated violence). Group sessions ""aimed to develop skills and motivation to avoid perpetrating violence within the community"" and group members encouraged to support each other and introduced a 'buddy system'.","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Mixed","In Person",,"Individual sessions: 90 to 120 minutes; Group sessions: 60 to 90 minutes","Individual sessions: weekly; Group sessions: weekly","6",,"attended all individual and group therapy sessions (6 sessions each)","0.61",,,,,,,,,,,"Community","0","0","1","1",,"0","Other (former child soldiers)",,"Medium","Robjant K, Koebach A, Schmitt S, et al. The treatment of posttraumatic stress symptoms and aggression in female former child soldiers using adapted Narrative Exposure therapy - a RCT in Eastern Democratic Republic of Congo. Behav Res Ther. 2019 Dec;123:103482. doi: 10.1016/j.brat.2019.103482. PMID: 31639529.",,"2020"
"robjant2019_B","Psychotherapy","PTSD","Control",,"92","B","46",,"TAU","Treatment as usual (TAU)","Services available through NGO, including: ""occupational training courses, empathic listening and basic counselling, problem solving and practical support, provided whenever needed""; participant was visited at home if more than a week from last drop in.","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person",,,"Weekly","6",,,,,,,,,,,,,,"Community","0","0","1","1",,"0","Other (former child soldiers)",,"Medium","Robjant K, Koebach A, Schmitt S, et al. The treatment of posttraumatic stress symptoms and aggression in female former child soldiers using adapted Narrative Exposure therapy - a RCT in Eastern Democratic Republic of Congo. Behav Res Ther. 2019 Dec;123:103482. doi: 10.1016/j.brat.2019.103482. PMID: 31639529.",,"2020"
"rodgman2016_A","Pharmacotherapy","PTSD","PTSD",,"8","A","8","3 in first study period","Doxazosin extended release","Doxazosin","Extended-release alpha-1 noradrenergic antagonist with 15 to 19 hour half-life; initiated at 4 mg/day and increased by 4 mg every 4 days to final dose of 16 mg/day","No","Not Applicable","Yes","Antiadrenergic","No","Not Applicable","No","No","No","No","No","Individual","In Person","Initiated at 4 mg, titrated to 16 mg",,"Daily","2.29",,,,,,,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"Medium","Rodgman C, Verrico CD, Holst M, et al. Doxazosin XL reduces symptoms of posttraumatic stress disorder in veterans with PTSD: a pilot clinical trial. J Clin Psychiatry. 2016 May;77(5):e561-5. doi: 10.4088/JCP.14m09681. PMID: 27249080.","49795","2019"
"rodgman2016_B","Pharmacotherapy","PTSD","Control",,"8","B","8","5 in first study period","Placebo","Placebo","Placebo capsules identical to active treatment, dose increased over study period","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person",,,"Daily","2.29",,,,,,,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"Medium","Rodgman C, Verrico CD, Holst M, et al. Doxazosin XL reduces symptoms of posttraumatic stress disorder in veterans with PTSD: a pilot clinical trial. J Clin Psychiatry. 2016 May;77(5):e561-5. doi: 10.4088/JCP.14m09681. PMID: 27249080.","49795","2019"
"rogers1999_A","Psychotherapy","PTSD","PTSD",,"12","A","6",,"Group EMDR","Eye Movement Desensitization and Reprocessing (EMDR)","Intervention follow method as described by Shapiro (1995). Subjects asked to concentrate on a visual image, the negative statement, and the sensation while tracking the therapist's finger back and forth. When subjects report minimal distress, they were asked to concentrate on the visual image and positive cognition during eye movements.","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"60 to 90 minutes","Once","1",,,,,,,,,,,,,,"Veteran","0","1","0",,,,"Combat-related",,"High","Rogers S, Silver SM, Goss J, et al. A single session, group study of exposure and Eye Movement Desensitization and Reprocessing in treating posttraumatic stress disorder among Vietnam War veterans: preliminary data. J Anxiety Disord. 1999 Jan-Apr;13(1-2):119-30. doi: 10.1016/S0887-6185(98)00043-7. PMID: 10225504.","14686","2019"
"rogers1999_B","Psychotherapy","PTSD","PTSD",,"12","B","6",,"Exposure therapy","Exposure therapy","Intervention based on explosion procedure described in Lyons and Keane (1989). Subjects were guided in a progress muscle relaxation exercise, then visualized the experience while paying attention to sensory, cognitive, and emotional cues. The scene was repeated with relaxation.","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"60 to 90 minutes","Once","1",,,,,,,,,,,,,,"Veteran","0","1","0",,,,"Combat-related",,"High","Rogers S, Silver SM, Goss J, et al. A single session, group study of exposure and Eye Movement Desensitization and Reprocessing in treating posttraumatic stress disorder among Vietnam War veterans: preliminary data. J Anxiety Disord. 1999 Jan-Apr;13(1-2):119-30. doi: 10.1016/S0887-6185(98)00043-7. PMID: 10225504.","14686","2019"
"rosenbaum2015_A","Complementary and integrative health (CIH)","PTSD","PTSD",,"81","A","39",,"Exercise program","Exercise","Resistance training and pedometer-based walking program. Resistance training included one supervised exercise session and two home-based unsupervised exercise sessions per week.

Participants also received usual care which could include psychotherapy, pharmaceutical interventions, and group therapy.","No","Not Applicable","No","Not Applicable","Yes","Other physical activity and recreational therapies","No","No","No","No","No","Individual","In Person",,"30 minutes","Three times weekly","12",,,,,,,,,"2","7/12 supervised exercise sessions",,,,"Community",,,"1","0.1605",,"0.8395","Mixed","other (trauma experienced through occupation, not specified)","Medium","Rosenbaum S, Sherrington C, Tiedemann A. Exercise augmentation compared with usual care for post-traumatic stress disorder: a randomized controlled trial. Acta Psychiatr Scand. 2015 May;131(5):350-9. doi: 10.1111/acps.12371. PMID: 25443996.","44069","2019"
"rosenbaum2015_B","Complementary and integrative health (CIH)","PTSD","PTSD",,"81","B","42",,"TAU","Treatment as usual (TAU)","Usual care which could include psychotherapy, pharmaceutical interventions, and group therapy.","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,,,,"12",,,,,,,,,,,,,,"Community",,,"1","0.1605",,"0.8395","Mixed","other (trauma experienced through occupation, not specified)","Medium","Rosenbaum S, Sherrington C, Tiedemann A. Exercise augmentation compared with usual care for post-traumatic stress disorder: a randomized controlled trial. Acta Psychiatr Scand. 2015 May;131(5):350-9. doi: 10.1111/acps.12371. PMID: 25443996.","44069","2019"
"rothbaum1997_A","Psychotherapy","PTSD","PTSD",,"21","A","11",,"EMDR","Eye Movement Desensitization and Reprocessing (EMDR)","Individual sessions following treatment manual; patient imagines a scene that represents the entire trauma, focusing on sensations of anxiety while rehearsing words that match the picture and simultaneously follows therapist's finger moving back and forth until anxiety is decreased; patient then follows same procedure while rehearsing new, preferred belief, until the new statement feels true to the patient. The first session was comprised of information gathering, without EMDR.","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"90 minutes","Weekly","4",,,,,,,,,,,,,,"Community",,,"1","1",,"0","Rape/sexual assault",,"Medium","Rothbaum BO. A controlled study of Eye Movement Desensitization and Reprocessing in the treatment of posttraumatic stress disordered sexual assault victims. Bull Menninger Clin. 1997 Summer;61(3):317-34.  PMID: 9260344.","09058","2019"
"rothbaum1997_B","Psychotherapy","PTSD","Control",,"21","B","10",,"Waitlist","Waitlist",,"No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","No","No","No",,,,,,"4",,,,,,,,,,,,,,"Community",,,"1","1",,"0","Rape/sexual assault",,"Medium","Rothbaum BO. A controlled study of Eye Movement Desensitization and Reprocessing in the treatment of posttraumatic stress disordered sexual assault victims. Bull Menninger Clin. 1997 Summer;61(3):317-34.  PMID: 9260344.","09058","2019"
"rothbaum2005_A","Psychotherapy","PTSD","PTSD",,"72","A","25",,"EMDR","Eye Movement Desensitization and Reprocessing (EMDR)","Patient imagines a scene representing the worst part of the trauma, focuses on sensations of distress and rehearses negative thoughts, simultaneously following therapist's fingers back and forth at least 20 times each repetition until distress drops to 0 or 1 (measured 0 to 10 on subjective units of discomfort scale); patient then rehearses new, preferred belief while tracking therapist's finger until new statement feels true to the participant; uses cognitive interweaves to accomplish cognitive work. First two sessions for education and treatment planning; remaining 7 sessions were EMDR treatment.","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"90 minutes","Twice weekly","4 to 5","9 sessions total","completed treatment protocol","0.80",,,,,,,,,,,"Community",,,"1","1",,"0","Rape/sexual assault",,"Medium","Rothbaum BO, Astin MC, Marsteller F. Prolonged exposure versus Eye Movement Desensitization and Reprocessing (EMDR) for PTSD rape victims. J Trauma Stress. 2005 Dec;18(6):607-16. doi: 10.1002/jts.20069. PMID: 16382428.","19662","2019"
"rothbaum2005_B","Psychotherapy","PTSD","PTSD",,"72","B","23",,"PE","Prolonged Exposure (PE)","Patients instructed to imaging assault scene and describe aloud while anxiety levels are monitored, repeating the process for 45 to 60 minutes, followed by discussion of patient's reaction; patients instructed to listen to recording of narrative at least once a day and assigned homework. Two sessions for treatment planning including construction of a hierarchy of avoided situations for in vivo exposure homework; 7 sessions of imaginative exposure.","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"90 minutes","Twice weekly","4 to 5","9 sessions total","completed treatment protocol","0.87",,,,,,,,,,,"Community",,,"1","1",,"0","Rape/sexual assault",,"Medium","Rothbaum BO, Astin MC, Marsteller F. Prolonged exposure versus Eye Movement Desensitization and Reprocessing (EMDR) for PTSD rape victims. J Trauma Stress. 2005 Dec;18(6):607-16. doi: 10.1002/jts.20069. PMID: 16382428.","19662","2019"
"rothbaum2005_C","Psychotherapy","PTSD","Control",,"72","C","24",,"Waitlist","Waitlist","Waitlist after pretreatment assessment, then randomly assigned to PE or EMDR after posttreatment assessment.","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,,,,"4 to 5",,"completed treatment protocol","0.833",,,,,,,,,,,"Community",,,"1","1",,"0","Rape/sexual assault",,"Medium","Rothbaum BO, Astin MC, Marsteller F. Prolonged exposure versus Eye Movement Desensitization and Reprocessing (EMDR) for PTSD rape victims. J Trauma Stress. 2005 Dec;18(6):607-16. doi: 10.1002/jts.20069. PMID: 16382428.","19662","2019"
"rothbaum2006_A","Mixed: Psychotherapy & pharmacotherapy","PTSD","PTSD",,"65","A","34",,"Sertraline + PE","Sertraline + Prolonged Exposure (PE)","SSRI antidepressant and prolonged exposure therapy comprised of psychoeducation, breathing retraining, in vivo exposure, prolonged imaginal exposure, and homework.","Yes","TF","Yes","Antidepressant: SSRI","No","Not Applicable","No","No","No","No","No","Individual","In Person","Sertraline dose: 25 to 200 mg, previously titrated to maximum dose tolerated in Phase I

PE session length: 90 to 120 minutes",,"Sertraline: daily

PE: Twice a week","5",,,,,"Sertraline: compliance as number of tablets taken divided by number of tablets that should have been taken, using medication dispensing data and unused medication returns (average % compliance with regimen)",,"Average % compliance with regimen 7.1% (SD 7.99) at Week 10 and 97.1% (SD 5.86) at Week 15 endpoint for both sertraline groups (% of patients being 100% adherent NR)",,,,"173.1 mg at Week 10 and 173.5 mg at Week 15 (average for both sertraline groups)","(44.26) mg at Week 10 and (42.82) mg at Week 15 (average for both sertraline groups)",,"Community",,,"1","0.646",,"0.354","Mixed","child sexual abuse, child physical abuse, accidents, combat-related, other (death [not combat-related] of another person)","Medium","Rothbaum BO, Cahill SP, Foa EB, et al. Augmentation of sertraline with prolonged exposure in the treatment of posttraumatic stress disorder. J Trauma Stress. 2006 Oct;19(5):625-38. doi: 10.1002/jts.20170. PMID: 17075912.","80288","2019"
"rothbaum2006_B","Mixed: Psychotherapy & pharmacotherapy","PTSD","Control",,"65","B","31",,"Sertraline","Sertraline","SSRI antidepressant, continuation of medication following 10 weeks of open-label treatment with flexible dosing titrated over first 5 weeks.","No","Not Applicable","Yes","Antidepressant: SSRI","No","Not Applicable","No","No","No","No","No","Individual","In Person","Dose: 25 to 200 mg, previously titrated to maximum dose tolerated prior to randomization",,"Daily","5",,,,,"Sertraline: compliance as number of tablets taken divided by number of tablets that should have been taken, using medication dispensing data and unused medication returns (average % compliance with regimen)",,"Average % compliance with regimen 7.1% (SD 7.99) at Week 10 and 97.1% (SD 5.86) at Week 15 endpoint for both sertraline groups (% of patients being 100% adherent NR)",,,,"173.1 mg at Week 10 and 173.5 mg at Week 15 (average for both sertraline groups)","(44.26) mg at Week 10 and (42.82) mg at Week 15 (average for both sertraline groups)",,"Community",,,"1","0.646",,"0.354","Mixed","child sexual abuse, child physical abuse, accidents, combat-related, other (death [not combat-related] of another person)","Medium","Rothbaum BO, Cahill SP, Foa EB, et al. Augmentation of sertraline with prolonged exposure in the treatment of posttraumatic stress disorder. J Trauma Stress. 2006 Oct;19(5):625-38. doi: 10.1002/jts.20170. PMID: 17075912.","80288","2019"
"rothbaum2008_A","Pharmacotherapy","PTSD","PTSD",,"25","A","14",,"Risperidone augmentation","Risperidone augmentation","Augmentation of an SSRI antidepressant (sertraline) with an atypical antipsychotic; all participants treated with sertraline in phase 1, and non-responders randomized to augmentation with risperidone or placebo; dose increased weekly by 0.5 mg/day as tolerated to maximum 2 mg/day, or 3 mg/day ""on a case-by-case basis."" Sertraline continued through phase 2, mean dose at endpoint 147 mg for risperidone arm.","No","Not Applicable","Yes","Antipsychotic","No","Not Applicable","No","No","No","No","No","Individual","In Person","Initiated at 0.5 mg, titrated to maximum of 2 or 3 mg",,"Daily","8",,,,,,,,,,,"2.1 mg",,,"Community",,,"1","0.8",,"0.2","Mixed","rape/sexual assault, intimate partner violence, accidents, community/school violence, other (stalking, break-in, witnessed killing or suicide attempt)","High","Rothbaum BO, Killeen TK, Davidson JRT, et al. Placebo-controlled trial of risperidone augmentation for selective serotonin reuptake inhibitor-resistant civilian posttraumatic stress disorder. J. Clin. Psychiatry. 2008;69(4):520-5. doi: 10.4088/JCP.v69n0402. PMID: 18278987.","30519","2019"
"rothbaum2008_B","Pharmacotherapy","PTSD","Control",,"25","B","11",,"Placebo augmentation","Placebo","Augmentation of an SSRI antidepressant (sertraline) with placebo matching risperidone; all participants treated with sertraline in phase 1, and non-responders randomized to augmentation with risperidone or placebo; sertraline continued through phase 2.","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person",,,"Daily","8",,,,,,,,,,,"1.77 mg equivalent",,,"Community",,,"1","0.8",,"0.2","Mixed","rape/sexual assault, intimate partner violence, accidents, community/school violence, other (stalking, break-in, witnessed killing or suicide attempt)","High","Rothbaum BO, Killeen TK, Davidson JRT, et al. Placebo-controlled trial of risperidone augmentation for selective serotonin reuptake inhibitor-resistant civilian posttraumatic stress disorder. J. Clin. Psychiatry. 2008;69(4):520-5. doi: 10.4088/JCP.v69n0402. PMID: 18278987.","30519","2019"
"rothbaum2014_A","Mixed: Psychotherapy & pharmacotherapy","PTSD","PTSD",,"156","A","53",,"Virtual reality exposure therapy + D-cycloserine","Virtual reality exposure therapy (VRET) + D-cycloserine","Virtual reality exposure: sessions comprised of exposure to subject's most traumatic memories using computer-generated virtual Iraq or Afghanistan environments with simulated field/combat situations and trigger stimuli (auditory, visual, olfactory, and tactile), manipulated by the therapist with attempt to match patient-described stimuli followed by experience processing, integration, and associations. This therapy differed from typical exposure therapy in that there was no homework assigned. 

D-cycloserine: NMDA glutamate receptor partial agonist","Yes","TF","Yes","Other pharmacotherapy","No","Not Applicable","No","No","No","No","No","Individual","In Person","Drug dose: 50 mg (30 minutes prior to session)

Sessions: 90 minutes (30 minutes prior to exposure for medication and assessments including startle responses and cortisol sampling). 30 to 45 minutes continuous exposure, until anxiety level decreases, 15 to 20 minutes processing time. One introductory session without medication or exposure was given.",,"Weekly","6",,,,,,,,,,,,,,"Veteran","0","1","0","0.0513",,"0.9487","Combat-related",,"Medium","Rothbaum BO, Price M, Jovanovic T, et al. A randomized, double-blind evaluation of D-cycloserine or alprazolam combined with virtual reality exposure therapy for posttraumatic stress disorder in Iraq and Afghanistan War veterans. Am J Psychiatry. 2014 Jun;171(6):640-8. doi: 10.1176/appi.ajp.2014.13121625. PMID: 24743802.","42150","2019"
"rothbaum2014_B","Mixed: Psychotherapy & pharmacotherapy","PTSD","PTSD",,"156","B","50",,"Virtual reality exposure + alprazolam","Virtual reality exposure therapy (VRET) + alprazolam","Virtual reality exposure: sessions comprised of exposure to subject's most traumatic memories using computer-generated virtual Iraq or Afghanistan environments with simulated field/combat situations and trigger stimuli (auditory, visual, olfactory, and tactile), manipulated by the therapist with attempt to match patient-described stimuli followed by experience processing, integration, and associations. This therapy differed from typical exposure therapy in that there was no homework assigned. 

Alprazolam: benzodiazepine","Yes","TF","Yes","Antianxiety: benzodiazepine","No","Not Applicable","No","No","No","No","No","Individual","In Person","Dose: 0.25 mg (30 minutes prior to session)

Sessions: 90 minutes (30 minutes prior to exposure for medication and assessments including startle responses and cortisol sampling). 30 to 45 minutes continuous exposure, until anxiety level decreases, 15 to 20 minutes processing time. One introductory session without medication or exposure was given.",,"Weekly","6",,,,,,,,,,,,,,"Veteran","0","1","0","0.0513",,"0.9487","Combat-related",,"Medium","Rothbaum BO, Price M, Jovanovic T, et al. A randomized, double-blind evaluation of D-cycloserine or alprazolam combined with virtual reality exposure therapy for posttraumatic stress disorder in Iraq and Afghanistan War veterans. Am J Psychiatry. 2014 Jun;171(6):640-8. doi: 10.1176/appi.ajp.2014.13121625. PMID: 24743802.","42150","2019"
"rothbaum2014_C","Mixed: Psychotherapy & pharmacotherapy","PTSD","PTSD",,"156","C","53",,"Virtual reality exposure + placebo","Virtual reality exposure therapy (VRET)","Virtual reality exposure: sessions comprised of exposure to subject's most traumatic memories using computer-generated virtual Iraq or Afghanistan environments with simulated field/combat situations and trigger stimuli (auditory, visual, olfactory, and tactile), manipulated by the therapist with attempt to match patient-described stimuli followed by experience processing, integration, and associations. This therapy differed from typical exposure therapy in that there was no homework assigned. 

Placebo: administered 30 minutes prior to session.","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","Dose: NA

Sessions: 90 minutes (30 minutes prior to exposure for medication and assessments including startle responses and cortisol sampling). 30 to 45 minutes continuous exposure, until anxiety level decreases, 15 to 20 minutes processing time. One introductory session without medication or exposure was given.",,"Weekly","6",,,,,,,,,,,,,,"Veteran","0","1","0","0.0513",,"0.9487","Combat-related",,"Medium","Rothbaum BO, Price M, Jovanovic T, et al. A randomized, double-blind evaluation of D-cycloserine or alprazolam combined with virtual reality exposure therapy for posttraumatic stress disorder in Iraq and Afghanistan War veterans. Am J Psychiatry. 2014 Jun;171(6):640-8. doi: 10.1176/appi.ajp.2014.13121625. PMID: 24743802.","42150","2019"
"sack2016_A","Psychotherapy","PTSD","PTSD",,"139","A","47",,"Exposure with eyes fixated and moving","Eye Movement Desensitization and Reprocessing (EMDR)","Exposure with eyes moving while fixated on therapist's moving hand; treatment followed EMDR manual by Solomon and Shapiro, except for variation in stimulation (eye movement); treatment focuses on  distressing trauma-related images, beliefs, and bodily sensations; therapy ended when PTSD diagnostic criteria no longer met, or 3 sessions without subjective symptom reduction, with maximum of 8 sessions.","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,,"Weekly",,"maximum 8 sessions","completed treatment course","0.8723",,,,,"4.2","1.8",,,,,"Community",,,"1","0.64",,"0.36","Mixed","accidents, natural or manmade disasters, community/school violence, other (sexual trauma)","Medium","Sack M, Zehl S, Otti A, et al. A comparison of dual attention, eye movements, and exposure only during Eye Movement Desensitization and Reprocessing for posttraumatic stress disorder: results from a randomized clinical trial. Psychother Psychosom. 2016;85(6):357-65. doi: 10.1159/000447671. PMID: 27744424.","49086","2019"
"sack2016_B","Psychotherapy","PTSD","PTSD",,"139","B","47",,"Exposure with eyes fixated and not moving","Eye Movement Desensitization and Reprocessing (EMDR)","Exposure with eyes fixated on therapist's nonmoving hand; treatment followed EMDR manual by Solomon and Shapiro, except for variation in stimulation (eye movement); treatment focuses on distressing trauma-related images, beliefs, and bodily sensations; therapy ended when PTSD diagnostic criteria no longer met, or 3 sessions without subjective symptom reduction, with maximum of 8 sessions.","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,,"Weekly",,"maximum 8 sessions","completed treatment course","0.8085",,,,,"4.7","1.9",,,,,"Community",,,"1","0.64",,"0.36","Mixed","accidents, natural or manmade disasters, community/school violence, other (sexual trauma)","Medium","Sack M, Zehl S, Otti A, et al. A comparison of dual attention, eye movements, and exposure only during Eye Movement Desensitization and Reprocessing for posttraumatic stress disorder: results from a randomized clinical trial. Psychother Psychosom. 2016;85(6):357-65. doi: 10.1159/000447671. PMID: 27744424.","49086","2019"
"sack2016_C","Psychotherapy","PTSD","PTSD",,"139","C","45",,"Exposure without eye fixation","Eye Movement Desensitization and Reprocessing (EMDR)","Exposure without explicit task of fixating on external focus of attention (eyes closed or eyes open and looking unfocused into the room); treatment followed EMDR manual by Solomon and Shapiro, except for variation in stimulation (eye movement); treatment focuses on distressing trauma-related images, beliefs, and bodily sensations; therapy ended when PTSD diagnostic criteria no longer met, or 3 sessions without subjective symptom reduction, with maximum of 8 sessions.","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,,"Weekly",,"maximum 8 sessions","completed treatment course","0.8222",,,,,"3.9","1.8",,,,,"Community",,,"1","0.64",,"0.36","Mixed","accidents, natural or manmade disasters, community/school violence, other (sexual trauma)","Medium","Sack M, Zehl S, Otti A, et al. A comparison of dual attention, eye movements, and exposure only during Eye Movement Desensitization and Reprocessing for posttraumatic stress disorder: results from a randomized clinical trial. Psychother Psychosom. 2016;85(6):357-65. doi: 10.1159/000447671. PMID: 27744424.","49086","2019"
"sack2017_A","Mixed: Psychotherapy & pharmacotherapy","PTSD","PTSD",,"35","A","35",,"Oxytocin + trauma memory reactivation","Oxytocin + exposure (experimental paradigm)","Intranasal oxytocin (Syntocinon, Novartis, Brazil) administered 45 minutes before trauma-script exposure. Trauma-script stress exposure used a script of 2 minutes and did not include an imagery period.","No","Not Applicable","Yes","Other pharmacotherapy","No","Not Applicable","No","No","No","No","No","Individual","In Person","24 IU",,"Once (single dose)","1",,,,,"NA (administered in clinic)","1",,,,,"24 IU",,,"Community",,,"1","1",,"0","Mixed","rape/sexual assault, child sexual abuse, community/school violence, accidents, natural or manmade disasters, other (""non-sexual violence by a family member"")","Low","Sack M, Spieler D, Wizelman L, et al. Intranasal oxytocin reduces provoked symptoms in female patients with posttraumatic stress disorder despite exerting sympathomimetic and positive chronotropic effects in a randomized controlled trial. BMC Med. 2017 Feb 17;15:40. doi: 10.1186/s12916-017-0801-0. PMID: 28209155.","47377","2019"
"sack2017_B","Mixed: Psychotherapy & pharmacotherapy","PTSD","Control",,"35","B","35",,"Placebo + trauma memory reactivation","Placebo + trauma memory reactivation","Intranasal placebo administered 45 minutes before trauma-script exposure. Placebo spray included all ingredients as the oxytocin intranasal spray except for the oxytocin. Trauma-script stress exposure used a script of 2 minutes and did not include an imagery period.","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person",,,"Once (single dose)","1",,,,,"NA (administered in clinic)","1",,,,,,,,"Community",,,"1","1",,"0","Mixed","rape/sexual assault, child sexual abuse, community/school violence, accidents, natural or manmade disasters, other (""non-sexual violence by a family member"")","Low","Sack M, Spieler D, Wizelman L, et al. Intranasal oxytocin reduces provoked symptoms in female patients with posttraumatic stress disorder despite exerting sympathomimetic and positive chronotropic effects in a randomized controlled trial. BMC Med. 2017 Feb 17;15:40. doi: 10.1186/s12916-017-0801-0. PMID: 28209155.","47377","2019"
"sannibale2013_B","Psychotherapy","PTSD+SUD","SUD","Not integrated","62","B","29",,"Alcohol support","Cognitive behavioral therapy (CBT) for alcohol use","CBT for AUD plus supportive counseling. CBT was based on Project MATCH and the Combined Behavioral Intervention Manual (same as AUD portion for Integrated therapy intervention). Included structured homework. Supportive counseling is present-centered, manualized therapy, and targeted AUD symptoms only in this intervention.","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"90 minutes","Weekly","12",,"completed ≥9 sessions","0.6207",,,,,,,"median 10.00 (NR)",,,,"Community","0","0","1","0.5323",,"0.4677","Mixed","child physical abuse, child sexual abuse, rape/sexual assault, community/school violence, intimate partner violence, accidents, other (""witnessed injury/killing/mutilation"", ""news of someone close"", ""danger of losing life/other"")","Medium","Sannibale C, Teesson M, Creamer MC, et al. Randomized controlled trial of cognitive behaviour therapy for comorbid post-traumatic stress disorder and alcohol use disorders. Addiction. 2013 Aug;108(8):1397-410. doi: 10.1111/add.12167. PMID: 25328957.","40190","2020"
"sannibale2013_A","Psychotherapy","PTSD+SUD","PTSD+SUD","Integrated","62","A","33",,"Integrated therapy","Integrated cognitive behavioral therapy for PTSD and AUD","Integrated exposure-based CBT for PTSD and AUD. CBT for PTSD was manualized, and incorporated exposure therapy and cognitive restructuring; integrated with CBT for AUD, a manual-guided therapy based on Project MATCH and the Combined Behavioral Intervention Manual (same as AUD portion for Alcohol support intervention). Included structured homework.","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"90 minutes","Weekly","12",,"completed ≥9 sessions","0.6061",,,,,,,"median 11.0 (NR)",,,,"Community","0","0","1","0.5323",,"0.4677","Mixed","child physical abuse, child sexual abuse, rape/sexual assault, community/school violence, intimate partner violence, accidents, other (""witnessed injury/killing/mutilation"", ""news of someone close"", ""danger of losing life/other"")","Medium","Sannibale C, Teesson M, Creamer MC, et al. Randomized controlled trial of cognitive behaviour therapy for comorbid post-traumatic stress disorder and alcohol use disorders. Addiction. 2013 Aug;108(8):1397-410. doi: 10.1111/add.12167. PMID: 25328957.","40190","2020"
"santarnecchi2019_B","Psychotherapy","PTSD","PTSD",,"37","B","17",,"EMDR","Eye Movement Desensitization and Reprocessing (EMDR)","Therapy includes identification of  disturbing memories of traumatic event and focusing on these memories while following finger movements performed by therapist","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"1 hour","Weekly","4","average",,,,,,,"4","2",,,,,"Community","0","0","1","0.3871",,"0.6129","Natural or manmade disasters",,"High","Santarnecchi E, Bossini L, Vatti G, et al. Psychological and brain connectivity changes following trauma-focused CBT and EMDR treatment in single-episode PTSD patients. Front Psychol. 2019;10:129. doi: 10.3389/fpsyg.2019.00129. PMID: 30858808.","52130","2020"
"santarnecchi2019_A","Psychotherapy","PTSD","PTSD",,"37","A","14",,"Trauma-focused CBT","Trauma-focused cognitive behavioral therapy (TF-CBT)","Includes narrative recollection of traumatic event, relaxation exercises, psychoeducation, exposure therapy, and home assignments","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,,"Weekly","10","average",,,,,,,"10","2",,,,,"Community","0","0","1","0.3871",,"0.6129","Natural or manmade disasters",,"High","Santarnecchi E, Bossini L, Vatti G, et al. Psychological and brain connectivity changes following trauma-focused CBT and EMDR treatment in single-episode PTSD patients. Front Psychol. 2019;10:129. doi: 10.3389/fpsyg.2019.00129. PMID: 30858808.","52130","2020"
"sautter2015_A","Psychotherapy","PTSD","PTSD",,"114","A","58","29 couples","Structured Approach Therapy","Structured Approach Therapy","PTSD treatment and couples-based therapy by individual therapist; manual-based interventions organized within a stress inoculation therapy (SIT) framework including psychoeducation (2 sessions), emotion activation and skills training (4 sessions), and disclosure-based exposure (6 sessions); homework assignment with each session. Up to 3 additional sessions were permitted if it wasn't possible to complete the protocol within 12 sessions.","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Couple","In Person",,"60 minutes",,,"72.41%","received ≥12 sessions","0.72409999999999997",,,,,"10.31",,,,,,"Veteran",,"1",,,"Veterans: 1.75%
Partners: 98.25%",,,,"Medium","Sautter FJ, Glynn SM, Cretu JB, et al. Efficacy of structured approach therapy in reducing PTSD in returning veterans: A randomized clinical trial. Psychol Serv. 2015 Aug;12(3):199-212. doi: 10.1037/ser0000032. PMID: 26213789.","44509","2019"
"sautter2015_B","Psychotherapy","PTSD","PTSD",,"114","B","56","28 couples","PTSD Family Education","PTSD Family Education","PTSD treatment and couples-based therapy, manualized and adapted from the Support and Family Education (SAFE) program and behavioral family therapy family education sections; treatment using lectures, discussion, and written materials designed to educate about PTSD and PTSD-related conditions. Avoided skills training and other therapeutic interventions. Up to 3 additional sessions were permitted if it wasn't possible to complete the protocol within 12 sessions.","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Couple","In Person",,"60 minutes",,,"12 to 15 sessions total","received ≥12 sessions","0.75",,,,,"9.61",,,,,,"Veteran",,"1",,,"Veterans: 1.75%
Partners: 98.25%",,,,"Medium","Sautter FJ, Glynn SM, Cretu JB, et al. Efficacy of structured approach therapy in reducing PTSD in returning veterans: A randomized clinical trial. Psychol Serv. 2015 Aug;12(3):199-212. doi: 10.1037/ser0000032. PMID: 26213789.","44509","2019"
"saygin2002_A","Pharmacotherapy","PTSD","PTSD",,"60","A","30",,"Sertraline","Sertraline","SSRI antidepressant; flexible dosing based on ""clinical status""","No","Not Applicable","Yes","Antidepressant: SSRI","No","Not Applicable","No","No","No","No","No","Individual","In Person","50 to 100 mg",,"Daily","20",,,,,,,,,,,"68.33 mg/day","21.7",,"Community",,,"1","0.7593",,"0.2407","Natural or manmade disasters",,"High","Saygin MZ, Sungur MZ, Sabol EU, et al. Nefazodone versus sertraline in the treatment of posttraumatic stress disorder. Klinik Psikofarmakol B√ºlteni. 2002 Jan;12(1):1-5.","24668","2019"
"saygin2002_B","Pharmacotherapy","PTSD","PTSD",,"60","B","30",,"Nefazodone","Nefazodone","Serotonin antagonist and reuptake inhibitor; flexible dose based on ""clinical status""","No","Not Applicable","Yes","Antidepressant: Other","No","Not Applicable","No","No","No","No","No","Individual","In Person","200 to 400 mg",,"Daily","20",,,,,,,,,,,"332.35 mg/day","63.5",,"Community",,,"1","0.7593",,"0.2407","Natural or manmade disasters",,"High","Saygin MZ, Sungur MZ, Sabol EU, et al. Nefazodone versus sertraline in the treatment of posttraumatic stress disorder. Klinik Psikofarmakol B√ºlteni. 2002 Jan;12(1):1-5.","24668","2019"
"schacht2017_A","Psychotherapy","PTSD","PTSD+SUD","Not integrated","58","A","28",,"PE with incentive","Prolonged Exposure (PE)","Manualized therapy according to Foa, Hembree, & Rothbaum (2007) that includes breathing retraining for relaxation and imaginal and in vivo exposure. Incentive was gift card or clinic fee voucher beginning at $30 for Session 1, escalating $10 per session  with maximum total amount equaling $480. If the participant missed a session, the next attended session reset earnings to $30. Participants who missed 4 consecutive weeks were withdrawn from PE therapy but remained eligible to participate in followup assessments","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"60 minutes","Weekly","12",,"completed 12 sessions or at least 9 sessions and demonstrated a 70% reduction on MPSS-R score","0.3571",,,,,"7.11","4.1",,,,,"Community",,,"1","0.7931",,"0.2069","Mixed","child sexual assault, child physical assault, intimate partner violence, other (unexpected death of loved one)","Medium","Schacht RL, Brooner RK, King VL, et al. Incentivizing attendance to prolonged exposure for PTSD with opioid use disorder patients: a randomized controlled trial. J Consult Clin Psychol. 2017 Jul;85(7):689-701. doi: 10.1037/ccp0000208. PMID: 28414485","47904","2019"
"schacht2017_B","Psychotherapy","PTSD","PTSD+SUD","Not integrated","58","B","30",,"PE","Prolonged Exposure (PE)","Manualized therapy according to Foa, Hembree, & Rothbaum (2007) that includes breathing retraining for relaxation and imaginal and in vivo exposure. Participants received $40 for completing each followup assessment","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"60 minutes","Weekly","12",,"completed 12 sessions or at least 9 sessions and demonstrated a 70% reduction on MPSS-R score","0.0333",,,,,"1.80","2.57",,,,,"Community",,,"1","0.7931",,"0.2069","Mixed","child sexual assault, child physical assault, intimate partner violence, other (unexpected death of loved one)","Medium","Schacht RL, Brooner RK, King VL, et al. Incentivizing attendance to prolonged exposure for PTSD with opioid use disorder patients: a randomized controlled trial. J Consult Clin Psychol. 2017 Jul;85(7):689-701. doi: 10.1037/ccp0000208. PMID: 28414485","47904","2019"
"schneier2012_A","Mixed: Psychotherapy & pharmacotherapy","PTSD","PTSD",,"37","A","19",,"PE + paroxetine","Prolonged Exposure (PE) + paroxetine","PE: trauma-focused CBT comprised of guided exposure to traumatic memories and situations to enhance emotional processing.

Paroxetine: controlled-release; SSRI","Yes","TF","Yes","Antidepressant: SSRI","No","Not Applicable","No","No","No","No","No","Individual","In Person","Session length: 90 minutes

Dose: 12.5 mg for 1 week, then 25 mg for 3 weeks, then increased as tolerated to maximum of 50 mg",,"Psychotherapy: weekly

Paroxetine: daily","10",,"completed 10 weeks randomized treatment","0.6842",,"NR (""monitored compliance using pill counts"")",,,,,,"32.2 mg (mean maximum daily dose for at least 1 week)","13.4",,"Community",,,"1","0.5405",,"0.4595","Terrorism/political violence/forced displacement",,"Medium","Schneier FR, Neria Y, Pavlicova M, et al. Combined prolonged exposure therapy and paroxetine for PTSD related to the World Trade Center attack: a randomized controlled trial. Am J Psychiatry. 2012 Jan;169(1):80-8. doi: 10.1176/appi.ajp.2011.11020321. PMID: 21908494.","37261","2019"
"schneier2012_B","Mixed: Psychotherapy & pharmacotherapy","PTSD","PTSD",,"37","B","18",,"PE + placebo","Prolonged Exposure (PE) + placebo","PE: trauma-focused CBT comprised of guided exposure to traumatic memories and situations to enhance emotional processing.

Placebo: matching placebo tablets","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","Session length: 90 minutes

Dose: matching placebo to paroxetine which was prescribed at 12.5 mg for 1 week, then 25 mg for 3 weeks, then increased as tolerated to maximum of 50 mg",,"Psychotherapy: weekly

Placebo: daily","10",,"completed 10 weeks randomized treatment","0.7222",,"NR (""monitored compliance using pill counts"")",,,,,,"36.8 mg (paroxetine equivalent) (mean maximum daily dose attained for at least 1 week)","12.1",,"Community",,,"1","0.5405",,"0.4595","Terrorism/political violence/forced displacement",,"Medium","Schneier FR, Neria Y, Pavlicova M, et al. Combined prolonged exposure therapy and paroxetine for PTSD related to the World Trade Center attack: a randomized controlled trial. Am J Psychiatry. 2012 Jan;169(1):80-8. doi: 10.1176/appi.ajp.2011.11020321. PMID: 21908494.","37261","2019"
"schneier2015_A","Pharmacotherapy","PTSD","PTSD",,"38","A","18",,"Mirtazapine augmentation","Mirtazapine","Atypical antidepressant (tetracyclic, alpha-2 antagonist); mirtazapine increased after 4 weeks' treatment based on response and adverse events. All patients in both treatment arms also received the SSRI sertraline, initiated at 25 mg/day and titrated up to 200 mg/day.","No","Not Applicable","Yes","Antidepressant: Other","No","Not Applicable","No","No","No","No","No","Individual","In Person","15 to 45 mg; initiated at 30 mg for 4 weeks, increased as tolerated if continued PTSD symptoms to maximum of 45 mg, decreased if needed for adverse events to minimum dose of 15 mg",,"Daily at bedtime","24",,,,,,,,,,,"32.5 mg/d","11.8",,"Community",,,"1","0.6389",,"0.3611","Mixed","rape/sexual assault, community/school violence","Medium","Schneier FR, Campeas R, Carcamo J, et al. Combined mirtazapine and SSRI treatment of PTSD: a placebo-controlled trial. Depress Anxiety. 2015 Aug;32(8):570-9. doi: 10.1002/da.22384. PMID: 26115513.","44165","2019"
"schneier2015_B","Pharmacotherapy","PTSD","PTSD",,"38","B","20",,"Placebo augmentation","Placebo","Placebo capsules matching mirtazapine; all patients in both treatment arms also received the SSRI sertraline, initiated at 25 mg/day and titrated up to 200 mg/day.","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","15 to 45 mg mirtazapine equivalent; initiated at 30 mg for 4 weeks, increased as tolerated if continued PTSD symptoms to maximum of 45 mg, decreased if needed for adverse events to minimum dose of 15 mg",,"Daily at bedtime","24",,,,,,,,,,,"36.7 mg/day placebo equivalent to mirtazapine","7.7",,"Community",,,"1","0.6389",,"0.3611","Mixed","rape/sexual assault, community/school violence","Medium","Schneier FR, Campeas R, Carcamo J, et al. Combined mirtazapine and SSRI treatment of PTSD: a placebo-controlled trial. Depress Anxiety. 2015 Aug;32(8):570-9. doi: 10.1002/da.22384. PMID: 26115513.","44165","2019"
"schnurr2007_B","Psychotherapy","PTSD","PTSD",,"284","B","143",,"PCT","Present Centered Therapy (PCT)","Individual therapy delivered according to a manual, with focus on current life problems as manifestations of PTSD; included psychoeducation about PTSD and treatment rationale; review of general daily difficulties,  with therapist helping patient to identifying daily stresses and discussing in supportive, nondirective mode; reviewing accomplishments made during therapy; and making plans for the future.","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"90 minutes","Weekly",,"10 sessions total","completed treatment course","0.7832",,,,,"9.3",,,,,,"Mixed","0.0246","0.9754","0","1",,"0","Mixed","combat-related, MST, rape/sexual assault, community/school violence, natural or manmade disasters, illness/medical procedure, accidents, other (sexual trauma, not specified)","Medium","Schnurr PP, Friedman MJ, Engel CC, et al. Cognitive behavioral therapy for posttraumatic stress disorder in women: a randomized controlled trial. JAMA. 2007 Feb 28;297(8):820-30. doi: 10.1001/jama.297.8.820. PMID: 17327524.","29137","2020"
"schnurr2007_A","Psychotherapy","PTSD","PTSD",,"284","A","141",,"PE","Prolonged Exposure (PE)","Individual therapy delivered according to a manual; treatment included psychoeducation about common reactions to trauma; breathing retraining; imaginal exposure through prolonged (repeated) recounting of trauma memories during sessions; exposure homework, both imaginal (listen to recording of trauma recounting) and in vivo (safe situations avoided due to trauma-related fear); discussion of thoughts and feelings related to exposure exercises.","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"90 minutes","Weekly",,"10 sessions total","completed treatment course","0.617",,,,,"8.0",,,,,,"Mixed","0.0246","0.9754","0","1",,"0","Mixed","combat-related, MST, rape/sexual assault, community/school violence, natural or manmade disasters, illness/medical procedure, accidents, other (sexual trauma, not specified)","Medium","Schnurr PP, Friedman MJ, Engel CC, et al. Cognitive behavioral therapy for posttraumatic stress disorder in women: a randomized controlled trial. JAMA. 2007 Feb 28;297(8):820-30. doi: 10.1001/jama.297.8.820. PMID: 17327524.","29137","2020"
"schnurr2003_A","Psychotherapy","PTSD","PTSD",,"360","A","180",,"Trauma-focused group therapy","Trauma-focused cognitive behavioral therapy (TF-CBT)","Exposure-based treatment in a group context following manualized protocol; includes psychoeducation, symptom self-management, coping resource assessment, exposure, cognitive restructuring, relapse prevention, and coping skills training, and exposure homework.","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Group","In Person",,"1.5 to 2 hours","Active treatment: weekly

Booster sessions: monthly","30",,"≥80% of weekly sessions","0.589",,,,,,,"Active treatment: 21.77/30; Booster sessions: 3.24/5",,,,"Veteran","0","1","0","0",,"1","Combat-related",,"Low","Schnurr PP, Friedman MJ, Foy DW, et al. Randomized trial of trauma-focused group therapy for posttraumatic stress disorder. Arch Gen Psychiatry. 2003 May;60(5):481-9. doi: 10.1001/archpsyc.60.5.481. PMID: 12742869.","23438","2019"
"schnurr2003_B","Psychotherapy","PTSD","PTSD",,"360","B","180",,"Group PCT","Present Centered Therapy (PCT)","Group therapy following manualized protocol; includes psychoeducation, connection between PTSD symptoms and difficulties in relationships, problem-solving, specific individual issues, development of plans to deal with issues with interaction of group members for input and feedback, review of experience and progress.","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Group","In Person",,"1.5 hours","Active treatment: weekly

Booster sessions: monthly","30",,"completed ≥80% of weekly sessions","0.617",,,,,,,"Active treatment: 23.49/30; Booster sessions: 3.65/5",,,,"Veteran","0","1","0","0",,"1","Combat-related",,"Low","Schnurr PP, Friedman MJ, Foy DW, et al. Randomized trial of trauma-focused group therapy for posttraumatic stress disorder. Arch Gen Psychiatry. 2003 May;60(5):481-9. doi: 10.1001/archpsyc.60.5.481. PMID: 12742869.","23438","2019"
"schnurr2013_A","Collaborative care","PTSD","PTSD",,"195","A","96",,"Three Component Model","Three Component Model","Collaborative care delivered by primary care provider and care manager (psychologist). Treatment at primary care provider's discretion and could include mental health specialty referral. Support calls by care managers until trial end or participant met response criteria (30% reduction in PCL, for those with depression also 50% reduction in PHQ-9 score); calls focused on barriers to adherence, helping to overcome barriers, and measuring treatment response.","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","No","No","Yes","Individual","Phone",,"Support calls: 15 minutes","Support calls: weeks 1, 4, and 8, then every 4 weeks","24",,,,,,,,,,,,,,"Veteran",,"1",,"0.0872",,"0.9128","Mixed","combat-related, rape/sexual assault, accidents, natural or manmade disaster, community/school violence","Medium","Schnurr PP, Friedman MJ, Oxman TE, et al. RESPECT-PTSD: re-engineering systems for the primary care treatment of PTSD, a randomized controlled trial. J Gen Intern Med. 2013 Jan;28(1):32-40. doi: 10.1007/s11606-012-2166-6. PMID: 22865017.","39174","2019"
"schnurr2013_B","Collaborative care","PTSD","Control",,"195","B","99",,"TAU","Treatment as usual (TAU)","Treatment at primary care provider's discretion and could include referral to a mental health specialist.","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,,,,"26",,,,,,,,,,,,,,"Veteran",,"1",,"0.0872",,"0.9128","Mixed","combat-related, rape/sexual assault, accidents, natural or manmade disaster, community/school violence","Medium","Schnurr PP, Friedman MJ, Oxman TE, et al. RESPECT-PTSD: re-engineering systems for the primary care treatment of PTSD, a randomized controlled trial. J Gen Intern Med. 2013 Jan;28(1):32-40. doi: 10.1007/s11606-012-2166-6. PMID: 22865017.","39174","2019"
"schoorl2013_A","Nonpharmacologic cognitive","PTSD","PTSD",,"102","A","48",,"Attentional Bias Modification","Attention bias modification (ABM)","200 trials of the Dot-Probe test (80% neutral/trauma-related pairs; 20% neutral/neutral pairs); performed at home on a secured website.","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","Yes","No","No","No","Individual","Technology Alone",,"15 to 20 minutes",,"3","8 sessions total",,,,,,,,,,,,,"Community",,,"1","0.7549",,"0.2451","Mixed","other (childhood trauma unspecified, adult trauma unspecified)","Medium","Schoorl M, Putman P, Van Der Does W. Attentional bias modification in posttraumatic stress disorder: a randomized controlled trial. Psychother Psychosom. 2013;82(2):99-105. doi: 10.1159/000341920. PMID: 23295710","41171","2019"
"schoorl2013_B","Nonpharmacologic cognitive","PTSD","Control",,"102","B","54",,"Attentional Bias","Attention bias modification (ABM)","200 trials of the Dot-Probe test (no neutral/neutral pairs); performed at home on a secured website.","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","Technology Alone",,"15 to 20 minutes",,"3","8 sessions total",,,,,,,,,,,,,"Community",,,"1","0.7549",,"0.2451","Mixed","other (childhood trauma unspecified, adult trauma unspecified)","Medium","Schoorl M, Putman P, Van Der Does W. Attentional bias modification in posttraumatic stress disorder: a randomized controlled trial. Psychother Psychosom. 2013;82(2):99-105. doi: 10.1159/000341920. PMID: 23295710","41171","2019"
"seo2010_A","Pharmacotherapy","PTSD","PTSD",,"40","A","20",,"Mirtazapine","Mirtazapine","Atypical antidepressant; could be titrated upward after second visit at clinician's discretion","No","Not Applicable","Yes","Antidepressant: Other","No","Not Applicable","No","No","No","No","No","Individual","In Person","Initiated at 15 mg, titrated to maximum 60 mg",,"Daily","8",,,,,,,,,,,,,,"Community",,,"1","0.7",,"0.3","Mixed","rape/sexual assault, accidents, community/school violence, other (witnessing accident)","Medium","Seo H-J, Jung Y-E, Bahk W-M, et al. A comparison of mirtazapine and paroxetine for the treatment of patients with posttraumatic stress disorder: a randomized open-label trial. Clin Psychopharmacol Neurosci. 2010;8(2):84-9.","35572","2019"
"seo2010_B","Pharmacotherapy","PTSD","PTSD",,"40","B","20",,"Paroxetine","Paroxetine","SSRI antidepressant; could be titrated upward after second visit at clinician's discretion","No","Not Applicable","Yes","Antidepressant: SSRI","No","Not Applicable","No","No","No","No","No","Individual","In Person","Initiated at 10 mg, titrated to maximum 60 mg",,"Daily","8",,,,,,,,,,,,,,"Community",,,"1","0.7",,"0.3","Mixed","rape/sexual assault, accidents, community/school violence, other (witnessing accident)","Medium","Seo H-J, Jung Y-E, Bahk W-M, et al. A comparison of mirtazapine and paroxetine for the treatment of patients with posttraumatic stress disorder: a randomized open-label trial. Clin Psychopharmacol Neurosci. 2010;8(2):84-9.","35572","2019"
"shapiro2015_A","Psychotherapy","PTSD","PTSD",,"17","A","8",,"EMDR for Recent Trauma Episode","Eye Movement Desensitization and Reprocessing (EMDR)","Brief EMDR (2 to 4 sessions), consisting of an adaptation of EMDR and Recent Event protocols","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"90 minutes","Once daily","0.29",,,,,,,,,,,,,,"Community",,,"1","0.941",,"0.059","Terrorism/political violence/forced displacement",,"High","Shapiro E, Laub B. Early EMDR intervention following a community critical incident: a randomized clinical trial. Journal of EMDR Practice and Research. 2015 Feb;9(1):17-27. doi: 10.1891/1933-3196.9.1.17","47811","2019"
"shapiro2015_B","Psychotherapy","PTSD","Control",,"17","B","9",,"Waitlist/Delayed Treatment","Waitlist",,"No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,,,,"1",,,,,,,,,,,,,,"Community",,,"1","0.941",,"0.059","Terrorism/political violence/forced displacement",,"High","Shapiro E, Laub B. Early EMDR intervention following a community critical incident: a randomized clinical trial. Journal of EMDR Practice and Research. 2015 Feb;9(1):17-27. doi: 10.1891/1933-3196.9.1.17","47811","2019"
"shemesh2011_A","Psychotherapy","PTSD","PTSD",,"60","A","30",,"CBT using imaginal exposure","Imaginal exposure","Trauma-focused CBT with imaginal exposure following manual; differs from commonly used CBT for trauma by: no homework or in vivo exposure; fewer number of sessions; therapy delivered on premises of cardiology clinic.","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,,,,"3 to 5 sessions total","received full course of CBT","0.80",,,,,,,"median 3",,,,"Community",,,"1","0.3333",,"0.6667","Illness/medical procedure",,"High","Shemesh E, Annunziato RA, Weatherley BD, et al. A randomized controlled trial for the safety and promise of cognitive-behavioral therapy using imaginal exposure in patients with posttraumatic stress disorder resulting from cardiovascular illness. J Clin Psychiatry. 2011 Feb;72(2):168-74. doi: 10.4088/JCP.09m05116blu. PMID: 20441725","34244","2019"
"shemesh2011_B","Psychotherapy","PTSD","Control",,"60","B","30",,"Control","Education","Educational sessions discussing adherence to medical regimen.","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person",,,,,"1 to 3 sessions total","received intervention","0.9667",,,,,,,"median 2",,,,"Community",,,"1","0.3333",,"0.6667","Illness/medical procedure",,"High","Shemesh E, Annunziato RA, Weatherley BD, et al. A randomized controlled trial for the safety and promise of cognitive-behavioral therapy using imaginal exposure in patients with posttraumatic stress disorder resulting from cardiovascular illness. J Clin Psychiatry. 2011 Feb;72(2):168-74. doi: 10.4088/JCP.09m05116blu. PMID: 20441725","34244","2019"
"shestatsky1988_A","Pharmacotherapy","PTSD","PTSD",,"13","A","13","7 in first period","Phenelzine","Phenelzine","MAOI antidepressant, titrated to maximum tolerated dosage; 1st period 5 weeks, washout 2 weeks, 2nd period 5 weeks","No","Not Applicable","Yes","Antidepressant: MAOI","No","Not Applicable","No","No","No","No","No","Individual","In Person","Initiated at 30 mg, titrated to maximum 90 mg",,"Daily","5",,,,,,,,,,,"66",,,"Mixed",,"0.4","0.6",,,,"Mixed","combat-related, accidents, terrorism/political violence/forced displacement, other (accident with death of son)","High","Shestatsky M, Greenberg D, Lerer B. A controlled trial of phenelzine in posttraumatic stress disorder. Psychiatry Res. 1988 May;24(2):149-55. doi: 10.1016/0165-1781(88)90057-1. PMID: 3406235.","00758","2019"
"shestatsky1988_B","Pharmacotherapy","PTSD","Control",,"13","B","13","6 in first period","Placebo","Placebo","Placebo","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person",,,"Daily","5",,,,,,,,,,,,,,"Mixed",,"0.4","0.6",,,,"Mixed","combat-related, accidents, terrorism/political violence/forced displacement, other (accident with death of son)","High","Shestatsky M, Greenberg D, Lerer B. A controlled trial of phenelzine in posttraumatic stress disorder. Psychiatry Res. 1988 May;24(2):149-55. doi: 10.1016/0165-1781(88)90057-1. PMID: 3406235.","00758","2019"
"simon2008_A","Mixed: Psychotherapy & pharmacotherapy","PTSD","PTSD",,"25","A","11",,"PE + paroxetine controlled release","Prolonged Exposure (PE) + paroxetine","Trauma-focused CBT plus SSRI; 5 additional sessions of PE augmented with addition of controlled release paroxetine. (Participants randomized after Phase I if SPRINT ≥6 or CGI-S ≥3 after eight 90- to 120-minute individual PE sessions over a 4- to 6-week period).","Yes","TF","Yes","Antidepressant: SSRI","No","Not Applicable","No","No","No","No","No","Individual","In Person","Session length: 90 to 120 minutes

Dose: 12.5 to 62.5 mg; titration: flexible dose initiated at 12.5 mg titrated up to maximum dose of 62.5 mg based on efficacy and tolerability",,"Psychotherapy: every 2 weeks

Paroxetine: daily","10",,,,,,,,,,,"45.8 mg/day","16.5",,"Community",,,"1","0.5652",,"0.4348","Mixed","rape/sexual assault, intimate partner violence, accidents, illness/medical procedure, other (exposure to war)","Medium","Simon NM, Connor KM, Lang AJ, et al. Paroxetine CR augmentation for posttraumatic stress disorder refractory to prolonged exposure therapy. J Clin Psychiatry. 2008 Mar;69(3):400-5. PMID: 18348595.","30521","2019"
"simon2008_B","Mixed: Psychotherapy & pharmacotherapy","PTSD","PTSD",,"25","B","14",,"PE + placebo","Prolonged Exposure (PE) + placebo","Trauma-focused CBT plus placebo; 5 additional sessions of PE augmented with addition of matched pill placebo. (Participants randomized after Phase I if SPRINT ≥6 or CGI-S ≥3 after eight 90- to 120-minute individual PE sessions over a 4- to 6-week period).","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","Session length: 90 to 120 minutes

Dose: equivalent to 12.5 to 62.5 mg paroxetine controlled release; titration: flexible dose initiated at 12.5 mg titrated up to maximum dose of 62.5 mg based on efficacy and tolerability",,"Psychotherapy: once every 2 weeks

Placebo: daily","10",,,,,,,,,,,"44.8 mg equivalent to paroxetine controlled release","15.5",,"Community",,,"1","0.5652",,"0.4348","Mixed","rape/sexual assault, intimate partner violence, accidents, illness/medical procedure, other (exposure to war)","Medium","Simon NM, Connor KM, Lang AJ, et al. Paroxetine CR augmentation for posttraumatic stress disorder refractory to prolonged exposure therapy. J Clin Psychiatry. 2008 Mar;69(3):400-5. PMID: 18348595.","30521","2019"
"sloan2018a_B","Psychotherapy","PTSD","PTSD",,"126","B","63",,"CPT","Cognitive Processing Therapy (CPT)","Trauma-focused therapy; patients taught to recognize and challenge dysfunctional cognitions about their traumatic event and current thoughts about themselves, others, and the world; write 2 trauma accounts (at home) including sensory details, thoughts, and feelings associated with the trauma then read the account daily until the next session; additional between-session assignments given after each session.","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"60 minutes","Weekly","12",,"received CPT as randomized","0.5873",,,,,,,,,,,"Mixed",,"0.2619","0.7381","0.4762",,"0.5278","Mixed","combat-related, rape/sexual assault, child sexual abuse, child physical abuse, accidents, community/school violence","Medium","Sloan DM, Marx BP, Lee DJ, et al. A brief exposure-based treatment vs cognitive processing therapy for posttraumatic stress disorder: a randomized noninferiority clinical trial. JAMA Psychiatry. 2018 Mar 1;75(3):233-9. doi: 10.1001/jamapsychiatry.2017.4249. PMID: 29344631.","49592","2020"
"sloan2018a_A","Psychotherapy","PTSD","PTSD",,"126","A","63",,"Written exposure therapy","Written Exposure Therapy (WET)","Patients instructed to write about a specific traumatic event, focusing on details of the event and the thoughts and feelings that occurred during the event, for 30 minutes each session; no assignments between sessions.","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"60 minutes (initial session); 40 minutes (remaining 4 sessions)","Weekly","5",,"received written exposure therapy as randomized","0.9365",,,,,,,,,,,"Mixed",,"0.2619","0.7381","0.4762",,"0.5278","Mixed","combat-related, rape/sexual assault, child sexual abuse, child physical abuse, accidents, community/school violence","Medium","Sloan DM, Marx BP, Lee DJ, et al. A brief exposure-based treatment vs cognitive processing therapy for posttraumatic stress disorder: a randomized noninferiority clinical trial. JAMA Psychiatry. 2018 Mar 1;75(3):233-9. doi: 10.1001/jamapsychiatry.2017.4249. PMID: 29344631.","49592","2020"
"sloan2018b_B","Psychotherapy","PTSD","PTSD",,"198","B","100",,"Group PCT","Present Centered Therapy (PCT)","Core components of present-centered treatment include psychoeducation, peer support, and  peer-facilitated problem solving. No trauma-focused work or clinician instruction in skill development. Weekly home therapy assignments.","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Group","In Person",,"2 hours","Approximately weekly (14 sessions over 16 weeks)","16",,"attended ≥10 of 14 sessions","0.79",,,,,,,,,,,"Veteran","0","1","0","0",,"1","Mixed","Combat-related; Child physical abuse; Child sexual abuse; Rape/sexual assault; Accidents; Community/school violence; Other (death or trauma to friend or loved one)","Medium","Sloan DM, Unger W, Lee DJ, et al. A randomized controlled trial of group cognitive behavioral treatment for veterans diagnosed with chronic posttraumatic stress disorder. J Trauma Stress. 2018b Dec;31(6):886-98. doi: 10.1002/jts.22338. PMID: 30499227.","51291","2020"
"sloan2018b_A","Psychotherapy","PTSD","PTSD",,"198","A","98",,"Group CBT","Trauma-focused cognitive behavioral therapy (TF-CBT)","Group cognitive-behavioral intervention focused on trauma. Includes in vivo, written, and imaginal exposure, progressive muscle relaxation, cognitive restructuring, and behavioral activation. Between-session practice (homework) emphasized.","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Group","In Person",,"2 hours","Approximately weekly (14 sessions over 16 weeks)","16",,"attended ≥10 of 14 sessions","0.6224",,,,,,,,,,,"Veteran","0","1","0","0",,"1","Mixed","Combat-related; Child physical abuse; Child sexual abuse; Rape/sexual assault; Accidents; Community/school violence; Other (death or trauma to friend or loved one)","Medium","Sloan DM, Unger W, Lee DJ, et al. A randomized controlled trial of group cognitive behavioral treatment for veterans diagnosed with chronic posttraumatic stress disorder. J Trauma Stress. 2018b Dec;31(6):886-98. doi: 10.1002/jts.22338. PMID: 30499227.","51291","2020"
"sloan2004_A","Psychotherapy","PTSD","PTSD",,"51","A","28",,"Written emotional disclosure","Written Exposure Therapy (WET)","Participants instructed to write about most traumatic/distressing experience of their lives with as much emotion and feeling as possible; in second and third sessions, could write about same or different experience.","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","Written",,"20 minutes","Daily","0.43",,"completed all writing sessions","1",,,,,"3",,,,,,"Community",,,"1","1",,"0","Mixed","rape/sexual assault, accidents, child sexual abuse, community/school violence, other (witness to murder)","Medium","Sloan DM, Marx BP. A closer examination of the structured written disclosure procedure. J Consult Clin Psychol. 2004 Apr;72(2):165-75. doi: 10.1037/0022-006X.72.2.165. PMID: 15065952.","28170","2019"
"sloan2004_B","Psychotherapy","PTSD","Control",,"51","B","23",,"Control writing condition","Control writing","Participants instructed to write about how they spent their time without describing any emotion or opinions, in as much detail as possible.","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","Written",,"20 minutes","Daily","0.43",,"completed all 3 writing sessions","1",,,,,"3",,,,,,"Community",,,"1","1",,"0","Mixed","rape/sexual assault, accidents, child sexual abuse, community/school violence, other (witness to murder)","Medium","Sloan DM, Marx BP. A closer examination of the structured written disclosure procedure. J Consult Clin Psychol. 2004 Apr;72(2):165-75. doi: 10.1037/0022-006X.72.2.165. PMID: 15065952.","28170","2019"
"sloan2007_A","Psychotherapy","PTSD","PTSD",,"85","A","28",,"Written disclosure focused on emotional expression","Written Exposure Therapy (WET)","Participants instructed to write about most traumatic experience of their lives with as much emotion and feeling as possible; participant asked to write about the same experience at each writing session.","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","Written",,"20 minutes","Daily","0.43",,"completed all 3 writing sessions",,"Overall 98.82%",,,,,,,,,,"Community",,,"1","0.8049",,"0.1951","Mixed","rape/sexual assault, community/school violence, accidents, other (witness to murder)","Medium","Sloan DM, Marx BP, Epstein EM, et al. Does altering the writing instructions influence outcome associated with written disclosure? Behav Ther. 2007 Jun;38(2):155-68. doi: 10.1016/j.beth.2006.06.005. PMID: 17499082.","32045","2019"
"sloan2007_B","Psychotherapy","PTSD","PTSD",,"85","B","27",,"Written disclosure focused on insight and cognitive assimilation","Written Exposure Therapy (WET)","Participants instructed to write about most traumatic experience of their lives with a focus on what the event has meant to them, how the event changed their lives (both good and bad), and challenge their dissonant thoughts about the event; asked to write about the same experience at each writing session.","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","Written",,"20 minutes","Daily","0.43",,"completed all 3 writing sessions",,"Overall 98.82%",,,,,,,,,,"Community",,,"1","0.8049",,"0.1951","Mixed","rape/sexual assault, community/school violence, accidents, other (witness to murder)","Medium","Sloan DM, Marx BP, Epstein EM, et al. Does altering the writing instructions influence outcome associated with written disclosure? Behav Ther. 2007 Jun;38(2):155-68. doi: 10.1016/j.beth.2006.06.005. PMID: 17499082.","32045","2019"
"sloan2007_C","Psychotherapy","PTSD","Control",,"85","C","27",,"Control writing condition","Control writing","Participants instructed to write about how they spent their time without describing any emotion or opinions.","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","Written",,"20 minutes","Daily","0.43",,"completed all 3 writing sessions",,"Overall 98.82%",,,,,,,,,,"Community",,,"1","0.8049",,"0.1951","Mixed","rape/sexual assault, community/school violence, accidents, other (witness to murder)","Medium","Sloan DM, Marx BP, Epstein EM, et al. Does altering the writing instructions influence outcome associated with written disclosure? Behav Ther. 2007 Jun;38(2):155-68. doi: 10.1016/j.beth.2006.06.005. PMID: 17499082.","32045","2019"
"sloan2011_A","Psychotherapy","PTSD","PTSD",,"47","A","24",,"Written emotional disclosure","Written Exposure Therapy (WET)","Procedure following Pennebaker 1997; participants were asked to write about the most traumatic experience of their lives with as much emotion and feeling as possible; asked to write about the same traumatic experience at each session.","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","Written",,"20 minutes","Daily","0.43",,"completed treatment course","0.9167",,,,,,,,,,,"Community",,,"1",,,,"Mixed","rape/sexual assault, community/school violence, accidents, combat-related, other (witness to a murder)","High","Sloan DM, Marx BP, Greenberg EM. A test of written emotional disclosure as an intervention for posttraumatic stress disorder. Behav Res Ther. 2011 Apr;49(4):299-304. doi: 10.1016/j.brat.2011.02.001. PMID: 21367400.","36171","2019"
"sloan2011_B","Psychotherapy","PTSD","Control",,"47","B","23",,"Control writing condition","Control writing","Procedure following Pennebaker 1997; participants were asked to write about how they spent their time each day without describing any emotion or opinions.","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual",,,"20 minutes","Daily","0.43",,"completed treatment course","0.9565",,,,,,,,,,,"Community",,,"1",,,,"Mixed","rape/sexual assault, community/school violence, accidents, combat-related, other (witness to a murder)","High","Sloan DM, Marx BP, Greenberg EM. A test of written emotional disclosure as an intervention for posttraumatic stress disorder. Behav Res Ther. 2011 Apr;49(4):299-304. doi: 10.1016/j.brat.2011.02.001. PMID: 21367400.","36171","2019"
"sloan2012_A","Psychotherapy","PTSD","PTSD",,"46","A","22",,"Written exposure therapy","Written Exposure Therapy (WET)","Exposure through writing about the same motor vehicle accident each session. Initial session focused on describing the event in detail and delving into deepest emotions and thoughts at the time of the accident; remaining sessions focused on most distressing part of the event (""hot spot""), and how it had affected participant's life. The therapist read writing instructions and answered questions; participants were left alone in the room for the writing exercise; therapists addressed concerns at the end of the writing exercise, checked that instructions were followed, and instructed participant to allow experiencing of trauma-related memories, images, thoughts, or feelings in between sessions.","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"1 hour (first session), 40 minutes (remaining 4 sessions); writing exercises 30 minutes per session","Weekly","5",,"completed all 5 treatment sessions","0.9091",,,,,,,,,,,"Community",,,"1","0.65",,"0.35","Accidents",,"Low","Sloan DM, Marx BP, Bovin MJ, et al. Written exposure as an intervention for PTSD: a randomized clinical trial with motor vehicle accident survivors. Behav Res Ther. 2012 Oct;50(10):627-35. doi: 10.1016/j.brat.2012.07.001. PMID: 22863540.","39268","2019"
"sloan2012_B","Psychotherapy","PTSD","Control",,"46","B","24",,"Waitlist","Waitlist","Participants encouraged to contact project coordinator any time if experiencing problems; contacted prior to followup assessments for reminder and to make sure they had not experienced a substantial increase in PTSD symptom severity. Participants were offered written exposure therapy after the 18-week assessment was completed.","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,,,,"18",,,,,,,,,,,,,,"Community",,,"1","0.65",,"0.35","Accidents",,"Low","Sloan DM, Marx BP, Bovin MJ, et al. Written exposure as an intervention for PTSD: a randomized clinical trial with motor vehicle accident survivors. Behav Res Ther. 2012 Oct;50(10):627-35. doi: 10.1016/j.brat.2012.07.001. PMID: 22863540.","39268","2019"
"smajkic2001_A","Pharmacotherapy","PTSD","PTSD",,"40","A","15",,"Sertraline","Sertraline","SSRI antidepressant, initiated at 50 mg, dose increased to 100 mg after 14 days based on tolerability","No","Not Applicable","Yes","Antidepressant: SSRI","No","Not Applicable","No","No","No","No","No","Individual","In Person","Initiated at 50 mg, titrated to 100 mg",,"Once daily","6",,,,,,,,,,,,,,"Community",,,"1","0.5625",,"0.4375","Terrorism/political violence/forced displacement",,"High","Smajkic A, Weine SM, Djuric-Bijedic Z, et al. Sertraline, paroxetine, and venlafaxine in refugee posttraumatic stress disorder with depression symptoms. J Trauma. Stress. 2001 Jul;14(3):445-52. doi: 10.1023/A:1011177420069. PMID: 11534876.","16085","2019"
"smajkic2001_B","Pharmacotherapy","PTSD","PTSD",,"40","B","12",,"Paroxetine","Paroxetine","SSRI antidepressant, dose maintained after 14 days if tolerated","No","Not Applicable","Yes","Antidepressant: SSRI","No","Not Applicable","No","No","No","No","No","Individual","In Person","20 mg",,"Once daily","6",,,,,,,,,,,,,,"Community",,,"1","0.5625",,"0.4375","Terrorism/political violence/forced displacement",,"High","Smajkic A, Weine SM, Djuric-Bijedic Z, et al. Sertraline, paroxetine, and venlafaxine in refugee posttraumatic stress disorder with depression symptoms. J Trauma. Stress. 2001 Jul;14(3):445-52. doi: 10.1023/A:1011177420069. PMID: 11534876.","16085","2019"
"smajkic2001_C","Pharmacotherapy","PTSD","PTSD",,"40","C","13",,"Venlafaxine","Venlafaxine","SNRI antidepressant, initiated at 37.5 mg, dose increased to 75 mg after 14 days based on tolerability","No","Not Applicable","Yes","Antidepressant: SNRI","No","Not Applicable","No","No","No","No","No","Individual","In Person","Initiated at 37.5 mg, titrated to 75 mg",,"Twice daily","6",,,,,,,,,,,,,,"Community",,,"1","0.5625",,"0.4375","Terrorism/political violence/forced displacement",,"High","Smajkic A, Weine SM, Djuric-Bijedic Z, et al. Sertraline, paroxetine, and venlafaxine in refugee posttraumatic stress disorder with depression symptoms. J Trauma. Stress. 2001 Jul;14(3):445-52. doi: 10.1023/A:1011177420069. PMID: 11534876.","16085","2019"
"smyth2008_A","Psychotherapy","PTSD","PTSD",,"25","A","10",,"Expressive writing","Written narrative exposure","Participants write about traumatic event, it's effect on their thoughts, feelings, and sensations, and the rationality of their negative beliefs","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","Written",,"20 minutes","3 sessions","0.14",,,,,,,,,,,,,,,,,,"0.56",,"0.44","Mixed","combat-related, rape/sexual assault","High","Smyth JM, Hockemeyer JR, Tulloch H. Expressive writing and post-traumatic stress disorder: effects on trauma symptoms, mood states, and cortisol reactivity. Br J Health Psychol. 2008 Feb;13(1):85-93. doi: 10.1348/135910707X250866. PMID: 18230238.","30627","2019"
"smyth2008_B","Psychotherapy","PTSD","Control",,"25","B","15",,"Emotionally neutral writing","Control writing","Participants write about time management and their daily plans","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person",,"20 minutes","3 sessions","0.14",,,,,,,,,,,,,,,,,,"0.56",,"0.44","Mixed","combat-related, rape/sexual assault","High","Smyth JM, Hockemeyer JR, Tulloch H. Expressive writing and post-traumatic stress disorder: effects on trauma symptoms, mood states, and cortisol reactivity. Br J Health Psychol. 2008 Feb;13(1):85-93. doi: 10.1348/135910707X250866. PMID: 18230238.","30627","2019"
"sonne2016_A","Mixed: Psychotherapy & pharmacotherapy","PTSD","PTSD",,"207","A","109",,"Sertraline + CBT","Sertraline + trauma-focused cognitive behavioral therapy (TF-CBT)","SSRI with 10 sessions with psychiatrist/medical doctor for drug management and pscyhoeducation, 16 sessions with psychologist using flexible manual-based cognitive therapy with elements of trauma-focused therapy, acceptance commitment therapy, and mindfulness. Group and individual sessions with a social worker offered.","Yes","TF","Yes","Antidepressant: SSRI","No","Not Applicable","No","No","No","No","No","Individual","In Person","Session length: NR

Dose: sertraline initiated at 25 to 50 mg/day, titrated weekly by 25 to 50 mg for first 6 weeks, then monthly up to 200 mg/day",,"Psychotherapy: weekly

Sertraline: daily","24 to 28",,"≥8 consecutive weeks of pharmacological treatment","0.8073",,"compliance monitored by pill count",,,,,,"96.21 mg/day",,,"Community",,,"1","0.401",,"0.599","Terrorism/political violence/forced displacement",,"Medium","Sonne C, Carlsson JM, Bech P, et al. Treatment of trauma-affected refugees with venlafaxine versus sertraline combined with psychotherapy - a randomised study. BMC Psychiatry. 2016 Nov 8;16(1):383. doi: 10.1186/s12888-016-1081-5. PMID: 27825327.","45853","2019"
"sonne2016_B","Mixed: Psychotherapy & pharmacotherapy","PTSD","PTSD",,"207","B","98",,"Venlafaxine + CBT","Venlafaxine plus trauma-focused cognitive behavioral therapy (TF-CBT)","SNRI with 10 sessions with psychiatrist/medical doctor for drug management and pscyho-education, 16 sessions with psychologist using flexible manual-based cognitive therapy with elements of trauma-focused therapy, acceptance commitment therapy, and mindfulness. Group and individual sessions with a social worker offered.","Yes","TF","Yes","Antidepressant: SNRI","No","Not Applicable","No","No","No","No","No","Individual","In Person","Session length: NR

Dose: venlafaxine initiated at 37.5 to 75 mg/day, titrated weekly by 37.5 to 75 mg for first 6 weeks, then monthly up to maximum 375 mg/day",,"Psychotherapy: weekly

Venlafaxine: daily","24 to 28",,"≥8 consecutive weeks of pharmacological compliance during the study period","0.6939",,"compliance monitored by pill count",,,,,,"125.41 mg/day",,,"Community",,,"1","0.401",,"0.599","Terrorism/political violence/forced displacement",,"Medium","Sonne C, Carlsson JM, Bech P, et al. Treatment of trauma-affected refugees with venlafaxine versus sertraline combined with psychotherapy - a randomised study. BMC Psychiatry. 2016 Nov 8;16(1):383. doi: 10.1186/s12888-016-1081-5. PMID: 27825327.","45853","2019"
"spence2011_A","Other mixed","PTSD","PTSD",,"44","A","23",,"Internet-delivered CBT","Internet-delivered CBT","Online lessons include in vivo and imaginal exposure, cognitive restructuring, and de-arousal strategies. Also includes an online discussion forum moderated by the therapist and written resources about assertiveness skills, anger management, strategies for improving sleep, diet, exercise, and reducing drug and alcohol use","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","No","Yes","No","Individual","Technology Assisted",,,,"8","7 lessons total",,,,,,,"6.74","0.54",,,,,"Community",,,"1","0.8095",,"0.1905","Mixed","rape/sexual assault, accidents, community/school violence, other (not specified)","Medium","Spence J, Titov N, Dear BF, et al. Randomized controlled trial of internet-delivered cognitive behavioral therapy for posttraumatic stress disorder. Depress Anxiety. 2011 Jul;28(7):541-50. doi: 10.1002/da.20835. PMID: 21721073.","37944","2019"
"spence2011_B","Other mixed","PTSD","Control",,"44","B","21",,"Waitlist","Waitlist",,"No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,,,,"8",,,,,,,,,,,,,,"Community",,,"1","0.8095",,"0.1905","Mixed","rape/sexual assault, accidents, community/school violence, other (not specified)","Medium","Spence J, Titov N, Dear BF, et al. Randomized controlled trial of internet-delivered cognitive behavioral therapy for posttraumatic stress disorder. Depress Anxiety. 2011 Jul;28(7):541-50. doi: 10.1002/da.20835. PMID: 21721073.","37944","2019"
"spence2014_A","Other mixed","PTSD","PTSD",,"125","A","66",,"Non-exposure, internet-delivered CBT","Internet-delivered CBT","Lessons include psychoeducation, stress management, and cognitive restructuring","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","No","Yes","No","Individual","Technology Assisted",,"10 to 20 minutes reading time",,"8","4 lessons total","reading all 4 lessons within 8 weeks","0.7879",,,,,,,,,,,"Community",,,"1","0.864",,"0.136","Mixed","combat-related, rape/sexual assault, accidents, illness/medical procedure, community/school violence, natural or manmade disasters, terrorism/political violence/forced displacement, other (not specified)","Medium","Spence J, Titov N, Johnston L, et al. Internet-based trauma-focused cognitive behavioural therapy for PTSD with and without exposure components: a randomised controlled trial. J Affect Disord. 2014 Jun;162:73-80. doi: 10.1016/j.jad.2014.03.009. PMID: 24767009.","42408","2019"
"spence2014_B","Other mixed","PTSD","PTSD",,"125","B","59",,"Internet-delivered CBT","Internet-delivered CBT","Lessons include psychoeducation, stress management, cognitive restructuring, and exposure components","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","No","Yes","No","Individual","Technology Assisted",,"10 to 20 minutes reading time",,"8","6 lessons total","reading all 6 lessons within 8 weeks","0.7288",,"completing ≥2 session of in vivo exposure, ≥2 sessions of imaginal exposure, or ≥2 sessions each of in vivo exposure and imaginal exposure",,"63.83%, 46.81%, 42.55%",,,,,,,"Community",,,"1","0.864",,"0.136","Mixed","combat-related, rape/sexual assault, accidents, illness/medical procedure, community/school violence, natural or manmade disasters, terrorism/political violence/forced displacement, other (not specified)","Medium","Spence J, Titov N, Johnston L, et al. Internet-based trauma-focused cognitive behavioural therapy for PTSD with and without exposure components: a randomised controlled trial. J Affect Disord. 2014 Jun;162:73-80. doi: 10.1016/j.jad.2014.03.009. PMID: 24767009.","42408","2019"
"spivak2006_A","Pharmacotherapy","PTSD","PTSD",,"40","A","20",,"Reboxetine","Reboxetine","Norepinephrine reuptake inhibitor antidepressant, 8 mg/day fixed dose","No","Not Applicable","Yes","Antidepressant: SNRI","No","Not Applicable","No","No","No","No","No","Individual","In Person","4 mg",,"Twice daily","8",,,,,"ensured by ""direct questioning and by counting of medication capsules""",,,,,,,,,"Community",,,"1","0.475",,"0.525","Accidents",,"Medium","Spivak B, Strous RD, Shaked G, et al. Reboxetine versus fluvoxamine in the treatment of motor vehicle accident-related posttraumatic stress disorder: a double-blind, fixed-dosage, controlled trial. J Clin Psychopharmacol. 2006 Apr;26(2):152-6. doi: 10.1097/01.jcp.0000203195.65710.f0. PMID: 16633143.","1548487","2019"
"spivak2006_B","Pharmacotherapy","PTSD","PTSD",,"40","B","20",,"Fluvoxamine","Fluvoxamine","SSRI antidepressant, fixed dose of 150 mg/day","No","Not Applicable","Yes","Antidepressant: SSRI","No","Not Applicable","No","No","No","No","No","Individual","In Person","75 mg",,"Twice daily","8",,,,,"ensured by ""direct questioning and by counting of medication capsules""",,,,,,,,,"Community",,,"1","0.475",,"0.525","Accidents",,"Medium","Spivak B, Strous RD, Shaked G, et al. Reboxetine versus fluvoxamine in the treatment of motor vehicle accident-related posttraumatic stress disorder: a double-blind, fixed-dosage, controlled trial. J Clin Psychopharmacol. 2006 Apr;26(2):152-6. doi: 10.1097/01.jcp.0000203195.65710.f0. PMID: 16633143.","1548487","2019"
"stappenbeck2015a_C","Psychotherapy","PTSD+SUD","Control","Not integrated","80","C","20",,"Attention control","Attention control","Scripted condition for attention control condition; participants given a copy of the script, short overview statement, homework materials, and a CD recording of the script and overview; therapist also provided 4 coaching calls. Nutrition guidance as ""comparable length interaction with the therapist that involved learning something germane to health but not specifically relevant to either PTSD or problematic alcohol use"". Participants learned plate method of nutrition, assessed current eating habits, and how to align diet with recommendations.","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person",,"Coaching calls: average 11 to 13 minutes","In-person session: once (single session); Coaching calls: weekly","5",,,,,,,,,,"Coaching calls: 3.4 (NR)",,,,"Mixed","0","0.269","0.731","0.487",,"0.513",,,"Medium","Stappenbeck CA, Luterek JA, Kaysen DL, et al. A controlled examination of two coping skills for daily alcohol use and PTSD symptom severity among dually diagnosed individuals. Behav Res Ther. 2015a Mar;66:8-17. doi: 10.1016/j.brat.2014.12.013. PMID: 25617814.","43808","2020"
"stappenbeck2015a_A","Psychotherapy","PTSD+SUD","PTSD+SUD","Not integrated","80","A","31",,"Cognitive Restructuring","Cognitive Therapy for PTSD (CT-PTSD)","Scripted condition for coping skills training;  participants given a copy of the script, short overview statement, homework materials, and a CD recording of the script and overview; therapist also provided 4 coaching calls. Participants were taught ""how trauma exposure can lead to distorted thoughts and beliefs, which in turn can lead to negative feelings and unhealthy behaviors. They were given “A-B-C” sheets and taught how to identify the antecedent..., beliefs and thoughts, and consequences"" and taught 3 questions from skill set in Cognitive Processing Therapy to evaluate accuracy of thought/belief, and guided through use of ABC sheet for a recent drinking or craving episode; participants were to practice at home with ABC sheets.","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"Coaching calls: average 11 to 13 minutes","In-person session: once (single session); Coaching calls: weekly","5",,,,,,,,,,"Coaching calls: 2.9 (NR)",,,,"Mixed","0","0.269","0.731","0.487",,"0.513",,,"Medium","Stappenbeck CA, Luterek JA, Kaysen DL, et al. A controlled examination of two coping skills for daily alcohol use and PTSD symptom severity among dually diagnosed individuals. Behav Res Ther. 2015a Mar;66:8-17. doi: 10.1016/j.brat.2014.12.013. PMID: 25617814.","43808","2020"
"stappenbeck2015a_B","Psychotherapy","PTSD+SUD","PTSD+SUD","Not integrated","80","B","29",,"Experiential Acceptance","Experiential Acceptance","Scripted condition for coping skills training;  participants given a copy of the script, short overview statement, homework materials, and a CD recording of the script and overview; therapist also provided 4 coaching calls. Participants introduced ""to the idea that avoiding thoughts and feelings is often associated with more distress and poorer coping. Instead, accepting thoughts and feelings can enable one to make choices consistent with one's values rather than having one's behavior driven by distress or urges to drink."", and to ""urge surfing"" and mindful breathing meditation; participants identified ways they avoided or tried to change thoughts or feelings and how experiential acceptance concepts could be used.","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"Coaching calls: average 11 to 13 minutes","In-person session: once (single session); Coaching calls: weekly","5",,,,,,,,,,"Coaching calls: 3.1 (NR)",,,,"Mixed","0","0.269","0.731","0.487",,"0.513",,,"Medium","Stappenbeck CA, Luterek JA, Kaysen DL, et al. A controlled examination of two coping skills for daily alcohol use and PTSD symptom severity among dually diagnosed individuals. Behav Res Ther. 2015a Mar;66:8-17. doi: 10.1016/j.brat.2014.12.013. PMID: 25617814.","43808","2020"
"stecker2014_A","Psychotherapy","PTSD","PTSD",,"300","A","143",,"Brief CBT by telephone","Cognitive behavioral therapy (CBT) without a trauma focus","CBT-based telephone session to identify and address beliefs about PTSD treatment","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","Phone",,"45 to 60 minutes","Once","1",,"received intervention","0.8601",,,,,,,,,,,"Mixed",,,"0","0.1277",,"0.8723",,,"High","Stecker T, McHugo GJ, Xie HY, et al. RCT of a brief phone-based CBT intervention to improve PTSD treatment utilization by returning service members. Psychiatr Serv. 2014 Oct;65(10):1232-7. doi: 10.1176/appi.ps.201300433. PMID: 24933496.","44566","2020"
"stecker2014_B","Psychotherapy","PTSD","Control",,"300","B","157",,"TAU","Treatment as usual (TAU)","Received baseline assessment and followup assessments calls only.","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","Phone",,,,"1",,,,,,,,,,,,,,"Mixed",,,"0","0.1277",,"0.8723",,,"High","Stecker T, McHugo GJ, Xie HY, et al. RCT of a brief phone-based CBT intervention to improve PTSD treatment utilization by returning service members. Psychiatr Serv. 2014 Oct;65(10):1232-7. doi: 10.1176/appi.ps.201300433. PMID: 24933496.","44566","2020"
"stein2002_A","Pharmacotherapy","PTSD","PTSD",,"19","A","10",,"Olanzapine augmentation","Olanzapine augmentation","Atypical antipsychotic + previously prescribed SSRI (fluoxetine, paroxetine or sertraline). Olanzapine started at 10 mg daily for 2 weeks, increased to 20 mg daily if needed and tolerated.","No","Not Applicable","Yes","Antipsychotic","No","Not Applicable","No","No","No","No","No","Individual","In Person","10 to 20 mg; titration: 10 mg for 2 weeks, optional increase to maximum of 20 mg",,"Daily at bedtime","8",,,,,,,,,,,"15.00 mg/day","5.25",,"Veteran","0","1","0","0",,"1","Combat-related",,"Medium","Stein MB, Kline NA, Matloff JL. Adjunctive olanzapine for SSRI-resistant combat-related PTSD: a double-blind, placebo-controlled study. Am J Psychiatry. 2002 Oct;159(10):1777-9. doi: 10.1176/appi.ajp.159.10.1777. PMID: 12359687.","24689","2019"
"stein2002_B","Pharmacotherapy","PTSD","PTSD",,"19","B","9",,"Placebo augmentation","Placebo","Placebo + previously prescribed SSRI. Placebo started at 10 mg equivalent daily for 2 weeks, increased to 20 mg equivalent daily if needed and tolerated.","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","10 to 20 mg equivalent; titration: 10 mg daily for 2 weeks, then optional; increase to 20 mg maximum",,"Daily at bedtime","8",,,,,,,,,,,"20.00 mg/day equivalent","0",,"Veteran","0","1","0","0",,"1","Combat-related",,"Medium","Stein MB, Kline NA, Matloff JL. Adjunctive olanzapine for SSRI-resistant combat-related PTSD: a double-blind, placebo-controlled study. Am J Psychiatry. 2002 Oct;159(10):1777-9. doi: 10.1176/appi.ajp.159.10.1777. PMID: 12359687.","24689","2019"
"steinert2016_A","Psychotherapy","PTSD","PTSD",,"86","A","53",,"Resource-oriented trauma therapy combined with EMDR","Resource-oriented trauma therapy combined with Eye Movement Desensitization and Reprocessing (EMDR)","Manualized trauma therapy aimed at strengthening resilience and coping capacities. Treatment elements include: psychoeducation; establishing a sense of safety and control; strengthening the adult ego of the patient, and focus on resource activation to enhance emotion regulation; techniques taught to patients include: imaginative techniques to distance from overwhelming traumatic emotions and intrusions; grounding techniques to help manage dissociative crises; and resource development and installation (an EMDR technique).","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"1 hour","Weekly","5",,"Completion: completed treatment course","0.9811",,,,,,,,,,,"Community",,,"1","0.6071",,"0.3929","Mixed","intimate partner violence, accidents, rape/sexual assault, combat-related, community/school violence, other (trafficking)","Medium","Steinert C, Bumke PJ, Hollekamp RL, et al. Treating post-traumatic stress disorder by resource activation in Cambodia. World Psychiatry. 2016 Jun;15(2):183-5. doi: 10.1002/wps.20303. PMID: 27265714.","45144","2019"
"steinert2016_B","Psychotherapy","PTSD","Control",,"86","B","33",,"Waitlist","Waitlist",,"No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,,,,"5",,"completed treatment course","0.9697",,,,,,,,,,,"Community",,,"1","0.6071",,"0.3929","Mixed","intimate partner violence, accidents, rape/sexual assault, combat-related, community/school violence, other (trafficking)","Medium","Steinert C, Bumke PJ, Hollekamp RL, et al. Treating post-traumatic stress disorder by resource activation in Cambodia. World Psychiatry. 2016 Jun;15(2):183-5. doi: 10.1002/wps.20303. PMID: 27265714.","45144","2019"
"stenmark2013_A","Psychotherapy","PTSD","PTSD",,"81","A","51",,"NET","Narrative Exposure Therapy (NET)","Therapist assists patient construct a chronological narrative of their life stories with emphasis on traumatic experiences. Therapeutic re-exposures to traumatic experiences continue until associated fear responses decline","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"90 minutes","Weekly","10",,,,,,,,,,,,,,"Community",,,"1","0.3086",,"0.6914",,,"High","Stenmark H, Catani C, Neuner F, et al. Treating PTSD in refugees and asylum seekers within the general health care system. A randomized controlled multicenter study. Behav Res Ther. 2013 Oct;51(10):641-7. doi: 10.1016/j.brat.2013.07.002. PMID: 23916633.","46540","2019"
"stenmark2013_B","Psychotherapy","PTSD","Control",,"81","B","30",,"TAU","Treatment as usual (TAU)","Therapists can use any intervention except for steps specific to NET, such as help with sleep problems, depressive symptoms, problems related to asylum status, etc.","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,,"90 minutes","Weekly","10",,,,,,,,,,,,,,"Community",,,"1","0.3086",,"0.6914",,,"High","Stenmark H, Catani C, Neuner F, et al. Treating PTSD in refugees and asylum seekers within the general health care system. A randomized controlled multicenter study. Behav Res Ther. 2013 Oct;51(10):641-7. doi: 10.1016/j.brat.2013.07.002. PMID: 23916633.","46540","2019"
"suris2013a_A","Mixed: Psychotherapy & pharmacotherapy","PTSD","PTSD",,"54","A",,,"Sirolimus + trauma memory reactivation","Sirolimus + imaginal exposure (experimental paradigm)","Single dose paired with reactivation of a specific trauma memory.

Sirolimus also known as rapamycin; developed as an antifungal, used as an immunosuppressant; regulates dendritic protein synthesis in the amygdala and dorsal hippocampus through the systemic inhibition of the protein kinase mTOR (mammalian target of rapamycin) pathway. After administration of sirolimus, participants wrote script describing most distressing combat trauma memory (about 45 minute process), in next session 7 days later, the participant listened to 3 recordings: standard neutral script, followed by personal combat script, then another standard neutral script (scripts approximately 30 to 40 seconds duration).","Yes","TF","Yes","Other pharmacotherapy","No","Not Applicable","No","No","No","No","No","Individual","In Person","Session length (session 2 when drug administered): mean 45 minutes (range 30 to 75)

Dose: 15 mg",,"Once (single dose)","1",,,,,,,,,,,"15 mg",,,"Veteran","0","1","0","0",,"1","Combat-related",,"High","Stenmark H, Catani C, Neuner F, et al. Treating PTSD in refugees and asylum seekers within the general health care system. A randomized controlled multicenter study. Behav Res Ther. 2013 Oct;51(10):641-7. doi: 10.1016/j.brat.2013.07.002. PMID: 23916633.","41233","2019"
"suris2013a_B","Mixed: Psychotherapy & pharmacotherapy","PTSD","PTSD",,"54","B",,,"Placebo + trauma memory reactivation","Imaginal exposure (experimental paradigm) + placebo","Placebo. After administration, participants wrote script describing most distressing combat trauma memory (about 45 minute process), in next session 7 days later, the participant listened to 3 recordings: standard neutral script, followed by personal combat script, then another standard neutral script (scripts approximately 30 to 40 seconds duration).","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","Session length (session 2 when drug administered): mean 45 minutes (range 30 to 75)

Dose: NA",,"Once (single dose)","1",,,,,,,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"High","Stenmark H, Catani C, Neuner F, et al. Treating PTSD in refugees and asylum seekers within the general health care system. A randomized controlled multicenter study. Behav Res Ther. 2013 Oct;51(10):641-7. doi: 10.1016/j.brat.2013.07.002. PMID: 23916633.","41233","2019"
"suris2013b_A","Psychotherapy","PTSD","PTSD",,"129","A","75",,"CPT","Cognitive Processing Therapy (CPT)","CBT designed for treatment of rape-related PTSD, includes education, cognitive restructuring, and writing trauma narratives","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,,"Once or twice weekly","12","12 sessions total",,,,,,,,,,,,,"Veteran","0","1","0","0.8488",,"0.1512","MST",,"High","Suris A, Link-Malcolm J, Chard K, et al. A randomized clinical trial of cognitive processing therapy for veterans with PTSD related to military sexual trauma. J Trauma Stress. 2013 Feb;26(1):28-37. doi: 10.1002/jts.21765. PMID: 23325750.","87369","2019"
"suris2013b_B","Psychotherapy","PTSD","Control",,"129","B","57",,"PCT","Present Centered Therapy (PCT)","General support, education, problem-solving and improving relationships, daily journaling","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,,"Once or twice weekly","12","12 sessions total",,,,,,,,,,,,,"Veteran","0","1","0","0.8488",,"0.1512","MST",,"High","Suris A, Link-Malcolm J, Chard K, et al. A randomized clinical trial of cognitive processing therapy for veterans with PTSD related to military sexual trauma. J Trauma Stress. 2013 Feb;26(1):28-37. doi: 10.1002/jts.21765. PMID: 23325750.","87369","2019"
"suris2017_A","Mixed: Psychotherapy & pharmacotherapy","PTSD","PTSD",,"54","A","26",,"Dexamethasone + brief trauma memory reactivation task","Dexamethasone + imaginal exposure (experimental paradigm)","Glucocorticoid paired with brief trauma memory reactivation task; patients in each arm received four treatment sessions, receiving drug or placebo 60 minutes before therapy sessions that included writing a trauma narrative and listening to staff audio recordings of the narrative; audio recordings were 30 to 45 seconds.","Yes","TF","Yes","Other pharmacotherapy","No","Not Applicable","No","No","No","No","No","Individual","In Person","0.15 mg/kg",,"Weekly","3",,,,,,,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"Medium","Suris A, Link-Malcolm J, Chard K, et al. A randomized clinical trial of cognitive processing therapy for veterans with PTSD related to military sexual trauma. J Trauma Stress. 2013 Feb;26(1):28-37. doi: 10.1002/jts.21765. PMID: 23325750.","49780","2019"
"suris2017_B","Mixed: Psychotherapy & pharmacotherapy","PTSD","Control",,"54","B","28",,"Placebo + brief trauma memory reactivation task","Imaginal exposure (experimental paradigm)","Placebo paired with brief trauma memory reactivation task; patients in each arm received four treatment sessions, receiving drug or placebo 60 minutes before therapy sessions that included writing a trauma narrative and listening to staff audio recordings of the narrative; audio recordings were 30 to 45 seconds.","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person",,,"Weekly","3",,,,,,,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"Medium","Suris A, Link-Malcolm J, Chard K, et al. A randomized clinical trial of cognitive processing therapy for veterans with PTSD related to military sexual trauma. J Trauma Stress. 2013 Feb;26(1):28-37. doi: 10.1002/jts.21765. PMID: 23325750.","49780","2019"
"talbot2014_A","Psychotherapy","PTSD","PTSD",,"45","A","29",,"CBT for insomnia","Cognitive Behavioral Therapy for Insomnia (CBT-I)","Patients instructed to write about a specific traumatic event, focusing on details of the event and the thoughts and feelings that occurred during the event, for 30 minutes each session; no assignments between sessions.","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,,,"8",,"received allocated intervention","0.931",,,,,,,,,,,"Mixed",,"0.20","0.80","0.6889",,"0.3111",,,"Low","Talbot LS, Maguen S, Metzler TJ, et al. Cognitive behavioral therapy for insomnia in posttraumatic stress disorder: a randomized controlled trial. Sleep. 2014 Feb 1;37(3):327-41. doi: 10.5665/sleep.3408. PMID: 24497661.","42060","2020"
"talbot2014_B","Psychotherapy","PTSD","Control",,"45","B","16",,"Waitlist","Waitlist","Monitored sleep using sleep diary and actigraphy; weekly telephone or email check-ins from study coordinator.","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,,,,"8",,"received allocated intervention","0.9375",,,,,,,,,,,"Mixed",,"0.20","0.80","0.6889",,"0.3111",,,"Low","Talbot LS, Maguen S, Metzler TJ, et al. Cognitive behavioral therapy for insomnia in posttraumatic stress disorder: a randomized controlled trial. Sleep. 2014 Feb 1;37(3):327-41. doi: 10.5665/sleep.3408. PMID: 24497661.","42060","2020"
"tarrier1999a_A","Psychotherapy","PTSD","PTSD",,"72","A","35",,"Imaginal exposure therapy","Exposure therapy","Trauma-focused therapy seeking habituation of emotional responses; patient described and visualized event with exposure continuing until emotional reactions decreased; hierarchy of events approaching most intense aspect of trauma could be used","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"1 hour","Weekly","16",,,,,,,,"10.4","4.2",,,,,"Community",,,"1","0.5806","treatment completers only","0.4194","Mixed","accidents, other (crime, not specified)","Medium","Tarrier N, Pilgrim H, Sommerfield C, et al. A randomized trial of cognitive therapy and imaginal exposure in the treatment of chronic posttraumatic stress disorder. J Consult Clin Psychol. 1999 Feb;67(1):13-8. doi: 10.1037//0022-006X.67.1.13. PMID: 10028204.","09173","2019"
"tarrier1999a_B","Psychotherapy","PTSD","PTSD",,"72","B","37",,"Cognitive therapy","Cognitive Therapy for PTSD (CT-PTSD)","Emotion focused therapy eliciting patients' beliefs about the meaning of the traumatic event, and identifying and modifying maladaptive cognitions and emotions; discussion of trauma itself avoided","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"1 hour","Weekly","16",,,,,,,,"11.9","4.6",,,,,"Community",,,"1","0.5806","treatment completers only","0.4194","Mixed","accidents, other (crime, not specified)","Medium","Tarrier N, Pilgrim H, Sommerfield C, et al. A randomized trial of cognitive therapy and imaginal exposure in the treatment of chronic posttraumatic stress disorder. J Consult Clin Psychol. 1999 Feb;67(1):13-8. doi: 10.1037//0022-006X.67.1.13. PMID: 10028204.","09173","2019"
"taylor2003a_C","Mixed: Psychotherapy & CIH","PTSD","PTSD",,"60","C","19",,"EMDR","Eye Movement Desensitization and Reprocessing (EMDR)","Treatment following Shapiro 1995 protocol, including Safe Place exercise and processing of a traumatic memory by recalling the memory and its associated feature while making lateral eye movements following therapist's finger until distress subsides","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,,,,,,,,,,,,,,,,,"Community","0","0","1","0.75",,"0.25","Mixed","rape/sexual assault, accidents, community/school violence","Medium","Taylor S, Thordarson DS, Maxfield L, et al. Comparative efficacy, speed, and adverse effects of three PTSD treatments: exposure therapy, EMDR, and relaxation training. J Consult Clin Psychol. 2003a Apr;71(2):330-8. doi: 10.1037/0022-006X.71.2.330. PMID: 12699027.","25484","2020"
"taylor2003a_A","Mixed: Psychotherapy & CIH","PTSD","PTSD",,"60","A","22",,"PE","Prolonged Exposure (PE)","Treatment following Marks et al. 1998 manual, including imaginal and in vivo exposure but does not include breathing retraining as part of Foa 1999 protocol","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"90 minutes",,,"8 sessions",,,,,,,,,,,,,"Community","0","0","1","0.75",,"0.25","Mixed","rape/sexual assault, accidents, community/school violence","Medium","Taylor S, Thordarson DS, Maxfield L, et al. Comparative efficacy, speed, and adverse effects of three PTSD treatments: exposure therapy, EMDR, and relaxation training. J Consult Clin Psychol. 2003a Apr;71(2):330-8. doi: 10.1037/0022-006X.71.2.330. PMID: 12699027.","25484","2020"
"taylor2003a_B","Mixed: Psychotherapy & CIH","PTSD","PTSD",,"60","B","19",,"Relaxation training","Relaxation","Treatment following Marks et al. 1998 protocol, including 3 different relaxation exercises","No","Not Applicable","No","Not Applicable","Yes","Relaxation","No","No","No","No","No","Individual","In Person",,"90 minutes",,,,,,,,,,,,,,,,"Community","0","0","1","0.75",,"0.25","Mixed","rape/sexual assault, accidents, community/school violence","Medium","Taylor S, Thordarson DS, Maxfield L, et al. Comparative efficacy, speed, and adverse effects of three PTSD treatments: exposure therapy, EMDR, and relaxation training. J Consult Clin Psychol. 2003a Apr;71(2):330-8. doi: 10.1037/0022-006X.71.2.330. PMID: 12699027.","25484","2020"
"taylor2008_A","Pharmacotherapy","PTSD","PTSD",,"13","A","13",,"Prazosin","Prazosin","Alpha-1 adrenoreceptor antagonist, titrated over 10 days with 1-mg dose increases every 2 to 3 days based on response and tolerability; 3-week crossover periods separated by 1-week washout","No","Not Applicable","Yes","Antiadrenergic","No","Not Applicable","No","No","No","No","No","Individual","In Person","Initiated at 1 mg, maximum NR",,"Daily at bedtime","3",,,,,,,,,,,"3.1 mg/day","1.3",,"Community",,,"1","0.8462",,"0.1538","Mixed","child physical abuse, child sexual abuse, rape/sexual assault, accidents, community/school violence","High","Taylor FB, Martin P, Thompson C, et al. Prazosin effects on objective sleep measures and clinical symptoms in civilian trauma posttraumatic stress disorder: a placebo-controlled study. Biol Psychiatry. 2008 Mar 15;63(6):629-32. doi: 10.1016/j.biopsych.2007.07.001. PMID: 17868655.","1548486","2019"
"taylor2008_B","Pharmacotherapy","PTSD","Control",,"13","B","13",,"Placebo","Placebo","Placebo capsules indistinguishable from active drug, titrated over 10 days with 1-mg equivalent dose increases every 2 to 3 days based on response and tolerability; 3-week crossover periods separated by 1-week washout","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","Initiated at 1 mg equivalent, maximum NR",,"Daily at bedtime","3",,,,,,,,,,,"3.2 mg/day equivalent","1.2",,"Community",,,"1","0.8462",,"0.1538","Mixed","child physical abuse, child sexual abuse, rape/sexual assault, accidents, community/school violence","High","Taylor FB, Martin P, Thompson C, et al. Prazosin effects on objective sleep measures and clinical symptoms in civilian trauma posttraumatic stress disorder: a placebo-controlled study. Biol Psychiatry. 2008 Mar 15;63(6):629-32. doi: 10.1016/j.biopsych.2007.07.001. PMID: 17868655.","1548486","2019"
"terheide2016_A","Psychotherapy","PTSD","PTSD",,"72","A","37",,"EMDR","Eye Movement Desensitization and Reprocessing (EMDR)","Included treatment planning and preparing patient for trauma-focused treatment (3 sessions), followed by desensitization and reprocessing (6 sessions), and evaluation; total 12 hours treatment. During desensitization and reprocessing, a focus on a traumatic image and the thoughts, sensations, feelings and memories that it elicits, is combined with an attention-demanding task such as tracking the therapist's fingers with the eyes. Followed Dutch version of EMDR protocol.","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"Treatment planning and preparation sessions: 60 minutes

EMDR sessions: 90 minutes",,,"9 sessions total",,,,,,,,,,,,,"Community",,,"1","0.2778",,"0.7222","Mixed","terrorism/political violence/forced displacement, community/school violence","Low","Ter Heide FJJ, Mooren TM, Van de Schoot R, et al. Eye Movement Desensitisation and Reprocessing therapy v. stabilisation as usual for refugees: randomised controlled trial. Br J Psychiatry. 2016 Oct;209(4):311-8. doi: 10.1192/bjp.bp.115.167775. PMID: 26892849.","45021","2019"
"terheide2016_B","Psychotherapy","PTSD","PTSD",,"72","B","37",,"Stabilization","Stabilization","Phase-oriented treatment in which first phase (stabilization) is aimed at enhancing safety, control over symptoms, and socio-psychological competencies through interventions such as emotion regulation and relational skills building, stress management, and cognitive restructuring; reprocessing of traumatic memories occurs in second phase. Stabilization as usual (not structured) used; 12 hours total treatment.","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person",,"60 minutes",,,"12 sessions total",,,,,,,,,,,,,"Community",,,"1","0.2778",,"0.7222","Mixed","terrorism/political violence/forced displacement, community/school violence","Low","Ter Heide FJJ, Mooren TM, Van de Schoot R, et al. Eye Movement Desensitisation and Reprocessing therapy v. stabilisation as usual for refugees: randomised controlled trial. Br J Psychiatry. 2016 Oct;209(4):311-8. doi: 10.1192/bjp.bp.115.167775. PMID: 26892849.","45021","2019"
"thorp2019_A","Mixed: Psychotherapy & CIH","PTSD","PTSD",,"87","A","41",,"PE","Prolonged Exposure (PE)","Treatment following Foa et al. 2007 protocol, including breathing retraining skills, imaginal exposure, and in-vivo exposures","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"90 minutes",,,"12 sessions",,,,,,,"9.39","4.51",,,,,"Veteran","0","1","0","0",,"1","Mixed","combat-related, natural or manmade disasters","Medium","Thorp S, Glassman LH. A randomized controlled trial of prolonged exposure therapy versus relaxation training for older veterans with military-related PTSD. J Anxiety Disord. 2019 May;64:45-54. doi: 10.1016/j.janxdis.2019.02.003. PMID: 30978622.","51843","2020"
"thorp2019_B","Mixed: Psychotherapy & CIH","PTSD","PTSD",,"87","B","46",,"Relaxation training","Relaxation","Treatment following Taylor et al. 2003 protocol, includes systematic steps to relax through tensing and releasing 16 muscle groups","No","Not Applicable","No","Not Applicable","Yes","Relaxation","No","No","No","No","No","Individual","In Person",,"90 minutes",,,"12 sessions",,,,,,,"9.89","4.18",,,,,"Veteran","0","1","0","0",,"1","Mixed","combat-related, natural or manmade disasters","Medium","Thorp S, Glassman LH. A randomized controlled trial of prolonged exposure therapy versus relaxation training for older veterans with military-related PTSD. J Anxiety Disord. 2019 May;64:45-54. doi: 10.1016/j.janxdis.2019.02.003. PMID: 30978622.","51843","2020"
"tripodi2019_A","Psychotherapy","PTSD+SUD","PTSD+SUD","Integrated","40","A","20",,"Seeking Safety","Seeking Safety","Seeking Safety in group format (2 groups of 10 women each); manualized intervention addressing both trauma and substance abuse, and ""designed to promote trauma recovery, increase coping strategies, reduce drug and alcohol use, and address mental health issues such as depression and PTSD that stem from traumatic exposure""; consists of 25 modules covering cognitive-behavioral and interpersonal skills, with group leader tailoring topics to the needs of participants.","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"90 minutes","2 times a week","12",,,,,,,,,,,,,,"Community","0","0","1","1",,"0",,,"Medium","Tripodi SJ, Mennicke AM, McCarter SA, et al. Evaluating seeking safety for women in prison: a randomized controlled trial. Res Soc Work Pract. 2019 Mar;29(3):281-90. doi: 10.1177/1049731517706550.",,"2020"
"tripodi2019_B","Psychotherapy","PTSD+SUD","Control","Not integrated","40","B","20",,"TAU","Treatment as usual (TAU)","Treatment-as-usual, available programming included residential substance abuse treatment, psychological services, mindful meditation, group intervention, and anger management.","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Mixed","In Person",,,,"12",,,,,,,,,,,,,,"Community","0","0","1","1",,"0",,,"Medium","Tripodi SJ, Mennicke AM, McCarter SA, et al. Evaluating seeking safety for women in prison: a randomized controlled trial. Res Soc Work Pract. 2019 Mar;29(3):281-90. doi: 10.1177/1049731517706550.",,"2020"
"tucker2001_A","Pharmacotherapy","PTSD","PTSD",,"323","A","151",,"Paroxetine","Paroxetine","SSRI antidepressant, dose increase of 10 mg/day allowed every 2 weeks based on clinician judgment; one dose reduction allowed for illness or adverse event if taking at least 30 mg/day; randomization followed 1-week placebo run-in, with responders excluded","No","Not Applicable","Yes","Antidepressant: SSRI","No","Not Applicable","No","No","No","No","No","Individual","In Person","Initiated at 20 mg, titrated to maximum 50 mg",,"Daily","12",,,,,,,,,,,,,,"Mixed",,"0.0684","0.9316","0.658",,"0.342","Mixed","combat-related, rape/sexual assault, accidents, community/school violence, other (serious injury, seeing someone hurt or die)","Medium","Tucker PM, Zaninelli R, Yehuda R, et al. Paroxetine in the treatment of chronic posttraumatic stress disorder: results of a placebo-controlled, flexible-dosage trial. J Clin Psychiatry. 2001;62(11):860-8. PMID: 11775045.","24214","2019"
"tucker2001_B","Pharmacotherapy","PTSD","Control",,"323","B","156",,"Placebo","Placebo","Titration not described, but one dose reduction allowed for illness or adverse event if taking at least 30 mg equivalent per day; randomization followed 1-week placebo run-in, with responders excluded","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person",,,"Daily","12",,,,,,,,,,,,,,"Mixed",,"0.0684","0.9316","0.658",,"0.342","Mixed","combat-related, rape/sexual assault, accidents, community/school violence, other (serious injury, seeing someone hurt or die)","Medium","Tucker PM, Zaninelli R, Yehuda R, et al. Paroxetine in the treatment of chronic posttraumatic stress disorder: results of a placebo-controlled, flexible-dosage trial. J Clin Psychiatry. 2001;62(11):860-8. PMID: 11775045.","24214","2019"
"tucker2003_A","Pharmacotherapy","PTSD","PTSD",,"59","A","25",,"Citalopram","Citalopram","SSRI","No","Not Applicable","Yes","Antidepressant: SSRI","No","Not Applicable","No","No","No","No","No","Individual","In Person","Start at 20 mg/day, titrated up or down by 10 mg/day each week to maximum 50 mg/day",,"Once daily","10",,,,,,,,,,,"36.2 mg/day",,,"Community",,,"1","0.7414",,"0.2586","Mixed","rape/sexual assault, combat-related, natural or manmade disasters, accidents, terrorism/political violence/forced displacement, community/school violence","Medium","Tucker P, Potter-Kimball R, Wyatt DB, et al. Can physiologic assessment and side effects tease out differences in PTSD trials? A double-blind comparison of citalopram, sertraline, and placebo. Psychopharmacol Bull. 2003 Summer;37(3):135-49.  PMID: 14608246.","26085","2019"
"tucker2003_B","Pharmacotherapy","PTSD","PTSD",,"59","B","23",,"Sertraline","Sertraline","SSRI","No","Not Applicable","Yes","Antidepressant: SSRI","No","Not Applicable","No","No","No","No","No","Individual","In Person","Start at 50 mg/day, titrated up or down by 50 mg/day per week, up to maximum 200 mg/day",,"Once daily","10",,,,,,,,,,,"134.1 mg/day",,,"Community",,,"1","0.7414",,"0.2586","Mixed","rape/sexual assault, combat-related, natural or manmade disasters, accidents, terrorism/political violence/forced displacement, community/school violence","Medium","Tucker P, Potter-Kimball R, Wyatt DB, et al. Can physiologic assessment and side effects tease out differences in PTSD trials? A double-blind comparison of citalopram, sertraline, and placebo. Psychopharmacol Bull. 2003 Summer;37(3):135-49.  PMID: 14608246.","26085","2019"
"tucker2003_C","Pharmacotherapy","PTSD","Control",,"59","C","10",,"Placebo","Placebo",,"No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person",,,"Once daily","10",,,,,,,,,,,,,,"Community",,,"1","0.7414",,"0.2586","Mixed","rape/sexual assault, combat-related, natural or manmade disasters, accidents, terrorism/political violence/forced displacement, community/school violence","Medium","Tucker P, Potter-Kimball R, Wyatt DB, et al. Can physiologic assessment and side effects tease out differences in PTSD trials? A double-blind comparison of citalopram, sertraline, and placebo. Psychopharmacol Bull. 2003 Summer;37(3):135-49.  PMID: 14608246.","26085","2019"
"tucker2007_A","Pharmacotherapy","PTSD","PTSD",,"40","A","20",,"Topiramate","Topiramate","Anticonvulsant","No","Not Applicable","Yes","Mood Stabilizer","No","Not Applicable","No","No","No","No","No","Individual","In Person","Initiated at 25 mg/day, titrated by 25 to 50 mg/week up to 400 mg/day over 8 weeks, then maintained at same dose for 4 weeks",,"Twice daily","12",,,,,,,,,,,"150 mg/day",,,"Community",,,"1","0.7895",,"0.2105","Mixed","child sexual abuse, child physical abuse, intimate partner violence, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (non-specified)","Medium","Tucker P, Trautman RP, Wyatt DB, et al. Efficacy and safety of topiramate monotherapy in civilian posttraumatic stress disorder: a randomized, double-blind, placebo-controlled study. J Clin Psychiatry. 2007 Feb;68(2):201-6. PMID: 17335317.","31122","2019"
"tucker2007_B","Pharmacotherapy","PTSD","Control",,"40","B","20",,"Placebo","Placebo","Placebo","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person",,,"Twice daily","12",,,,,,,,,,,,,,"Community",,,"1","0.7895",,"0.2105","Mixed","child sexual abuse, child physical abuse, intimate partner violence, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (non-specified)","Medium","Tucker P, Trautman RP, Wyatt DB, et al. Efficacy and safety of topiramate monotherapy in civilian posttraumatic stress disorder: a randomized, double-blind, placebo-controlled study. J Clin Psychiatry. 2007 Feb;68(2):201-6. PMID: 17335317.","31122","2019"
"tuerk2018_A","Mixed: Psychotherapy & pharmacotherapy","PTSD","PTSD",,"26","A","14",,"PE + Yohimbine","Prolonged Exposure (PE) + yohimbine","Yohimbine HCl: alpha-2 adrenergic receptor antagonist; oral dose given 1 hour prior to first imaginal exposure of PE treatment (session 3). PE: manualized trauma-focused treatment including psychoeducation, in vivo exposure, imaginal exposure, and discussion or processing of traumatic events, with homework focused on imaginal and in vivo exposures; early termination criteria: ≥1.5 standard deviation improvement from baseline on PCL-M, or total PCL-M score <30.","Yes","TF","Yes","Supplement","No","Not Applicable","No","No","No","No","No","Individual","In Person","21.6 mg",,"PE: weekly

Yohimbine: once (single dose)","NR (up to 15 sessions PE total)",,"completed the entire course of care","0.6429",,"administered in clinic",,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"Medium","Tuerk PW, Wangelin BC, Powers MB, et al. Augmenting treatment efficiency in exposure therapy for PTSD: a randomized double-blind placebo-controlled trial of yohimbine HCl. Cogn. Behav. Ther. 2018 Sep;47(5):351-71. doi: 10.1080/16506073.2018.1432679. PMID: 29448886.","50114","2019"
"tuerk2018_B","Mixed: Psychotherapy & pharmacotherapy","PTSD","PTSD",,"26","B","12",,"PE + placebo","Prolonged Exposure (PE) + placebo","Placebo: matching placebo given 1 hour prior to first imaginal exposure of PE treatment (session 3). PE: manualized trauma-focused treatment including psychoeducation, in vivo exposure, imaginal exposure, and discussion or processing of traumatic events, with homework focused on imaginal and in vivo exposures; early termination criteria: ≥1.5 standard deviation improvement from baseline on PCL-M, or total PCL-M score <30.","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person",,,"PE: weekly

Placebo: once","NR (up to 15 sessions PE total)",,"completed the entire course of care","0.6667",,"administered in clinic",,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"Medium","Tuerk PW, Wangelin BC, Powers MB, et al. Augmenting treatment efficiency in exposure therapy for PTSD: a randomized double-blind placebo-controlled trial of yohimbine HCl. Cogn. Behav. Ther. 2018 Sep;47(5):351-71. doi: 10.1080/16506073.2018.1432679. PMID: 29448886.","50114","2019"
"tylee2017_A","Psychotherapy","PTSD","PTSD",,"30","A","15",,"Reconsolidation of traumatic memories","Reconsolidation of Traumatic Memories (RTM)","Brief cognitive intervention targeting the intrusive symptoms of PTSD; procedure includes minimal, nontraumatizing exposure to target trauma, providing dissociative experiences of traumatic memory with structural alterations as needed, design of nontraumatizing versions, and ending when trauma can't be evoked and narrative can be told without significant autonomic arousal. Sessions were separated by ‚â•24 hours.","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"120 minutes",,"1 to 3","3 sessions total","completed treatment course","1",,,,,,,,,,,"Veteran","0","1","0","0",,"1","Mixed","combat-related, other (not specified)","High","Tylee DS, Gray R, Glatt SJ, et al. Evaluation of the reconsolidation of traumatic memories protocol for the treatment of PTSD: a randomized, wait-list-controlled trial. J Mil Veteran Fam Health. 2017;3(1):21-33. doi: 10.3138/jmvfh.4120.","49612","2019"
"tylee2017_B","Psychotherapy","PTSD","Control",,"30","B","15",,"Waitlist","Waitlist","Waitlist with no active contact with research team outside of assessments.","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,,,,"5",,"completed waiting period","1",,,,,,,,,,,"Veteran","0","1","0","0",,"1","Mixed","combat-related, other (not specified)","High","Tylee DS, Gray R, Glatt SJ, et al. Evaluation of the reconsolidation of traumatic memories protocol for the treatment of PTSD: a randomized, wait-list-controlled trial. J Mil Veteran Fam Health. 2017;3(1):21-33. doi: 10.3138/jmvfh.4120.","49612","2019"
"ulmer2011_A","Psychotherapy","PTSD","PTSD",,"22","A","13",,"Sleep intervention for PTSD","Cognitive Behavioral Therapy for Insomnia (CBT-I) + Imagery Rehearsal Training (IRT)","3 sessions of CBT for insomnia followed by 3 sessions of imagery rehearsal therapy; CBT for insomnia: individually tailored behavioral regimen based on sleep restriction theory, stimulus control, sleep hygiene, and identification and restructuring of dysfunctional beliefs and attitudes regarding sleep; imagery rehearsal therapy: included education about the role of learning in nightmares, visual imagery skill building, and instruction in rescripting nightmares. Participants also used an electronic sleep diary to record subjective sleep symptoms daily (interactive program on hand-held computer).","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"1 hour","Biweekly","12",,"completed treatment course","0.6923",,,,,,,,,,,"Veteran","0","1","0","0.3182",,"0.6818",,,"High","Ulmer CS, Edinger JD, Calhoun PS. A multi-component cognitive-behavioral intervention for sleep disturbance in veterans with PTSD: a pilot study. J Clin Sleep Med. 2011 Feb 15;7(1):57-68.  PMID: 21344046.","36068","2019"
"ulmer2011_B","Psychotherapy","PTSD","Control",,"22","B","9",,"Usual care","Electronic sleep diary","Participants also used an electronic sleep diary to record subjective sleep symptoms daily (interactive program on hand-held computer).","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","Written",,,,"12",,,,,,,,,,,,,,"Veteran","0","1","0","0.3182",,"0.6818",,,"High","Ulmer CS, Edinger JD, Calhoun PS. A multi-component cognitive-behavioral intervention for sleep disturbance in veterans with PTSD: a pilot study. J Clin Sleep Med. 2011 Feb 15;7(1):57-68.  PMID: 21344046.","36068","2019"
"vanderkolk2016_A","Complementary and integrative health (CIH)","PTSD","PTSD",,"52","A","28",,"Neurofeedback + TAU","Neurofeedback","EEG training following flexible, principle-based manual; training intended to teach subjects to alter the power spectrum of specific filtered frequencies of activity; reward indicated with auditory and visual feedback (auditory tones, progress in simple computer games); adjustment of reward frequency based on rated symptoms of over-arousal and under-arousal; training time increased by 3-minute increments when subject reported positive change.

Continuation of all ongoing treatments (psychotherapeutic and pharmacological).","No","Not Applicable","No","Not Applicable","Yes","Relaxation","No","No","No","No","No","Individual","In Person","Dose:
Inhibit frequencies: 2 to 6 Hz, and 22 to 36 Hz
Reward frequency: initial 10 to 13 Hz","Training time: 12 to 30 minutes","Twice weekly","12",,"completed protocol","0.7857",,,,,,,,,,,"Community",,,"1","0.8571",,"0.1429","Mixed","child other abuse, rape/sexual assault, intimate partner violence, other (not specified)","Medium","Van der Kolk BA, Hodgdon HB, Gapen MA, et al. A randomized controlled study of neurofeedback for chronic PTSD. PLoS One. 2016 Dec 16;11(12):e0166752. doi: 10.1371/journal.pone.0166752. PMID: 27992435.","46581","2019"
"vanderkolk2016_B","Complementary and integrative health (CIH)","PTSD","Control",,"52","B","24",,"TAU","Treatment as usual (TAU)","Continuation of all ongoing treatments (psychotherapeutic and pharmacological) during waiting period, received neurofeedback intervention after completing week 12 evaluation","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person",,,,"12",,,,,,,,,,,,,,"Community",,,"1","0.8571",,"0.1429","Mixed","child other abuse, rape/sexual assault, intimate partner violence, other (not specified)","Medium","Van der Kolk BA, Hodgdon HB, Gapen MA, et al. A randomized controlled study of neurofeedback for chronic PTSD. PLoS One. 2016 Dec 16;11(12):e0166752. doi: 10.1371/journal.pone.0166752. PMID: 27992435.","46581","2019"
"vangelderen2020_A","Other mixed","PTSD","PTSD",,"43","A","22",,"Multi-modular motion-assisted memory desensitization and reconsolidation (3MDR)","Multi-modular motion-assisted memory desensitization and reconsolidation (3MDR)","Manualized intervention combining techniques of virtual reality and EMDR. Participant walks on treadmill while viewing synchronized virtual reality environment, personalized for individual participant with images and music, and going through sequence for EMDR. Each session ended wth therapist-led discussion of experiences.","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"70 to 90 minutes","Weekly","6",,,,,,,,,,"treatment hours: mean 22.27 (SD 13.49)",,,,"Veteran","0","1","0","0.023",,"0.977","Mixed","combat-related, accidents, illness/medical procedure, community/school violence, terrorism/political violence/forced displacement, other (""severe human suffering"", ""death caused to someone else"", ""explosion or fire"")","Low","van Gelderen MJ, Nijdam MJ, Haagen JFG, et al. Interactive Motion-Assisted Exposure Therapy for Veterans with Treatment-Resistant Posttraumatic Stress Disorder: A Randomized Controlled Trial. Psychotherapy & Psychosomatics. 2020 Mar 23:1-13. doi: https://dx.doi.org/10.1159/000505977. PMID: 32203971.",,"2020"
"vangelderen2020_B","Other mixed","PTSD","Control",,"43","B","21",,"Non-specific treatment component control","Treatment as usual (TAU)","Non-trauma-focused treatment delivered by a team with psychiatrist and mental health worker; allowed ""case management, medication consults, stabilizing interventions, psychoeducation, systemic interventions and cognitive behavioral therapy without trauma-focused elements such as exposure or cognitive restructuring of distorted cognitions related to traumatic events""","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person",,,,,"Up to 16 weeks",,,,,,,,,"treatment hours: mean 20.35 (SD 22.79)",,,,"Veteran","0","1","0","0.023",,"0.977","Mixed","combat-related, accidents, illness/medical procedure, community/school violence, terrorism/political violence/forced displacement, other (""severe human suffering"", ""death caused to someone else"", ""explosion or fire"")","Low","van Gelderen MJ, Nijdam MJ, Haagen JFG, et al. Interactive Motion-Assisted Exposure Therapy for Veterans with Treatment-Resistant Posttraumatic Stress Disorder: A Randomized Controlled Trial. Psychotherapy & Psychosomatics. 2020 Mar 23:1-13. doi: https://dx.doi.org/10.1159/000505977. PMID: 32203971.",,"2020"
"vandenberg2015_A","Psychotherapy","PTSD","PTSD",,"155","A","53",,"PE","Prolonged Exposure (PE)","A psychotherapeutic approach that reduces PTSD symptom-severity by systematically exposing the subject, in both imaginary and in vivo ways, to previously avoided traumatic internal and external stimuli.","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"90 minutes","Weekly","8",,"NR; early completion defined as PSS-SR ≤10 on two consecutive occasions",,"15.1% early completers",,,,"7.1",,"Completers only",,,,"Community",,,"1","0.5419",,"0.4581","Mixed","rape/sexual assault, child sexual abuse, child other abuse, accidents, natural or manmade disasters, other (traumatic psychosis, war, physical abuse)","Low","van den Berg DP, de Bont PA, van der Vleugel BM, et al. Prolonged exposure vs Eye Movement Desensitization and Reprocessing vs waiting list for posttraumatic stress disorder in patients with a psychotic disorder: a randomized clinical trial. JAMA Psychiatry. 2015 Mar;72(3):259-67. doi: 10.1001/jamapsychiatry.2014.2637. PMID: 25607833.","43279","2019"
"vandenberg2015_B","Psychotherapy","PTSD","PTSD",,"155","B","55",,"EMDR","Eye Movement Desensitization and Reprocessing (EMDR)","A psychotherapeutic approach in which memory representations of traumatic life experiences are processed in order to change dysfunctional beliefs about self or others that originated from damaging traumatic experiences.","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"90 minutes","Weekly","8",,"NR; early completion defined as PSS-SR ≤10 on two consecutive occasions",,"3.6% were early completers",,,,"7.8",,"Completers only",,,,"Community",,,"1","0.5419",,"0.4581","Mixed","rape/sexual assault, child sexual abuse, child other abuse, accidents, natural or manmade disasters, other (traumatic psychosis, war, physical abuse)","Low","van den Berg DP, de Bont PA, van der Vleugel BM, et al. Prolonged exposure vs Eye Movement Desensitization and Reprocessing vs waiting list for posttraumatic stress disorder in patients with a psychotic disorder: a randomized clinical trial. JAMA Psychiatry. 2015 Mar;72(3):259-67. doi: 10.1001/jamapsychiatry.2014.2637. PMID: 25607833.","43279","2019"
"vandenberg2015_C","Psychotherapy","PTSD","Control",,"155","C","47",,"Waitlist","Waitlist",,"No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,,,,"24",,,,,,,,,,,,,,"Community",,,"1","0.5419",,"0.4581","Mixed","rape/sexual assault, child sexual abuse, child other abuse, accidents, natural or manmade disasters, other (traumatic psychosis, war, physical abuse)","Low","van den Berg DP, de Bont PA, van der Vleugel BM, et al. Prolonged exposure vs Eye Movement Desensitization and Reprocessing vs waiting list for posttraumatic stress disorder in patients with a psychotic disorder: a randomized clinical trial. JAMA Psychiatry. 2015 Mar;72(3):259-67. doi: 10.1001/jamapsychiatry.2014.2637. PMID: 25607833.","43279","2019"
"vandenderen2018_A","Psychotherapy","PTSD","PTSD",,"85","A","20",,"EMDR + CBT","Eye Movement Desensitization and Reprocessing (EMDR) + cognitive behavioral therapy (CBT) without a trauma focus","EMDR followed by CBT. Two introductory sessions with psychoeducation and discussion of grief and social support (introductory session content was the same for all interventions); 3 sessions of EMDR with alternating eye movements following standard Dutch EMDR treatment protocol; 3 sessions of CBT focused on identifying, challenging, and changing negative cognitions related to the loss with use of behavioral experiments and cognitive restructuring.","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"EMDR: 45 to 90 minutes

CBT: 45 minutes",,,"8 sessions total","completed the treatment","0.85",,,,,,,,,,,"Community",,,"1","0.7412",,"0.2588","Other (homicidally bereaved)",,"High","van Denderen M, de Keijser J, Stewart R, et al. Treating complicated grief and posttraumatic stress in homicidally bereaved individuals: a randomized controlled trial. Clin Psychol Psychother. 2018 Feb 26(25):497-508. doi: 10.1002/cpp.2183. PMID: 29479767.","49818","2019"
"vandenderen2018_B","Psychotherapy","PTSD","PTSD",,"85","B","22",,"CBT + EMDR","Cognitive behavioral therapy (CBT) + Eye Desensitization and Reprocessing (EMDR)","CBT followed by EMDR. Two introductory sessions with psychoeducation and discussion of grief and social support (introductory session content was the same for all interventions); 3 sessions of CBT focused on identifying, challenging, and changing negative cognitions related to the loss with use of behavioral experiments and cognitive restructuring; 3 sessions of EMDR with alternating eye movements following standard Dutch EMDR treatment protocol.","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"CBT: 45 minutes
EMDR: 45 to 90 minutes",,,"total 8 sessions",,,,,,,,,,,,,"Community",,,"1","0.7412",,"0.2588","Other (homicidally bereaved)",,"High","van Denderen M, de Keijser J, Stewart R, et al. Treating complicated grief and posttraumatic stress in homicidally bereaved individuals: a randomized controlled trial. Clin Psychol Psychother. 2018 Feb 26(25):497-508. doi: 10.1002/cpp.2183. PMID: 29479767.","49818","2019"
"vandenderen2018_C","Psychotherapy","PTSD","Control",,"85","C","43",,"Waitlist","Waitlist",,"No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,,,,"16",,,,,,,,,,,,,,"Community",,,"1","0.7412",,"0.2588","Other (homicidally bereaved)",,"High","van Denderen M, de Keijser J, Stewart R, et al. Treating complicated grief and posttraumatic stress in homicidally bereaved individuals: a randomized controlled trial. Clin Psychol Psychother. 2018 Feb 26(25):497-508. doi: 10.1002/cpp.2183. PMID: 29479767.","49818","2019"
"vanderkolk1994_A","Pharmacotherapy","PTSD","PTSD",,"64","A","33",,"Fluoxetine","Fluoxetine","SSRI antidepressant, Initiated at 20 mg, could titrate by 20 mg weekly up to 60 mg","No","Not Applicable","Yes","Antidepressant: SSRI","No","Not Applicable","No","No","No","No","No","Individual","In Person","20 mg to 60 mg",,"Daily","5",,,,,,,,,,,"20 mg",,,"Mixed","0","0.4844","0.5156","0.3438",,"0.6562","Mixed","combat-related, child physical abuse, child sexual abuse, rape/sexual assault, community/school violence, terrorism/political violence/forced displacement","Medium","Van der Kolk BA, Dreyfuss D, Michaels MJ, et al. Fluoxetine in posttraumatic stress disorder. J Clin Psychiatry. 1994;55(12):517-22. PMID: 7814344.","05244","2019"
"vanderkolk1994_B","Pharmacotherapy","PTSD","Control",,"64","B","31",,"Placebo","Placebo","Placebo","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person",,,"Daily","5",,,,,,,,,,,,,,"Mixed","0","0.4844","0.5156","0.3438",,"0.6562","Mixed","combat-related, child physical abuse, child sexual abuse, rape/sexual assault, community/school violence, terrorism/political violence/forced displacement","Medium","Van der Kolk BA, Dreyfuss D, Michaels MJ, et al. Fluoxetine in posttraumatic stress disorder. J Clin Psychiatry. 1994;55(12):517-22. PMID: 7814344.","05244","2019"
"vanderkolk2007_A","Mixed: Psychotherapy & pharmacotherapy","PTSD","PTSD",,"88","A","29",,"EMDR","Eye Movement Desensitization and Reprocessing (EMDR)","EMDR followed a manual developed for the study that was based on a standard protocol, and targeted trauma memories identified at baseline","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","90 minutes",,"Weekly","8",,,,,,,,,,,,,,"Community",,,"1","0.8295",,"0.1705","Mixed","combat-related, child physical abuse, child sexual abuse, rape/sexual assault, intimate partner violence, accidents, community/school violence, terrorism/political violence/forced displacement, other (""other adult victimization,"" ""traumatic loss,"" injury)","Medium","Van der Kolk BA, Spinazzola J, Blaustein ME, et al. A randomized clinical trial of Eye Movement Desensitization and Reprocessing (EMDR), fluoxetine, and pill placebo in the treatment of posttraumatic stress disorder: treatment effects and long-term maintenance. J Clin Psychiatry. 2007 Jan;68(1):37-46. doi: 10.4088/JCP.v68n0105. PMID: 17284128.","29236","2019"
"vanderkolk2007_B","Mixed: Psychotherapy & pharmacotherapy","PTSD","PTSD",,"88","B","30",,"Fluoxetine","Fluoxetine","SSRI antidepressant; dose increased weekly in 10-mg increments based on physician assessment of response and adverse effects","No","Not Applicable","Yes","Antidepressant: SSRI","No","Not Applicable","No","No","No","No","No","Individual","In Person","Sessions: 20 to 30 minute monitoring sessions

Dose: Initiated at 10 mg, titrated to maximum 60 mg",,"Sessions: Weekly

Drug: Daily","8",,,,,,,,,,,"modal dose 40 mg/day",,,"Community",,,"1","0.8295",,"0.1705","Mixed","combat-related, child physical abuse, child sexual abuse, rape/sexual assault, intimate partner violence, accidents, community/school violence, terrorism/political violence/forced displacement, other (""other adult victimization,"" ""traumatic loss,"" injury)","Medium","Van der Kolk BA, Spinazzola J, Blaustein ME, et al. A randomized clinical trial of Eye Movement Desensitization and Reprocessing (EMDR), fluoxetine, and pill placebo in the treatment of posttraumatic stress disorder: treatment effects and long-term maintenance. J Clin Psychiatry. 2007 Jan;68(1):37-46. doi: 10.4088/JCP.v68n0105. PMID: 17284128.","29236","2019"
"vanderkolk2007_C","Mixed: Psychotherapy & pharmacotherapy","PTSD","Control",,"88","C","29",,"Placebo","Placebo","Placebo pills increased weekly in 10-mg equivalent increments based on physician assessment of response and adverse effects","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","Sessions: 20 to 30 minute monitoring sessions

Dose: NA",,"Sessions: Weekly

Drug: Daily","8",,,,,,,,,,,,,,"Community",,,"1","0.8295",,"0.1705","Mixed","combat-related, child physical abuse, child sexual abuse, rape/sexual assault, intimate partner violence, accidents, community/school violence, terrorism/political violence/forced displacement, other (""other adult victimization,"" ""traumatic loss,"" injury)","Medium","Van der Kolk BA, Spinazzola J, Blaustein ME, et al. A randomized clinical trial of Eye Movement Desensitization and Reprocessing (EMDR), fluoxetine, and pill placebo in the treatment of posttraumatic stress disorder: treatment effects and long-term maintenance. J Clin Psychiatry. 2007 Jan;68(1):37-46. doi: 10.4088/JCP.v68n0105. PMID: 17284128.","29236","2019"
"vanderkolk2014_A","Mixed: Psychotherapy & CIH","PTSD","PTSD",,"76","A",,,"Yoga + supportive therapy","Yoga","Trauma-informed Hatha yoga, including breathing, postures, and meditation elements","Yes","Non-TF","No","Not Applicable","Yes","Yoga","No","No","No","No","No","Group","In Person",,"1 hour","Weekly","10",,,,,,,,,,,,,,"Community",,,"1","1",,"0",,,"Medium","van der Kolk BA, Stone L, West J, et al. Yoga as an adjunctive treatment for posttraumatic stress disorder: a randomized controlled trial. J Clin Psychiatry. 2014 Jun;75(6):e559-65. doi: 10.4088/JCP.13m08561. PMID: 25004196.","42647","2019"
"vanderkolk2014_B","Mixed: Psychotherapy & CIH","PTSD","Control",,"76","B",,,"Women's health education + supportive therapy","Women's health education plus Supportive Therapy","Education focusing on active participation and support, and to increase self-efficacy (no discussion of trauma)","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Group","In Person",,"1 hour","Weekly","10",,,,,,,,,,,,,,"Community",,,"1","1",,"0",,,"Medium","van der Kolk BA, Stone L, West J, et al. Yoga as an adjunctive treatment for posttraumatic stress disorder: a randomized controlled trial. J Clin Psychiatry. 2014 Jun;75(6):e559-65. doi: 10.4088/JCP.13m08561. PMID: 25004196.","42647","2019"
"vantwoutfrank2019_A","Other mixed","PTSD","PTSD",,"20","A",,,"Transcranial direct current stimulation + Virtual reality exposure","Transcranial direct current stimulation (tDCS) + Virtual reality exposure (VRET)","Simultaneous transcranial direct current stimulation and virtual reality exposure
Transcranial direct current stimulation: stimulation targeting ventromedial prefrontal cortex using neuroConn DC Stimulator Plus
Virtual reality exposure: ""head-mounted display with integrated head tracking and stereo earphones presenting combat-related multisensory information"". Each session included driving scenarios with presentation of warzone events.","Yes","TF","No","Not Applicable","No","Not Applicable","Yes","No","No","No","No","Individual","In Person","Dose: 2 mA (transcranial direct current stimulation)","Session length: 25 minutes",,"2","total 6 sessions",,,,,,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"High","van 't Wout-Frank M, Shea MT, Larson VC, et al. Combined transcranial direct current stimulation with virtual reality exposure for posttraumatic stress disorder: feasibility and pilot results. Brain Stimul. 2019 Jan - Feb;12(1):41-3. doi: 10.1016/j.brs.2018.09.011. PMID: 30266416.",,"2020"
"vantwoutfrank2019_B","Other mixed","PTSD","PTSD",,"20","B",,,"Sham transcranial direct current stimulation + Virtual reality exposure","Virtual reality exposure (VRET) plus sham","Simultaneous sham transcranial direct current stimulation and virtual reality exposure
Sham transcranial direct current stimulation: sham stimulation using neuroConn DC Stimulator Plus
Virtual reality exposure: ""head-mounted display with integrated head tracking and stereo earphones presenting combat-related multisensory information"". Each session included driving scenarios with presentation of warzone events.","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"Session length: 25 minutes",,"2","total 6 sessions",,,,,,,,,,,,,"Veteran","0","1","0","0",,"1","Combat-related",,"High","van 't Wout-Frank M, Shea MT, Larson VC, et al. Combined transcranial direct current stimulation with virtual reality exposure for posttraumatic stress disorder: feasibility and pilot results. Brain Stimul. 2019 Jan - Feb;12(1):41-3. doi: 10.1016/j.brs.2018.09.011. PMID: 30266416.",,"2020"
"vera2011_A","Psychotherapy","PTSD","PTSD",,"14","A","7",,"PE","Prolonged Exposure (PE)","Individual therapy delivered following the culturally adapted Spanish version of PE manual; this version includes language, idioms, and examples relevant to Latino culture. An addition, optional introductory session was provided with participants and spouse or partner, giving an overview of PTSD and the goals and methods of PE. PE therapy included psychoeducation, imaginal exposure, in vivo exposure, discussion of exposure and processing of traumatic memories, and homework with imaginal and in vivo exposure.","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"90 to 120 minutes","Weekly","16",,"completed all sessions","0.7143",,,,,,,,,,,"Community",,,"1","0",,"1",,,"High","Vera M, Reyes-Rabanillo ML, Juarbe D, et al. Prolonged exposure for the treatment of Spanish-speaking Puerto Ricans with posttraumatic stress disorder: a feasibility study. BMC Res. Notes. 2011 Oct 17;4:415. doi: 10.1186/1756-0500-4-415. PMID: 22005187.","38256","2019"
"vera2011_B","Psychotherapy","PTSD","Control",,"14","B","7",,"Usual care","Treatment as usual (TAU)","Participants referred to mental health provider at the study setting or could self-refer for outside provider; treatment in ""most cases"" included pharmacologic medication and/or psychotherapy; allowed changes in psychotropic medication.","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,,,,"16",,"≥1 mental health visit","1",,,,,,,,,,,"Community",,,"1","0",,"1",,,"High","Vera M, Reyes-Rabanillo ML, Juarbe D, et al. Prolonged exposure for the treatment of Spanish-speaking Puerto Ricans with posttraumatic stress disorder: a feasibility study. BMC Res. Notes. 2011 Oct 17;4:415. doi: 10.1186/1756-0500-4-415. PMID: 22005187.","38256","2019"
"villarreal2016_A","Pharmacotherapy","PTSD","PTSD",,"80","A","42",,"Quetiapine","Quetiapine","Second generation antipsychotic","No","Not Applicable","Yes","Antipsychotic","No","Not Applicable","No","No","No","No","No","Individual","In Person","Target 400 mg, initiated at 25 mg daily, titrate to 400 mg by 2 weeks. Could go up to 800 mg max (50 mg minimum)",,"Daily","12",,,,,,,,,,,"258 mg/day",,,"Veteran","0","1","0","0.0625",,"0.9375",,,"High","Villarreal G, Hamner MB, Ca√±ive JM, et al. Efficacy of quetiapine monotherapy in posttraumatic stress disorder: a randomized, placebo-controlled trial. Am J Psychiatry. 2016 Dec;173(12):1205-12. doi: 10.1176/appi.ajp.2016.15070967. PMID: 27418378.","45102","2019"
"villarreal2016_B","Pharmacotherapy","PTSD","Control",,"80","B","38",,"Placebo","Placebo","Placebo titrated as per active study drug","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person",,,"Daily","12",,,,,,,,,,,"463 mg quetiapine equivalent",,,"Veteran","0","1","0","0.0625",,"0.9375",,,"High","Villarreal G, Hamner MB, Ca√±ive JM, et al. Efficacy of quetiapine monotherapy in posttraumatic stress disorder: a randomized, placebo-controlled trial. Am J Psychiatry. 2016 Dec;173(12):1205-12. doi: 10.1176/appi.ajp.2016.15070967. PMID: 27418378.","45102","2019"
"wagner2019_A","Psychotherapy","PTSD","PTSD",,"80","A","42",,"Behavioral activation","Behavioral activation (BA)","Treatment following Bartell et al. 2001 protocol, including behavioral analyses for assessing avoidance patterns, activity scheduling and monitoring of reactions, present-centered strategies to decrease rumination, and psychoeducation","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"45 to 60 minutes",,,"8 sessions",,,,,,,"6.65","2.88",,,,,"Veteran","0","1","0","0.0625",,"0.9375","Other (military-related)",,"High","Wagner AW, Jakupcak M, Kowalski HM, et al. Behavioral activation as a treatment for posttraumatic stress disorder among returning veterans: a randomized trial. Psychiatr Serv. 2019 Oct 1;70(10):867-73. doi: 10.1176/appi.ps.201800572. PMID: 31337325.","52288","2020"
"wagner2019_B","Psychotherapy","PTSD","PTSD",,"80","B","38",,"Standard care","Treatment as usual (TAU)","Participants were allowed any standard care, including PE, CPT, alternative treatments and coping-skills training (e.g., acceptance and commitment therapy, anger management). All patients were offered ≥6 individual psychotherapy appointments","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person",,,,,"≥6 sessions",,,,,,,"2.55","2.40","individual psychotherapy sessions",,,,"Veteran","0","1","0","0.0625",,"0.9375","Other (military-related)",,"High","Wagner AW, Jakupcak M, Kowalski HM, et al. Behavioral activation as a treatment for posttraumatic stress disorder among returning veterans: a randomized trial. Psychiatr Serv. 2019 Oct 1;70(10):867-73. doi: 10.1176/appi.ps.201800572. PMID: 31337325.","52288","2020"
"wagner2007_A","Psychotherapy","PTSD","PTSD",,"8","A","4",,"Behavioral Activation","Behavioral activation (BA)","Identification and enactment of activities that are reinforcing to individual's long-term goals. Program includes identification of goals and activities, identification of patterns of avoidance that block attainment of these goals, and alternative coping strategies. Psychoeducation modified to include descriptions of PTSD symptoms and emphasize the role of avoidance in PTSD","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"60 to 90 minutes",,,"4 to 6 sessions total",,,,,,,"5.75","0.5",,,,,"Community",,,"1","0.625",,"0.375","Accidents",,"High","Wagner AW, Zatzick DF, Ghesquiere A, et al. Behavioral activation as an early intervention for posttraumatic stress disorder and depression among physically injured trauma survivors. Cogn Behav Pract. 2007 Nov;14(4):341-9. doi: 10.1016/j.cbpra.2006.05.002.","32469","2019"
"wagner2007_B","Psychotherapy","PTSD","Control",,"8","B","4",,"TAU","Treatment as usual (TAU)","Participants offered a list of community referrals","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.625",,"0.375","Accidents",,"High","Wagner AW, Zatzick DF, Ghesquiere A, et al. Behavioral activation as an early intervention for posttraumatic stress disorder and depression among physically injured trauma survivors. Cogn Behav Pract. 2007 Nov;14(4):341-9. doi: 10.1016/j.cbpra.2006.05.002.","32469","2019"
"wahbeh2016_A","Complementary and integrative health (CIH)","PTSD","PTSD",,"114","A",,,"Mindfulness meditation","Mindfulness","Body scan mindfulness technique training; at each session the research assistant read a script defining mindfulness, explaining each aspect of the definition and provided examples for how to deepen the skills and their importance to mindfulness practice; training was with an audio recording, performed in silence, stillness and sitting upright; instructed to gently redirect wandering attention back to the body part that was the focus of awareness. Guided meditation did not direct attention to the breath or breathing process. Participants were asked to practice at home daily between sessions using the same recording, and submit weekly logs of practice.","No","Not Applicable","No","Not Applicable","Yes","Meditation","No","No","No","No","No","Individual","In Person",,"20 minutes","Weekly","6",,,,,,,,,,,,,,"Veteran","0","1","0","0.0588",,"0.9412","Other (not specified)",,"High","Wahbeh H, Goodrich E, Goy E, et al. Mechanistic pathways of mindfulness meditation in combat veterans with posttraumatic stress disorder. J Clin Psychol. 2016 Apr;72(4):365-83. doi: 10.1002/jclp.22255. PMID: 26797725.","48070","2019"
"wahbeh2016_B","Complementary and integrative health (CIH)","PTSD","PTSD",,"114","B",,,"Slow breathing (RESPeRATE biofeedback device)","Biofeedback","Used the RESPeRATE breathing biofeedback device designed to reduce respiratory rate.","No","Not Applicable","No","Not Applicable","Yes","Relaxation","No","No","No","No","No","Individual","In Person",,"20 minutes","Weekly","6",,,,,,,,,,,,,,"Veteran","0","1","0","0.0588",,"0.9412","Other (not specified)",,"High","Wahbeh H, Goodrich E, Goy E, et al. Mechanistic pathways of mindfulness meditation in combat veterans with posttraumatic stress disorder. J Clin Psychol. 2016 Apr;72(4):365-83. doi: 10.1002/jclp.22255. PMID: 26797725.","48070","2019"
"wahbeh2016_C","Complementary and integrative health (CIH)","PTSD","PTSD",,"114","C",,,"Mindfulness meditation + slow breathing","Mindfulness meditation + slow breathing","Mindfulness training focusing attention on the breath; at each session the research assistant read a script defining mindfulness, explaining each aspect of the definition and provided examples for how to deepen the skills and their importance to mindfulness practice; training was with an audio recording and participants sat upright; attention directed to the breath with conscious observation of breathing, naturally slowing their breath. Participants were asked to practice at home daily between sessions using the same recording, and submit weekly logs of practice.","No","Not Applicable","No","Not Applicable","Yes","Meditation","No","No","No","No","No","Individual","In Person",,"20 minutes","Weekly","6",,,,,,,,,,,,,,"Veteran","0","1","0","0.0588",,"0.9412","Other (not specified)",,"High","Wahbeh H, Goodrich E, Goy E, et al. Mechanistic pathways of mindfulness meditation in combat veterans with posttraumatic stress disorder. J Clin Psychol. 2016 Apr;72(4):365-83. doi: 10.1002/jclp.22255. PMID: 26797725.","48070","2019"
"wahbeh2016_D","Complementary and integrative health (CIH)","PTSD","Control",,"114","D",,,"Sitting quietly","Sitting quietly","Participants sat quietly while listening to a neutral-content audiobook during sessions. Participants were asked to practice at home daily between sessions by sitting quietly alone and engaging in an activity besides watching TV or browsing the internet, asked to submit weekly logs of practice.","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person",,"20 minutes","Weekly","6",,,,,,,,,,,,,,"Veteran","0","1","0","0.0588",,"0.9412","Other (not specified)",,"High","Wahbeh H, Goodrich E, Goy E, et al. Mechanistic pathways of mindfulness meditation in combat veterans with posttraumatic stress disorder. J Clin Psychol. 2016 Apr;72(4):365-83. doi: 10.1002/jclp.22255. PMID: 26797725.","48070","2019"
"walters2020_A","Psychotherapy","PTSD","PTSD",,"23","A","12",,"IRT + CBT-I","Cognitive Behavioral Therapy for Insomnia (CBT-I) + Imagery Rehearsal Training (IRT)","IRT: manualized therapy for nightmares; did not include exposure to the nightmare
CBT-I: comprised of ""psychoeducation on chronic insomnia, sleep restriction, stimulus control, sleep hygiene, stress reduction and relaxation, decatastrophization of consequences through cognitive restructuring, and relapse prevention""","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"60 minutes","Weekly","12","5 weeks IRT and 7 weeks CBT-I","completed treatment","0.6667",,,,,,,,,,,"Mixed","0.1778","0.8222","0","0.1739",,"0.8261","Combat-related",,"High","Walters EM, Jenkins MM, Nappi CM, et al. The impact of prolonged exposure on sleep and enhancing treatment outcomes with evidence-based sleep interventions: a pilot study. Psychol Trauma. 2020 Feb;12(2):175-85. doi: 10.1037/tra0000478. PMID: 31246050.",,"2020"
"walters2020_B","Psychotherapy","PTSD","PTSD",,"23","B","11",,"Supportive care therapy","Supportive counseling","Nondirective Rogerian therapy, strictly avoided components of IRT and CBT-I. Uses empathetic listening, clarification of goals, and nondirective questioning to help participants ""better understand their emotional response to PTSD symptoms and provide supportive, unconditional positive regard to managing their own PTSD symptoms"".","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"60 minutes","Weekly","12",,"completed treatment","0.7273",,,,,,,,,,,"Mixed","0.1778","0.8222","0","0.1739",,"0.8261","Combat-related",,"High","Walters EM, Jenkins MM, Nappi CM, et al. The impact of prolonged exposure on sleep and enhancing treatment outcomes with evidence-based sleep interventions: a pilot study. Psychol Trauma. 2020 Feb;12(2):175-85. doi: 10.1037/tra0000478. PMID: 31246050.",,"2020"
"wang2012_A","Other mixed","PTSD","PTSD",,"138","A","69",,"Electroacupuncture","Acupuncture","Scalp electroacupuncture on Sishencong, Baihui, Shenting, and Fengchi points using continuous wave of 100 Hz.","No","Not Applicable","No","Not Applicable","Yes","Acupuncture","No","No","No","No","No","Individual","In Person","30 minutes",,"Every other day","12",,"completed treatment","0.942",,,,,,,,,,,"Community",,,"1","0.5814",,"0.4186","Natural or manmade disasters",,"Medium","Wang Y, Hu YP, Wang WC, et al. Clinical studies on treatment of earthquake-caused posttraumatic stress disorder using electroacupuncture. Evid Based Complement Alternat Med. 2012;2012:431279. doi: 10.1155/2012/431279. PMID: 23049609.","40245","2019"
"wang2012_B","Other mixed","PTSD","PTSD",,"138","B","69",,"Paroxetine","Paroxetine","SSRI","No","Not Applicable","Yes","Antidepressant: SSRI","No","Not Applicable","No","No","No","No","No","Individual","In Person","20 mg",,"Daily","12",,"completed treatment","0.928",,,,,,,,,,,"Community",,,"1","0.5814",,"0.4186","Natural or manmade disasters",,"Medium","Wang Y, Hu YP, Wang WC, et al. Clinical studies on treatment of earthquake-caused posttraumatic stress disorder using electroacupuncture. Evid Based Complement Alternat Med. 2012;2012:431279. doi: 10.1155/2012/431279. PMID: 23049609.","40245","2019"
"watson1997_A","Complementary and integrative health (CIH)","PTSD","PTSD",,"90","A","30",,"Relaxation Instruction","Relaxation","Participants seated in a comfortable reclining chair and instructed to relax as much as possible","No","Not Applicable","No","Not Applicable","Yes","Relaxation","No","No","No","No","No","Individual","In Person",,"30 minutes",,,"10 sessions total",,,,,,,,,,,,,"Veteran","0","1","0","0",,"1",,,"High","Watson CG, Tuorila JR, Vickers KS, et al. The efficacies of three relaxation regimens in the treatment of PTSD in Vietnam War veterans. J Clin Psychol. 1997 Dec;53(8):917-23. doi: 10.1002/(SICI)1097-4679(199712)53:8<917::AID-JCLP17>3.0.CO;2-N. PMID: 9403395.","09969","2019"
"watson1997_B","Complementary and integrative health (CIH)","PTSD","PTSD",,"90","B","30",,"Relaxation Instruction with deep breathing exercise","Relaxation with deep breathing exercise","Participants seated in a comfortable reclining chair and instructed to relax and practice deep breathing","No","Not Applicable","No","Not Applicable","Yes","Relaxation","No","No","No","No","No","Individual","In Person",,"30 minutes",,,"10 sessions total",,,,,,,,,,,,,"Veteran","0","1","0","0",,"1",,,"High","Watson CG, Tuorila JR, Vickers KS, et al. The efficacies of three relaxation regimens in the treatment of PTSD in Vietnam War veterans. J Clin Psychol. 1997 Dec;53(8):917-23. doi: 10.1002/(SICI)1097-4679(199712)53:8<917::AID-JCLP17>3.0.CO;2-N. PMID: 9403395.","09969","2019"
"watson1997_C","Complementary and integrative health (CIH)","PTSD","PTSD",,"90","C","30",,"Relaxation instruction with deep breathing and biofeedback","Relaxation with deep breathing and biofeedback","Participants seated in a comfortable reclining chair and instructed to relax and practice deep breathing. In addition, a tone indicating level of relaxation by change one tone for every tenth of a degree Fahrenheit was played","No","Not Applicable","No","Not Applicable","Yes","Relaxation","No","No","No","No","No","Individual","In Person",,"30 minutes",,,"10 sessions total",,,,,,,,,,,,,"Veteran","0","1","0","0",,"1",,,"High","Watson CG, Tuorila JR, Vickers KS, et al. The efficacies of three relaxation regimens in the treatment of PTSD in Vietnam War veterans. J Clin Psychol. 1997 Dec;53(8):917-23. doi: 10.1002/(SICI)1097-4679(199712)53:8<917::AID-JCLP17>3.0.CO;2-N. PMID: 9403395.","09969","2019"
"watts2012_A","Nonpharmacologic biological","PTSD","PTSD",,"20","A","10",,"rTMS","Transcranial magnetic stimualtion (TMS)","Neuronetic 2100 (Neuronetics, LLC, Marietta, GA) used. Before the first session, the right motor threshold was determined by increasing the intensity of stimulation by 2.5% increments over the right motor cortex until there is any movement of the digits of the left hand. For subsequent treatments the coil was placed 4 cm anterior parasagittally and 2 cm laterally of the motor strip location that caused hand movement. This placement approximated the location of the right dorsolateral prefrontal cortex. Active rTMS was delivered to the right dorsolateral prefrontal cortex at 90% of motor threshold","No","Not Applicable","No","Not Applicable","No","Not Applicable","Yes","No","No","No","No","Individual","In Person","Cycles were 1 Hz for a total of 20 minutes per day. Each 1 minute cycle consisted of a 20-second stimulation train with a 40-second intertrain interval.","Cycles were 1 Hz for a total of 20 minutes per day. Each 1 minute cycle consisted of a 20-second stimulation train with a 40-second intertrain interval.","Daily","1.43",,,,,,,,,,,,,,"Veteran",,"1",,"0.1",,"0.9","Mixed","combat-related, rape/sexual assault, community/school violence, other (multiple trauma)","Medium","Watts BV, Landon B, Groft A, et al. A sham controlled study of repetitive transcranial magnetic stimulation for posttraumatic stress disorder. Brain Stimul. 2012 Jan;5(1):38-43. doi: 10.1016/j.brs.2011.02.002. PMID: 22264669.","38446","2019"
"watts2012_B","Nonpharmacologic biological","PTSD","Control",,"20","B","10",,"Sham rTMS","Sham","Motor threshold determined by increasing the intensity of stimulation by 2.5% increments over the right motor cortex until left-hand digit movement. Subsequent treatments given using a sham magnetic coil that looks and sounds identical to the active coil, but prevents magnetic energy from leaving the device.","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person","Cycles were 1 Hz for a total of 20 minutes per day. Each 1 minute cycle consisted of a 20-second stimulation train with a 40-second intertrain interval.","Cycles were 1 Hz for a total of 20 minutes per day. Each 1 minute cycle consisted of a 20-second stimulation train with a 40-second intertrain interval.","Daily","1.43",,,,,,,,,,,,,,"Veteran",,"1",,"0.1",,"0.9","Mixed","combat-related, rape/sexual assault, community/school violence, other (multiple trauma)","Medium","Watts BV, Landon B, Groft A, et al. A sham controlled study of repetitive transcranial magnetic stimulation for posttraumatic stress disorder. Brain Stimul. 2012 Jan;5(1):38-43. doi: 10.1016/j.brs.2011.02.002. PMID: 22264669.","38446","2019"
"wells2012_A","Psychotherapy","PTSD","PTSD",,"20","A","10",,"Metacognitive therapy","Metacognitive Therapy","Manualized Intervention (Wells, 2009; Wells & Sembi, 2004) intends to modify metacognitive beliefs about rumination, worry, attention, and symptoms, and generate generic plans for coping with threat","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,,,,"8 sessions total",,,,,,,"6.4",,,,,,"Community",,,"1","0.55",,"0.45","Mixed","rape/sexual assault, community/school violence, accidents","Medium","Wells A, Colbear JS. Treating posttraumatic stress disorder with metacognitive therapy: a preliminary controlled trial. J Clin Psychol. 2012 Apr;68(4):373-81. doi: 10.1002/jclp.20871. PMID: 24469928.","38376","2019"
"wells2012_B","Psychotherapy","PTSD","Control",,"20","B","10",,"Waitlist","Waitlist",,"No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,,,,,,,,,,,,,,,,,,"Community",,,"1","0.55",,"0.45","Mixed","rape/sexual assault, community/school violence, accidents","Medium","Wells A, Colbear JS. Treating posttraumatic stress disorder with metacognitive therapy: a preliminary controlled trial. J Clin Psychol. 2012 Apr;68(4):373-81. doi: 10.1002/jclp.20871. PMID: 24469928.","38376","2019"
"wells2015_A","Psychotherapy","PTSD","PTSD",,"32","A","11",,"Metacognitive therapy","Metacognitive Therapy","Manualized intervention according to Wells & Sembi 2004 that teaches participant to postpone worry, rumination, and going over memories in response to trigger thoughts. Intervention also includes attention modification to shift individual out of threat-modes of processing","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"60 minutes","Weekly","8",,,,,,,,,,,,,,"Community",,,"1","0.375",,"0.625","Mixed","combat-related, rape/sexual assault, accidents, community/school violence, other (fire)","Medium","Wells A, Walton D, Lovell K, et al. Metacognitive therapy versus prolonged exposure in adults with chronic post-traumatic stress disorder. Cognit Ther Res. 2015 February;39(1):70-80. doi: 10.1007/s10608-014-9636-6.","50330","2019"
"wells2015_B","Psychotherapy","PTSD","PTSD",,"32","B","11",,"PE","Prolonged Exposure (PE)","Trauma-focused CBT according to manual by Marks et al. (1998)","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"60 minutes","Weekly","8",,,,,,,,,,,,,,"Community",,,"1","0.375",,"0.625","Mixed","combat-related, rape/sexual assault, accidents, community/school violence, other (fire)","Medium","Wells A, Walton D, Lovell K, et al. Metacognitive therapy versus prolonged exposure in adults with chronic post-traumatic stress disorder. Cognit Ther Res. 2015 February;39(1):70-80. doi: 10.1007/s10608-014-9636-6.","50330","2019"
"wells2015_C","Psychotherapy","PTSD","Control",,"32","C","10",,"Waitlist","Waitlist",,"No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,,,,"8",,,,,,,,,,,,,,"Community",,,"1","0.375",,"0.625","Mixed","combat-related, rape/sexual assault, accidents, community/school violence, other (fire)","Medium","Wells A, Walton D, Lovell K, et al. Metacognitive therapy versus prolonged exposure in adults with chronic post-traumatic stress disorder. Cognit Ther Res. 2015 February;39(1):70-80. doi: 10.1007/s10608-014-9636-6.","50330","2019"
"whitworth2019b_B","Complementary and integrative health (CIH)","PTSD","Control",,"22","B","11",,"Attention control","Attention control","Individual sessions in which ""participants learned about various topics unrelated to exercise, trauma, or PTSD (e.g., nutrition, human anatomy, the universe) through videos and handouts.""","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person",,"30 minutes","3 times per week","3",,,,,,,,"8.3","2.1",,,,,"Community","0",,"1","0.818",,"0.182","Mixed","combat-related, rape/sexual assault, accidents, illness/medical procedure, community/school violence, natural or manmade disasters, other (unspecified type of child abuse, unspecified ""other"")","Medium","Whitworth JW, Nosrat S, SantaBarbara NJ, et al. High intensity resistance training improves sleep quality and anxiety in individuals who screen positive for posttraumatic stress disorder: a randomized controlled feasibility trial. Ment Health Phys Act. 2019b;16:43-9. doi: 10.1016/j.mhpa.2019.04.001.","52118","2020"
"whitworth2019b_A","Complementary and integrative health (CIH)","PTSD","PTSD",,"22","A","11",,"Resistance training","Exercise","Individual resistance training; each session comprised of: ""5-min warm up on a stationary bicycle, five resistance training exercises (i.e., squat, bench press, pulldown, overhead press, and biceps curl) done over the course of 20 min, and a 5-min cool down on a stationary bicycle.""","No","Not Applicable","No","Not Applicable","Yes","Other physical activity and recreational therapies","No","No","No","No","No","Individual","In Person",,"30 minutes","3 times per week","3",,,,,,,,"8.4","2.1",,,,,"Community","0",,"1","0.818",,"0.182","Mixed","combat-related, rape/sexual assault, accidents, illness/medical procedure, community/school violence, natural or manmade disasters, other (unspecified type of child abuse, unspecified ""other"")","Medium","Whitworth JW, Nosrat S, SantaBarbara NJ, et al. High intensity resistance training improves sleep quality and anxiety in individuals who screen positive for posttraumatic stress disorder: a randomized controlled feasibility trial. Ment Health Phys Act. 2019b;16:43-9. doi: 10.1016/j.mhpa.2019.04.001.","52118","2020"
"whitworth2019c_A","Complementary and integrative health (CIH)","PTSD","PTSD",,"30","A","15",,"High-intensity resistance exercise","Exercise","One-on-one sessions of resistance exercise; each 30-minute session included 5 minutes warm up on stationary bicycle, 5 resistance exercises over 20 minutes, and 5 minutes cool down on stationary bicycle, led by certified personal trainer.","No","Not Applicable","No","Not Applicable","Yes","Other physical activity and recreational therapies","No","No","No","No","No","Individual","In Person",,"30 minutes","3 times per week","3",,,,,,,,"7.20","2.31",,,,,"Community","0","0","1","0.733",,"0.267","Mixed","rape/sexual assault, community/school violence, other (""sudden or unexpected loss of a child or spouse"")","Medium","Whitworth JW, Nosrat S, SantaBarbara NJ, et al. Feasibility of Resistance Exercise for Posttraumatic Stress and Anxiety Symptoms: A Randomized Controlled Pilot Study. Journal of Traumatic Stress. 2019 Dec;32(6):977-84. doi: https://dx.doi.org/10.1002/jts.22464. PMID: 31743507.","1548217","2020"
"whitworth2019c_B","Complementary and integrative health (CIH)","PTSD","Control",,"30","B","15",,"Time-matched control","Psychoeducation","One-on-one sessions by same interventionist and same site as for the exercise intervention (Intervention A); sessions included videos on educational topics, excluding exercise and mental health.","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person",,"30 minutes","3 times per week","3",,,,,,,,"6.60","2.44",,,,,"Community","0","0","1","0.733",,"0.267","Mixed","rape/sexual assault, community/school violence, other (""sudden or unexpected loss of a child or spouse"")","Medium","Whitworth JW, Nosrat S, SantaBarbara NJ, et al. Feasibility of Resistance Exercise for Posttraumatic Stress and Anxiety Symptoms: A Randomized Controlled Pilot Study. Journal of Traumatic Stress. 2019 Dec;32(6):977-84. doi: https://dx.doi.org/10.1002/jts.22464. PMID: 31743507.","1548217","2020"
"yeh2011_A","Pharmacotherapy","PTSD","PTSD",,"35","A","17",,"Topiramate","Topiramate","Initiated at 25 mg/day, increased weekly by 25 mg/day up to 200 mg/day","No","Not Applicable","Yes","Mood Stabilizer","No","Not Applicable","No","No","No","No","No","Individual","In Person","25 to 200 mg",,"Once daily","12",,,,,"compliance monitored by pill count",,,,,,"102.94 mg/day",,,"Community",,,"1","0.6774",,"0.3226",,,"Medium","Yeh MS, Mari JJ, Costa MC, et al. A double-blind randomized controlled trial to study the efficacy of topiramate in a civilian sample of PTSD. CNS Neurosci Ther. 2011 Oct;17(5):305-10. doi: 10.1111/j.1755-5949.2010.00188.x. PMID: 21554564.","35220","2019"
"yeh2011_B","Pharmacotherapy","PTSD","Control",,"35","B","18",,"Placebo","Placebo","Placebo","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person",,,"Once daily","12",,,,,,,,,,,,,,"Community",,,"1","0.6774",,"0.3226",,,"Medium","Yeh MS, Mari JJ, Costa MC, et al. A double-blind randomized controlled trial to study the efficacy of topiramate in a civilian sample of PTSD. CNS Neurosci Ther. 2011 Oct;17(5):305-10. doi: 10.1111/j.1755-5949.2010.00188.x. PMID: 21554564.","35220","2019"
"yehuda2014_A","Psychotherapy","PTSD","PTSD",,"52","A","37",,"PE","Prolonged Exposure (PE)","Administered according to manualized protocol (Foa et al, 2007); includes education about reactions to trauma, breathing retraining, exposure to trauma memories and situation the patient avoids, and discussion of thoughts and feelings related to exposure exercises.","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"90 minutes","Weekly","12",,"completed, did not choose to discontinue treatment","0.6757",,,,,,,,,,,"Veteran","0","1","0","0.1081",,"0.8919","Combat-related",,"High","Yehuda R, Pratchett LC, Elmes MW, et al. Glucocorticoid-related predictors and correlates of post-traumatic stress disorder treatment response in combat veterans. Interface Focus. 2014 Oct 6;4(5):20140048. doi: 10.1098/rsfs.2014.0048. PMID: 25285201.","42868","2019"
"yehuda2014_B","Psychotherapy","PTSD","Control",,"52","B","15",,"Minimal attention","Minimal attention","Delivered according to manualized protocol developed by Foa et al. 2007; phone calls by study therapist to the patient to monitor symptoms","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","Phone",,"30 minutes","Weekly","12",,"completed, did not discontinue treatment","0.80",,,,,,,,,,,"Veteran","0","1","0","0.1081",,"0.8919","Combat-related",,"High","Yehuda R, Pratchett LC, Elmes MW, et al. Glucocorticoid-related predictors and correlates of post-traumatic stress disorder treatment response in combat veterans. Interface Focus. 2014 Oct 6;4(5):20140048. doi: 10.1098/rsfs.2014.0048. PMID: 25285201.","42868","2019"
"yehuda2015_A","Mixed: Psychotherapy & pharmacotherapy","PTSD","PTSD",,"24","A","12",,"Hydrocortisone + PE","Hydrocortisone prior to Prolonged Exposure (PE)","Synthetic glucocorticoid with anti-inflammatory effects administered 20 minutes prior to PE sessions 3 to 10 + manualized PE consisting of guided imaginal exposure.","Yes","TF","Yes","Steroids","No","Not Applicable","No","No","No","No","No","Individual","In Person","Session length: NR

Dose: 30 mg",,,"NR (10 sessions total)",,,,,,,,"9.42","2.02",,,,,"Veteran","0","1","0",,,,"Mixed","combat-related, accidents, other (interpersonal violence)","Low","Yehuda R, Bierer LM, Pratchett LC, et al. Cortisol augmentation of a psychological treatment for warfighters with posttraumatic stress disorder: Randomized trial showing improved treatment retention and outcome. Psychoneuroendocrinology. 2015 Jan;51:589-97. doi: 10.1016/j.psyneuen.2014.08.004. PMID: 25212409.","42838","2019"
"yehuda2015_B","Mixed: Psychotherapy & pharmacotherapy","PTSD","PTSD",,"24","B","12",,"PE + placebo","Prolonged Exposure (PE) + placebo","Placebo plus manualized PE consisting of guided imaginal exposure.","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","Session length: NR

Dose: NA",,,"NR (10 sessions total)",,,,,,,,"6.00","3.74",,,,,"Veteran","0","1","0",,,,"Mixed","combat-related, accidents, other (interpersonal violence)","Low","Yehuda R, Bierer LM, Pratchett LC, et al. Cortisol augmentation of a psychological treatment for warfighters with posttraumatic stress disorder: Randomized trial showing improved treatment retention and outcome. Psychoneuroendocrinology. 2015 Jan;51:589-97. doi: 10.1016/j.psyneuen.2014.08.004. PMID: 25212409.","42838","2019"
"yuen2015_A","Psychotherapy","PTSD","PTSD",,"74","A","36",,"PE via telehealth","Prolonged Exposure (PE)","Home-based telehealth PE by videoconferencing; main components of PE included psychoeducation, situational (in vivo) exposure, and imaginal exposure followed by processing of imaginal recounting experience. Number of sessions (8 to 12) determined on a case-by-case basis, mutually agreed upon by participant and therapist.","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","Video",,"90 minutes",,,"8 to 12 sessions total","variable number of sessions agreed upon with therapist","0.6389",,,,,,,,,,,"Veteran","0","1","0","0.019",,"0.981","Combat-related",,"Medium","Yuen EK, Gros DF, Price M, et al. Randomized controlled trial of home-based telehealth versus in-person prolonged exposure for combat-related PTSD in veterans: preliminary results. J Clin Psychol. 2015 Jun;71(6):500-12. doi: 10.1002/jclp.22168. PMID: 25809565.","44639","2019"
"yuen2015_B","Psychotherapy","PTSD","PTSD",,"74","B","38",,"PE in-person","Prolonged Exposure (PE)","In-person PE; main components of PE included psychoeducation, situational (in vivo) exposure, and imaginal exposure followed by processing of imaginal recounting experience. Number of sessions (8 to 12) determined on a case-by-case basis, mutually agreed upon by participant and therapist.","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person",,"90 minutes",,,"8 to 12 total sessions","completed treatment course","0.7632",,,,,,,,,,,"Veteran","0","1","0","0.019",,"0.981","Combat-related",,"Medium","Yuen EK, Gros DF, Price M, et al. Randomized controlled trial of home-based telehealth versus in-person prolonged exposure for combat-related PTSD in veterans: preliminary results. J Clin Psychol. 2015 Jun;71(6):500-12. doi: 10.1002/jclp.22168. PMID: 25809565.","44639","2019"
"yurtsever2018_A","Psychotherapy","PTSD","PTSD",,"63","A","28",,"EMDR Group Traumatic Episode Protocol","Eye Movement Desensitization and Reprocessing (EMDR)","Manualized intervention (Shapiro 2013) based on Recent Traumatic Episode Protocol (Shapiro and Laub, 2008) that includes procedures and measures for containment and safety","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Group","In Person",,"4 hours","Daily","0.29",,,,,,,,,,,,,,"Community",,,"1","0.766",,"0.234","Terrorism/political violence/forced displacement",,"Medium","Yurtsever A, Konuk E, Akyüz T, et al. An Eye Movement Desensitization and Reprocessing (EMDR) group intervention for Syrian refugees with post-traumatic stress symptoms: results of a randomized controlled trial. Front Psychol. 2018 Jun 12;9:493. doi: 10.3389/fpsyg.2018.00493. PMID: 29946275.","51112","2019"
"yurtsever2018_B","Psychotherapy","PTSD","Control",,"63","B","29",,"Waitlist","Waitlist",,"No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,,,,"1",,,,,,,,,,,,,,"Community",,,"1","0.766",,"0.234","Terrorism/political violence/forced displacement",,"Medium","Yurtsever A, Konuk E, Akyüz T, et al. An Eye Movement Desensitization and Reprocessing (EMDR) group intervention for Syrian refugees with post-traumatic stress symptoms: results of a randomized controlled trial. Front Psychol. 2018 Jun 12;9:493. doi: 10.3389/fpsyg.2018.00493. PMID: 29946275.","51112","2019"
"zalta2019_A","Nonpharmacologic biological","PTSD","PTSD",,"15","A","9",,"Re-timer","Re-timer","Device emitting LED green light (~500 nm, 500 lux)","No","Not Applicable","No","Not Applicable","No","Not Applicable","Yes","No","No","No","No","Individual","In Person",,"1 hour","Daily","4",,,,,"days initiated treatment",,"19.67 (5.81) days",,,,"32.45 minutes per day","5.30 minutes per day",,"Community","0","0","1","0.5333",,"0.4667","Mixed","combat-related, rape/sexual assault, accidents, community/school violence","Medium","Zalta AK, Bravo K, Valdespino‐Hayden Z, et al. A placebo‐controlled pilot study of a wearable morning bright light treatment for probable PTSD. Depress Anxiety. 2019 Jul;36(7):617-24. doi: 10.1002/da.22897. PMID: 30995350.","52251","2020"
"zalta2019_B","Nonpharmacologic biological","PTSD","Control",,"15","B","6",,"Placebo Re-timer","Sham","Same device with additional filter that reduces light intensity to a level that will not shift circadian timing (7 lux)","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person",,"1 hour","Daily","4",,,,,"days initiated treatment",,"24.17 (6.01) days",,,,"39.22 minutes per day","5.81 minutes per day",,"Community","0","0","1","0.5333",,"0.4667","Mixed","combat-related, rape/sexual assault, accidents, community/school violence","Medium","Zalta AK, Bravo K, Valdespino‐Hayden Z, et al. A placebo‐controlled pilot study of a wearable morning bright light treatment for probable PTSD. Depress Anxiety. 2019 Jul;36(7):617-24. doi: 10.1002/da.22897. PMID: 30995350.","52251","2020"
"zang2013_A","Psychotherapy","PTSD","PTSD",,"22","A","11",,"NET","Narrative Exposure Therapy (NET)","Treatment following Schauer et al. 2005 manual, includes patient constructing a detailed chronological report of his/her own biography with a special focus on traumatic experiences and encouraged to relive emotions.","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"90 minutes","Spaced 2-4 days apart","2","4 sessions",,,,,,,,,,,,,"Community","0","0","1","0.7727",,"0.2273","Natural or manmade disasters",,"Low","Zang Y, Hunt NC, Cox T. A randomised controlled pilot study: the effectiveness of narrative exposure therapy with adult survivors of the Sichuan earthquake. BMC Psychiatry. 2013 Jan 31;13:41. doi: 10.1186/1471-244X-13-41. PMID: 23363689.","46041","2020"
"zang2013_B","Psychotherapy","PTSD","Control",,"22","B","11",,"Waitlist","Waitlist",,"No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,,,,"2",,,,,,,,,,,,,,"Community","0","0","1","0.7727",,"0.2273","Natural or manmade disasters",,"Low","Zang Y, Hunt NC, Cox T. A randomised controlled pilot study: the effectiveness of narrative exposure therapy with adult survivors of the Sichuan earthquake. BMC Psychiatry. 2013 Jan 31;13:41. doi: 10.1186/1471-244X-13-41. PMID: 23363689.","46041","2020"
"zang2014_A","Psychotherapy","PTSD","PTSD",,"30","A","10",,"NET","Narrative Exposure Therapy (NET)","Standard Narrative Exposure Therapy; patients constructed detailed autobiography with special focus on traumatic experiences; encouraged to relive emotions while reporting events; received written report of narrative","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"60 to 90 minutes","About twice weekly","2","flexible number of total sessions","completed entire course of treatment and followup","1",,,,,"4",,,,,,"Community",,,"1","0.9",,"0.1","Natural or manmade disasters",,"Medium","Zang Y, Hunt NC, Cox T. Adapting narrative exposure therapy for Chinese earthquake survivors: a pilot randomised controlled feasibility study. BMC Psychiatry. 2014 Oct 3;14:262. doi: 10.1186/s12888-014-0262-3. PMID: 25927297.","46042","2019"
"zang2014_B","Psychotherapy","PTSD","PTSD",,"30","B","10",,"NET-Revised","Narrative Exposure Therapy (NET)","Revised Narrative Exposure Therapy adapted to a single traumatic event; patient first constructed detailed earthquake narrative, then completed chronologic autobiography; encouraged to relive emotions while reporting events; final reading of autobiography without written report","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,"60 to 120 minutes","Every 1 to 2 days","1","flexible total number of sessions","completed entire course of treatment and followup","1",,,,,,,,,,,"Community",,,"1","0.9",,"0.1","Natural or manmade disasters",,"Medium","Zang Y, Hunt NC, Cox T. Adapting narrative exposure therapy for Chinese earthquake survivors: a pilot randomised controlled feasibility study. BMC Psychiatry. 2014 Oct 3;14:262. doi: 10.1186/s12888-014-0262-3. PMID: 25927297.","46042","2019"
"zang2014_C","Psychotherapy","PTSD","Control",,"30","C","10",,"Waitlist","Waitlist","Received NET-Revised after 3-week waiting period; assessed at 2 weeks after trial entry, comparable to post-treatment assessment for immediate treatment groups (T2)","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,,,,"2",,,,,,,,,,,,,,"Community",,,"1","0.9",,"0.1","Natural or manmade disasters",,"Medium","Zang Y, Hunt NC, Cox T. Adapting narrative exposure therapy for Chinese earthquake survivors: a pilot randomised controlled feasibility study. BMC Psychiatry. 2014 Oct 3;14:262. doi: 10.1186/s12888-014-0262-3. PMID: 25927297.","46042","2019"
"ziemba2014_A","Psychotherapy","PTSD","PTSD",,"18","A",,,"Telemedicine-administered CBT","Cognitive behavioral therapy (CBT) without a trauma focus",,"Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","Video",,,"Weekly","10",,,,,,,,,,,,,,"Mixed",,,"0","0.9",,"0.1",,,"Medium","Ziemba SJ, Bradley NS, Landry L-AP, et al. Posttraumatic stress disorder treatment for Operation Enduring Freedom/Operation Iraqi Freedom combat veterans through a civilian community-based telemedicine network. Telemed J E Health. 2014 May;20(5):446-50. doi: 10.1089/tmj.2013.0312. PMID: 24617961.","46063","2019"
"ziemba2014_B","Psychotherapy","PTSD","PTSD",,"18","B",,,"Face-to-face-administered CBT","Cognitive behavioral therapy (CBT) without a trauma focus",,"Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Individual","In Person",,,"Weekly","10",,,,,,,,,,,,,,"Mixed",,,"0","0.9",,"0.1",,,"Medium","Ziemba SJ, Bradley NS, Landry L-AP, et al. Posttraumatic stress disorder treatment for Operation Enduring Freedom/Operation Iraqi Freedom combat veterans through a civilian community-based telemedicine network. Telemed J E Health. 2014 May;20(5):446-50. doi: 10.1089/tmj.2013.0312. PMID: 24617961.","46063","2019"
"zlotnick2009_A","Psychotherapy","PTSD+SUD","PTSD+SUD","Integrated","49","A","27",,"Seeking Safety + TAU","Seeking Safety","Seeking safety: group modality (3 to 5 women per group) while in prison, with optional individual ""booster"" sessions upon release from prison; ""primary goals of SS are psychoeducation and the development of coping skills to help clients attain safety from both PTSD and SUD; it is present-focused, abstinence-oriented, and emphasizes an empowering, compassionate approach.""
TAU: abstinence-oriented residential substance use treatment program following 12-step model in ""psychoeducation large-group format, with weekly individual case management and drug counseling""; participants required to attend all components of TAU treatment to remain in program.","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Mixed","In Person",,"Seeking Safety group sessions: 90 minutes; Seeking Safety individual sessions: 60 minutes; TAU: NR (total 30 hours per week)","Seeking Safety group sessions: three times a week; Seeking Safety individual sessions: weekly; TAU: NR (total 30 hours per week)",,"Seeking Safety group sessions: 6 to 8 plus; Seeking Safety individual sessions: 12 weekly sessions offered for all participants in the SS group after group sessions ended; TAU: 12",,,,,,,,,"Seeking Safety group sessions: 15.6 (6.2); Seeking Safety individual sessions: 3.3 (3.8)",,,,"Community","0",,"1","1",,"0","Mixed","rape/sexual assault, community/school violence","High","Zlotnick C, Johnson JE, Najavits LM. Randomized controlled pilot study of cognitive-behavioral therapy in a sample of incarcerated women with substance use disorder and PTSD. Behav Ther. 2009 Dec;40(4):325-36. doi: 10.1016/j.beth.2008.09.004. PMID: 19892078.","32555","2020"
"zlotnick2009_B","Psychotherapy","PTSD+SUD","SUD","Not integrated","49","B","22",,"TAU for substance use","Treatment as usual (TAU) for substance use","Abstinence-oriented residential substance use treatment program following 12-step model in ""psychoeducation large-group format, with weekly individual case management and drug counseling""; participants required to attend all components of TAU treatment to remain in program.","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Mixed","In Person",,"NR (total 30 hours per week)","NR (total 30 hours per week)","12",,,,,,,,,,,,,,"Community","0",,"1","1",,"0","Mixed","rape/sexual assault, community/school violence","High","Zlotnick C, Johnson JE, Najavits LM. Randomized controlled pilot study of cognitive-behavioral therapy in a sample of incarcerated women with substance use disorder and PTSD. Behav Ther. 2009 Dec;40(4):325-36. doi: 10.1016/j.beth.2008.09.004. PMID: 19892078.","32555","2020"
"zlotnick1997_A","Psychotherapy","PTSD","PTSD",,"46","A","23",,"Group affect management therapy","Affect management therapy","Intervention based on Linehan's Dialectical Behavior Therapy (Linehan, 1993) and Matsakis's Treatment Guide for Post-Traumatic Stress Disorder (Matsakis, 1994). Intervention includes psychoeducation, skill building, and application skills. Materials covered include dissociation, flashbacks, ""safe"" sleep, identification of emotions, crisis planning, anger management, techniques for distraction, self-soothing, distress tolerance, and relaxation. Participants also received individual psychotherapy with medication management.","Yes","Non-TF","No","Not Applicable","No","Not Applicable","No","No","No","No","No","Group","In Person",,"2 hours","Weekly","15",,,,,,,,,,,,,,"Community",,,"1","1",,"0","Child sexual abuse",,"High","Zlotnick C, Shea MT, Rosen KH, et al. An affect-management group for women with posttraumatic stress disorder and histories of childhood sexual abuse. J Trauma Stress. 1997 Jul;10(3):425-36. doi: 10.1023/A:1024841321156. PMID: 9246650.","13731","2019"
"zlotnick1997_B","Psychotherapy","PTSD","Control",,"46","B","23",,"Waitlist","Waitlist","Participants continued to receive individual psychotherapy with medication management","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No",,,,,,"15",,,,,,,,,,,,,,"Community",,,"1","1",,"0","Child sexual abuse",,"High","Zlotnick C, Shea MT, Rosen KH, et al. An affect-management group for women with posttraumatic stress disorder and histories of childhood sexual abuse. J Trauma Stress. 1997 Jul;10(3):425-36. doi: 10.1023/A:1024841321156. PMID: 9246650.","13731","2019"
"zoellner2017_A","Mixed: Psychotherapy & pharmacotherapy","PTSD","PTSD",,"42","A","15",,"Methylene blue + imaginal exposure","Imaginal exposure (experimental paradigm) followed by methylene blue","Methylene blue (methylthioninium chloride) stimulates mitochondrial metabolism and cerebral oxygen consumption, and may enhance post extinction memory consolidation; given after sessions two through six of six 50-minute daily imaginal exposure sessions based on the PE manual","Yes","TF","Yes","Other pharmacotherapy","No","Not Applicable","No","No","No","No","No","Individual","In Person","Session length: 50 minutes

Dose: 260 mg",,"Daily","0.86",,,,,,,,,,,,,,"Community",,,"1","0.7143",,"0.2857","Mixed","combat-related, child physical abuse, child sexual abuse, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (not specified)","Medium","Zoellner LA, Telch M, Foa EB, et al. Enhancing extinction learning in posttraumatic stress disorder with brief daily imaginal exposure and methylene blue: a randomized controlled trial. J Clin Psychiatry. 2017;78(7):e782-e9. doi: 10.4088/JCP.16m10936. PMID: 28686823.","48582","2019"
"zoellner2017_B","Mixed: Psychotherapy & pharmacotherapy","PTSD","PTSD",,"42","B","16",,"Placebo + imaginal exposure","Imaginal exposure + placebo","Placebo containing inert dye to allow blinding (methylene blue turns urine light green or blue); given after sessions two through six of six 50-minute daily imaginal exposure sessions based on the PE manual","Yes","TF","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person","Session length: 50 minutes

Dose: NA",,"Daily","0.86",,,,,,,,,,,,,,"Community",,,"1","0.7143",,"0.2857","Mixed","combat-related, child physical abuse, child sexual abuse, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (not specified)","Medium","Zoellner LA, Telch M, Foa EB, et al. Enhancing extinction learning in posttraumatic stress disorder with brief daily imaginal exposure and methylene blue: a randomized controlled trial. J Clin Psychiatry. 2017;78(7):e782-e9. doi: 10.4088/JCP.16m10936. PMID: 28686823.","48582","2019"
"zoellner2017_C","Mixed: Psychotherapy & pharmacotherapy","PTSD","Control",,"42","C","11",,"Waitlist","Waitlist","No intervention through 1 month follow-up","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person",,,,"NR (through 1 month post-treatment follow-up)",,,,,,,,,,,,,,"Community",,,"1","0.7143",,"0.2857","Mixed","combat-related, child physical abuse, child sexual abuse, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (not specified)","Medium","Zoellner LA, Telch M, Foa EB, et al. Enhancing extinction learning in posttraumatic stress disorder with brief daily imaginal exposure and methylene blue: a randomized controlled trial. J Clin Psychiatry. 2017;78(7):e782-e9. doi: 10.4088/JCP.16m10936. PMID: 28686823.","48582","2019"
"zohar2002_A","Pharmacotherapy","PTSD","PTSD",,"42","A","23",,"Sertraline","Sertraline","SSRI; dose adjustment in 50-mg increments allowed every 2 weeks based on response; randomized treatment followed 1-week placebo run-in with responders excluded (≥20% CAPS-2 decrease)","No","Not Applicable","Yes","Antidepressant: SSRI","No","Not Applicable","No","No","No","No","No","Individual","In Person","Initiated at 50 mg, titrated to maximum 200 mg",,"Daily","10",,,,,"monitored with pill counts",,,,,,"120 mg/day","60",,"Veteran","0","1","0","0.88",,"0.12","Mixed","combat-related, accidents, other (captivity)","Medium","Zohar J, Amital D, Miodownik C, et al. Double-blind placebo-controlled pilot study of sertraline in military veterans with posttraumatic stress disorder. J Clin Psychopharmacol. 2002;22(2):190-5. doi: 10.1097/00004714-200204000-00013. PMID: 11910265.","24564","2019"
"zohar2002_B","Pharmacotherapy","PTSD","Control",,"42","B","19",,"Placebo","Placebo","Placebo not further described; randomized treatment followed 1-week placebo run-in with responders excluded (≥20% CAPS-2 decrease)","No","Not Applicable","No","Not Applicable","No","Not Applicable","No","No","Yes","No","No","Individual","In Person",,,"Daily","10",,,,,"monitored with pill counts",,,,,,"147 mg/day equivalent","56",,"Veteran","0","1","0","0.88",,"0.12","Mixed","combat-related, accidents, other (captivity)","Medium","Zohar J, Amital D, Miodownik C, et al. Double-blind placebo-controlled pilot study of sertraline in military veterans with posttraumatic stress disorder. J Clin Psychopharmacol. 2002;22(2):190-5. doi: 10.1097/00004714-200204000-00013. PMID: 11910265.","24564","2019"
"zucker2009_A","Complementary and integrative health (CIH)","PTSD","PTSD",,"45","A",,"NR (19 completers)","Respiratory sinus arrhythmia biofeedback","Biofeedback","Biofeedback training using portable StressEraser device (Helicor, New York) which non-invasively measures respiratory sinus arrhythmia of heart rate oscillations; optimal heart rate rhythm achieved at about 6 breaths-per-minute.","No","Not Applicable","No","Not Applicable","Yes","Relaxation","No","No","No","No","No","Individual","In Person",,"20 minutes","Daily","4",,,,,,,,,,,,,,"Community",,,"1","0.447",,"0.553",,,"High","Zucker TL, Samuelson KW, Muench F, et al. The effects of respiratory sinus arrhythmia biofeedback on heart rate variability and posttraumatic stress disorder symptoms: a pilot study. Appl Psychophysiol Biofeedback. 2009;34(2):135-43. doi: 10.1007/s10484-009-9085-2. PMID: 19396540.","33842","2019"
"zucker2009_B","Complementary and integrative health (CIH)","PTSD","PTSD",,"45","B",,"NR (19 completers)","Progressive muscle relaxation","Progressive muscle relaxation (PMR)","Recorded progressive muscle relaxation exercise instruction derived from Putting Your Worries on a Shelf (Linehan, 2005).","No","Not Applicable","No","Not Applicable","Yes","Relaxation","No","No","No","No","No","Individual","In Person",,"20 minutes","Daily","4",,,,,,,,,,,,,,"Community",,,"1","0.447",,"0.553",,,"High","Zucker TL, Samuelson KW, Muench F, et al. The effects of respiratory sinus arrhythmia biofeedback on heart rate variability and posttraumatic stress disorder symptoms: a pilot study. Appl Psychophysiol Biofeedback. 2009;34(2):135-43. doi: 10.1007/s10484-009-9085-2. PMID: 19396540.","33842","2019"
